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The Monitoring the Future study consists of two major components: the ongoing surveys of 
American secondary school students conducted in schools and the ongoing panel studies of high 
school graduates from the last 29 graduating classes conducted by mail. This volume—the second in 
a two-volume set from the Monitoring the Future study—provides findings on the substance use and 
related behaviors from the panel respondents. It also contains findings on follow-up respondents’ 
attitudes and beliefs about drugs, as well as on several particularly salient dimensions of their social 
environments. Volume I presents similar findings for secondary students in grades 8, 10, and 12. 
Several segments of the adult population are covered in this volume. One important segment covered 
here is American college students; a second is their age peers who are not attending college, 
sometimes called the “forgotten half.” Also covered in this volume are young adult high school 
graduates up through age 30, as well as high school graduates at the specific ages of 35, 40, and 45. 
Monitoring the Future is a long-term research program conducted at the University of Michigan’s 
Institute for Social Research under a series of investigator-initiated research grants from the National 
Institute on Drug Abuse. Now in its 31st year, it comprises, in part, ongoing series of annual 
nationally representative surveys of 12th-grade students (begun in 1975) and of 8th- and 10th-grade 
students (begun in 1991).  
Over the years, follow-up surveys have been conducted by mail of representative samples of the 
previous participants from each high school senior class. The present volume presents data from the 
1977 through 2005 follow-up surveys of the graduating high school classes of 1976 through 2004 as 
these respondents have progressed into adulthood—now through age 45 for the oldest respondents, 
and soon to be through age 50.   
To permit this volume to stand alone, we have repeated some material from Volume I. Specifically, 
chapter 2 in the present volume is the same as chapter 2 in Volume I; it provides an integrated 
overview of the key findings presented in both volumes. Chapter 3, “Study Design and Procedures,” 
is also the same as chapter 3, Volume I. The reader already familiar with Volume I may wish to skip 
over these chapters. Other than these two chapters, the content of the two volumes does not overlap. 
 
SURVEYS OF COLLEGE STUDENTS 
 
The follow-up samples in Monitoring the Future have provided very good coverage of the national 
college student population for a quarter of a century—since 1980. College students tend to be a 
difficult population to study. They generally are not well covered in normal household surveys, 
which typically exclude dormitories, fraternities, and sororities. Further, institution-based samples of 
college students must be quite large in order to attain accurate national representation because of the 
great heterogeneity in the types of student populations served in those institutions. Obtaining good 
samples and high response rates within many institutions may also pose difficulties. The current 
1




study, which in essence draws the college sample in senior year of high school, has considerable 
advantages for generating a broadly representative sample of college students who emerge from each 
graduating cohort (and it does so at very low cost). Further, its “before,” “during,” and “after” 
college design permits examination of the many changes associated with the college experience. 
Moreover, it has comparable panel data on the high school graduates who are not attending college, 
a segment that is important not only in its own right but also for purposes of providing a comparison 
group for the college students. 
As defined here, the college student population comprises all full-time students, one to four years 
post-high school, enrolled in a two- or four-year college in March during the year of the survey. 
More is said about this sample definition in chapters 3 and 8. Results on the prevalence of drug use 
among college students in 2005 are reported in chapter 8, and results on the trends in substance use 
among college students over the past 26 national surveys are reported in chapter 9. Chapters 8 and 9 
also report data on the portion of the follow-up samples who are in the same age band as the college 
students but who are not enrolled in college. 
 
SURVEYS OF YOUNG ADULTS AND THOSE AGES 35, 40, AND 45 
 
A “young adult” sample, on which we also report here, comprises representative samples from each 
graduating class from 1993 to 2004, all surveyed in 2005. Since 18 is the modal age of 12th graders, 
the young adults covered here correspond to modal ages 19 through 30. (The college students are 
included as a part of this young adult sample.) The study design calls for annual follow-up surveys of 
each class cohort (though each individual participates in a follow-up survey only every two years) 
through age 30, after which surveys occur at five-year intervals beginning at age 35. In 2005 the 
graduating classes of 1978, 1983, and 1988 were sent the “age 45,” “age 40,” and “age 35” 
questionnaires, respectively. Data were collected from 45-year-old respondents for the first time in 
2003. Panel data into middle adulthood on nationally representative samples of the population are 
extremely rare and valuable. This is especially true for panel data on successive class cohorts from the 
general population, because it allows the differentiation of period-, age-, and cohort-related change. 
In this volume, we have reweighted respondent data to adjust for the effects of panel attrition on 
measures such as drug use by using a statistical technique called poststratification, which will be 
explained later. We are less able to adjust for the absence of high school dropouts who were not 
included in the original high school senior sample. Because nearly all college students have 
completed high school, the omission of dropouts should have almost no effect on the college student 
population estimates, but this omission does affect the estimates for entire age groups. Therefore, the 
reader is cautioned that the omission of about 15% of each cohort who drop out of high school will 
make the drug use estimates given here for the various young adult age bands somewhat low for the 
age group as a whole. The proportional effect may be greatest for some of the most dangerous drugs, 
such as heroin, crack, and methamphetamine, as well as for cigarettes—the use of which is highly 
correlated with educational aspirations and attainment. 
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GENERAL PURPOSES OF THE RESEARCH 
 
The research purposes of the Monitoring the Future study are extensive and can be sketched only 
briefly here.1 One major purpose is to serve a social monitoring or social indicator function, intended 
to characterize accurately the levels and trends in certain behaviors, attitudes, beliefs, and conditions 
in the population. Social indicators can have important agenda-setting functions for society, and they 
are useful for gauging progress toward national goals and providing an indication of the impacts of 
major historical events or social changes. Another purpose of the study is to develop knowledge that 
increases our understanding of how and why changes in these behaviors, attitudes, beliefs, and so on 
are taking place. (In health-related disciplines, such work is usually labeled epidemiology.) These 
two broad purposes are addressed in the current series of volumes.   
The many additional purposes for the research are addressed in other types of publications and 
professional products. These include helping to determine what types of young people are at greatest 
risk for developing various patterns of drug abuse; gaining a better understanding of the lifestyles and 
value orientations associated with various patterns of drug use, and monitoring how those orientations 
are shifting over time; determining the immediate and more general aspects of the social environment 
that are associated with drug use and abuse; and determining how drug use is affected by major 
transitions into and out of social environments (such as military service, civilian employment, college, 
unemployment) or social roles (marriage, pregnancy, parenthood). We also seek to determine the life 
course of the various drug-using behaviors during this period of development; distinguish such “age 
effects” from cohort and period effects that are influencing drug use; determine the effects of social 
legislation on various types of substance use; and determine the changing connotations of drug use and 
changing patterns of multiple drug use among youth. We believe that differentiating between period, 
age, and cohort effects on use of various types of substances has been a particularly important 
contribution of the project; its cohort-sequential research design is especially well suited to allow such 
differentiation. In fact, a number of important cohort effects that emerged in the 1990s in terms of both 
use and attitudes about use will be featured in this volume.   
One additional purpose, related to but somewhat distinct from the others, is addressed here. This year, 
for the first time, data are being included on the prevalence and interconnectedness of risk and risk-
reduction behaviors related to the spread of the human immunodeficiency virus (HIV), which causes 
acquired immunodeficiency syndrome (AIDS). A set of questions about these behaviors was included 
in the 2004 and 2005 follow-up surveys in two of the six questionnaire forms that were administered to 
21- to 30-year-olds. The initial results from that work are presented and discussed in chapter 10. 
 
Readers interested in publications dealing with any of these other areas are invited to visit the 
study’s Web site at www.monitoringthefuture.org. A complete listing of all publications from the 
study is available there, as well as abstracts and/or complete manuscripts for many of those 
publications. Complete text of press releases from the study is also provided. Additional information 
may be requested through the Web site or by writing to the authors at the Institute for Social 
Research, the University of Michigan, Ann Arbor, Michigan, 48106-1248.   
                                                 
1For a more complete listing and discussion of the study’s many objectives, see Johnston, L. D., O’Malley, P. M., Schulenberg, J. E., & Bachman, J. G. 
(2001). The aims and objectives of the Monitoring the Future study and progress toward fulfilling them as of 2001. (Monitoring the Future Occasional 
Paper No. 52). Ann Arbor, MI: Institute for Social Research. 139 pp. It is available online at www.monitoringthefuture.org/pubs.html#papers. 
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AN OVERVIEW AND INTEGRATION   
ACROSS FIVE POPULATIONS 
 
 
Monitoring the Future, which is now in its 31st year, has become one of the nation’s most relied-
upon sources of information on changes taking place in licit and illicit psychoactive drug use 
among American adolescents, college students, young adults, and more recently, middle-aged 
adults. During the last three decades, the study has tracked and reported on the use of an ever-
growing array of such substances in these populations. 
 
This annual series of monographs, written by the study’s investigators and published by its 
sponsor—the National Institute on Drug Abuse—is one of the major vehicles by which the 
epidemiological findings from the study are reported. This two-volume monograph reports 
findings from the inception of the study in 1975 through 2005—the results of 31 national surveys 
encompassing a 30-year period. (A companion series of annual reports provides a much briefer, 
advance synopsis of the key findings from the latest surveys of secondary school students.6) 
 
Monitoring the Future has conducted in-school surveys of nationally representative samples of 
(a) 12th-grade students each year since 1975 and (b) 8th- and 10th-grade students each year since 
1991. In addition, beginning with the class of 1976, the project has conducted follow-up mail 
surveys on representative subsamples of the respondents from each previously participating 
12th-grade class. These follow-up surveys continue into young adulthood and beyond. 
 
A number of important findings have been summarized in this chapter to provide the reader with 
an overview of the key results. Because so many populations, drugs, and prevalence intervals are 
discussed here, a single integrative set of tables (Tables 2-1 through 2-4) show the 1991–2005 
trends for all drugs on all five populations: 8th-grade students, 10th-grade students, 12th-grade 
students, full-time college students ages 19–22, and all young adults through age 28 who are 
high school graduates. (Note that the young adult group includes the college student population.) 
Volume II contains additional data on older age bands: specifically, ages 35, 40, and 45. 
 
 
TRENDS IN ILLICIT DRUG USE 
 
Early in the 1990s we noted an increase in use of several illicit drugs among secondary students 
and some important changes among the students in terms of certain key attitudes and beliefs 
related to drug use. In the volume reporting 1992 survey results, we noted the beginning of such 
reversals in both use and attitudes among 8th graders, the youngest respondents surveyed in this 
study, and also a reversal in attitudes among the 12th graders. Specifically, the proportions 
                                                 
6Johnston, L. D., O’Malley P. M., Bachman, J. G., & Schulenberg J. E. (2006). Monitoring the Future national results on adolescent drug use: 
Overview of key findings, 2005. (NIH Publication No. 06-5882). Bethesda, MD: National Institute on Drug Abuse. (Also available on the Web at 
http://monitoringthefuture.org.) 
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seeing great risk in using drugs began to decline, as did the proportions saying they disapproved 
of use. As we suggested then, those reversals indeed presaged “an end to the improvements in 
the drug situation that the nation may be taking for granted.” The use of illicit drugs rose sharply 
in all three grade levels after 1992 as negative attitudes and beliefs about drug use continued to 
erode. This pattern continued into the mid-1990s, and beyond that for some drugs.  
 
In 1997, for the first time in six years, the overall rate of illicit drug use finally began to decline 
among 8th graders. And although use of marijuana continued to rise that year among the 10th 
and 12th graders, their use of several other drugs leveled off and relevant attitudes and beliefs 
also began to reverse in many cases. In 1998, the illicit drug use continued a gradual decline 
among 8th graders and started to decline at 10th and 12th grades. In 1999, 2000, and 2001, the 
decline in use continued for 8th graders, whereas it held fairly level among 10th and 12th 
graders. In 2002 and 2003, use by 8th and 10th graders decreased significantly and use by 12th 
graders finally began to drop, albeit by less than a statistically significant amount. Nonsignificant 
declines continued for all three grades in 2004. The long-term decline in illicit drug use among 
8th graders came to a halt in 2005, but continued among 10th and 12th graders. As we have 
noted previously, the gradual decline observed among the 8th graders suggested an eventual 
further decline at the upper grades. We are now seeing those declines.  
 
As will be illustrated below in the discussion of specific drugs, the increase in use of many drugs 
during the 1990s among secondary school students, combined with fairly level rates of use 
among college students and young adults, resulted in some unusual reversals in the usage rates 
by age. Figure 2-1 illustrates the point. In the early years of the epidemic, illicit drug use rates 
clearly were higher in the college-age group (and eventually the young adults) than they were 
among secondary school students. But by the late 1990s, the highest rates of active use (i.e., use 
within the prior year or prior 30 days) tended to be found in the late secondary school years. In 
fact, in 1996 and 1997 both 10th and 12th graders actually had higher annual prevalence rates for 
illicit drug use (i.e., higher percentages reported use within the prior year) than either college 
students or young adults. This changed somewhat after 2001, as the earlier heavier-using cohorts 
of adolescents began to comprise the college student and young adult populations. At the same 
time, use among the secondary students was declining.  
 
• In 2005 the rank order by age group for annual prevalence of using any illicit drug was 
12th graders (38%), college students (37%), 19- to 28-year-olds (33%), 10th graders 
(30%), and 8th graders (16%). With respect to using any illicit drug other than 
marijuana in the past 12 months, the rank order was 12th graders (20%), college students 
and 19- to 28-year-olds (both at 19%), 10th graders (13%), and 8th graders (8%). As can 
be seen by this divergence of trends for the different age groups, something other than a 
simple secular trend in drug use was taking place; specifically, important cohort 
differences were emerging. 
  
• From the early 1990s until 1997, marijuana use rose sharply among secondary school 
students as did their use of a number of other illicit drugs, though more gradually. We 
have called this period a “relapse phase” in the longer-term epidemic. An increase in 
marijuana use also occurred among American college students, largely reflecting 
“generational replacement” or cohort effect, wherein earlier graduating high school class 
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cohorts were replaced in the college population by more recent ones who were more 
drug-experienced before they left high school. This resurgence in illicit drug use spread 
up the age spectrum in a reversal of the way the epidemic spread several decades earlier. 
In the 1960s the epidemic began on the nation’s college campuses, and then the behavior 
diffused downward in age to high school students and eventually to junior high school 
students. This time the increases began in middle schools and radiated up the age 
spectrum. The graduating class cohorts in the middle and late 1990s carried with them the 
pattern of heavier drug use that emerged while they were in secondary school in the early 
1990s. 
 
The increases during the 1990s in use of any illicit drug (including use of marijuana and 
use of other illicit drugs treated as a class) were substantially larger, in both proportional 
and absolute terms, in the three secondary school grades than in either the college or 
young adult populations. Among college students and young adults, the annual 
prevalence of use of any illicit drug held remarkably stable from 1991 through 1997 at 
the same time that adolescent use rose appreciably (Figure 2-1). We projected that as 
generational replacement continued to occur we would likely see some increase in use of 
illicit drugs by the young adults. As would be expected, that happened sooner and more 
sharply among the college students. Peak rates were achieved in annual prevalence of any 
illicit drug in 1996 among 8th graders, in 1997 among 10th and 12th graders, in 2001 
among college students, and in 2004 among young adults. Similarly, the decline in use 
among secondary school students since those peak years has shown up only slightly so 
far among college students and only began in 2005 among young adults. 
 
Again, these diverging trends across age groups clearly show that changes during the 
1990s reflected some important cohort effects—lasting differences among class 
cohorts—rather than broad secular trends that would have appeared simultaneously in all 
of the age groups. During all of the previous years of the study, the use of most drugs 
moved in parallel across most age groups, indicating that secular change was prevailing. 
 
• Similar to the use patterns for illicit drugs, the trend for cigarette smoking evidenced a 
generational replacement effect during the 1990s in that college students showed a sharp 
increase in smoking beginning in 1995 as the heavier-smoking cohorts of adolescents 
from the early to mid-1990s entered college. This has been a more typical pattern of 
change for cigarettes, however, since differences in cigarette smoking rates among class 
cohorts tend to remain through the life course and also tend to account for much of the 
overall change in use observed at any given age.    
 
In the early 1990s, cigarette smoking among 8th and 10th graders rose by about 50%—a 
particularly sharp and worrisome rise to which this study called widespread attention. 
Smoking also had been rising among 12th graders since 1992. The increase in current 
smoking ended among 8th and 10th graders in 1996, among 12th graders in 1997, and 
among college students in 1999. The appreciable decline in the smoking rate that first 
began among the 8th graders in 1996 now appears to be radiating up the age spectrum as 
this cohort ages. (Their 30-day prevalence rate fell from 21% in 1996 to 9% in 2005.) 
Among the young adult stratum there has been little evidence yet of a decline in current 
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smoking. The rate is still about the same as it was in 1995 (29%); but with time we 
expect their current smoking also will drop as the cohort effect works its way up the age 
bands. Smoking among college students has been falling for several years. The most 
recent data, however, show that the decline in cigarette smoking long observed among 
8th-grade students did not continue in 2005. The decline in smoking rates had been 
decelerating in all three grades over the past couple of years, so this leveling is not 
surprising, although it is of concern. It seems predictable, given what we know about 
cohort effects and smoking, that the declines in the upper grades will also halt soon; but 
for the moment, other than for the 8th graders, all populations under study continued to 
show some modest decline in 30-day smoking rates for 2005 (see Table 2-3). 
 
• During the 1990s, the annual prevalence of marijuana use tripled among 8th graders 
(from 6% in 1991 to 18% in 1996), more than doubled among 10th graders (from 15% in 
1992 to 35% in 1997), and nearly doubled among 12th graders (from 22% in 1992 to 
39% in 1997). Among college students, however, the increase in marijuana use, 
presumably largely due to a “generational replacement effect,” was much more gradual. 
Annual prevalence of use rose by about one third from 27% in 1991 to 36% in 1998. 
Marijuana use began to decline in 1997 among 8th graders and then did the same in 1998 
among 10th and 12th graders. Its rate of decline was rather modest, however, perhaps due 
in part to effects of the public debates over medical use of marijuana. In 2001, use 
remained level in all three grades, but between 2001 and 2004 all three grades showed 
significant declines in their annual prevalence of marijuana use, with the proportional 
decline greatest among the 8th graders. As with cigarettes, the decline in annual 
prevalence of marijuana use among 8th graders came to a halt in 2005, following a one 
third decline from the peak level in 1996, while nonsignificant declines continued in the 
upper grades and among young adults. To date, the decline in marijuana use from recent 
peak levels among college students has been quite modest, and young adults showed no 
evidence of a decline until 2005 (see Table 2-2). 
 
Daily marijuana use rose substantially among secondary school and college students 
between 1992 and 2000, but somewhat less so among young adults (see Table 2-4). Daily 
use began a slow decline after 1999 among 8th graders, after 2001 among 10th graders, 
and after 2003 among 12th graders, consistent with a cohort-effect pattern. It appears that 
the college student and young adult rates at least leveled in 2004, and may have begun to 
reverse (see Table 2-4). However, neither the change in 2004 or in 2005 reached 
statistical significance. Prevalence of daily marijuana use has been slow to decline even 
though annual and 30-day prevalence figures have been dropping. Still, the rates today 
are low in relation to the peaks reported in the late 1970s. For example, 12th graders’ 
daily use prevalence of 5.0% in 2005 is less than half the 10.7% peak figure reached in 
1978, at the height of the illicit drug epidemic, and a bit below the recent high of 6.0% 
recorded in 2003.  
 
The amount of perceived risk associated with using marijuana fell during the earlier 
period of increased use in the late 1970s, and fell again during the more recent resurgence 
of use in the 1990s. Indeed, perceived risk among 12th graders began to decline a year 
before use began to rise in the upturn of the 1990s, making perceived risk a leading 
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indicator of change in use. (The same may have happened in 8th grade, as well, but we do 
not have data starting early enough to check that possibility.) The decline in perceived 
risk halted after 1997 for 8th and 10th graders, and annual prevalence began to decline a 
year or two later. Again, perceived risk was a leading indicator of change in use, as it has 
proven to be for a number of drugs. As is discussed in Volume I, chapter 8, on attitudes 
and beliefs toward drugs, these attitudes themselves show evidence of cohort effects over 
the past decade and a half. 
 
Personal disapproval of marijuana use slipped considerably among 8th graders between 
1991 and 1996 and among 10th and 12th graders between 1992 and 1997. For example, 
the proportions of 8th, 10th, and 12th graders who said they disapproved of trying 
marijuana once or twice fell by 17, 21, and 19 percentage points, respectively, over those 
intervals of decline. There has since been some increase in disapproval among 8th 
graders and, beginning more recently, among 10th and 12th graders. Over the past three 
years, both perceived risk and personal disapproval of marijuana use have risen among 
10th and 12th graders, suggesting that the recent downturn in use can be expected to 
continue. The recent rise in risk and disapproval among 8th graders halted in 2005 as the 
decline in use ended. 
 
• Among 12th graders, the proportions using any illicit drug other than marijuana in the 
past year rose from a low of 15% in 1992 to 21% in 1997 to 22% in 2001 (substantially 
below the 34% peak rate reached two decades earlier, in 1981). All of the younger groups 
showed significant increases between 1992 and 1997, with use beginning to increase in 
1992 among 8th graders, in 1993 among 10th and 12th graders, and in 1995 among 
college students—again reflecting evidence of a cohort effect. Use peaked in 1996 among 
8th and 10th graders and by 1997 among 12th graders, and it appears to have peaked in 
2004 among the college students and young adults. The 8th graders have shown some 
gradual decline in their use of the other illicit drugs, treated as a class, since 1996; the 
decline among 10th graders paused after 1998 and did not resume until after 2001; 12th-
grade use also showed some declines after 2001, and stands at about two percentage 
points lower (at 20%) in 2005. Among college students and young adults, the annual 
prevalence rates for any illicit drug other than marijuana continued to rise through 2004, 
likely due to a continuing cohort effect. The increases among college students and young 
adults ended in 2005, with both groups showing very slight declines.  
  
• Between 1989 and 1992 we noted an increase among 12th graders, college students, and 
young adults in their use of LSD, a drug quite popular in the late 1960s and early 1970s. 
In 1992 the newly added populations (8th and 10th graders) were also showing an 
increase in LSD use; and for several more years, modest increases persisted in all five 
populations. Use of LSD peaked in 1995 among college students and young adults and in 
1996 among 8th, 10th, and 12th graders, after which LSD use gradually declined in all 
five populations until 2001, when it sharply declined. Overall, the pattern for LSD use 
seems more consistent with secular change than a cohort effect. The different age groups 
moved in parallel for the most part, likely in response to historical events in the 
environment, including a sharp reduction in LSD availability after 2001. 
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Prior to the significant increase in LSD use among 12th graders in 1993, there was a 
significant 4.3-percentage-point decline between 1991 and 1992 in the proportion seeing 
great risk associated with trying LSD. (Once again this belief proved a leading indicator 
of change in use.) The decline in perceived risk continued through 1997 and halted in 
1998. The proportion of 12th graders disapproving of LSD use also began to decline in 
1992 and continued to decline through 1996.  
 
Because LSD was one of the earliest drugs to be popularly used in the overall American 
drug epidemic, young people of that era may have been relatively unaware of the risks of 
use. They had less opportunity to learn vicariously about the consequences of use by 
observing others around them or to learn from intense media coverage of the issue, which 
occurred some years earlier. We were concerned that this type of “generational 
forgetting” of the dangers of a drug, which occurs as a result of generational replacement, 
could set the stage for a whole new epidemic of use. In fact, perceived harmfulness of 
LSD began to decline after 1991 among 12th graders. The measures for perceived risk 
and disapproval among 8th and 10th graders, first used in 1993, both showed declines 
until 1997 or 1998, after which they leveled and then declined some. In 2004, 12th 
graders’ personal disapproval of trying LSD increased significantly with no further 
change in 2005. Because the decline in use in the last few years generally has not been 
accompanied by expected changes in these attitudes and beliefs, we suspected that some 
displacement by another drug might have been taking place, at least through 2001. The 
most logical candidate is ecstasy, which, like LSD, is used for its hallucinogenic effects; 
ecstasy was popular in the club scene and was very much on the rise through 2001. After 
2001 a sharp decline in the reported availability of LSD in all five populations very likely 
played a role in the sharp decline in use among all of them. 
 
• Questions about the use of ecstasy (MDMA) have been included in the follow-up surveys 
of college students and young adults since 1989; however, because of our concern about 
stimulating interest in an attractive-sounding and little-known drug, these questions were 
not added to the secondary school surveys until 1996. From 1989 to 1994, the annual 
prevalence rates tended to be quite low in the older age groups for whom we had data, but 
in 1995 these rates increased substantially—from 0.5% to 2.4% among college students, 
and from 0.7% to 1.6% among young adults generally. 
 
When data were first gathered on secondary school students in 1996, the 10th and 12th 
graders showed higher rates of annual use (both 4.6%) than the college students (2.8%). 
Ecstasy use then fell steadily at all three grades of secondary school between 1996 and 
1998, though it did not fall in the older age groups. But between 1998 and 2001, use rose 
sharply in all five populations. In fact, annual prevalence more than doubled in that three-
year period among 12th graders, college students, and young adults, and nearly doubled 
in the lower grades. In 2000 even the 8th graders showed a significant increase in use. 
Among young adults, the increase in use occurred primarily among those under age 29. 
Ecstasy use for all five age groups declined slightly in 2002, but only significantly for the 
10th graders; declined again in 2003, with significant drops for all groups except the 
college students; and showed some decline again in 2004, with the largest decreases 
among the college students and young adults. This pattern suggests that both cohort 
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effects and a secular trend may have been at work. Once again, this decline in use among 
the secondary students was predicted by an increase in perceived risk in 2001—an 
increase that continued through 2004. The annual prevalence fell by half in 2004 alone 
among the college students, and all five groups are at rates that range from one half to 
three quarters lower than their recent peaks in 2001. In 2005 the decline continued for 
12th graders and young adults, but levels remained essentially unchanged for the other 
groups. 
 
Ecstasy use among all five populations has been moving fairly synchronously since 1999, 
which suggests that a secular trend (some change in events in the social environment) has 
affected everyone. We believe an important change during this period was the increasing 
availability of information on the adverse effects of ecstasy use via stories in the popular 
media, dissemination of the scientific evidence by the National Institute on Drug Abuse, 
and an anti-ecstasy media campaign by the Partnership for a Drug-Free America and the 
Office of National Drug Control Policy, initiated in 2002.  
 
The quite dramatic increase in reported availability of ecstasy through 2001 was 
substantiated by law enforcement data on ecstasy seizures. Of the 12th graders surveyed 
in 1991, only 22% thought they could get ecstasy fairly easily, but a decade later (in 
2001) 62% thought that they could. Since 2001, however, ecstasy availability has been 
decreasing in all three grades, possibly due in part to the steep decline in the number of 
users, who serve as supply points for others. See Figure 8-6 in Volume I, chapter 8, for a 
graphic presentation of the trends in ecstasy use, availability, and perceived risk.  
  
• In the decade between 1982 and 1992, annual prevalence rates for amphetamine use 
(other than that ordered by a physician) among 12th graders fell by nearly two thirds, 
from 20.3% to 7.1%. Rates among college students fell even more over the same interval, 
from 21.1% to 3.6%. During the relapse phase in the overall drug epidemic, annual use 
increased by about half among 8th and 10th graders between 1991 and 1996, and 
increased as well among 12th graders and college students between 1992 and 1996. After 
1996 the age groups diverged, with amphetamine use declining gradually among 8th and 
10th graders and continuing to rise among 12th graders, college students, and young 
adults until about 2002. The decline continued through 2004 for 8th graders and through 
2005 for 10th graders, while the rise among the 12th graders and college students finally 
halted by 2003. The 12th graders and the young adults exhibited significant declines in 
annual prevalence of amphetamine use in 2005. This pattern of cross-age-group change 
suggests a cohort effect for amphetamine use.  
 
The increase in non-medical use of amphetamines (and a concurrent decrease in 
disapproval) that began among 12th graders in 1993 followed a sharp drop in perceived 
risk a year earlier (which, as we have noted for a number of drugs, often serves as a 
leading indicator). Following a period of decline, perceived risk among 12th graders 
generally drifted up from 1995 through 2005; disapproval also drifted up from 1996 
through 2005. Actual use of amphetamines (non-medical) among 12th graders remained 
fairly steady from 1997 through 2004, and then showed a significant decrease in 2005. 
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• Use of the specific amphetamine Ritalin showed a distinct increase around 1997—with 
annual prevalence among 12th graders going from 0.1% in 1992 to 2.8% in 1997—and 
then stayed level for a few years. (See Volume I, Appendix E, Table E-2.7) Because of its 
increasing importance, a differently structured question was introduced for Ritalin use in 
2001. This new question, which we prefer to the original, does not use a prior branching 
question and produced somewhat higher prevalence rates. Results from the new question 
suggest that Ritalin use may have declined slightly in recent years in all five populations 
(see Table 2-2).  
 
• Methamphetamine questions were introduced in 1999 because of rising concern about its 
use; but a modest decline in use actually was observed among all five populations 
through 2002, with the exception of young adults, whose use has held relatively steady. 
In 2005 only the 12th graders showed a significant decline in annual use from 3.4% in 
2004 to 2.5% in 2005, although use decreased nonsignificantly among college students.  
 
• We have had questions for a longer time—since 1990—about the use of ice (a 
crystallized form of methamphetamine that can be smoked, much like crack). The use of 
ice increased between the early and late 1990s among all the populations we asked about 
use: 12th graders, college students, and young adults. The estimates are a bit “bouncy” 
due to the relatively small sample sizes asked about this drug, but it appears that ice use 
has held fairly steady since 1999 among 12th graders, while it may have risen some 
among college students and young adults generally. 
 
• Inhalants are defined as fumes or gases that are inhaled to get high, and they include 
common household substances such as glues, aerosols, butane, and solvents. In the early 
1990s, there was a troublesome increase in inhalant use among secondary school 
students, followed by a reversal after 1995. After reaching a low point around 2002 or 
2003 in grades 8, 10, and 12, use of inhalants has increased modestly in these grades. 
Perceived risk among 8th and 10th graders has been declining fairly steadily since 2001, 
quite possibly as a result of generational forgetting of the dangers of these drugs. A new 
anti-inhalant campaign is being developed that might be effective in offsetting this 
change, much as a similar campaign did in the mid-1990s. 
  
One class of inhalants, amyl and butyl nitrites, became somewhat popular in the late 
1970s, but their use has been almost eliminated. The annual prevalence rate among 12th-
grade students was 6.5% in 1979 but only 0.6% in 2005.  
 
• Crack cocaine use spread rapidly from the early to the mid-1980s. Still, among 12th 
graders, the use of crack remained relatively low during this period (3.9% annual 
prevalence in 1987). Clearly, crack had quickly attained a reputation as a dangerous drug, 
and by the time of our first measurement of perceived risk in 1987, it was seen as the 
most dangerous of all of the drugs. Annual prevalence dropped sharply in the next few 
years, reaching 1.5% by 1991, where it remained through 1993. Perceived risk began a 
                                                 
7As is discussed in Appendix E of Volume I, the absolute prevalence rates for Ritalin probably were higher than these statistics indicate, but the 
trend story likely is quite accurate. See Table 2-2 for more accurate estimates of the absolute prevalence rates in recent years; these estimates are 
based on a new question that does not require the respondent to first indicate some amphetamine use before asking about his or her Ritalin use. 
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long and substantial decline after 1990. Use began to rise gradually after 1993, from 
1.5% to 2.7% by 1999, before finally declining in 2000 and then leveling. 
 
Among 8th and 10th graders, crack use rose gradually in the 1990s: from 0.7% in 1991 to 
2.1% by 1998 among 8th graders, and from 0.9% in 1992 to 2.5% in 1998 among 10th 
graders. Use among 12th graders peaked a year later, in 1999, at 2.7% and among young 
adults at 1.4%. Since those peak years, crack use has declined by about one third in all 
three grades, yet held fairly steady among college students and young adults. In general, 
the prevalence rates for this drug are relatively low—between 0.8% and 1.9% in all five 
groups. Among 12th graders, the group with the highest prevalence rate, annual crack 
prevalence among the college-bound is considerably lower than among those not bound 
for college (1.6% for college-bound versus 3.4% for noncollege-bound, in 2005).  
 
We believe that the particularly intense and early media coverage of the hazards of crack 
cocaine likely had the effect of “capping” an epidemic early by deterring many would-be 
users and by motivating many experimenters to desist use. As has been mentioned, when 
we first measured crack use in 1987, it had the highest level of perceived risk of any 
illicit drug. Also, it did not turn out to be “instantly addicting” upon first-time use, as had 
been reported widely. In recent years, roughly 4% of 12th graders reported trying crack; 
however, only about 1% reported any use in the prior month, and of these recent users, 
only about half (i.e., about 0.5% of the total sample) reported using crack more than one 
or two times in the prior month. It thus appears that among the small numbers of 12th 
graders who have ever tried crack, the great majority did not establish a pattern of 
continued use, let alone develop an addiction. 
 
In 1993 the levels of perceived risk and disapproval associated with crack dropped in all 
three grade levels, foretelling the rise in use that occurred in all three grades between 
1994 and 1998. Because more than a decade had passed since the 1986 anti-crack media 
frenzy, it is quite possible that “generational forgetting” contributed to the declines in risk 
and disapproval. Indeed, perceived risk of crack use eroded steadily at all grade levels 
from 1991 (or 1992 in the case of the 12th graders) through 2000. Since then there has 
not been much systematic change in risk or disapproval of crack, though any change has 
generally been in an upward direction. 
 
• Use of cocaine8 in general began to decline a year earlier than crack, probably because 
crack was still in the process of diffusing to new parts of the country, being still quite 
new. Between 1986 and 1987 the annual prevalence rate for cocaine dropped 
dramatically, by about one fifth in all three populations being studied at that time—12th 
graders, college students, and young adults. The decline occurred when young people 
finally began to view experimental and occasional use—the type of use in which they are 
most likely to engage—as more dangerous. This change was probably influenced by the 
extensive media campaigns launched the preceding year, but also almost surely by the 
highly publicized cocaine-related deaths in 1986 of sports stars Len Bias and Don 
                                                 
8Unless otherwise specified, all references to “cocaine” refer to the use of cocaine in any form, including crack. 
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Rogers. By 1992 the annual prevalence of cocaine use had fallen by about two thirds 
among the three populations for which long-term data are available (12th graders, college 
students, and young adults). 
 
During the 1990s, however, cocaine use in all five age populations increased some, both 
beginning and ending in a staggered pattern by age. Use rose among 8th graders from 
1991 to 1998, among 10th and 12th graders from 1992 to 1999, among college students 
from 1994 to 2004, and among young adults from 1996 through 2004. (Note that a 
turnaround has yet to occur in the two older groups, and they are currently at or near their 
highest use levels since 1990.) So, again, there is evidence of a cohort effect at work. 
 
The story regarding attitudes and beliefs is informative. Having risen substantially after 
1986, the perceived risk of using cocaine actually showed some (nonsignificant) decline 
in 1992 among 12th graders. In 1993, perceived risk for cocaine other than crack fell 
sharply in all grades and disapproval began to decline in all grades, though not as sharply 
as perceived risk. The decline in perceived risk had virtually ended by 1995 among 8th 
graders, by 1998 among 10th graders, and by 2001 among 12th graders, suggesting a 
cohort effect at work in this important belief, which tends to drive use. Disapproval 
declined between 1991 and 1996 among 8th graders, before leveling; it also declined 
from 1992 through 1998 among 10th and 12th graders, with the exception of an increase 
for 12th graders in 1995. These changes foretold a subsequent leveling of use at each 
grade level. Use has since drifted down gradually in all grades. 
 
The perceived availability of cocaine among 12th graders rose steadily from 1983 to 
1989, suggesting that availability played no role in the substantial downturn in use that 
occurred after 1986. After 1989, however, perceived availability fell some among 12th 
graders—which may be explained in part by the greatly reduced proportions of 12th 
graders who said they have any friends who use, because friendship circles are an 
important part of the supply system. From 1992 through 1998 or 1999, perceived 
availability of powder cocaine changed little in the three grades, but after 1998 it declined 
fairly steadily among the 8th graders through 2004 and among the 10th and 12th graders 
through 2003, after which it leveled in 8th grade and rose some in the upper grades. 
 
As with all the illicit drugs, lifetime cocaine prevalence climbs with age; in 2005 it 
reached 39% among 45-year-olds. Unlike all of the other illicit drugs, active use of 
cocaine—i.e., annual or monthly prevalence—holds fairly steady after high school (and, 
until recent years, it increased in use after high school) rather than declining. (See Figure 
4-6 in Volume II.) Nearly all of the other illicit drugs show a decline in active use with 
age. 
 
• PCP use fell sharply among 12th graders between 1979 and 1982, from an annual 
prevalence of 7.0% to 2.2%. It reached a low point of 1.2% in 1988, rose some in the 
1990s to 2.6% in 1996 during the relapse period in the general drug epidemic, and then 
declined to 1.1% by 2002, about where it remained in 2005. For young adults, the annual 
prevalence rate rose very slightly from 0.2% in 1996 to 0.6% in 2001, where it remained 
for 2005. 
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• Looking at the long-term trends, we see that the annual prevalence of heroin use among 
12th graders fell by half between 1975 (1.0%) and 1979 (0.5%), then stabilized for 15 
years, through 1994. Heroin use was also stable in the early 1990s among the other four 
populations covered here. Then, in 1994 for 8th graders and in 1995 for all other groups, 
use suddenly increased, with rates doubling or tripling in one or two years for 12th 
graders, college students, and young adults, and then remaining at the new higher levels 
among all five populations for the rest of the decade. Between 1999 and 2000, however, 
use significantly decreased among 8th graders (from 1.4% to 1.1%) and significantly 
increased among 12th graders (from 1.1% to 1.5%), with the latter change due entirely to 
an increase in non-injection use. Use of heroin declined significantly among 10th and 
12th graders in 2001, as did use of heroin without a needle. In 2002 little change took 
place among the secondary school students, but young adults showed a significant 
decline in their reported heroin use. A significant decline in use of heroin overall, as well 
as use of heroin without a needle, occurred among 10th graders in 2003. In sum, all age 
groups have annual prevalence rates of heroin use in 2005 that are below their recent 
peaks (by roughly one third to one half in the case of 8th, 10th, and 12th graders, but by 
less among the college students and young adults).   
 
Two factors very likely contributed to the upturn in heroin use in the 1990s. One is a 
long-term decline in the perceived risk of harm, probably due to “generational 
forgetting,” because it had been a long time since the country had experienced a heroin 
epidemic. The second factor, not unrelated to the first, is that in the 1990s the greatly 
increased purity of heroin allowed it to be used by means other than injection. This may 
have lowered an important psychological barrier for some potential users, making heroin 
use less aversive and making it seem less addictive and less risky, because avoiding 
injection reduces the likelihood of transmission of HIV, hepatitis, or other serious blood-
borne diseases. By introducing some new questions on heroin use in 1995, we were able 
to show that significant proportions of past-year users in all five populations were indeed 
taking heroin by means other than injection. (See Table 2-2 and chapter 4 of Volume I for 
details.) 
 
The risk perceived to be associated with heroin fell for more than a decade after the study 
began, with 60% of the 1975 12th graders seeing a great risk of trying heroin once or 
twice and only 46% of the 1986 12th graders saying the same. Between 1986 and 1991, 
perceived risk rose some, from 46% to 55%, undoubtedly reflecting the newly recognized 
threat of HIV infection associated with heroin injection. After 1991, however, perceived 
risk fell again (to 51% by 1995), this time perhaps reflecting the fact that the newer 
heroin available on the street could be administered by methods other than injection. 
Between 1996 and 1998, perceived risk among 12th graders rose—perhaps as the result 
of an anti-heroin campaign launched by the Partnership for a Drug-Free America in June 
1996, as well as the visibility of heroin-related deaths of some celebrities in the 
entertainment and fashion design worlds. The perceived risk of trying heroin decreased 
among 12th graders in 1999, however, foretelling a significant increase in their use of the 
drug in 2000. In 2001, as the perceived risk of trying heroin increased slightly, 12th 
graders’ use declined significantly. Since 2002, perceived risk declined some among 12th 
graders.   
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Questions about the degree of risk perceived to be associated with heroin use were 
introduced into the questionnaires for 8th and 10th graders in 1995. The questions asked 
specifically and only about use “without using a needle” because we thought this was the 
form of heroin use of greatest concern at that point. (Similar questions were asked of 12th 
graders, as well, in one of the six questionnaire forms.) In general, perceived risk for 
heroin use without a needle rose in all three grades in 1996 and 1997, before leveling. 
 
• The use of narcotics other than heroin is reported only for 12th graders and older 
populations because we believe that younger students are not accurately discriminating 
among the drugs that should be included or excluded from this general class. Use 
declined gradually over most of the first half of the study in these groups. Twelfth graders 
had an annual prevalence rate in 1977 of 6.4%, which fell to 3.3% by 1992. But from 
about 1992 through 2001, all of the older age groups showed a continuing increase, 
reaching peak levels of use in 2003 or 2004. The specific drugs in this class are listed in 
Table E-4 in Appendix E of Volume I. Among these, Vicodin, codeine, OxyContin, and 
Percocet are commonly mentioned by 12th graders in recent years. They also account for 
much of the increase in use of the general class, though reported use of other substances 
in the class have increased as well.   
 
• In 2002, free-standing questions were included for two drugs in this class—Vicodin and 
OxyContin—and the observed prevalence rates suggest that these two drugs very likely 
help to account for the upturn in the use of the general class of narcotics other than 
heroin. In 2003 Vicodin had attained surprisingly high prevalence rates in the five 
populations under study here—an annual prevalence of 2.8% in 8th grade, 7.2% in 10th 
grade, 10.5% in 12th grade, 7.5% among college students, and 8.6% among young adults. 
In 2005 the rates were similar, at 2.6%, 5.9%, 9.5%, 9.6%, and 9.3% (respectively). 
Lower rates were found for OxyContin than Vicodin in 2003 across all age groups—
1.7%, 3.6%, 4.5%, 2.2%, and 2.6% annual prevalence (respectively)—but given that it is 
a highly addictive narcotic drug, the rates are not inconsequential. In 2005 the rates had 
risen for 8th graders, 12th graders, and young adults, and in fact the use of OxyContin by 
12th graders and young adults has been rising steadily and significantly since 2002. 
Because OxyContin has received considerable adverse publicity in recent years, it is 
possible that perceived risk (which we do not measure) will increase. But because its use 
appears to have originated in several fairly delimited geographic areas, it seems likely 
that OxyContin will be diffusing to new communities for some time to come; this could 
delay its turnaround overall, as seems to have happened earlier for crack and ecstasy.  
 
• Use of tranquilizers among 12th graders saw a long and substantial decline from 11% 
annual prevalence in 1977 to 2.8% in 1992. After 1992, use increased significantly 
among 12th graders (as has been true with most of the drugs), reaching 5.8% in 1999 and 
then 7.7% in 2002 (although because the question was revised slightly in 2001 to include 
Xanax as an example of a tranquilizer, part of the increase may be artifactual). Since then 
annual prevalence has leveled or even dropped a bit (6.8% in 2005). Reported 
tranquilizer use also increased modestly among 8th graders, from 1.8% in 1991 to 3.3% 
in 1996, before declining to 2.6% in 1998 and leveling since then. As with a number of 
other drugs, the downturn in use began considerably earlier among the 8th graders than 
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among their older counterparts. Among 10th graders, annual prevalence remained stable 
between 1991 and 1994, at around 3.3%, and increased significantly to 5.6% in 2000. 
Use declined after 2001, reaching 4.8% in 2005. After a period of stability, college 
student use also showed an increase between 1994 and 2003, more than tripling in that 
period. For the young adult sample, after a long period of decline, annual prevalence 
more than doubled between 1997 and 2005. Most of the reported tranquilizer use in 
recent years has involved Valium and Xanax. (See Table E-3 in Appendix E of Volume 
I.) 
 
• The long-term gradual decline in sedative (barbiturate) use, which has been observed 
since 1975, when the study began, halted in 1992. Use among 12th graders then rose 
during the relapse phase in the drug epidemic, from 2.8% in 1992 to 6.7% by 2002—still 
well below the peak rate of 10.7% in 1975—and reached 7.2% in 2005. The 2005 annual 
prevalence of this class of drugs is lower among young adults (4.2%) and college 
students (3.9%) than among 12th graders (7.2%). Use among college students began to 
rise a few years later than it did among 12th graders, likely reflecting a cohort effect. 
(Data are not included here for 8th and 10th graders, again because we believe that the 
younger students have more problems with proper classification of the relevant drugs.) 
Among young adults, sedative use has increased since the early 1990s, rising from 1.6% 
in 1992 to 4.2% in 2005.  
 
• Methaqualone, another sedative drug, has shown a trend pattern quite different from 
barbiturates. Methaqualone use rose among 12th graders from 1975 to 1981, when annual 
prevalence reached 7.6%. Its use then fell very sharply, declining to 0.2% by 1993 before 
rising significantly during the general drug resurgence in the 1990s, to 1.1% by 1996. 
Use then leveled before decreasing significantly to 0.3% in 2000, but rose a bit to 0.9% in 
2005. Use also fell among all young adults and among college students, who had annual 
prevalence rates of only 0.3% and 0.2%, respectively, by 1989—the last year they were 
asked about this drug. In the late 1980s, shrinking availability may well have played a 
role in the decline, as legal manufacture and distribution of methaqualone ceased. 
Because of its very low usage rates, only the 12th graders are now asked about use of this 
drug. 
 
• It should be noted that during much of the 1990s and into the 2000s we were seeing a 
virtually uninterrupted increase among 12th graders, college students, and young adults 
in the use of nearly all illicit drugs that are central nervous system depressants. These 
include sedatives (barbiturates), tranquilizers, and narcotics other than heroin. All of 
these drugs tended to fall from favor from the mid-1970s through the early 1990s, but 
many made a comeback after the early 1990s, a resurgence that now seems to be leveling 
off. 
 
• To summarize, for many years five classes of illicitly used drugs—marijuana, 
amphetamines, cocaine, LSD, and inhalants—had an impact on appreciable proportions 
of young Americans in their late teens and 20s. In 2005, 12th graders showed annual 
prevalence rates for these drugs of 33.6%, 8.6%, 5.1%, 1.8%, and 5.0% (respectively), 
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reflecting declines in just about all of them, but in LSD in particular. Among college 
students in 2005, the comparable annual prevalence rates are 33.3%, 6.7%, 5.7%, 0.7%, 
and 1.8%; and for all young adults the rates are 28.2%, 5.1%, 6.9%, 0.8%, and 1.3%. 
Because LSD use has fallen so precipitously since 2001 in all five populations, it really 
no longer ranks as one of the major drugs of abuse, whereas narcotics other than heroin 
have become quite important due to their long-term rise that began in the 1990s. These 
narcotics now have annual prevalence rates of 9.0% among 12th graders, 8.4% among 
college students, and 8.7% among young adults. Tranquilizers also have become more 
important due to a similar rise in use, with prevalence rates of 6.8%, 6.4%, and 6.7% 
across the same three populations, as have sedatives, with rates of 7.2%, 3.9% and 4.2%, 
respectively. The increase in the use of these prescription-type drugs, combined with the 
decline in use of many of the illegal drugs, means that the use of prescription-type drugs 
has become a more important part of the nation’s overall drug problem. 
 
• Joining this set of long-established, more prevalent drugs was MDMA (ecstasy) for a 
period of time. However, annual prevalence rates for MDMA have dropped considerably 
between 2000 and 2005, from 3.1% to 1.7% for 8th graders, from 5.4% to 2.6% for 10th 
graders, from 8.2% to 3.0% for 12th graders, from 9.1% to 2.9% among college students, 
and from 7.2% to 3.0% among young adults.   
 
• In 8th grade, inhalants rank second only to marijuana among the illicitly used drugs in 
terms of annual prevalence, and they actually rank first on lifetime use. Because the use 
of inhalants reflects a form of illicit psychoactive drug use, and because of its importance 
among the younger adolescents, an additional index of “illicit drug use including 
inhalants” was introduced in Tables 2-1 through 2-3. The inclusion of inhalants makes 
relatively little difference in the illicit drug index prevalence rates for the older age 
groups but considerable difference for the younger ones. For example, in 2005 the 
proportion of 8th graders reporting any illicit drug use in their lifetime, exclusive of 
inhalants, was 21%, whereas including inhalants raised the figure to 30%. 
 
• Several additional classes of drugs have been added to the study’s coverage in recent 
years, and they are all discussed in chapter 4 of Volume I. These include ketamine, GHB, 
and Rohypnol, which are so-called “club drugs” (in addition to LSD and ecstasy). In 
general, these drugs have low prevalence rates that have declined over the past several 
years among 8th, 10th, or 12th graders: the 2005 annual prevalence rates for ketamine are 
0.6%, 1.0%, and 1.6%, respectively; for GHB, 0.5%, 0.8%, and 1.1%; and for Rohypnol, 
0.7% and 0.5% for 8th and 10th graders (the Rohypnol question for 12th graders was 
changed in 2002 and in 2005 stands at 1.2%). There was little change in the use of any of 
them this year except for significant declines in 12th graders’ use of GHB. The two 
narcotic drugs added to our coverage in 2002—OxyContin and Vicodin—show higher 
prevalence rates, as noted earlier.  
  
• Two new substances used primarily by males to develop their physique and physical 
strength were added to the question set in 2001. One is androstenedione, a precursor to 
anabolic steroid, which could be purchased over the counter until early 2005. Among 
males, where use is heavily concentrated, the 2005 annual prevalence rates are 1.0%, 
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1.4%, and 2.7% in grades 8, 10, and 12. (Among females, the rates are 0.3%, 0.4%, and 
0.5%.) As is discussed in chapter 10 of Volume I, the proportion of young males who 
report past-year use of androstenedione and/or steroids is appreciable. In 2001, when the 
“andro” question was introduced, the annual prevalence rate was 8.0% for 12th-grade 
boys. The rate has fallen considerably in all three grades since then, and in 2005 it was 
3.8% among 12th-grade boys. 
 
• Another physique-enhancing substance that is not a drug, but rather a type of protein 
supplement, is creatine. Because we thought its use often was combined with the use of 
steroids and androstenedione, we included a question on it in 2001 and found prevalence 
of use to be very high. Among boys, who again are the primary users, the 2005 annual 
prevalence for creatine is 2.3%, 9.3%, and 15.6%, in grades 8, 10, and 12. In other words, 
one in every six 12th-grade boys had used creatine in the prior year. (For girls, the rates 
are far lower at 0.4%, 1.0%, and 0.9%.)  
 
• Beginning in 1982, the study included a set of questions about the use of nonprescription 
stimulants, including stay-awake pills, diet pills, and the so-called “look-alikes.” The 
annual prevalence among 12th graders of over-the-counter stay-awake pills, which 
usually contain caffeine as their active ingredient, nearly doubled between 1982 and 
1990, increasing from 12% to 23%. After 1990 this statistic fell, reaching 10% by 2005, 
the lowest level ever reported. Earlier decreases also occurred among the college-aged 
young adult population (ages 19 to 22), in which annual prevalence was 26% in 1989 and 
declined to 12% in 2003—its lowest level since 1986. The look-alikes also have shown 
some falloff in recent years. Among 12th graders, annual prevalence decreased slightly 
from 6.8% in 1995 to 5.0% in 1999, increased to 7.1% in 2001, and then decreased to 
4.2% by 2005, the lowest level ever reported. Among young adults aged 19 to 22, use of 
look-alikes also declined from 6.0% in 1995 to 2.7% in 2005. Among 12th graders, 
annual prevalence rates for over-the-counter diet pills declined from 15% to 10% 
between 1986 and 1995, increased to 15% by 2002, then declined to 10% in 2005. 
(Among 12th-grade girls in 2005, 18% had tried diet pills by the end of senior year, 13% 
used them in the past year, and 7% used them in just the past 30 days.) Among young 
adults aged 19 to 22 annual prevalence rates declined from 17% to 7% between 1986 and 
1995, rose to 15% by 2004, and then declined again to 12% in 2005. Use of these over-
the-counter drugs by 12th graders is covered in chapter 10 of Volume I. 
College-Noncollege Differences in Illicit Drug Use  
• For analytic purposes, American college students are defined here as those respondents 
one to four years past high school who were actively enrolled full-time in a two- or four-
year college. For nearly all categories of illicit drugs college students show lower rates 
of use than their age mates not in college. The only exception relates to inhalants, where 
they have equivalent rates. For a few categories of drugs—including any illicit drug, 
marijuana, and heroin—college students also show annual usage rates that are about 
average for all high school graduates their age. (College students are about average on 
the index of any illicit drug use because they have average rates of marijuana use, which 
largely drives the index.) 
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• Although college-bound 12th graders have generally had below-average rates of use on 
all of the illicit drugs while they were in high school, these students’ eventual use of 
some illicit drugs attained parity with, or even exceeded, the rates of those who do not 
attend college. As results from the study published in two recent books have shown, this 
college effect of “catching up” is largely explainable in terms of differential rates of 
leaving the parental home after high school graduation and of getting married. College 
students are more likely than their age peers to have left the parental home and its 
constraining influences and less likely to have entered marriage, with its constraining 
influences.9   
 
• In general, since 1980, the trends in illicit substance use among American college 
students have paralleled those of their age peers not in college, with a period of 
substantial decline in the use of most drugs sometime after 1980. Further, from 1980 until 
1992, all young adult high school graduates through age 28, as well as college students 
taken separately, showed trends that were highly parallel (for the most part) to trends 
among 12th graders. After 1992 a number of drugs showed an increase in use among 12th 
graders (as well as 8th and 10th graders), but not among college students and young 
adults for some period of time. 
 
This divergence, combined with the fact that the upturn began first among the 8th graders 
(in 1992), suggests that cohort effects were emerging for illicit drug use, as we discussed 
earlier. In fact, as those heavier-using cohorts of 12th graders entered the college years, 
we saw a lagged increase in the use of several drugs in college. For example, annual 
prevalence reached a low point among 12th graders in 1992 for a number of drugs (e.g., 
cocaine, amphetamines, sedatives [barbiturates], tranquilizers, other narcotics, and any 
illicit drug other than marijuana) before rising thereafter; among college students, those 
same drugs reached a low two years later in 1994, and then began to rise gradually. Then, 
in 1998, as marijuana use was declining in the three grades of secondary school, we saw 
a sharp increase in use among college students. Consistent with our earlier predictions, 
the evidence for cohort effects resulting from generational replacement is impressive. 
Male-Female Differences in Illicit Drug Use 
• Regarding gender differences in the three older populations (12th graders, college 
students, and young adults), males are more likely to use most illicit drugs, and the 
differences tend to be largest at the higher frequency levels. For example, 2005 daily 
marijuana use rates among 12th graders are 7.2% for males versus 2.8% for females; 
among all adults (aged 19 to 30 years) the rates are 6.6% for males versus 3.5% for 
females; and among college students the rates are 5.6% for males versus 3.2% for 
females. 
 
• The 8th- and 10th-grade samples evidence fewer and smaller gender differences in the 
use of drugs—perhaps because girls tend to date and then emulate older boys, who are in 
                                                 
9Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking , drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. See also Bachman, J. G., 
O’Malley, P. M., Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in young adulthood: 
Changes in social activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates. 
20




age groups considerably more likely to use drugs. While the rate of prior-year marijuana 
use is slightly higher for males, the rate for the use of any illicit drug other than 
marijuana tends to be slightly higher for females. There is little male-female difference 
in 8th and 10th grades in the use of LSD, ecstasy (MDMA), cocaine, crack, heroin, 
Ritalin, Rohypnol, and GHB. The use of inhalants, amphetamines, and tranquilizers is 
slightly higher among females. 
 
 
TRENDS IN ALCOHOL USE 
 
• Several findings about alcohol use in these age groups are noteworthy. First, despite the 
fact that it is illegal for virtually all secondary school students and most college students 
to purchase alcoholic beverages, their experience with alcohol is widespread. Alcohol has 
been tried by 41% of current 8th graders, 63% of 10th graders, 75% of 12th graders, and 
87% of college students; and active use is also widespread. Most important, perhaps, is 
the prevalence of occasions of heavy drinking—five or more drinks in a row at least 
once in the prior two-week period—which was reported by 11% of the 8th graders, 21% 
of the 10th graders, 27% of 12th graders, and 40% of college students. Heavy drinking 
peaks in the early 20s, and recedes with age after that, reflected by the 36% rate found in 
the entire young adult sample and the 29% rate found among 29- to 30-year-olds. 
 
Alcohol use did not increase as use of other illicit drugs decreased among 12th graders 
from the late 1970s to the early 1990s, although it was (and still is) common to hear such 
a “displacement hypothesis” asserted. This study demonstrates that the opposite seems to 
be true. After 1980, when illicit drug use was declining, the monthly prevalence of 
alcohol use among 12th graders also declined gradually, but substantially, from 72% in 
1980 to 51% in 1992. Daily alcohol use declined by half over the same interval, from a 
peak of 6.9% in 1979 to 3.4% in 1992; and the prevalence of drinking five or more 
drinks in a row during the prior two-week interval fell from 41% in 1983 to 28% in 
1993—nearly a one third decline. When illicit drug use rose again in the 1990s, there was 
evidence that alcohol use (particularly binge drinking) was rising some as well—albeit 
not nearly as sharply as did marijuana use. In the late 1990s, as illicit drug use leveled in 
secondary schools and began a gradual decline, similar trends were observed for alcohol. 
Therefore the long-term evidence from this study indicates that alcohol use moves much 
more in concert with illicit drug use than counter to it.   
 
College-Noncollege Differences in Alcohol Use 
• Trends in alcohol use among college students are quite different than those for 12th 
graders or noncollege respondents of the same age. (See Figure 9-14 in Volume II.) From 
1980 to 1993, college students showed considerably less drop-off in monthly prevalence 
of alcohol use (82% to 70%) than did 12th graders (72% to 51%), and also less decline in 
occasions of heavy drinking (from 44% to 40%) than either 12th graders (41% to 27%) 
or their noncollege age-mates (41% to 34%). Because both their noncollege age-mates 
and high school students were showing greater declines, the college students stood out as 
having maintained a high rate of heavy (or binge) drinking. Since 1993, this behavior has 
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changed little among college students—in fact, their rate of binge drinking in 2005, 40%, 
is the same as their 1993 rate—while the rate among noncollege age-mates increased to 
35% in 2005 and 12th graders’ rate increased to 32% in 1998, but then decreased to 27% 
by 2005. Still, college students continue to stand out as having a relatively high rate of 
binge drinking. 
 
Although college-bound 12th graders are consistently less likely than their noncollege-
bound counterparts to report occasions of heavy drinking, the higher rates of such 
drinking among college students than among noncollege peers indicate that these 12th 
graders catch up to and pass their peers in binge drinking after high school graduation. As 
stated above, we have shown that this differential change after high school is largely 
attributable to college students’ greater likelihood of leaving the parental home and 
smaller likelihood of getting married in the four years after graduating from high school 
than their noncollege peers. A recent publication from the study also shows that 
membership in a fraternity or sorority tends to increase heavy episodic drinking and 
marijuana use.10 
 
• Since 1980, college students have generally had daily drinking rates that were slightly 
lower than their age peers, suggesting that they were more likely to confine their drinking 
to weekends, when they tend to drink a lot. The rate of daily drinking among the 
noncollege group fell from 8.3% in 1980 to 3.2% in 1994, but by 2000 had risen to 5.8%, 
and stood at 5.1% in 2005. Daily drinking by the college group also dropped in 
approximately the same time period, from 6.5% in 1980 to 3.0% in 1995, and then 
increased to 4.5% in 1997 and to 4.6% in 2005. 
Male-Female Differences in Alcohol Use 
• College men report much higher rates of daily drinking than college women (8.6% versus 
2.3% in 2005). This gender difference also exists in the noncollege group (9.0% versus 
2.3% in 2005). 
 
• Given that the physiological impacts of five drinks are considerably greater for the 
typical young female versus the typical young male, it is not surprising that we find 
substantial gender differences in the prevalence of having five or more drinks in a row. 
Among 12th graders the rates in 2005 are 22% for females versus 33% for males. This 
difference generally has been diminishing very gradually since the study began; in 1975 
there was a 23-percentage-point difference between them, versus an 11-point difference 
in 2005. 
 
• Among college students and young adults generally, there also are substantial gender 
differences in alcohol use, with college males drinking the most. For example, 50% of 
college males report having five or more drinks in a row over the previous two weeks 
versus 34% of college females. There has not been a great deal of change in this gender 
difference since 1980. 
                                                 
10McCabe, S. E., Schulenberg, J. E., Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Kloska, D. D. (2005). Selection and socialization 
effects of fraternities and sororities on U.S. college student substance use: A multi-cohort national longitudinal study. Addiction, 100, 512–524. 
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TRENDS IN CIGARETTE SMOKING 
 
Quite a number of very important findings about cigarette smoking among American 
adolescents and young adults have emerged during the life of the study, and we believe that one 
of the study’s more important contributions to the long-term health of the nation’s people has 
been to document and call attention to these trends. Despite the demonstrated health risks 
associated with smoking, young people have continued to establish regular cigarette habits 
during late adolescence in sizeable proportions, and, during the first half of the 1990s, in growing 
proportions. In fact, since the study began in 1975, cigarettes have consistently remained the 
class of abusable substances most frequently used on a daily basis by high school students. 
• During most of the 1980s, when smoking rates were falling steadily among adults, we 
reported that smoking among adolescents was not declining. Then the situation went 
from bad to worse. Among 8th and 10th graders, the current (past 30-day) smoking rate 
increased by about half between 1991 (when their use was first measured) and 1996; and 
among 12th graders, the current smoking rate rose by nearly one third between 1992 and 
1997. This study played an important role in bringing these disturbing increases in 
adolescent smoking to public attention during those years. 
 
Fortunately, there have been some important declines in current smoking since 1996 
among 8th and 10th graders, and since 1997 among 12th graders. In fact, the declines 
have more than offset the increases observed earlier in the 1990s. In 2005, 9% of 8th 
graders (down from 14% in 1991 and 21% in 1996) reported smoking one or more 
cigarettes in the prior 30 days—a decline of more than one half from the recent peak. 
Some 15% of 10th graders were current smokers in 2005 (down from 21% in 1991 and 
30% in 1996), representing a one half drop from the recent peak rate. And in 2005, 23% 
of 12th graders were current smokers (versus 28% in 1991 and 37% in 1997), 
representing a more than one-third drop from the recent peak. In 2004 the decline in the 
smoking rate among 12th graders appeared to halt, even though the decline continued in 
the lower grades, albeit at a much decelerated rate. In 2005 the decline halted among 8th 
graders, while continuing very gradually among 12th graders. Despite these very 
important recent improvements, nearly one quarter of today’s young Americans are 
current smokers by the time they complete high school; and other research consistently 
shows that smoking rates are substantially higher among those who drop out before 
graduating. Perhaps the most important fact at present is that the improvement appears to 
be drawing to an end, with a halt in the decline among 8th graders and a substantial 
slowing of the decline in the upper grades.  
 
Among college students the peak rate in current smoking was not reached until 1999 
(31%), but since then has declined moderately (to 24% in 2005). The young adults 19 to 
28 years old have shown little change in rates of current smoking between 1996 (30%) 
and 2005 (29%). However, we would expect that, as the cohort effects work their way up 
the age spectrum, smoking will among this age group as well. 
 
• During the mid-1990s, daily smoking rates increased by about half among 8th graders 
(from a low of 7.0% in 1992 to 10.4% in 1996) and 10th graders (from a low of 12.3% in 
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1992 to 18.3% in 1996), while daily smoking among 12th graders increased by 43% 
(from a low of 17.2% in 1992 to 24.6% in 1997).11 In 1997 we saw the first evidence of a 
change in the situation, as daily smoking rates declined among 8th graders and leveled 
among 10th graders, followed by a significant decline in 10th and 12th graders’ daily 
smoking rates by 1998. All three grades have shown continual declines in daily smoking 
in the years since, with a significant decline among 12th graders in 2005. Among college 
students daily smoking increased by nearly half from 1994 (13%) through 1999 (19%)—
reflecting the cohort replacement effect of the heavier-smoking 12th-grade classes—
before a turnaround began in 2000, decreasing the level of daily use to 12% by 2005. The 
decline since 2000 has been smallest among young adults: prevalence rates were 22% in 
2000 and 20% in 2005.  
 
• The dangers that survey participants perceive to be associated with pack-a-day smoking 
differ greatly by grade level and seem to be unrealistically low at all grade levels. 
Currently, about three quarters of the 12th graders (77%) report that pack-a-day smokers 
run a great risk of harming themselves physically or in other ways, but only 62% of the 
8th graders say the same. All three grades showed a decrease in perceived risk between 
1993 and 1995, as use was rising rapidly, but a slightly larger and offsetting increase in 
perceived risk occurred between 1995 and 2000, presaging the subsequent downturn in 
smoking. Between 2000 and 2003, perceived risk remained relatively level in all grades. 
In 2004, perceived risk increased significantly among 8th and 10th graders and showed a 
nonsignificant increase among 12th graders: but in 2005 only the 12th graders showed a 
continuation of the rise. 
 
• Disapproval of cigarette smoking was in decline for a longer period: from 1991 through 
1996 among 8th and 10th graders, and from 1992 to 1996 among 12th graders. Since then 
there has been a fairly steady increase in disapproval of cigarette smoking in all three 
grades—at least through 2005, when the increase halted among 8th graders. Undoubtedly 
the heavy media coverage of the tobacco issue (the proposed settlement with the state 
attorneys general, the congressional debate, the eventual state settlements, etc.) had an 
important influence on these attitudes and beliefs. However, that coverage diminished 
considerably in 1998, raising the question of whether these changes in youth attitudes 
would continue. It may well be, of course, that the removal of certain kinds of cigarette 
advertising and promotion, combined with national- and state-level antismoking 
campaigns and more recent significant increases in cigarette prices, have served to 
sustain and prolong these changes. In terms of media effects, this study has shown 
important changes in reported recall of antismoking ads resulting from both state and 
national campaigns.12 
                                                 
11For 12th graders, during a much earlier period (from 1977 to 1981), there had been a substantial decline in daily smoking, a leveling for nearly a 
decade (through 1990), and a slight decline in 1991 and 1992. 
   
12Johnston, L. D., Terry-McElrath, Y. M., O’Malley, P. M., & Wakefield, M. (2005). Trends in recall and appraisal of anti-smoking advertising 
among American youth: National survey results, 1997-2001. Prevention Science, 6, 1–19. 
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Age and Cohort-Related Differences in Cigarette Smoking 
• Initiation of smoking occurs most often in grades 6 through 9 (i.e., at modal ages 11-12 to 
14-15), although according to the 2005 8th graders, 10% had already initiated smoking 
before grade 6. The initiation rate trails off considerably by 12th grade, although a 
number of the light smokers in 12th grade make the transition to heavy smoking in the 
first two years after high school. Analyses presented in this volume and elsewhere have 
shown that cigarette smoking evidences a clear “cohort effect.” That is, if a class (or 
birth) cohort establishes an unusually high rate of smoking at an early age relative to 
other cohorts, the rate is likely to remain high throughout the life cycle relative to that of 
other birth cohorts at equivalent ages. 
 
• As we reported in the “Other Findings From the Study” chapter in the 1986 volume in 
this series, some 53% of the 12th graders who were half-pack-a-day (or more) smokers in 
senior year in 1985 said that they had tried to quit smoking and found they could not. Of 
those who had been daily smokers in 12th grade, nearly three quarters still were daily 
smokers seven to nine years later (based on the 1985 follow-up survey), despite the fact 
that in high school only 5% of them thought they would “definitely” be smoking five 
years hence. A more recent analysis, based on the 1995 follow-up survey, showed similar 
results. Nearly two thirds (63%) of those who had been daily smokers in the 12th grade 
were still daily smokers seven to nine years later, although in high school only 3% of 
them had thought they would “definitely” be smoking five years hence. Clearly, the 
smoking habit is established at an early age, it is difficult to break for those young people 
who have it, and young people greatly overrate their own ability to quit. Additional data 
from the 8th- and 10th-grade students show us that younger children are even more likely 
than older ones to underestimate seriously the dangers of smoking. 
 
• The surveys of 8th and 10th graders also show that cigarettes are readily available to 
teens: 59% of 8th graders and 82% of 10th graders say that cigarettes would be “fairly 
easy” or “very easy” for them to get, if they want them. Between 1992 (when these 
questions were first asked) and 1997, there was little change in reported availability. 
Since then, however, perceived availability of cigarettes has decreased significantly for 
8th and 10th graders, quite likely reflecting the impact of new regulations and related 
enforcement efforts aimed at reducing the sale of cigarettes to children. (Twelfth graders 
are not asked this question.)13 
College-Noncollege Differences in Cigarette Smoking 
• A striking difference in smoking rates has long existed between college-bound and 
noncollege-bound 12th graders. For example, in 2005, smoking a half-pack or more per 
day is about three times as prevalent among the noncollege-bound 12th graders as among 
the college bound (15.0% versus 4.6%). Among respondents of college age (one to four 
years past high school), those not in college show the same dramatically higher rate of 
                                                 
13For a more detailed examination of recent changes in youth access to cigarettes, see Johnston, L. D., O’Malley, P. M., & Terry-McElrath, Y. M. 
(2004). Methods, locations, and ease of cigarette access for American youth, 1997–2002. American Journal of Preventive Medicine, 27, 267–276. 
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half-pack-a-day smoking than those who are in college—17.9% versus 6.7%, 
respectively. Clearly, the differences precede college attendance. 
 
• In the first half of the 1990s, smoking rose among college students and their same-age 
peers, although the increases were not as steep for either group as they were among 12th 
graders. But in 1998 and 1999, while smoking was declining among secondary school 
students at all grades, smoking increased significantly for college students, no doubt 
reflecting the cohort effect from earlier, heavier-smoking classes of 12th graders moving 
into the older age groups. Between 1991 and 1999, the 30-day prevalence of cigarette 
smoking by college students rose from 23% to 31%, or by about one third, and daily 
smoking rose from 14% to 19%, also by about one-third. The year 2000 showed, for the 
first time in several years, a decline in college student smoking, one which continued 
with a significant decline, to 23%, in 2003, though it did not appear to continue into 2005 
(24%). (Because of the smaller numbers of cases in the college student samples, the trend 
lines are not always as smooth as they are for most of the other groups discussed here.) 
Some decline also has been observed among their noncollege-aged peers, but only since 
2001. 
Male-Female Differences in Cigarette Smoking 
• In the 1970s, 12th-grade females caught up to and passed 12th-grade males in rates of 
current smoking. Both genders then showed a decline in use followed by a long, fairly 
level period, with use by females consistently higher, but with the gender difference 
diminishing. In the early 1990s, another crossover occurred when rates rose more among 
males than among females, and males have been consistently slightly higher in rates of 
current smoking since 1991. 
 
• Among college students, females had slightly higher probabilities of being daily smokers 
from 1980 through 1994—although this long-standing gender difference was not seen 
among their age peers who were not in college. However, a crossover occurred between 
1994 and 2001, with males exceeding females in daily smoking—an echo of the 
crossover among 12th graders in 1991. Since about 2001 there has been little consistent 





The three largest ethnic groups in the population—Whites, African Americans, and Hispanics—
are examined here for 8th, 10th, and 12th graders. (Sample size limitations simply do not allow 
finer subgroup breakdowns unless data from many years are combined. Separate publications 
from the study have done just that.) A number of interesting findings emerge from the 
comparison of these three groups, and the reader is referred to chapters 4 and 5 of Volume I for a  
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full discussion of them and to Appendix D for a tabular documentation of them across all drugs.14 
The trends for these three subgroups are also presented graphically in an occasional paper 
available on-line.15 
 
• African American 12th graders have consistently shown lower usage rates than White 
12th graders for most drugs, both licit and illicit. At the lower grade levels, where few 
have yet dropped out of school, African American students also are lower on many drugs 
though not all. (In 2005 marijuana is an exception at the lower grades.) The differences 
are quite large for some drugs, including inhalants, LSD, hallucinogens other than 
LSD, powder cocaine, amphetamines, methamphetamine, and tranquilizers. 
 
• African American students currently have a much lower 30-day prevalence rate of 
cigarette smoking than White students (11% versus 28% among 12th graders in 2005) 
because their smoking rate declined from 1983 to 1992, while the rate for White students 
stabilized for some years. After 1992, smoking rates rose among both White and African 
American 12th graders, but by 1998 there was a leveling, and since then a reversal, in 
both groups in all grades. The White students showed a continuing decline in 2004 and 
2005 for all three grades, while smoking rates among African American students have 
stayed about level.  
 
• In 12th grade, occasions of heavy drinking are much less likely to be reported by African 
American students (11%) than by White students (33%) or Hispanic students (24%). 
 
• In 12th grade, of the three racial/ethnic groups, Whites tend to have the highest rates of 
use on a number of drugs, including marijuana, hallucinogens, LSD specifically, 
hallucinogens other than LSD, ecstasy, narcotics other than heroin, amphetamines, 
sedatives (barbiturates), tranquilizers, alcohol, getting drunk, cigarettes, and smokeless 
tobacco. 
 
• However, Hispanics have the highest usage rate in 12th grade for a number of the most 
dangerous drugs, for example, inhalants, cocaine, heroin in general and heroin with and 
without a needle, crack, other cocaine, and crystal methamphetamine (ice). Further, in 
8th grade, Hispanics have the highest rates not only for these drugs, but for many of the 
others, as well. For example, in 8th grade, the 2005 annual prevalence of marijuana use 
                                                 
14Periodically we publish comparisons that contain a number of the smaller racial/ethnic groups in the population, based on data combined for a 
number of contiguous years in order to attain adequate sample sizes. The first was Bachman, J. G., Wallace, J. M. Jr., O’Malley, P. M., Johnston, 
L. D., Kurth, C. L., & Neighbors, H. W. (1991). Racial/ethnic differences in smoking, drinking, and illicit drug use among American high school 
seniors, 1976–1989. American Journal of Public Health, 81, 372–377. More recent articles are: Wallace, J. M., Jr., Bachman J. G., O’Malley, P. 
M., Johnston, L. D., Schulenberg, J. E., & Cooper, S. M. (2002). Tobacco, alcohol and illicit drug use: Racial and ethnic differences among U.S. 
high school seniors, 1976–2000. Public Health Reports, 117 (Supplement 1), S67–S75; Wallace, J. M., Jr., Bachman J. G., O’Malley, P. M., 
Schulenberg, J. E., Cooper, S. M., & Johnston, L. D. (2003). Gender and ethnic differences in smoking, drinking, and illicit drug use among 
American 8th, 10th, and 12th grade students, 1976–2000. Addictions, 98, 225–234; and Delva, J., Wallace, J. M., Jr., O’Malley, P. M., Bachman, 
J. G., Johnston, L. D., & Schulenberg, J. E. (2005). The epidemiology of alcohol, marijuana, and cocaine use among Mexican American, Puerto 
Rican, Cuban American, and other Latin American 8th-grade students in the United States: 1991–2002. American Journal of Public Health, 95, 
696–702. 
   
15Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2006). Demographic subgroup trends for various licit and illicit drugs, 








for Hispanics is 15%, versus 11% for Whites and 14% for African Americans; the two-
week prevalence of binge drinking is 15% for Hispanics, 11% for Whites, and 8% for 
African Americans. In other words, Hispanics have the highest rates of use for many 
drugs in 8th grade, but not in 12th, which suggests that their considerably higher dropout 
rate (compared to Whites and African Americans) may change their relative ranking by 
12th grade. 
 
• With regard to trends, 12th graders in all three racial/ethnic groups exhibited a decline in 
cocaine use from 1986 through 1992, although the decline was less steep among African 
American 12th graders because their earlier increase in use was not as large as the 
increase among White and Hispanic students. 
 
• For virtually all of the illicit drugs, the three groups have tended to trend in parallel. 
Because White 12th graders had achieved the highest level of use on a number of 
drugs—including amphetamines, sedatives (barbiturates), and tranquilizers—they also 




DRUG USE IN EIGHTH GRADE 
 
It may be useful to focus specifically on the youngest age group in the study—the 8th graders, 
most of whom are 13 or 14 years old—because the exceptional levels of both licit and illicit drug 
use that they report help illustrate the nation’s urgent need to continue to address the substance 
abuse problems among its young. 
 
• Among 8th graders in 2005, 41% report having tried alcohol (more than just a few sips), 
and one in five (20%) say they have already been drunk at least once. 
 
• A quarter of the 8th graders in 2005 (26%) have tried cigarettes, and one in eleven 
(9.3%) say they have smoked in the prior month. Shocking to most adults is the fact that 
only 62% of 8th graders recognize that there is great risk associated with being a pack-a-
day smoker. While an increasing proportion will recognize the risk by 12th grade, for 
many this is too late, because by then they will have developed a smoking habit. 
 
• Smokeless tobacco has been tried by 15% of male 8th graders, is used currently by 5.3% 
of them, and is used daily by 1.2%. (Rates are much higher among males than among 
females.) 
 
• One 8th grader in six (17%) reported using inhalants, and 1 in 24 (4.2%) reported use in 
just the past month. This is the only class of drugs for which use is substantially higher in 
8th grade than in 10th or 12th grade. 
 
• Marijuana has been tried by nearly one in every six 8th graders (17%) and has been used 
in the prior month by almost 1 in every 15 (6.6%). 
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• A surprisingly large number of 8th graders (7.4%) say they have tried prescription-type 
amphetamines without medical instruction; 2.3% say they have used them in the prior 30 
days. 
 
• Relatively few 8th graders in 2005 say they have tried most of the other illicit drugs. 
(This is consistent with the retrospective reports from 12th graders concerning the grades 
in which they first used the various drugs.) But the proportions having at least some 
experience with them is not inconsequential. Even a rate as low as 3% represents about 
one child in every 30-student classroom. The 2005 8th-grade proportions reporting any 
lifetime experience with the other illicit drugs are: tranquilizers (4.1%), hallucinogens 
other than LSD (3.3%), methamphetamine (3.1%), cocaine other than crack (2.9%), 
ecstasy (2.8%), crack (2.4%), LSD (1.9%), steroids (1.7% overall, and 1.9% among 
males), heroin (1.5%), and Rohypnol (1.1%). 
 
• In total, 30% of all 8th graders in 2005 have tried some illicit drug other than marijuana 
(including inhalants), while 12% or about one in eight have tried some illicit drug other 
than marijuana or inhalants. Put another way, in an average 30-student classroom of 8th 
graders, nine have used some illicit drug and three or four have used some drug other 
than marijuana. 
 
• The very large number of 8th graders who have already begun using the so-called 
“gateway drugs” (tobacco, alcohol, inhalants, and marijuana) suggests that a substantial 
number are also at risk of proceeding further to such drugs as LSD, cocaine, 
amphetamines, and heroin. 
 
 
DRUG USE BY AGE 45 
 
Because we have now followed graduating 12th graders into their 40s, we can characterize the 
drug-using history of today’s 45-year-olds (at least those who are high school graduates). This is 
important not only because it characterizes how use by these respondents has developed over 
more than two decades since they left high school, but also because many of them are now 
themselves the parents of adolescents. Their own past experiences with drug use may complicate 
their communications with their children regarding drugs and, worse, their active use of 
substances may set an example for their children. The level of lifetime use they have attained is 
striking. (See chapter 4 of Volume II for greater detail and discussion.) 
 
• Among 45-year-old high school graduates in 2005, we estimate that about four fifths 
(79%) have tried marijuana and that nearly three quarters (72%) have tried an illicit drug 
other than marijuana. (These estimates are adjusted to correct for panel attrition, as 
described in chapter 4 of Volume II.) 
 
Their current behavior is far less extreme than those statistics might imply, however. One 
in eight (12%) indicates using marijuana in the last 12 months, while 1 in 12 (8%) affirms 
use of any other illicit drug in that time period. Their past-month prevalence rates are 
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lower still—7.2% and 3.7%, respectively. About 1 in 50 (2.1%) is a current daily 
marijuana user, though a great many more have been at some time in the past. 
 
• Quite high proportions of the 45-year-old respondents in 2005 have had some experience 
during their lifetime with non-medical use of several of the specific illicit drugs other 
than marijuana. These include amphetamines (52%), cocaine in any form (44%), non-
crack forms of cocaine (37%), tranquilizers (36%), hallucinogens of any type (31%), 
narcotics other than heroin (30%), sedatives (barbiturates) (27%), LSD specifically 
(18%), and other hallucinogens (17%). In sum, today’s adults in their mid-40s tend to be 
a very drug-experienced segment of the population, as might be expected from the fact 
that they graduated from high school near the peak of the drug epidemic. To repeat, 79% 
have tried marijuana and 72% have tried some illicit drug other than marijuana. 
 
• Among the illicit drugs other than marijuana that have been used in just the past year by 
this age group (outside of medical regimen) are cocaine (2.9% annual prevalence), 
narcotics other than heroin (3.1%), tranquilizers (2.9%), and non-crack forms of 
cocaine (2.6%). Little active use is reported by these respondents for LSD, other 
hallucinogens, amphetamines, crack, or heroin. (Of course, we would not expect heavy 
heroin or crack users to have remained in the panel studies.) 
   
• Alcohol consumption is relatively high among these 45-year-olds, with about two thirds 
(65%) indicating that they consumed at least one alcoholic drink in the prior 30 days, 
8.5% reporting current daily drinking (defined as drinking on 20 or more occasions in the 
prior 30 days), and 20% indicating occasional heavy drinking (defined as five or more 
drinks on at least one occasion in the prior two weeks). The rate of occasional heavy 
drinking is much lower than was exhibited by this cohort when they were of high school 
and college ages. 
 
• More than one in five (22%) of these 45-year-old high school graduates currently smokes 
cigarettes. Almost all of those are current daily smokers (20%). 
 
 
SUMMARY AND CONCLUSIONS 
 
We can summarize the findings on trends as follows: over more than a decade—from the late 
1970s to the early 1990s—the use of a number of illicit drugs declined appreciably among 12th-
grade students, and declined even more among American college students and young adults. 
These substantial improvements—which seem largely explainable in terms of changes in 
attitudes about drug use, beliefs about the risks of drug use, and peer norms against drug use—
have some extremely important policy implications. One is that these various substance-using 
behaviors among American young people are malleable—they can be changed. It has been done 
before. The second is that demand-side (rather than supply-side) factors appear to have been 
pivotal in bringing about most of those changes. The reported levels of marijuana availability, as 
reported by 12th graders, have held fairly steady throughout the life of the study. (Moreover, 
both abstainers and quitters rank availability and price very low on their list of reasons for not 
using.) And, in fact, the perceived availability of cocaine actually was rising during the 
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beginning of the sharp decline in cocaine and crack use, which occurred when the risks 
associated with that drug rose sharply. (See the last section of chapter 9, Volume I, for more 
examples and further discussion of this point.) 
 
However, improvements surely are not inevitable; and when they occur, they should not be taken 
for granted. Relapse is always possible and, indeed, just such a “relapse” in the longer-term 
epidemic occurred during the early to mid-1990s, as the country let down its guard on many 
fronts. (See chapter 8 of Volume I for a more detailed discussion of this point.) 
 
In 1992, 8th graders exhibited a significant increase in annual use of marijuana, cocaine, LSD, 
and hallucinogens other than LSD, as well as an increase in inhalant use. (In fact, all five 
populations showed some increase in LSD use, continuing a longer-term trend for college 
students and young adults.) Further, the attitudes and beliefs of 12th graders regarding drug use 
began to soften. 
 
In 1993, use of several drugs began to rise among 10th and 12th graders, as well, fulfilling our 
earlier predictions based on eroding beliefs about the dangers of drugs and decreasing 
disapproval of drug use. Increases occurred in a number of the so-called “gateway drugs”—
marijuana, cigarettes, and inhalants—increases that we argued boded ill for the later use of 
other drugs in the usual sequence of drug use involvement. Indeed, the proportion of students 
reporting the use of any illicit drug other than marijuana rose steadily after 1991 among 8th 
and 10th graders and after 1992 among 12th graders. (This proportion increased by more than 
half among 8th graders, with annual prevalence rising from 8.4% in 1991 to 13.1% in 1996.) The 
softening attitudes about crack and other forms of cocaine also provided a basis for concern—
and in fact the use of both increased fairly steadily through 1998. 
 
Over the years, this study has demonstrated that changes in perceived risk and disapproval have 
been important causes of change in the use of a number of drugs. These beliefs and attitudes are 
almost certainly influenced by the amount and nature of public attention paid to the drug issue in 
the historical period during which young people are growing up. A substantial decline in 
attention to this issue in the early 1990s very likely helps to explain why the increases in 
perceived risk and disapproval among students ceased and began to backslide. News coverage of 
the drug issue plummeted between 1989 and 1993 (although it made a considerable comeback as 
surveys—including this one—began to document that the problem was worsening again), and 
the media’s pro bono placement of ads from the Partnership for a Drug-Free America also fell 
considerably. (During that period the 12th graders in this study showed a steady decline in their 
recalled exposure to such ads and in the judged impact of such ads on their own drug-taking 
behavior.) 
 
Also, the deterioration in the drug abuse situation first began among our youngest cohorts—
perhaps because they had not had the same opportunities for vicarious learning from the adverse 
drug experiences of people around them and people portrayed in the media—those we have 
called the “unfortunate role models.” Clearly, there was a danger that, as the drug epidemic 
subsided in the 1980s and early 1990s, newer cohorts would have far less opportunity to learn 
through informal means about the dangers of drugs—that what we have called a “generational 
forgetting” of those risks would occur through a process of generational replacement of older, 
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more drug-savvy cohorts with newer, more naive ones. If true, this suggests that as drug use 
subsides, as it did by the early 1990s, the nation must redouble its efforts to ensure that such 
naive cohorts learn these lessons about the dangers of drugs through more formal means—from 
schools, parents, and focused messages in the media, for example—and that this more formalized 
prevention effort be institutionalized so that it will endure for the long term. Clearly, for the 
foreseeable future, American young people will be aware of the psychoactive potential of a host 
of drugs and will continue to have access to them. That means that each new generation of young 
people must learn the reasons that they should not use drugs. Otherwise, their natural curiosity 
and desires for new experiences will lead a great many of them to use. 
 
Another lesson that derives from the epidemiological data in this study is that social influences 
that tend to reduce the initiation of substance use also have the potential to deter the continuation 
of use by those who have already begun to use, particularly if they are not yet deeply involved in 
use. Chapter 5 of Volume I shows how increased quitting rates have contributed importantly to 
downturns in the use of a number of drugs at different historical periods. The lesson for 
prevention is that primary prevention should not be the only goal of intervention programs; 
early-stage users may be persuaded to quit when their beliefs and attitudes regarding drugs are 
changed. 
 
The following facts help to put into perspective the magnitude and variety of substance use 
problems that presently remain among American young people: 
 
• Nearly a third (30%) of today’s 8th graders have tried an illicit drug (if inhalants are 
included as an illicit drug), and more than half (54%) of 12th graders have done so. 
 
• By their late 20s, 6 in every 10 (60%) of today’s young adults have tried an illicit drug, 
and a third (34%) have tried some illicit drug other than marijuana (usually in addition 
to marijuana). (These figures do not include inhalants.) 
 
• Today more than one in seven Americans (16% in 2005) has tried cocaine by the age of 
30, and 8% have tried it by their senior year of high school (i.e., by age 17 or 18). More 
than 1 in every 29 12th graders (3.5%) has tried crack. In the young adult sample, 1 in 16 
(6.4%) has tried crack by age 29-30. 
 
• More than 1 in every 20 12th graders (5.0%) in 2005 smokes marijuana daily, and this 
rate has shown relatively little decline so far. Among young adults aged 19 to 28, the 
percentage is about the same (4.9%) and very close to the recent peak level. Among those 
same 12th graders in 2005, one in every seven (15%) has been a daily marijuana smoker 
at some time for at least a month, and among young adults the comparable figure is one 
in five (20%). 
 
• Nearly three in ten 12th graders (27%) consumed five or more drinks in a row at least 
once in the two weeks prior to the survey, and we know that such behavior tends to 
increase among young adults one to four years past high school. Half (50%) of all male 
college students report binge drinking. 
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• Almost a quarter (23%) of 12th graders in 2005 were current cigarette smokers, and 14% 
already were current daily smokers. In addition, we know from studying previous cohorts 
that many young adults increase their rates of smoking within a year or so after they leave 
high school. 
 
• Despite the substantial improvement in this country’s drug situation in the 1980s and the 
early 1990s, and then some further improvement beginning in the late 1990s, American 
secondary school students and young adults show a level of involvement with illicit drugs 
that is among the highest in the world’s industrialized nations.16 Even by longer-term 
historical standards in this country, these rates remain extremely high, though in general 
they are not as high as in the peak years of the epidemic in the late 1970s. Heavy drinking 
also remains widespread and troublesome; and certainly the continuing initiation to 
cigarette smoking of a large, albeit declining, proportion of young people remains a 
matter of the greatest public health concern. Unfortunately, the declines in youth smoking 
have decelerated sharply in all grades and actually came to a halt among 8th graders in 
2005, indicating that improvements in youth smoking overall may soon come to a halt. 
 
• Finally, we note the seemingly unending capacity of pharmacological experts and 
amateurs to discover new substances with abuse potential that can be used to alter mood 
and consciousness, and of young people to discover the abuse potential of existing 
products, such as Robitussin, and to “rediscover” older drugs, such as LSD and heroin. 
While as a society we have made significant progress on a number of fronts in the fight 
against drug abuse, we must remain vigilant against the opening of new fronts, as well as 
the reemergence of trouble on older ones. In particular, we must guard against 
generational forgetting due to a lack of public attention to the issue. 
   
One of the dynamics that keeps the drug epidemic rolling is the emergence of new drugs 
whose hazards are little known. In 1999 we saw this happen with the drug ecstasy 
(MDMA). Other drugs like Rohypnol, ketamine, GHB, and OxyContin have appeared in 
the past decade and now must be added to the list of drugs under study. The spread of 
such new drugs appears to be facilitated and hastened today by young people’s 
widespread use of chat rooms and other sites on the Internet. We predict a continuous 
flow of such new substances onto the scene and believe that the task of rapidly 
documenting their emergence, establishing their adverse consequences, and quickly 
demystifying them will remain important means by which policymakers, researchers, and 
educators deal with the continuing threats posed by such drugs. 
 
The drug problem is not an enemy that can be vanquished, as in a war. It is more a recurring and 
relapsing problem that must be contained to the greatest extent possible on an ongoing basis. 
Therefore, it is a problem that requires an ongoing, dynamic response from our society—one that 
                                                 
16A published report from an international collaborative study, modeled largely after Monitoring the Future, provides comparative data from 
national school surveys of 15- to 16-year-olds that was completed in 2003 in 35 European countries. It also includes 2003 MTF data from 10th 
graders in the United States. See Hibell, B., Andersson, B., Bjarnasson, T., Ahlström, S., Balakireva, O., Kokkevi, A., & Morgan, M. (Eds.). 
(2004). The ESPAD report 2003 (The European School Survey Project on Alcohol and Other Drugs): Alcohol and other drug use among students 
in 35 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs, and the Council of Europe. 
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takes into account the continuing generational replacement of our children, the generational 
forgetting of the dangers of drugs that can occur with that replacement, and the perpetual stream 
of new abusable substances that will threaten to lure our young people into involvement with 
drugs. 
34
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 18.7 20.6 22.5 25.7 28.5 31.2 29.4 29.0 28.3 26.8 26.8 24.5 22.8 21.5 21.4 -0.1
      10th Grade 30.6 29.8 32.8 37.4 40.9 45.4 47.3 44.9 46.2 45.6 45.6 44.6 41.4 39.8 38.2 -1.6
      12th Grade 44.1 40.7 42.9 45.6 48.4 50.8 54.3 54.1 54.7 54.0 53.9 53.0 51.1 51.1 50.4 -0.7
      College Students 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2 53.7 53.6 51.8 53.9 52.2 52.3 +0.1
      Young Adults 62.2 60.2 59.6 57.5 57.4 56.4 56.7 57.0 57.4 58.2 58.1 59.0 60.2 60.5 60.4 -0.1
      8th Grade 14.3 15.6 16.8 17.5 18.8 19.2 17.7 16.9 16.3 15.8‡ 17.0 13.7 13.6 12.2 12.1 -0.1
      10th Grade 19.1 19.2 20.9 21.7 24.3 25.5 25.0 23.6 24.0 23.1‡ 23.6 22.1 19.7 18.8 18.0 -0.8
      12th Grade 26.9 25.1 26.7 27.6 28.1 28.5 30.0 29.4 29.4 29.0‡ 30.7 29.5 27.7 28.7 27.4 -1.3
      College Students 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5 25.8 26.3 26.9 27.6 28.0 26.5 -1.5
      Young Adults 37.8 37.0 34.6 33.4 32.8 31.0 30.5 29.9 30.2 31.3 31.6 32.8 33.9 35.2 34.0 -1.2
  Including Inhalants a,c
      8th Grade 28.5 29.6 32.3 35.1 38.1 39.4 38.1 37.8 37.2 35.1 34.5 31.6 30.3 30.2 30.0 -0.3
      10th Grade 36.1 36.2 38.7 42.7 45.9 49.8 50.9 49.3 49.9 49.3 48.8 47.7 44.9 43.1 42.1 -1.0
      12th Grade 47.6 44.4 46.6 49.1 51.5 53.5 56.3 56.1 56.3 57.0 56.0 54.6 52.8 53.0 53.5 +0.5
      College Students 52.0 50.3 49.1 47.0 47.0 49.1 50.7 55.4 54.4 54.6 53.1 52.3 54.1 52.9 53.9 +1.1
      Young Adults 63.4 61.2 61.2 58.5 59.0 58.2 58.4 58.5 58.5 59.5 59.0 59.6 60.6 62.5 61.4 -1.1
      8th Grade 10.2 11.2 12.6 16.7 19.9 23.1 22.6 22.2 22.0 20.3 20.4 19.2 17.5 16.3 16.5 +0.2
      10th Grade 23.4 21.4 24.4 30.4 34.1 39.8 42.3 39.6 40.9 40.3 40.1 38.7 36.4 35.1 34.1 -1.0
      12th Grade 36.7 32.6 35.3 38.2 41.7 44.9 49.6 49.1 49.7 48.8 49.0 47.8 46.1 45.7 44.8 -0.9
      College Students 46.3 44.1 42.0 42.2 41.7 45.1 46.1 49.9 50.8 51.2 51.0 49.5 50.7 49.1 49.1 0.0
      Young Adults 58.6 56.4 55.9 53.7 53.6 53.4 53.8 54.4 54.6 55.1 55.7 56.8 57.2 57.4 57.0 -0.4
      8th Grade 17.6 17.4 19.4 19.9 21.6 21.2 21.0 20.5 19.7 17.9 17.1 15.2 15.8 17.3 17.1 -0.2
      10th Grade 15.7 16.6 17.5 18.0 19.0 19.3 18.3 18.3 17.0 16.6 15.2 13.5 12.7 12.4 13.1 +0.6
      12th Grade 17.6 16.6 17.4 17.7 17.4 16.6 16.1 15.2 15.4 14.2 13.0 11.7 11.2 10.9 11.4 +0.5
      College Students 14.4 14.2 14.8 12.0 13.8 11.4 12.4 12.8 12.4 12.9 9.6 7.7 9.7 8.5 7.1 -1.4
      Young Adults 13.4 13.5 14.1 13.2 14.5 14.1 14.1 14.2 14.2 14.3 12.8 12.4 12.2 11.6 10.3 -1.4
— — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 1.6 1.5 1.4 1.7 1.5 1.8 2.0 2.7 1.7 0.8 1.9 1.5 1.6 1.3 1.1 -0.1
      College Students — — — — — — — — — — — — — — — —
      Young Adults 1.4 1.2 1.3 1.0 — — — — — — — — — — — —
      8th Grade 3.2 3.8 3.9 4.3 5.2 5.9 5.4 4.9 4.8 4.6‡ 5.2 4.1 4.0 3.5 3.8 +0.3
      10th Grade 6.1 6.4 6.8 8.1 9.3 10.5 10.5 9.8 9.7 8.9‡ 8.9 7.8 6.9 6.4 5.8 -0.7
      12th Grade 9.6 9.2 10.9 11.4 12.7 14.0 15.1 14.1 13.7 13.0‡ 14.7 12.0 10.6 9.7 8.8 -0.9
      College Students 11.3 12.0 11.8 10.0 13.0 12.6 13.8 15.2 14.8 14.4 14.8 13.6 14.5 12.0 11.0 -1.0
      Young Adults 15.7 15.7 15.4 15.4 16.1 16.4 16.8 17.4 18.0 18.4 18.3 19.6 19.7 19.3 17.6 -1.7 s
Nitritese
      8th Grade
Hallucinogensb,f
(Table continued on next page)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 2.7 3.2 3.5 3.7 4.4 5.1 4.7 4.1 4.1 3.9 3.4 2.5 2.1 1.8 1.9 +0.1
      10th Grade 5.6 5.8 6.2 7.2 8.4 9.4 9.5 8.5 8.5 7.6 6.3 5.0 3.5 2.8 2.5 -0.4
      12th Grade 8.8 8.6 10.3 10.5 11.7 12.6 13.6 12.6 12.2 11.1 10.9 8.4 5.9 4.6 3.5 -1.1 s
      College Students 9.6 10.6 10.6 9.2 11.5 10.8 11.7 13.1 12.7 11.8 12.2 8.6 8.7 5.6 3.7 -1.9 s
      Young Adults 13.5 13.8 13.6 13.8 14.5 15.0 15.0 15.7 16.2 16.4 16.0 15.1 14.6 13.4 11.2 -2.2 sss
      8th Grade 1.4 1.7 1.7 2.2 2.5 3.0 2.6 2.5 2.4 2.3‡ 3.9 3.3 3.2 3.0 3.3 +0.3
      10th Grade 2.2 2.5 2.8 3.8 3.9 4.7 4.8 5.0 4.7 4.8‡ 6.6 6.3 5.9 5.8 5.2 -0.6
      12th Grade 3.7 3.3 3.9 4.9 5.4 6.8 7.5 7.1 6.7 6.9‡ 10.4 9.2 9.0 8.7 8.1 -0.6
      College Students 6.0 5.7 5.4 4.4 6.5 6.5 7.5 8.7 8.8 8.2 10.7 11.0 12.8 10.1 10.6 +0.6
      Young Adults 8.4 8.0 7.6 7.4 7.8 7.9 8.5 9.4 9.3 9.9 12.0 15.0 16.4 15.6 15.4 -0.2
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 2.9 2.4 2.9 2.8 2.7 4.0 3.9 3.9 3.4 3.4 3.5 3.1 2.5 1.6 2.4 +0.8
      College Students — — — — — — — — — — — — — — — —
      Young Adults 3.1 2.0 1.9 2.0 2.2 1.9 2.4 2.7 2.3 2.3 3.1 2.5 3.0 2.7 2.0 -0.8
      8th Grade — — — — — 3.4 3.2 2.7 2.7 4.3 5.2 4.3 3.2 2.8 2.8 -0.1
      10th Grade — — — — — 5.6 5.7 5.1 6.0 7.3 8.0 6.6 5.4 4.3 4.0 -0.3
      12th Grade — — — — — 6.1 6.9 5.8 8.0 11.0 11.7 10.5 8.3 7.5 5.4 -2.1 ss
      College Students 2.0 2.9 2.3 2.1 3.1 4.3 4.7 6.8 8.4 13.1 14.7 12.7 12.9 10.2 8.3 -2.0
      Young Adults 3.2 3.9 3.8 3.8 4.5 5.2 5.1 7.2 7.1 11.6 13.0 14.6 15.3 16.0 14.9 -1.1
      8th Grade 2.3 2.9 2.9 3.6 4.2 4.5 4.4 4.6 4.7 4.5 4.3 3.6 3.6 3.4 3.7 +0.3
      10th Grade 4.1 3.3 3.6 4.3 5.0 6.5 7.1 7.2 7.7 6.9 5.7 6.1 5.1 5.4 5.2 -0.2
      12th Grade 7.8 6.1 6.1 5.9 6.0 7.1 8.7 9.3 9.8 8.6 8.2 7.8 7.7 8.1 8.0 -0.1
      College Students 9.4 7.9 6.3 5.0 5.5 5.0 5.6 8.1 8.4 9.1 8.6 8.2 9.2 9.5 8.8 -0.7
      Young Adults 21.0 19.5 16.9 15.2 13.7 12.9 12.1 12.3 12.8 12.7 13.1 13.5 14.7 15.2 14.3 -0.8
      8th Grade 1.3 1.6 1.7 2.4 2.7 2.9 2.7 3.2 3.1 3.1 3.0 2.5 2.5 2.4 2.4 +0.1
      10th Grade 1.7 1.5 1.8 2.1 2.8 3.3 3.6 3.9 4.0 3.7 3.1 3.6 2.7 2.6 2.5 -0.1
      12th Grade 3.1 2.6 2.6 3.0 3.0 3.3 3.9 4.4 4.6 3.9 3.7 3.8 3.6 3.9 3.5 -0.4
      College Students 1.5 1.7 1.3 1.0 1.8 1.2 1.4 2.2 2.4 2.5 2.0 1.9 3.1 2.0 1.7 -0.3
      Young Adults 4.8 5.1 4.3 4.4 3.8 3.9 3.6 3.8 4.3 4.6 4.7 4.3 4.7 4.2 4.1 -0.1
      8th Grade 2.0 2.4 2.4 3.0 3.4 3.8 3.5 3.7 3.8 3.5 3.3 2.8 2.7 2.6 2.9 +0.4
      10th Grade 3.8 3.0 3.3 3.8 4.4 5.5 6.1 6.4 6.8 6.0 5.0 5.2 4.5 4.8 4.6 -0.2
      12th Grade 7.0 5.3 5.4 5.2 5.1 6.4 8.2 8.4 8.8 7.7 7.4 7.0 6.7 7.3 7.1 -0.2
      College Students 9.0 7.6 6.3 4.6 5.2 4.6 5.0 7.4 7.8 8.1 8.3 8.6 8.5 9.3 8.1 -1.1
      Young Adults 19.8 18.4 15.1 13.9 12.4 11.9 11.3 11.5 11.8 11.7 12.1 12.8 13.5 14.4 13.3 -1.1
change
(Table continued on next page)
  Hallucinogens
    Other Than LSDb
  LSD
  PCPg
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  Cracki
  Other Cocainej
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 1.2 1.4 1.4 2.0 2.3 2.4 2.1 2.3 2.3 1.9 1.7 1.6 1.6 1.6 1.5 -0.2
      10th Grade 1.2 1.2 1.3 1.5 1.7 2.1 2.1 2.3 2.3 2.2 1.7 1.8 1.5 1.5 1.5 0.0
      12th Grade 0.9 1.2 1.1 1.2 1.6 1.8 2.1 2.0 2.0 2.4 1.8 1.7 1.5 1.5 1.5 0.0
      College Students 0.5 0.5 0.6 0.1 0.6 0.7 0.9 1.7 0.9 1.7 1.2 1.0 1.0 0.9 0.5 -0.4
      Young Adults 0.9 0.9 0.9 0.8 1.1 1.3 1.3 1.6 1.7 1.8 2.0 1.8 1.9 1.9 1.7 -0.2
      8th Grade —  — — — 1.5 1.6 1.3 1.4 1.6 1.1 1.2 1.0 1.0 1.1 1.0 -0.1
      10th Grade — — — — 1.0 1.1 1.1 1.2 1.3 1.0 0.8 1.0 0.9 0.8 0.8 0.0
      12th Grade — — — — 0.7 0.8 0.9 0.8 0.9 0.8 0.7 0.8 0.7 0.7 0.9 +0.2
      College Students — — — — 0.4 0.1 0.2 0.5 0.8 0.7 0.2 0.3 0.1 0.1 0.3 +0.3
      Young Adults — — — — 0.4 0.4 0.3 0.4 0.6 0.4 0.6 0.4 0.5 0.4 0.6 +0.2
      8th Grade —  — — — 1.5 1.6 1.4 1.5 1.4 1.3 1.1 1.0 1.1 1.0 0.9 -0.2
      10th Grade — — — — 1.1 1.7 1.7 1.7 1.6 1.7 1.3 1.3 1.0 1.1 1.1 0.0
      12th Grade — — — — 1.4 1.7 2.1 1.6 1.8 2.4 1.5 1.6 1.8 1.4 1.3 -0.1
      College Students — — — — 0.5 1.0 1.2 2.1 1.0 2.5 1.3 1.2 1.1 1.0 0.3 -0.7
      Young Adults — — — — 0.9 1.3 1.5 1.7 1.9 2.1 2.1 1.8 2.2 2.1 1.8 -0.2
      8th Grade —  — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 6.6 6.1 6.4 6.6 7.2 8.2 9.7 9.8 10.2 10.6 9.9‡ 13.5 13.2 13.5 12.8 -0.7
      College Students 7.3 7.3 6.2 5.1 7.2 5.7 8.2 8.7 8.7 8.9 11.0‡ 12.2 14.2 13.8 14.4 +0.6
      Young Adults 9.3 8.9 8.1 8.2 9.0 8.3 9.2 9.1 9.5 10.0 11.5‡ 13.9 16.8 17.6 17.8 +0.3
      8th Grade 10.5 10.8 11.8 12.3 13.1 13.5 12.3 11.3 10.7 9.9 10.2 8.7 8.4 7.5 7.4 -0.1
      10th Grade 13.2 13.1 14.9 15.1 17.4 17.7 17.0 16.0 15.7 15.7 16.0 14.9 13.1 11.9 11.1 -0.8
      12th Grade 15.4 13.9 15.1 15.7 15.3 15.3 16.5 16.4 16.3 15.6 16.2 16.8 14.4 15.0 13.1 -1.9 s
      College Students 13.0 10.5 10.1 9.2 10.7 9.5 10.6 10.6 11.9 12.3 12.4 11.9 12.3 12.7 12.3 -0.4
      Young Adults 22.4 20.2 18.7 17.1 16.6 15.3 14.6 14.3 14.1 15.0 15.0 14.8 15.2 15.9 14.6 -1.3 s
      8th Grade —  — — — — — — — 4.5 4.2 4.4 3.5 3.9 2.5 3.1 +0.6
      10th Grade —  — — — — — — — 7.3 6.9 6.4 6.1 5.2 5.3 4.1 -1.2 s
      12th Grade — — — — — — — — 8.2 7.9 6.9 6.7 6.2 6.2 4.5 -1.7 ss
      College Students —  — — — — — — — 7.1 5.1 5.3 5.0 5.8 5.2 4.1 -1.1
      Young Adults — — — — — — — — 8.8 9.3 9.0 9.1 8.9 9.0 8.3 -0.7
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 3.3 2.9 3.1 3.4 3.9 4.4 4.4 5.3 4.8 4.0 4.1 4.7 3.9 4.0 4.0 0.0
      College Students 1.3 0.6 1.6 1.3 1.0 0.8 1.6 2.2 2.8 1.3 2.3 2.0 2.9 2.2 2.4 +0.2
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  With a Needlel
  Without a Needlel
Other Narcoticsm,n




1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 6.2 5.5 6.3 7.0 7.4 7.6 8.1 8.7 8.9 9.2 8.7 9.5 8.8 9.9 10.5 +0.7
      College Students 3.5 3.8 3.5 3.2 4.0 4.6 5.2 5.7 6.7 6.9 6.0 5.9 5.7 7.2 8.5 +1.3
      Young Adults 8.2 7.4 6.5 6.4 6.7 6.6 6.5 6.9 7.4 8.1 7.8 8.0 8.7 9.7 10.0 +0.4
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 1.3 1.6 0.8 1.4 1.2 2.0 1.7 1.6 1.8 0.8 1.1 1.5 1.0 1.3 1.3 +0.1
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 3.8 4.1 4.4 4.6 4.5 5.3 4.8 4.6 4.4 4.4‡ 5.0 4.3 4.4 4.0 4.1 +0.1
      10th Grade 5.8 5.9 5.7 5.4 6.0 7.1 7.3 7.8 7.9 8.0‡ 9.2 8.8 7.8 7.3 7.1 -0.2
      12th Grade 7.2 6.0 6.4 6.6 7.1 7.2 7.8 8.5 9.3 8.9‡ 10.3 11.4 10.2 10.6 9.9 -0.7
      College Students 6.8 6.9 6.3 4.4 5.4 5.3 6.9 7.7 8.2 8.8 9.7 10.7 11.0 10.6 11.9 +1.3
      Young Adults 11.8 11.3 10.5 9.9 9.7 9.3 8.6 9.6 9.6 10.5 11.9 13.4 13.8 14.9 14.5 -0.4
      8th Grade — — — — — 1.5 1.1 1.4 1.3 1.0 1.1 0.8 1.0 1.0 1.1 +0.1
      10th Grade — — — — — 1.5 1.7 2.0 1.8 1.3 1.5 1.3 1.0 1.2 1.0 -0.2
      12th Grade — — — — — 1.2 1.8 3.0 2.0 1.5 1.7 — — — — —
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
  Any Use
      8th Grade 70.1 69.3‡ 55.7 55.8 54.5 55.3 53.8 52.5 52.1 51.7 50.5 47.0 45.6 43.9 41.0 -2.9 ss
      10th Grade 83.8 82.3‡ 71.6 71.1 70.5 71.8 72.0 69.8 70.6 71.4 70.1 66.9 66.0 64.2 63.2 -1.0
      12th Grade 88.0 87.5‡ 80.0 80.4 80.7 79.2 81.7 81.4 80.0 80.3 79.7 78.4 76.6 76.8 75.1 -1.7
      College Students 93.6 91.8 89.3 88.2 88.5 88.4 87.3 88.5 88.0 86.6 86.1 86.0 86.2 84.6 86.6 +2.1
      Young Adults 94.1 93.4 92.1 91.2 91.6 91.2 90.7 90.6 90.2 90.7 89.9 90.2 89.3 89.4 89.1 -0.2
      8th Grade 26.7 26.8 26.4 25.9 25.3 26.8 25.2 24.8 24.8 25.1 23.4 21.3 20.3 19.9 19.5 -0.5
      10th Grade 50.0 47.7 47.9 47.2 46.9 48.5 49.4 46.7 48.9 49.3 48.2 44.0 42.4 42.3 42.1 -0.1
      12th Grade 65.4 63.4 62.5 62.9 63.2 61.8 64.2 62.4 62.3 62.3 63.9 61.6 58.1 60.3 57.5 -2.8
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
  Flavored Alcoholic
    Beveragesg,o
      8th Grade — — — — — — — — — — — — — 37.9 35.5 -2.5
      10th Grade — — — — — — — — — — — — — 58.6 58.8 +0.2
      12th Grade — — — — — — — — — — — — — 71.0 73.6 +2.5
      College Students — — — — — — — — — — — — — 79.0 84.5 +5.5
      Young Adults — — — — — — — — — — — — — 83.2 84.6 +1.4
Lifetime
TABLE 2-1 (cont'd)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
  Any Use
      8th Grade 44.0 45.2 45.3 46.1 46.4 49.2 47.3 45.7 44.1 40.5 36.6 31.4 28.4 27.9 25.9 -2.0 s
      10th Grade 55.1 53.5 56.3 56.9 57.6 61.2 60.2 57.7 57.6 55.1 52.8 47.4 43.0 40.7 38.9 -1.7
      12th Grade 63.1 61.8 61.9 62.0 64.2 63.5 65.4 65.3 64.6 62.5 61.0 57.2 53.7 52.8 50.0 -2.8 s
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 22.2 20.7 18.7 19.9 20.0 20.4 16.8 15.0 14.4 12.8 11.7 11.2 11.3 11.0 10.1 -0.9
      10th Grade 28.2 26.6 28.1 29.2 27.6 27.4 26.3 22.7 20.4 19.1 19.5 16.9 14.6 13.8 14.5 +0.6
      12th Grade — 32.4 31.0 30.7 30.9 29.8 25.3 26.2 23.4 23.1 19.7 18.3 17.0 16.7 17.5 +0.8
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 1.9 1.7 1.6 2.0 2.0 1.8 1.8 2.3 2.7 3.0 2.8 2.5 2.5 1.9 1.7 -0.2
      10th Grade 1.8 1.7 1.7 1.8 2.0 1.8 2.0 2.0 2.7 3.5 3.5 3.5 3.0 2.4 2.0 -0.4
      12th Grade 2.1 2.1 2.0 2.4 2.3 1.9 2.4 2.7 2.9 2.5 3.7 4.0 3.5 3.4 2.6 -0.7
      College Students — — — — — — — — — — — — — — — —
      Young Adults 1.7 1.9 1.5 1.3 1.5 1.5 1.4 1.4 1.9 1.4 1.4 1.6 1.8 1.9 1.8 -0.1
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Weighted  Ns 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
8th Graders 17,500 18,600 18,300 17,300 17,500 17,800 18,600 18,100 16,700 16,700 16,200 15,100 16,500 17,000 16,800
10th Graders 14,800 14,800 15,300 15,800 17,000 15,600 15,500 15,000 13,600 14,300 14,000 14,300 15,800 16,400 16,200
12th Graders 15,000 15,800 16,300 15,400 15,400 14,300 15,400 15,200 13,600 12,800 12,800 12,900 14,600 14,600 14,700
College Students 1,410 1,490 1,490 1,410 1,450 1,450 1,480 1,440 1,440 1,350 1,340 1,260 1,270 1,400 1,400
Young Adults 6,600 6,800 6,700 6,500 6,400 6,300 6,400 6,200 6,000 5,700 5,800 5,300 5,300 5,700 5,400
Notes:   Level of significance of difference between the two most recent classes:  s = .05, ss = .01, sss = .001.
              ‘—’ indicates data not available.
              ‘*’ indicates less than .05 percent but greater than 0 percent.
              ‘‡’ indicates some change in the question.  See relevant footnote for that drug.  See relevant figure to assess the
              Any apparent inconsistency between the change estimate and the prevalence of use estimates for the two most
              recent classes  is due to rounding error.  
              impact of the wording changes. 
and young adults only:  Data based on two of six forms; N is two-sixths of N indicated.
without injection.  In 1996, the heroin question was changed in all remaining 8th- and 10th-grade forms.  Data presented here  
represent the combined data from all forms.
lFor 8th and 10th graders only:  Data based on one of two forms in 1995; N is one-half of N indicated.  Data based on all forms 
beginning in 1996.  For 12th graders only:  Data based on three of six forms; N is one-half of N indicated.  For college students  
iFor college students and young adults only:  Data based on five of six forms beginning in 2002; N is five-sixths of N indicated.   
gFor 12th graders and young adults only:  Data based on one of six forms; N is one-sixth of N indicated.
hFor 8th and 10th graders only:  Data based on one of two forms in 1996; N is one-half of N indicated.  Data based on one-
and in two of six forms for college students and young adults.  Separate questions were asked for use with injection and   
Footnotes for Table 2-1 to Table 2-4
indicated.  Data based on two of six forms beginning in 2002; N is two-sixths of N indicated.  For college students and young 
adults only:  Data based on two of six forms in 1991–2001; N is two-sixths of N indicated.  Data based on three of six forms  
beginning in 2002; N is one-half of N indicated.   
are based on all forms beginning in 2002.  Data for “any illicit drug other than marijuana” and “hallucinogens” are also
affected by these changes and have been handled in a parallel manner.
only:  Data based on two of six forms; N is two-sixths of N indicated.  Questions about nitrite use were dropped from the young 
adult questionnaires in 1995.
indicated.  Data based on three of six forms beginning in 1999; N is one-half of N indicated.
dInhalants are unadjusted for underreporting of amyl and butyl nitrites.
eFor 12th graders only:  Data based on one of six forms; N is one-sixth of N indicated.  For college students and young adults 
third of N indicated in 1997–2001 due to changes in the questionnaire forms.  Data based on two of four forms beginning in  
2002; N is one-half of N indicated.  For 12th graders only:  Data based on one of six forms in 1996–2001;  N is one-sixth of N 
fHallucinogens are unadjusted for underreporting of PCP.
jFor 12th graders only:  Data based on four of six forms; N is four-sixths of N indicated.  For college students and young adults  
only:  Data based on four of six forms; N is four-sixths of N indicated.
kIn 1995, the heroin question was changed in one of two forms for 8th and 10th graders, in three of six forms for 12th graders, 
aFor 12th graders, college students, and young adults only:  Use of “any illicit drug” includes any use of marijuana, LSD, other 
hallucinogens, crack, other cocaine, or heroin or any use of other narcotics, amphetamines, sedatives (barbiturates), or
tranquilizers not under a doctor’s orders.  For 8th and 10th graders only:  The use of other narcotics and barbiturates has been    
cFor 12th graders, college students, and young adults only:  Data based on five of six forms in 1991–98; N is five-sixths of N
excluded because these younger respondents appear to overreport use (perhaps because they include the use of 
nonprescription drugs in their answers). 
bIn 2001 the question text was changed on half of the questionnaire forms for each age group.  “Other psychedelics” was   
changed to “other hallucinogens” and “shrooms” was added to the list of examples.  For the tranquilizer list of examples, 
Miltown was replaced with Xanax.  For 8th, 10th, and 12th graders only:  The 2001 data presented here are based on the 
changed forms only; N is one-half of N indicated.  In 2002 the remaining forms were changed to the new wording.  The data    
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actual daily use is measured, and for 5+ drinks, for which the prevalence of having five or more drinks in a row in 
the last two weeks is measured. 
observed 2003 to 2004 change in a slightly different version of the flavored alcoholic beverage question.  In 2004 the original 
question was revised to include wine coolers among the examples―a change that had very little effect on the observed 
prevalence of use rate in 2004.
xDaily use is defined as use on 20 or more occasions in the past 30 days except for cigarettes and smokeless tobacco, for which  
revision of the question text resulted in rather little change in the reported prevalence of use.  The data for all forms are used 
to provide the most reliable estimate of change.
tFor 8th and 10th graders only:  Data based on one of two forms for 1991–96 and on two of four forms beginning in 1997; N is
wFor 12th graders only:  The 2003 flavored alcoholic beverage data were created by adjusting the 2004 data to reflect the
mOnly drug use not under a doctor’s orders is included here.
nIn 2002 the question text was changed in half of the questionnaire forms.   The list of examples of narcotics other than heroin 
effect from the wording change.  The remaining forms were changed in 2005.  For college students and young adults:  The 
for these groups.  In 1994 the remaining forms were changed to the new wording.  The data are based on all forms beginning
in 1994.  In 2004, the question text was changed slightly in half of the forms.  An examination of the data did not show any  
beginning in 2001; N is one-half of N indicated.  For college students and young adults only:  Data based on two of six forms;  
N is two-sixths of N indicated.  
one-half of N indicated.  For 12th graders only:  Data based on one of six forms; N is one-sixth of N indicated.  For college  
students and young adults only:  Questions about smokeless tobacco use were dropped from the analyses in 1989.
uFor 12th graders only:  Data based on two of six forms in 2000; N is two-sixths of N indicated.  Data based on three of six forms   
in 2001; N is one-half of N indicated.  Data based on one of six forms beginning in 2002; N is one-sixth of N indicated.  For   
college students and young adults only:  Data based on two of six forms; N is two-sixths of N indicated.
vFor 12th graders only:  Data based on two of six forms in 2000; N is two-sixths of N indicated.  Data based on three of six forms 
based on one of six forms in 1996–2001; N is one-sixth of N indicated.  Data based on two of six forms beginning in 2002; N is 
students and young adults only:  Data based on two of six forms; N is two-sixths of N indicated.    
sFor 8th, 10th, and 12th graders only:  In 1993, the question text was changed slightly in half of the forms to indicate that a 
“drink” meant “more than just a few sips.”  The 1993 data are based on the changed forms only; N is one-half of N indicated 
2003.
two-sixths of N indicated.  Data for 2001 and 2002 are not comparable due to changes in the questionnaire forms.  For college 
was updated:  Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—were replaced with  
Vicodin, OxyContin, and Percocet.  The 2002 data presented here are based on the changed forms only; N is one-half of N 
indicated.  In 2003, the remaining forms were changed to the new wording.  The data are based on all forms beginning in 
oFor 8th and 10th graders only:  Data based on one of four forms; N is one-third of N indicated.
pFor 12th graders, college students, and young adults only:  Data based on two of six forms; N is two-sixths of N indicated.  
qFor 12th graders only:  Data based on one of six forms; N is one-sixth of N indicated.
rFor 8th and 10th graders only:  Data based on one of two forms in 1996; N is one-half of N indicated.  Data based on three of
 four forms in 1997–98; N is two-thirds of N indicated.  Data based on two of four forms in 1999–2001; N is one-third of N  
indicated.  Data based on one of four forms beginning in 2002; N is one-sixth of N indicated.  For 12th graders only:  Data 
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 11.3 12.9 15.1 18.5 21.4 23.6 22.1 21.0 20.5 19.5 19.5 17.7 16.1 15.2 15.5 +0.3
      10th Grade 21.4 20.4 24.7 30.0 33.3 37.5 38.5 35.0 35.9 36.4 37.2 34.8 32.0 31.1 29.8 -1.3
      12th Grade 29.4 27.1 31.0 35.8 39.0 40.2 42.4 41.4 42.1 40.9 41.4 41.0 39.3 38.8 38.4 -0.4
      College Students 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9 36.1 37.9 37.0 36.5 36.2 36.6 +0.4
      Young Adults 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 -0.9
      8th Grade 8.4 9.3 10.4 11.3 12.6 13.1 11.8 11.0 10.5 10.2‡ 10.8 8.8 8.8 7.9 8.1 +0.1
      10th Grade 12.2 12.3 13.9 15.2 17.5 18.4 18.2 16.6 16.7 16.7‡ 17.9 15.7 13.8 13.5 12.9 -0.7
      12th Grade 16.2 14.9 17.1 18.0 19.4 19.8 20.7 20.2 20.7 20.4‡ 21.6 20.9 19.8 20.5 19.7 -0.7
      College Students 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4 15.6 16.4 16.6 17.9 18.6 18.5 -0.1
      Young Adults 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 -0.2
  Including Inhalants a,c
      8th Grade 16.7 18.2 21.1 24.2 27.1 28.7 27.2 26.2 25.3 24.0 23.9 21.4 20.4 20.2 20.4 +0.3
      10th Grade 23.9 23.5 27.4 32.5 35.6 39.6 40.3 37.1 37.7 38.0 38.7 36.1 33.5 32.9 31.7 -1.2
      12th Grade 31.2 28.8 32.5 37.6 40.2 41.9 43.3 42.4 42.8 42.5 42.6 42.1 40.5 39.1 40.3 +1.2
      College Students 29.8 31.1 31.7 31.9 33.7 35.1 35.5 39.1 37.4 37.0 38.2 37.7 36.0 35.9 37.9 +1.9
      Young Adults 27.8 29.2 28.9 29.2 30.4 30.2 30.1 30.6 30.6 31.2 33.2 32.4 32.7 34.9 32.8 -2.1
      8th Grade 6.2 7.2 9.2 13.0 15.8 18.3 17.7 16.9 16.5 15.6 15.4 14.6 12.8 11.8 12.2 +0.4
      10th Grade 16.5 15.2 19.2 25.2 28.7 33.6 34.8 31.1 32.1 32.2 32.7 30.3 28.2 27.5 26.6 -0.9
      12th Grade 23.9 21.9 26.0 30.7 34.7 35.8 38.5 37.5 37.8 36.5 37.0 36.2 34.9 34.3 33.6 -0.6
      College Students 26.5 27.7 27.9 29.3 31.2 33.1 31.6 35.9 35.2 34.0 35.6 34.7 33.7 33.3 33.3 0.0
      Young Adults 23.8 25.2 25.1 25.5 26.5 27.0 26.8 27.4 27.6 27.9 29.2 29.3 29.0 29.2 28.2 -1.0
      8th Grade 9.0 9.5 11.0 11.7 12.8 12.2 11.8 11.1 10.3 9.4 9.1 7.7 8.7 9.6 9.5 -0.1
      10th Grade 7.1 7.5 8.4 9.1 9.6 9.5 8.7 8.0 7.2 7.3 6.6 5.8 5.4 5.9 6.0 +0.1
      12th Grade 6.6 6.2 7.0 7.7 8.0 7.6 6.7 6.2 5.6 5.9 4.5 4.5 3.9 4.2 5.0 +0.9
      College Students 3.5 3.1 3.8 3.0 3.9 3.6 4.1 3.0 3.2 2.9 2.8 2.0 1.8 2.7 1.8 -0.9
      Young Adults 2.0 1.9 2.1 2.1 2.4 2.2 2.3 2.1 2.3 2.1 1.7 1.6 1.4 1.7 1.3 -0.5
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 0.9 0.5 0.9 1.1 1.1 1.6 1.2 1.4 0.9 0.6 0.6 1.1 0.9 0.8 0.6 -0.2
      College Students — — — — — — — — — — — — — — — —
      Young Adults 0.2 0.1 0.4 0.3 — — — — — — — — — — — —
      8th Grade 1.9 2.5 2.6 2.7 3.6 4.1 3.7 3.4 2.9 2.8‡ 3.4 2.6 2.6 2.2 2.4 +0.2
      10th Grade 4.0 4.3 4.7 5.8 7.2 7.8 7.6 6.9 6.9 6.1‡ 6.2 4.7 4.1 4.1 4.0 -0.1
      12th Grade 5.8 5.9 7.4 7.6 9.3 10.1 9.8 9.0 9.4 8.1‡ 9.1 6.6 5.9 6.2 5.5 -0.7
      College Students 6.3 6.8 6.0 6.2 8.2 6.9 7.7 7.2 7.8 6.7 7.5 6.3 7.4 5.9 5.0 -0.9
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 1.7 2.1 2.3 2.4 3.2 3.5 3.2 2.8 2.4 2.4 2.2 1.5 1.3 1.1 1.2 +0.1
      10th Grade 3.7 4.0 4.2 5.2 6.5 6.9 6.7 5.9 6.0 5.1 4.1 2.6 1.7 1.6 1.5 -0.1
      12th Grade 5.2 5.6 6.8 6.9 8.4 8.8 8.4 7.6 8.1 6.6 6.6 3.5 1.9 2.2 1.8 -0.4
      College Students 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4 4.3 4.0 2.1 1.4 1.2 0.7 -0.5
      Young Adults 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 1.2 0.9 0.8 -0.1
      8th Grade 0.7 1.1 1.0 1.3 1.7 2.0 1.8 1.6 1.5 1.4‡ 2.4 2.1 2.1 1.9 2.0 +0.2
      10th Grade 1.3 1.4 1.9 2.4 2.8 3.3 3.3 3.4 3.2 3.1‡ 4.3 4.0 3.6 3.7 3.5 -0.2
      12th Grade 2.0 1.7 2.2 3.1 3.8 4.4 4.6 4.6 4.3 4.4‡ 5.9 5.4 5.4 5.6 5.0 -0.6
      College Students 3.1 2.6 2.7 2.8 4.0 4.1 4.9 4.4 4.5 4.4 5.5 5.8 7.1 5.6 5.0 -0.7
      Young Adults 1.7 1.9 1.9 2.0 2.5 2.8 3.1 3.0 3.0 3.4 3.5 4.0 4.9 4.5 4.2 -0.2
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.4 1.4 1.6 1.8 2.6 2.3 2.1 1.8 2.3 1.8 1.1 1.3 0.7 1.3 +0.6
      College Students — — — — — — — — — — — — — — — —
      Young Adults 0.3 0.3 0.2 0.3 0.3 0.2 0.5 0.6 0.6 0.3 0.6 0.3 0.3 0.1 0.6 +0.5
      8th Grade — — — — — 2.3 2.3 1.8 1.7 3.1 3.5 2.9 2.1 1.7 1.7 -0.1
      10th Grade — — — — — 4.6 3.9 3.3 4.4 5.4 6.2 4.9 3.0 2.4 2.6 +0.2
      12th Grade — — — — — 4.6 4.0 3.6 5.6 8.2 9.2 7.4 4.5 4.0 3.0 -0.9
      College Students 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5 9.1 9.2 6.8 4.4 2.2 2.9 +0.8
      Young Adults 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 4.5 3.5 3.0 -0.5
      8th Grade 1.1 1.5 1.7 2.1 2.6 3.0 2.8 3.1 2.7 2.6 2.5 2.3 2.2 2.0 2.2 +0.2
      10th Grade 2.2 1.9 2.1 2.8 3.5 4.2 4.7 4.7 4.9 4.4 3.6 4.0 3.3 3.7 3.5 -0.2
      12th Grade 3.5 3.1 3.3 3.6 4.0 4.9 5.5 5.7 6.2 5.0 4.8 5.0 4.8 5.3 5.1 -0.2
      College Students 3.6 3.0 2.7 2.0 3.6 2.9 3.4 4.6 4.6 4.8 4.7 4.8 5.4 6.6 5.7 -0.9
      Young Adults 6.2 5.7 4.7 4.3 4.4 4.1 4.7 4.9 5.4 5.4 5.8 5.8 6.6 7.1 6.9 -0.2
      8th Grade 0.7 0.9 1.0 1.3 1.6 1.8 1.7 2.1 1.8 1.8 1.7 1.6 1.6 1.3 1.4 +0.1
      10th Grade 0.9 0.9 1.1 1.4 1.8 2.1 2.2 2.5 2.4 2.2 1.8 2.3 1.6 1.7 1.7 0.0
      12th Grade 1.5 1.5 1.5 1.9 2.1 2.1 2.4 2.5 2.7 2.2 2.1 2.3 2.2 2.3 1.9 -0.3
      College Students 0.5 0.4 0.6 0.5 1.1 0.6 0.4 1.0 0.9 0.9 0.9 0.4 1.3 1.3 0.8 -0.5
      Young Adults 1.2 1.4 1.3 1.1 1.1 1.1 1.0 1.1 1.4 1.2 1.3 1.0 1.0 1.3 1.2 -0.1
      8th Grade 1.0 1.2 1.3 1.7 2.1 2.5 2.2 2.4 2.3 1.9 1.9 1.8 1.6 1.6 1.7 +0.1
      10th Grade 2.1 1.7 1.8 2.4 3.0 3.5 4.1 4.0 4.4 3.8 3.0 3.4 2.8 3.3 3.0 -0.3
      12th Grade 3.2 2.6 2.9 3.0 3.4 4.2 5.0 4.9 5.8 4.5 4.4 4.4 4.2 4.7 4.5 -0.2
      College Students 3.2 2.4 2.5 1.8 3.3 2.3 3.0 4.2 4.2 4.1 4.1 5.0 5.1 6.3 5.0 -1.2
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  Other Cocainej
(Table continued on next page)
    Other Than LSDb
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 0.7 0.7 0.7 1.2 1.4 1.6 1.3 1.3 1.4 1.1 1.0 0.9 0.9 1.0 0.8 -0.2
      10th Grade 0.5 0.6 0.7 0.9 1.1 1.2 1.4 1.4 1.4 1.4 0.9 1.1 0.7 0.9 0.9 0.0
      12th Grade 0.4 0.6 0.5 0.6 1.1 1.0 1.2 1.0 1.1 1.5 0.9 1.0 0.8 0.9 0.8 0.0
      College Students 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.2 0.5 0.4 0.1 0.2 0.4 0.3 -0.1
      Young Adults 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.3 0.4 +0.1
      8th Grade —  — — — 0.9 1.0 0.8 0.8 0.9 0.6 0.7 0.6 0.6 0.7 0.6 -0.1
      10th Grade — — — — 0.6 0.7 0.7 0.8 0.6 0.5 0.4 0.6 0.5 0.5 0.5 0.0
      12th Grade — — — — 0.5 0.5 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 +0.1
      College Students — — — — 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 +0.3
      Young Adults — — — — 0.1 0.1 0.1 0.1 0.1  * 0.3 0.0  * 0.1 0.2 +0.1
      8th Grade —  — — — 0.8 1.0 0.8 0.8 0.9 0.7 0.6 0.6 0.6 0.6 0.5 -0.1
      10th Grade — — — — 0.8 0.9 1.1 1.0 1.1 1.1 0.7 0.8 0.5 0.7 0.7 0.0
      12th Grade — — — — 1.0 1.0 1.2 0.8 1.0 1.6 0.8 0.8 0.8 0.7 0.8 +0.1
      College Students — — — — 0.0 0.8 0.4 0.9 0.3 0.8 0.6 0.2 0.1 0.6 0.2 -0.4
      Young Adults — — — — 0.3 0.4 0.4 0.7 0.6 0.5 0.9 0.2 0.4 0.3 0.4 +0.1
      8th Grade —  — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 3.5 3.3 3.6 3.8 4.7 5.4 6.2 6.3 6.7 7.0 6.7‡ 9.4 9.3 9.5 9.0 -0.5
      College Students 2.7 2.7 2.5 2.4 3.8 3.1 4.2 4.2 4.3 4.5 5.7‡ 7.4 8.7 8.2 8.4 +0.2
      Young Adults 2.5 2.5 2.2 2.5 3.0 2.9 3.3 3.4 3.8 4.1 5.0‡ 7.1 8.5 9.0 8.7 -0.3
  OxyContino,p
      8th Grade — — — — — — — — — — — 1.3 1.7 1.7 1.8 +0.1
      10th Grade — — — — — — — — — — — 3.0 3.6 3.5 3.2 -0.3
      12th Grade — — — — — — — — — — — 4.0 4.5 5.0 5.5 +0.6
      College Students — — — — — — — — — — — 1.5 2.2 2.5 2.1 -0.4
      Young Adults — — — — — — — — — — — 1.9 2.6 3.1 3.1 0.0
      8th Grade — — — — — — — — — — — 2.5 2.8 2.5 2.6 +0.1
      10th Grade — — — — — — — — — — — 6.9 7.2 6.2 5.9 -0.3
      12th Grade — — — — — — — — — — — 9.6 10.5 9.3 9.5 +0.2
      College Students — — — — — — — — — — — 6.9 7.5 7.4 9.6 +2.2
      Young Adults — — — — — — — — — — — 8.2 8.6 8.9 9.3 +0.3
      8th Grade 6.2 6.5 7.2 7.9 8.7 9.1 8.1 7.2 6.9 6.5 6.7 5.5 5.5 4.9 4.9 +0.1
      10th Grade 8.2 8.2 9.6 10.2 11.9 12.4 12.1 10.7 10.4 11.1 11.7 10.7 9.0 8.5 7.8 -0.7
      12th Grade 8.2 7.1 8.4 9.4 9.3 9.5 10.2 10.1 10.2 10.5 10.9 11.1 9.9 10.0 8.6 -1.4 s
      College Students 3.9 3.6 4.2 4.2 5.4 4.2 5.7 5.1 5.8 6.6 7.2 7.0 7.1 7.0 6.7 -0.2
      Young Adults 4.3 4.1 4.0 4.5 4.6 4.2 4.6 4.5 4.7 5.4 5.8 5.9 5.8 6.2 5.1 -1.2 ss
Heroink
  Without a Needlel
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade — — — — — — — — — — 2.9 2.8 2.6 2.5 2.4 -0.1
      10th Grade — — — — — — — — — — 4.8 4.8 4.1 3.4 3.4 +0.1
      12th Grade — — — — — — — — — — 5.1 4.0 4.0 5.1 4.4 -0.7
      College Students — — — — — — — — — — — 5.7 4.7 4.7 4.2 -0.5
      Young Adults — — — — — — — — — — — 2.9 2.9 2.7 2.5 -0.3
      8th Grade — — — — — — — — 3.2 2.5 2.8 2.2 2.5 1.5 1.8 +0.2
      10th Grade — — — — — — — — 4.6 4.0 3.7 3.9 3.3 3.0 2.9 -0.1
      12th Grade — — — — — — — — 4.7 4.3 3.9 3.6 3.2 3.4 2.5 -0.9 s
      College Students — — — — — — — — 3.3 1.6 2.4 1.2 2.6 2.9 1.7 -1.2
      Young Adults — — — — — — — — 2.8 2.5 2.8 2.5 2.7 2.8 2.4 -0.4
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.3 1.7 1.8 2.4 2.8 2.3 3.0 1.9 2.2 2.5 3.0 2.0 2.1 2.3 +0.3
      College Students 0.1 0.2 0.7 0.8 1.1 0.3 0.8 1.0 0.5 0.5 0.6 0.8 0.9 1.1 1.4 +0.3
      Young Adults 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 1.3 1.5 1.6 +0.1
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 3.4 2.8 3.4 4.1 4.7 4.9 5.1 5.5 5.8 6.2 5.7 6.7 6.0 6.5 7.2 +0.7
      College Students 1.2 1.4 1.5 1.2 2.0 2.3 3.0 2.5 3.2 3.7 3.8 3.7 4.1 4.2 3.9 -0.2
      Young Adults 1.8 1.6 1.9 1.8 2.1 2.2 2.4 2.5 2.8 3.4 3.7 3.9 3.9 4.4 4.2 -0.2
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 0.5 0.6 0.2 0.8 0.7 1.1 1.0 1.1 1.1 0.3 0.8 0.9 0.6 0.8 0.9 +0.1
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 1.8 2.0 2.1 2.4 2.7 3.3 2.9 2.6 2.5 2.6‡ 2.8 2.6 2.7 2.5 2.8 +0.3
      10th Grade 3.2 3.5 3.3 3.3 4.0 4.6 4.9 5.1 5.4 5.6‡ 7.3 6.3 5.3 5.1 4.8 -0.3
      12th Grade 3.6 2.8 3.5 3.7 4.4 4.6 4.7 5.5 5.8 5.7‡ 6.9 7.7 6.7 7.3 6.8 -0.6
      College Students 2.4 2.9 2.4 1.8 2.9 2.8 3.8 3.9 3.8 4.2 5.1 6.7 6.9 6.7 6.4 -0.3
      Young Adults 3.5 3.4 3.1 2.9 3.4 3.2 3.1 3.8 3.7 4.6 5.5 7.0 6.8 7.4 6.7 -0.7
      8th Grade — — — — — 1.0 0.8 0.8 0.5 0.5 0.7 0.3 0.5 0.6 0.7 +0.1
      10th Grade — — — — — 1.1 1.3 1.2 1.0 0.8 1.0 0.7 0.6 0.7 0.5 -0.3
      12th Grade — — — — — 1.1 1.2 1.4 1.0 0.8 0.9‡ 1.6 1.3 1.6 1.2 -0.4
      College Students — — — — — — — — — — — 0.7 0.4 0.3 0.1 -0.2
      Young Adults — — — — — — — — — — — 0.3 0.5 0.1 0.1 0.0
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
GHBo,u
      8th Grade — — — — — — — — — 1.2 1.1 0.8 0.9 0.7 0.5 -0.2
      10th Grade — — — — — — — — — 1.1 1.0 1.4 1.4 0.8 0.8 0.0
      12th Grade — — — — — — — — — 1.9 1.6 1.5 1.4 2.0 1.1 -0.9 s
      College Students — — — — — — — — — — — 0.6 0.3 0.7 0.4 -0.3
      Young Adults — — — — — — — — — — — 0.8 0.6 0.5 0.3 -0.2
      8th Grade — — — — — — — — — 1.6 1.3 1.3 1.1 0.9 0.6 -0.3
      10th Grade — — — — — — — — — 2.1 2.1 2.2 1.9 1.3 1.0 -0.3
      12th Grade — — — — — — — — — 2.5 2.5 2.6 2.1 1.9 1.6 -0.3
      College Students — — — — — — — — — — — 1.3 1.0 1.5 0.5 -1.0
      Young Adults — — — — — — — — — — — 1.2 0.9 0.6 0.5 -0.1
  Any Use
      8th Grade 54.0 53.7‡ 45.4 46.8 45.3 46.5 45.5 43.7 43.5 43.1 41.9 38.7 37.2 36.7 33.9 -2.7 ss
      10th Grade 72.3 70.2‡ 63.4 63.9 63.5 65.0 65.2 62.7 63.7 65.3 63.5 60.0 59.3 58.2 56.7 -1.5
      12th Grade 77.7 76.8‡ 72.7 73.0 73.7 72.5 74.8 74.3 73.8 73.2 73.3 71.5 70.1 70.6 68.6 -2.1 s
      College Students 88.3 86.9 85.1 82.7 83.2 82.9 82.4 84.6 83.6 83.2 83.0 82.9 81.7 81.2 83.0 +1.8
      Young Adults 86.9 86.2 85.3 83.7 84.7 84.0 84.3 84.0 84.1 84.0 84.3 84.9 83.3 84.4 83.8 -0.6
      8th Grade 17.5 18.3 18.2 18.2 18.4 19.8 18.4 17.9 18.5 18.5 16.6 15.0 14.5 14.5 14.1 -0.4
      10th Grade 40.1 37.0 37.8 38.0 38.5 40.1 40.7 38.3 40.9 41.6 39.9 35.4 34.7 35.1 34.2 -0.9
      12th Grade 52.7 50.3 49.6 51.7 52.5 51.9 53.2 52.0 53.2 51.8 53.2 50.4 48.0 51.8 47.7 -4.1 s
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade — — — — — — — — — — — — — 30.4 27.9 -2.5 s
      10th Grade — — — — — — — — — — — — — 49.7 48.5 -1.2
      12th Grade — — — — — — — — — — — — 55.2 55.8 58.4 +2.5
      College Students — — — — — — — — — — — — — 63.2 67.0 +3.8
      Young Adults — — — — — — — — — — — — — 62.7 58.4 -4.4
  Any Use
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade — — — — — — — — — — — — — — — —
      College Students 35.6 37.3 38.8 37.6 39.3 41.4 43.6 44.3 44.5 41.3 39.0 38.3 35.2 36.7 36.0 -0.7
      Young Adults 37.7 37.9 37.8 38.3 38.8 40.3 41.8 41.6 41.1 40.9 41.11 39.1 38.6 39.0 39.1 +0.1
      8th Grade — — — — — — — — — 3.9 2.7 2.7 2.0 1.7 1.6 -0.1
      10th Grade — — — — — — — — — 6.4 4.9 3.1 2.8 2.1 1.6 -0.5
      12th Grade — — — — — — — — — 9.2 7.0 5.9 4.0 3.6 3.3 -0.3
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
  Been Drunkp
Alcohols
(Table continued on next page)
Bidiso,p
Cigarettes
    Beveragesg,o,w





  Flavored Alcoholic
Ketamineo,v
Trends in Annual Prevalence of Use of Various Drugs for Eighth, Tenth,
46
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Kretekso,p
      8th Grade — — — — — — — — — — 2.6 2.6 2.0 1.9 1.4 -0.5
      10th Grade — — — — — — — — — — 6.0 4.9 3.8 3.7 2.8 -0.9
      12th Grade — — — — — — — — — — 10.1 8.4 6.7 6.5 7.1 +0.6
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 1.0 1.1 0.9 1.2 1.0 0.9 1.0 1.2 1.7 1.7 1.6 1.5 1.4 1.1 1.1 -0.1
      10th Grade 1.1 1.1 1.0 1.1 1.2 1.2 1.2 1.2 1.7 2.2 2.1 2.2 1.7 1.5 1.3 -0.3
      12th Grade 1.4 1.1 1.2 1.3 1.5 1.4 1.4 1.7 1.8 1.7 2.4 2.5 2.1 2.5 1.5 -1.1 sss
      College Students — — — — — — — — — — — — — — — —
      Young Adults 0.5 0.4 0.3 0.4 0.5 0.3 0.5 0.4 0.6 0.4 0.4 0.4 0.5 0.5 0.5 0.0
Note:      See Table 2-1 for relevant footnotes.
TABLE 2-2 (cont'd)
Trends in Annual Prevalence of Use of Various Drugs for Eighth, Tenth,
and Twelfth Graders, College Students, and Young Adults (Ages 19-28) 






1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 5.7 6.8 8.4 10.9 12.4 14.6 12.9 12.1 12.2 11.9 11.7 10.4 9.7 8.4 8.5 +0.1
      10th Grade 11.6 11.0 14.0 18.5 20.2 23.2 23.0 21.5 22.1 22.5 22.7 20.8 19.5 18.3 17.3 -1.0
      12th Grade 16.4 14.4 18.3 21.9 23.8 24.6 26.2 25.6 25.9 24.9 25.7 25.4 24.1 23.4 23.1 -0.2
      College Students 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6 21.5 21.9 21.5 21.4 21.2 19.5 -1.7
      Young Adults 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 -0.5
      8th Grade 3.8 4.7 5.3 5.6 6.5 6.9 6.0 5.5 5.5 5.6‡ 5.5 4.7 4.7 4.1 4.1 0.0
      10th Grade 5.5 5.7 6.5 7.1 8.9 8.9 8.8 8.6 8.6 8.5‡ 8.7 8.1 6.9 6.9 6.4 -0.6
      12th Grade 7.1 6.3 7.9 8.8 10.0 9.5 10.7 10.7 10.4 10.4‡ 11.0 11.3 10.4 10.8 10.3 -0.5
      College Students 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4 6.9 7.5 7.8 8.2 9.1 8.2 -0.8
      Young Adults 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8.3 8.5 8.2 -0.3
  Including Inhalants a,c
      8th Grade 8.8 10.0 12.0 14.3 16.1 17.5 16.0 14.9 15.1 14.4 14.0 12.6 12.1 11.2 11.2 0.0
      10th Grade 13.1 12.6 15.5 20.0 21.6 24.5 24.1 22.5 23.1 23.6 23.6 21.7 20.5 19.3 18.4 -1.0
      12th Grade 17.8 15.5 19.3 23.0 24.8 25.5 26.9 26.6 26.4 26.4 26.5 25.9 24.6 23.3 24.2 +1.0
      College Students 15.1 16.5 15.7 16.4 19.6 18.0 19.6 21.0 21.8 22.6 21.9 21.9 21.6 21.7 19.0 -2.7
      Young Adults 15.4 15.3 15.1 16.1 16.1 16.4 16.9 16.7 17.4 18.8 19.2 19.5 20.1 19.6 18.0 -1.6
      8th Grade 3.2 3.7 5.1 7.8 9.1 11.3 10.2 9.7 9.7 9.1 9.2 8.3 7.5 6.4 6.6 +0.3
      10th Grade 8.7 8.1 10.9 15.8 17.2 20.4 20.5 18.7 19.4 19.7 19.8 17.8 17.0 15.9 15.2 -0.7
      12th Grade 13.8 11.9 15.5 19.0 21.2 21.9 23.7 22.8 23.1 21.6 22.4 21.5 21.2 19.9 19.8 -0.2
      College Students 14.1 14.6 14.2 15.1 18.6 17.5 17.7 18.6 20.7 20.0 20.2 19.7 19.3 18.9 17.1 -1.8
      Young Adults 13.5 13.3 13.4 14.1 14.0 15.1 15.0 14.9 15.6 16.1 16.7 16.9 17.3 16.5 15.8 -0.7
      8th Grade 4.4 4.7 5.4 5.6 6.1 5.8 5.6 4.8 5.0 4.5 4.0 3.8 4.1 4.5 4.2 -0.3
      10th Grade 2.7 2.7 3.3 3.6 3.5 3.3 3.0 2.9 2.6 2.6 2.4 2.4 2.2 2.4 2.2 -0.2
      12th Grade 2.4 2.3 2.5 2.7 3.2 2.5 2.5 2.3 2.0 2.2 1.7 1.5 1.5 1.5 2.0 +0.5
      College Students 0.9 1.1 1.3 0.6 1.6 0.8 0.8 0.6 1.5 0.9 0.4 0.7 0.4 0.4 0.3 -0.1
      Young Adults 0.5 0.6 0.7 0.5 0.7 0.5 0.5 0.7 0.8 0.5 0.4 0.5 0.3 0.3 0.2 -0.1
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 0.4 0.3 0.6 0.4 0.4 0.7 0.7 1.0 0.4 0.3 0.5 0.6 0.7 0.7 0.5 -0.3
      College Students — — — — — — — — — — — — — — — —
      Young Adults * 0.1 0.2 0.1 — — — — — — — — — — — —
      8th Grade 0.8 1.1 1.2 1.3 1.7 1.9 1.8 1.4 1.3 1.2‡ 1.6 1.2 1.2 1.0 1.1 +0.1
      10th Grade 1.6 1.8 1.9 2.4 3.3 2.8 3.3 3.2 2.9 2.3‡ 2.1 1.6 1.5 1.6 1.5 0.0
      12th Grade 2.2 2.1 2.7 3.1 4.4 3.5 3.9 3.8 3.5 2.6‡ 3.3 2.3 1.8 1.9 1.9 0.0
      College Students 1.2 2.3 2.5 2.1 3.3 1.9 2.1 2.1 2.0 1.4 1.8 1.2 1.8 1.3 1.2 -0.1
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Any Illicit Drug Other
  Than Marijuanaa,b
Inhalantsc,d
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 0.6 0.9 1.0 1.1 1.4 1.5 1.5 1.1 1.1 1.0 1.0 0.7 0.6 0.5 0.5 0.0
      10th Grade 1.5 1.6 1.6 2.0 3.0 2.4 2.8 2.7 2.3 1.6 1.5 0.7 0.6 0.6 0.6 0.0
      12th Grade 1.9 2.0 2.4 2.6 4.0 2.5 3.1 3.2 2.7 1.6 2.3 0.7 0.6 0.7 0.7 0.0
      College Students 0.8 1.8 1.6 1.8 2.5 0.9 1.1 1.5 1.2 0.9 1.0 0.2 0.2 0.2 0.1 0.0
      Young Adults 0.8 1.1 0.8 1.1 1.3 0.7 0.9 1.0 0.8 0.8 0.7 0.3 0.2 0.1 0.1 0.0
      8th Grade 0.3 0.4 0.5 0.7 0.8 0.9 0.7 0.7 0.6 0.6‡ 1.1 1.0 1.0 0.8 0.9 +0.1
      10th Grade 0.4 0.5 0.7 1.0 1.0 1.0 1.2 1.4 1.2 1.2‡ 1.4 1.4 1.2 1.4 1.3 -0.1
      12th Grade 0.7 0.5 0.8 1.2 1.3 1.6 1.7 1.6 1.6 1.7‡ 1.9 2.0 1.5 1.7 1.6 -0.1
      College Students 0.6 0.7 1.1 0.8 1.6 1.2 1.2 0.7 1.2 0.8 0.8 1.1 1.7 1.2 1.1 -0.2
      Young Adults 0.3 0.5 0.6 0.6 0.6 0.6 0.7 0.5 0.6 0.7 0.6 0.8 1.2 0.9 0.8 -0.1
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 0.5 0.6 1.0 0.7 0.6 1.3 0.7 1.0 0.8 0.9 0.5 0.4 0.6 0.4 0.7 +0.3
      College Students — — — — — — — — — — — — — — — —
      Young Adults 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.0 -0.1
      8th Grade — — — — — 1.0 1.0 0.9 0.8 1.4 1.8 1.4 0.7 0.8 0.6 -0.2
      10th Grade — — — — — 1.8 1.3 1.3 1.8 2.6 2.6 1.8 1.1 0.8 1.0 +0.2
      12th Grade — — — — — 2.0 1.6 1.5 2.5 3.6 2.8 2.4 1.3 1.2 1.0 -0.3
      College Students 0.2 0.4 0.3 0.2 0.7 0.7 0.8 0.8 2.1 2.5 1.5 0.7 1.0 0.7 0.8 +0.1
      Young Adults 0.1 0.3 0.3 0.2 0.4 0.3 0.6 0.8 1.3 1.9 1.8 1.3 0.8 0.6 0.6 0.0
      8th Grade 0.5 0.7 0.7 1.0 1.2 1.3 1.1 1.4 1.3 1.2 1.2 1.1 0.9 0.9 1.0 +0.1
      10th Grade 0.7 0.7 0.9 1.2 1.7 1.7 2.0 2.1 1.8 1.8 1.3 1.6 1.3 1.7 1.5 -0.1
      12th Grade 1.4 1.3 1.3 1.5 1.8 2.0 2.3 2.4 2.6 2.1 2.1 2.3 2.1 2.3 2.3 -0.1
      College Students 1.0 1.0 0.7 0.6 0.7 0.8 1.6 1.6 1.2 1.4 1.9 1.6 1.9 2.4 1.8 -0.6
      Young Adults 2.0 1.8 1.4 1.3 1.5 1.2 1.6 1.7 1.9 1.7 2.2 2.2 2.4 2.2 2.2 -0.1
      8th Grade 0.3 0.5 0.4 0.7 0.7 0.8 0.7 0.9 0.8 0.8 0.8 0.8 0.7 0.6 0.6 0.0
      10th Grade 0.3 0.4 0.5 0.6 0.9 0.8 0.9 1.1 0.8 0.9 0.7 1.0 0.7 0.8 0.7 -0.1
      12th Grade 0.7 0.6 0.7 0.8 1.0 1.0 0.9 1.0 1.1 1.0 1.1 1.2 0.9 1.0 1.0 -0.1
      College Students 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.1 0.3 0.4 0.4 0.1 -0.3
      Young Adults 0.4 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.0
      8th Grade 0.5 0.5 0.6 0.9 1.0 1.0 0.8 1.0 1.1 0.9 0.9 0.8 0.7 0.7 0.7 0.0
      10th Grade 0.6 0.6 0.7 1.0 1.4 1.3 1.6 1.8 1.6 1.6 1.2 1.3 1.1 1.5 1.3 -0.2
      12th Grade 1.2 1.0 1.2 1.3 1.3 1.6 2.0 2.0 2.5 1.7 1.8 1.9 1.8 2.2 2.0 -0.2
      College Students 1.0 0.9 0.6 0.3 0.8 0.6 1.3 1.5 1.0 0.9 1.5 1.4 1.9 2.2 1.8 -0.4
      Young Adults 1.8 1.7 1.1 1.0 1.3 1.1 1.5 1.5 1.6 1.5 1.8 2.0 2.1 2.1 1.9 -0.1
  Other Cocainej




    Other Than LSDb
  PCPg
(Table continued on next page)
Cocaine
TABLE 2-3 (cont'd)
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1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 0.3 0.4 0.4 0.6 0.6 0.7 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.0
      10th Grade 0.2 0.2 0.3 0.4 0.6 0.5 0.6 0.7 0.7 0.5 0.3 0.5 0.3 0.5 0.5 0.0
      12th Grade 0.2 0.3 0.2 0.3 0.6 0.5 0.5 0.5 0.5 0.7 0.4 0.5 0.4 0.5 0.5 0.0
      College Students 0.1 0.0 * 0.0 0.1 * 0.2 0.1 0.1 0.2 0.1 0.0  * 0.1 0.1 0.0
      Young Adults * 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 * 0.1 0.1 0.1 0.0
      8th Grade —  — — — 0.4 0.5 0.4 0.5 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.0
      10th Grade — — — — 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.0
      12th Grade — — — — 0.3 0.4 0.3 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.3 +0.1
      College Students — — — — 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0
      Young Adults — — — — 0.0 0.0 0.1 * 0.1 * 0.2 0.0  * 0.1 0.1 0.0
      8th Grade —  — — — 0.3 0.4 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.0
      10th Grade — — — — 0.3 0.3 0.4 0.5 0.5 0.4 0.2 0.4 0.2 0.3 0.3 0.0
      12th Grade — — — — 0.6 0.4 0.6 0.4 0.4 0.7 0.3 0.5 0.4 0.3 0.5 +0.1
      College Students — — — — 0.0 0.1 0.2 0.2 0.3 0.4 0.3 0.0 0.0 0.3 0.0 -0.3
      Young Adults — — — — 0.1 * 0.1 0.2 0.2 0.2 0.4 * 0.1 0.1 0.1 0.0
      8th Grade —  — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 1.1 1.2 1.3 1.5 1.8 2.0 2.3 2.4 2.6 2.9 3.0‡ 4.0 4.1 4.3 3.9 -0.4
      College Students 0.6 1.0 0.7 0.4 1.2 0.7 1.3 1.1 1.0 1.7 1.7‡ 3.2 2.3 3.0 3.1 +0.1
      Young Adults 0.6 0.7 0.7 0.6 0.9 0.7 0.9 0.9 1.2 1.4 1.7‡ 2.9 2.9 3.0 3.5 +0.5
      8th Grade 2.6 3.3 3.6 3.6 4.2 4.6 3.8 3.3 3.4 3.4 3.2 2.8 2.7 2.3 2.3 0.0
      10th Grade 3.3 3.6 4.3 4.5 5.3 5.5 5.1 5.1 5.0 5.4 5.6 5.2 4.3 4.0 3.7 -0.4
      12th Grade 3.2 2.8 3.7 4.0 4.0 4.1 4.8 4.6 4.5 5.0 5.6 5.5 5.0 4.6 3.9 -0.7 s
      College Students 1.0 1.1 1.5 1.5 2.2 0.9 2.1 1.7 2.3 2.9 3.3 3.0 3.1 3.2 2.9 -0.3
      Young Adults 1.5 1.5 1.5 1.7 1.7 1.5 1.7 1.7 1.9 2.3 2.4 2.5 2.5 2.4 2.1 -0.3
      8th Grade —  — — — — — — — 1.1 0.8 1.3 1.1 1.2 0.6 0.7 +0.2
      10th Grade —  — — — — — — — 1.8 2.0 1.5 1.8 1.4 1.3 1.1 -0.2
      12th Grade — — — — — — — — 1.7 1.9 1.5 1.7 1.7 1.4 0.9 -0.6 s
      College Students —  — — — — — — — 1.2 0.2 0.5 0.2 0.6 0.2 0.1 -0.1
      Young Adults — — — — — — — — 0.8 0.7 1.0 1.0 0.7 0.6 0.7 +0.1
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 0.6 0.5 0.6 0.7 1.1 1.1 0.8 1.2 0.8 1.0 1.1 1.2 0.8 0.8 0.9 +0.1
      College Students 0.0 0.0 0.3 0.5 0.3 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.2 +0.1
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(Table continued on next page)
  Methamphetamineo,p
  With a Needlel
  Without a Needlel
  Icep
50
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 1.4 1.1 1.3 1.7 2.2 2.1 2.1 2.6 2.6 3.0 2.8 3.2 2.9 2.9 3.3 +0.4
      College Students 0.3 0.7 0.4 0.4 0.5 0.8 1.2 1.1 1.1 1.1 1.5 1.7 1.7 1.5 1.3 -0.2
      Young Adults 0.5 0.5 0.6 0.6 0.8 0.8 0.9 0.9 1.1 1.3 1.7 1.5 1.5 1.8 1.7 -0.1
      8th Grade — — — — — — — — — — — — — — — —
      10th Grade — — — — — — — — — — — — — — — —
      12th Grade 0.2 0.4 0.1 0.4 0.4 0.6 0.3 0.6 0.4 0.2 0.5 0.3 0.4 0.5 0.5 0.0
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 0.8 0.8 0.9 1.1 1.2 1.5 1.2 1.2 1.1 1.4‡ 1.2 1.2 1.4 1.2 1.3 +0.1
      10th Grade 1.2 1.5 1.1 1.5 1.7 1.7 2.2 2.2 2.2 2.5‡ 2.9 2.9 2.4 2.3 2.3 -0.1
      12th Grade 1.4 1.0 1.2 1.4 1.8 2.0 1.8 2.4 2.5 2.6‡ 2.9 3.3 2.8 3.1 2.9 -0.2
      College Students 0.6 0.6 0.4 0.4 0.5 0.7 1.2 1.3 1.1 2.0 1.5 3.0 2.8 2.7 2.2 -0.5
      Young Adults 0.9 1.0 1.0 0.8 1.1 0.7 1.1 1.2 1.3 1.8 2.1 2.8 2.4 2.7 2.6 -0.1
      8th Grade — — — — — 0.5 0.3 0.4 0.3 0.3 0.4 0.2 0.1 0.2 0.2 0.0
      10th Grade — — — — — 0.5 0.5 0.4 0.5 0.4 0.2 0.4 0.2 0.3 0.2 0.0
      12th Grade — — — — — 0.5 0.3 0.3 0.3 0.4 0.3 — — — — —
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
  Any Use
      8th Grade 25.1 26.1‡ 24.3 25.5 24.6 26.2 24.5 23.0 24.0 22.4 21.5 19.6 19.7 18.6 17.1 -1.5
      10th Grade 42.8 39.9‡ 38.2 39.2 38.8 40.4 40.1 38.8 40.0 41.0 39.0 35.4 35.4 35.2 33.2 -2.0 s
      12th Grade 54.0 51.3‡ 48.6 50.1 51.3 50.8 52.7 52.0 51.0 50.0 49.8 48.6 47.5 48.0 47.0 -1.0
      College Students 74.7 71.4 70.1 67.8 67.5 67.0 65.8 68.1 69.6 67.4 67.0 68.9 66.2 67.7 67.9 +0.2
      Young Adults 70.6 69.0 68.3 67.7 68.1 66.7 67.5 66.9 68.2 66.8 67.0 68.3 67.0 68.4 68.6 +0.2
      8th Grade 7.6 7.5 7.8 8.7 8.3 9.6 8.2 8.4 9.4 8.3 7.7 6.7 6.7 6.2 6.0 -0.2
      10th Grade 20.5 18.1 19.8 20.3 20.8 21.3 22.4 21.1 22.5 23.5 21.9 18.3 18.2 18.5 17.6 -1.0
      12th Grade 31.6 29.9 28.9 30.8 33.2 31.3 34.2 32.9 32.9 32.3 32.7 30.3 30.9 32.5 30.2 -2.4
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
  Flavored Alcoholic
    Beveragesg,o
      8th Grade — — — — — — — — — — — — — 14.6 12.9 -1.7
      10th Grade — — — — — — — — — — — — — 25.1 23.1 -2.1
      12th Grade — — — — — — — — — — — — — 31.1 30.5 -0.6
      College Students — — — — — — — — — — — — — 34.1 30.9 -3.1
      Young Adults — — — — — — — — — — — — — 29.5 27.6 -1.9
TABLE 2-3 (cont'd)
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(Table continued on next page)
Sedatives (Barbiturates)m





1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
  Any Use
      8th Grade 14.3 15.5 16.7 18.6 19.1 21.0 19.4 19.1 17.5 14.6 12.2 10.7 10.2 9.2 9.3 +0.1
      10th Grade 20.8 21.5 24.7 25.4 27.9 30.4 29.8 27.6 25.7 23.9 21.3 17.7 16.7 16.0 14.9 -1.0
      12th Grade 28.3 27.8 29.9 31.2 33.5 34.0 36.5 35.1 34.6 31.4 29.5 26.7 24.4 25.0 23.2 -1.8
      College Students 23.2 23.5 24.5 23.5 26.8 27.9 28.3 30.0 30.6 28.2 25.7 26.7 22.5 24.3 23.8 -0.5
      Young Adults 28.2 28.3 28.0 28.0 29.2 30.1 29.9 30.9 30.3 30.1 30.2 29.2 28.4 29.2 28.6 -0.7
      8th Grade 6.9 7.0 6.6 7.7 7.1 7.1 5.5 4.8 4.5 4.2 4.0 3.3 4.1 4.1 3.3 -0.8
      10th Grade 10.0 9.6 10.4 10.5 9.7 8.6 8.9 7.5 6.5 6.1 6.9 6.1 5.3 4.9 5.6 +0.7
      12th Grade — 11.4 10.7 11.1 12.2 9.8 9.7 8.8 8.4 7.6 7.8 6.5 6.7 6.7 7.6 +0.9
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
      8th Grade 0.4 0.5 0.5 0.5 0.6 0.4 0.5 0.5 0.7 0.8 0.7 0.8 0.7 0.5 0.5 0.0
      10th Grade 0.6 0.6 0.5 0.6 0.6 0.5 0.7 0.6 0.9 1.0 0.9 1.0 0.8 0.8 0.6 -0.2
      12th Grade 0.8 0.6 0.7 0.9 0.7 0.7 1.0 1.1 0.9 0.8 1.3 1.4 1.3 1.6 0.9 -0.6 s
      College Students — — — — — — — — — — — — — — — —
      Young Adults 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 +0.1




Trends in Thirty-Day Prevalence of Use of Various Drugs for Eighth, Tenth,
and Twelfth Graders, College Students, and Young Adults (Ages 19-28) 
30-Day
change




1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
      8th Grade 0.2 0.2 0.4 0.7 0.8 1.5 1.1 1.1 1.4 1.3 1.3 1.2 1.0 0.8 1.0 +0.2
      10th Grade 0.8 0.8 1.0 2.2 2.8 3.5 3.7 3.6 3.8 3.8 4.5 3.9 3.6 3.2 3.1 -0.1
      12th Grade 2.0 1.9 2.4 3.6 4.6 4.9 5.8 5.6 6.0 6.0 5.8 6.0 6.0 5.6 5.0 -0.6
      College Students 1.8 1.6 1.9 1.8 3.7 2.8 3.7 4.0 4.0 4.6 4.5 4.1 4.7 4.5 4.0 -0.4
      Young Adults 2.3 2.3 2.4 2.8 3.3 3.3 3.8 3.7 4.4 4.2 5.0 4.5 5.3 5.0 4.9 -0.1
Alcohols,x
  Any daily use
      8th Grade 0.5 0.6‡ 1.0 1.0 0.7 1.0 0.8 0.9 1.0 0.8 0.9 0.7 0.8 0.6 0.5 -0.1
      10th Grade 1.3 1.2‡ 1.8 1.7 1.7 1.6 1.7 1.9 1.9 1.8 1.9 1.8 1.5 1.3 1.3 0.0
      12th Grade 3.6 3.4‡ 3.4 2.9 3.5 3.7 3.9 3.9 3.4 2.9 3.6 3.5 3.2 2.8 3.1 +0.3
      College Students 4.1 3.7 3.9 3.7 3.0 3.2 4.5 3.9 4.5 3.6 4.7 5.0 4.3 3.7 4.6 +0.9
      Young Adults 4.9 4.5 4.5 3.9 3.9 4.0 4.6 4.0 4.8 4.1 4.4 4.7 5.1 4.5 5.2 +0.6
  Been Drunk, dailyp,x
      8th Grade 0.1 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.0
      10th Grade 0.2 0.3 0.4 0.4 0.6 0.4 0.6 0.6 0.7 0.5 0.6 0.5 0.5 0.4 0.4 +0.1
      12th Grade 0.9 0.8 0.9 1.2 1.3 1.6 2.0 1.5 1.9 1.7 1.4 1.2 1.6 1.8 1.5 -0.3
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
  5+ drinks in a row
    in last 2 weeks
      8th Grade 12.9 13.4 13.5 14.5 14.5 15.6 14.5 13.7 15.2 14.1 13.2 12.4 11.9 11.4 10.5 -1.0
      10th Grade 22.9 21.1 23.0 23.6 24.0 24.8 25.1 24.3 25.6 26.2 24.9 22.4 22.2 22.0 21.0 -1.0
      12th Grade 29.8 27.9 27.5 28.2 29.8 30.2 31.3 31.5 30.8 30.0 29.7 28.6 27.9 29.2 28.1 -1.1
      College Students 42.8 41.4 40.2 40.2 38.6 38.3 40.7 38.9 40.0 39.3 40.9 40.1 38.5 41.7 40.1 -1.6
      Young Adults 34.7 34.2 34.4 33.7 32.6 33.6 34.4 34.1 35.8 34.7 35.9 35.9 35.8 37.1 37.0 -0.2
Cigarettes
  Any daily use
      8th Grade 7.2 7.0 8.3 8.8 9.3 10.4 9.0 8.8 8.1 7.4 5.5 5.1 4.5 4.4 4.0 -0.3
      10th Grade 12.6 12.3 14.2 14.6 16.3 18.3 18.0 15.8 15.9 14.0 12.2 10.1 8.9 8.3 7.5 -0.7
      12th Grade 18.5 17.2 19.0 19.4 21.6 22.2 24.6 22.4 23.1 20.6 19.0 16.9 15.8 15.6 13.6 -1.9 s
      College Students 13.8 14.1 15.2 13.2 15.8 15.9 15.2 18.0 19.3 17.8 15.0 15.9 13.8 13.8 12.4 -1.4
      Young Adults 21.7 20.9 20.8 20.7 21.2 21.8 20.6 21.9 21.5 21.8 21.2 21.2 20.3 20.8 19.6 -1.2
  1/2 pack+/day
      8th Grade 3.1 2.9 3.5 3.6 3.4 4.3 3.5 3.6 3.3 2.8 2.3 2.1 1.8 1.7 1.7 -0.1
      10th Grade 6.5 6.0 7.0 7.6 8.3 9.4 8.6 7.9 7.6 6.2 5.5 4.4 4.1 3.3 3.1 -0.2
      12th Grade 10.7 10.0 10.9 11.2 12.4 13.0 14.3 12.6 13.2 11.3 10.3 9.1 8.4 8.0 6.9 -1.1 s
      College Students 8.0 8.9 8.9 8.0 10.2 8.4 9.1 11.3 11.0 10.1 7.8 7.9 7.6 6.8 6.7 -0.1
      Young Adults 16.0 15.7 15.5 15.3 15.7 15.3 14.6 15.6 15.1 15.1 14.6 14.2 13.9 13.5 12.5 -1.0
      8th Grade 1.6 1.8 1.5 1.9 1.2 1.5 1.0 1.0 0.9 0.9 1.2 0.8 0.8 1.0 0.7 -0.3
      10th Grade 3.3 3.0 3.3 3.0 2.7 2.2 2.2 2.2 1.5 1.9 2.2 1.7 1.8 1.6 1.9 +0.3
      12th Grade — 4.3 3.3 3.9 3.6 3.3 4.4 3.2 2.9 3.2 2.8 2.0 2.2 2.8 2.5 -0.2
      College Students — — — — — — — — — — — — — — — —
      Young Adults — — — — — — — — — — — — — — — —
Note:       See Table 2-1 for relevant footnotes.
Source:  The Monitoring the Future Study, the University of Michigan.    
TABLE 2-4
Trends in Thirty-Day Prevalence of Daily Use of Various Drugs for Eighth, Tenth,
Smokeless Tobacco, daily t







Trends in Annual Prevalence of an Illicit Drug Use Index
Across Five Populations
         to exclude the inappropriate reporting of nonprescription stimulants.  The prevalence rate dropped
         slightly as a result of this methodological change. 
         NOTES: Use of "any illicit drugs" includes any use of marijuana, LSD, other hallucinogens, crack,  
         other cocaine, or heroin, or any use which is not under a doctor's orders of other opiates, stimulants,
         barbiturates, methaqualone (excluded since 1990), or tranquilizers.


































STUDY DESIGN AND PROCEDURES 
 
 
The Monitoring the Future study’s design yields analytic power well beyond the sum of its 
component parts. Those parts include the cross-sectional study, the repeated cross-sectional 
study, and the panel study. As a cross-sectional study, it provides point estimates of various 
behaviors and conditions at any given point in time. Repeating these cross-sectional studies over 
time allows an assessment of change across years in the same segments of the population. The 
panel-study feature permits the examination of change over time in the same individuals as they 
enter adult roles and environments and assume adult responsibilities. These are all important 
research objectives. However, with a series of panel studies of sequential graduating class 
cohorts of students, in what is known as a cohort-sequential design, we are able to distinguish 
among, and explain, three fundamentally different types of change: period-related, age-related, 
and cohort-related. It is this last feature that creates the synergistic effect in terms of analytic 
power.    
This chapter describes this complex research design, including the sampling plans and field 
procedures used in both the annual in-school cross-sectional surveys of 8th-, 10th-, and 12th-
grade students and the follow-up surveys into early and middle adulthood—the panel studies. 
Related methodological issues such as response rates, population coverage, and the validity of 
the measures are also discussed.  
We begin by describing the design that has been used consistently over the past 31 years to 
survey 12th graders; then we describe the more recently instituted design for 8th and 10th 
graders. Finally, we cover the design for the follow-up surveys of former 12th graders.13, 14 
 
RESEARCH DESIGN AND PROCEDURES FOR THE SURVEYS OF TWELFTH 
GRADERS 
 
Twelfth graders have been surveyed in the spring of each year since 1975. Each year’s data 
collection takes place in approximately 120 to 146 public and private high schools selected to 
provide an accurate representative cross section of 12th graders throughout the coterminous 
United States (see Figure 3-1). 
                                                 
13For a more detailed description of the study design, see Bachman, J. G., Johnston, L. D., & O’Malley, P. M. (2001). The Monitoring the Future 
project after twenty-seven years: Design and procedures. (Monitoring the Future Occasional Paper No. 54) Ann Arbor, MI: Institute for Social 
Research. 
14For a more detailed description of the full range of research objectives of Monitoring the Future, see Johnston, L. D., O’Malley, P. M., 
Schulenberg, J. E., & Bachman, J. G. (2001). The aims and objectives of the Monitoring the Future study and progress toward fulfilling them as 
of 2001. (Monitoring the Future Occasional Paper No. 52) Ann Arbor, MI: Institute for Social Research. 
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The Population Under Study 
We chose the senior year of high school because, for several reasons, it is an optimal point at 
which to monitor the drug use and related attitudes of youth. First, completion of high school 
represents the end of an important developmental stage in this society, demarcating both the end 
of universal education and, for many, the end of living full-time in the parental home. Therefore, 
it is a logical point at which to take stock of the cumulated influences of these two major 
environments on American youth. Further, completion of high school represents the jumping-off 
point from which young people diverge into widely differing social environments and 
experiences. Senior year, then, represents a good time to take a “before” measure, allowing 
calculation of changes that may be attributable to the many environmental and role transitions 
occurring in young adulthood. Finally, there were some important practical advantages to 
building the original system of data collections around samples of 12th graders. The need for 
systematically repeated, large-scale samples from which to make reliable estimates of change 
requires that considerable stress be laid on cost efficiency as well as feasibility. The last year of 
high school constitutes the final point at which a reasonably good national sample of an 
age-specific cohort can be drawn and studied economically. 
The Omission of Dropouts 
One limitation in the study design is the exclusion of those young men and women who drop out 
of high school before graduation—between 15% and 20% of each age cohort nationally, 
according to U.S. Census statistics. Clearly, the omission of high school dropouts introduces 
biases in the estimation of certain characteristics of the entire age group; however, for most 
purposes, the small proportion of dropouts sets outer limits on the bias. Further, since the bias 
from missing dropouts should remain just about constant from year to year, their omission 
should introduce little or no bias in change estimates. Indeed, we believe the changes observed 
over time for those who finish high school are likely to parallel the changes for dropouts in most 
instances. Appendix A to Volume I addresses the likely effects of the exclusion of dropouts on 
estimates of drug use prevalence and trends among the entire age cohort; see that appendix for a 
more detailed discussion of this issue.  
Sampling Procedures 
A multi-stage random sampling procedure is used to secure the nationwide sample of 12th 
graders each year. Stage 1 is the selection of particular geographic areas, Stage 2 is the selection 
(with probability proportionate to size) of one or more high schools in each area, and Stage 3 is 
the selection of 12th graders within each high school. Up to about 350 12th graders in each 
school may be included. In schools with fewer 12th graders, the usual procedure is to include all 
of them in the data collection, though a smaller sample is sometimes taken to accommodate the 
needs of the school. When a subset of 12th graders is to be selected, it is done either by randomly 
sampling entire classrooms or by some other unbiased, random method. Weights are assigned to 
compensate for differential probabilities of selection at each stage of sampling. Final weights are 
normalized to average 1.0 (so that the weighted number of cases equals the unweighted number 
of cases overall). This three-stage sampling procedure has yielded the numbers of participating 
schools and students over the years shown in Table 3-1. 
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About two weeks prior to the questionnaire administration date, parents of the target respondents 
are mailed a letter, usually from the principal, announcing and describing the study and 
providing them an opportunity to decline participation of their son or daughter if they wish. A 
flyer describing the study in more detail is enclosed with the letter. Copies of the same flyers are 
also given to the students by the teachers in the target classrooms in advance of the date of 
administration. The flyers make clear that participation is entirely voluntary. Local Institute for 
Social Research representatives and their assistants conduct the actual questionnaire 
administrations following standardized procedures detailed in a project instruction manual. The 
questionnaires are administered in classrooms during a normal class period whenever possible; 
however, circumstances in some schools require the use of larger group administrations. 
Teachers are asked to remain present in the classroom to help maintain order, but are asked to 
remain at their desks so that they cannot see students’ answers. 
Questionnaire Format 
Because many questions are needed to cover all of the topic areas in the study, much of the 
questionnaire content intended for 12th graders is divided into six different questionnaire forms 
distributed to participants in an ordered sequence that ensures six virtually identical random sub-
samples. (Five questionnaire forms were used between 1975 and 1988.) About one third of each 
questionnaire form consists of key, or “core,” variables common to all forms. All demographic 
variables, and nearly all of the drug use variables included in this report, are contained in this 
core set of measures. Many of the questions dealing with attitudes, beliefs, and perceptions of 
relevant features of the social environment are in a single form only, and the data are thus based 
on one fifth as many cases in 1975–1988 (approximately 3,300) and on one sixth as many cases 
beginning in 1989 (approximately 2,600). All tables in this report list the sample sizes upon 
which the statistics are based, stated in terms of the weighted number of cases (which is roughly 
equivalent to the actual number of cases). 
 
RESEARCH DESIGN AND PROCEDURES FOR THE SURVEYS OF LOWER 
GRADES 
 
In 1991, the study expanded to include nationally representative samples of 8th- and 10th-grade 
students. Surveys at these two grade levels have been conducted on an annual basis since 1991. 
In general, the procedures used for the annual in-school surveys of 8th- and 10th-grade students 
closely parallel those used for 12th graders, including the procedures for selecting schools and 
students, questionnaire administration, and questionnaire formats. A major exception is that only 
two different questionnaire forms were used from 1991 to 1996, expanding to four forms 
beginning in 1997, rather than the six used with 12th graders. Eighth and 10th graders both 
receive the same questionnaire forms and, for the most part, the questionnaire content is drawn 
from the 12th-grade questionnaires. Thus, key demographic variables and measures of drug use 
and related attitudes and beliefs are generally identical for all three grades. The forms used in 
both 8th and 10th grades have a common core (Parts B and C) that parallels the core used in 
12th-grade forms. Many fewer questions about other values and attitudes are included in the 8th- 
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and 10th-grade forms, in part because we think that many of them are likely to be more fully 
formed by 12th grade and, therefore, are best monitored there.  
For the national survey of 8th graders each year, approximately 150 schools (mostly junior high 
schools and middle schools) are sampled, and approximately 17,000 students have been surveyed 
annually. For the 10th graders, approximately 130 high schools are sampled and about 15,000 
students surveyed annually. (See Table 3-1 for specifics.)15 
Mode of Administration 
From 1991 to 1993, follow-ups for 8th and 10th graders were administered similarly to those for 
12th graders (see footnote 3). When follow-up surveys of new cohorts of 8th and 10th graders 
were no longer being conducted, the collection of personal identification information for follow-
up purposes was no longer necessary. For confidentiality reasons, this personal information had 
been gathered on a tear-off sheet at the back of each questionnaire. We believed that there were 
potential advantages in moving toward a fully anonymous procedure for these grade levels, 
including the following: (a) school cooperation might be easier to obtain; (b) any suppression 
effect that the confidential mode of administration might have could be both eliminated and 
quantified; and (c) if there were any mode of administration effect, it would be removed from the 
national data—which are widely compared with results of state and local surveys (nearly all of 
which use anonymous questionnaires)—thus making those comparisons more valid. Therefore, 
in 1998 for the first time, in half of the 8th- and 10th-grade schools surveyed, the questionnaires 
administered were made fully anonymous. Specifically, the half-sample of schools beginning 
their two-year participation in Monitoring the Future in 1998 received the anonymous 
questionnaires, while the half-sample participating in the study for their second and final year 
continued to get the confidential questionnaires.   
A careful examination of the 1998 results, based on the two equivalent half-samples at grade 8, 
and also at grade 10, revealed that there was no effect of this methodological change among 10th 
graders, and, at most, only a very modest effect in the self-reported substance use rates among 
8th graders (with prevalence rates slightly higher in the anonymous condition). The net effect of 
this methodological change is a possible increase in the observed 8th-grade prevalence estimates 
for marijuana, alcohol, and cigarettes in 1998 from what they would have been had there been no 
change in questionnaire administration. For those three drugs, that means that the declines in use 
in 1998 may be slightly understated for the 8th graders only. In other words, the direction of the 
change is the same as that shown in the tables, but the actual declines may be slightly larger than 
those shown. For example, the annual prevalence of marijuana use among 8th graders is shown 
to have fallen by 0.8 percentage points between 1997 and 1998; however, the half-sample of 8th-
                                                 
15The research design originally called for follow-up surveys of sub-samples of the 8th and 10th graders participating in the study, carried out at 
two-year intervals, similar to the 12th-grade follow-up samples. From 1991 to 1994, this plan influenced the design of the cross-sectional studies 
of 8th and 10th graders in an important way. In order to “recapture” many of the 8th-grade participants two years later in the normal 10th-grade 
cross-sectional study for that year, we selected the 8th-grade schools by drawing a sample of high schools and then selecting a sample of their 
“feeder schools” that contained 8th graders. This extra stage in the sampling process meant that many of the 8th-grade participants in, say, the 
1991 cross-sectional survey were also participants in the 1993 cross-sectional survey of 10th graders. Thus, a fair amount of panel data was 
generated at no additional cost. However, having followed this design from 1991 through 1993, we concluded that the savings in follow-up costs 
did not justify the complexities in sampling, administration, and interpretation. Therefore, since 1994, we have used a simplified design in which 
8th-grade schools are drawn independently of the 10th-grade school sample. Further follow-ups (at two-year intervals) have been conducted only 
on panels of students drawn from the first three cohorts of students surveyed in the 8th and 10th grades—that is, those surveyed in school in 
1991, 1992, and 1993. A book reporting results from these panels is now nearing completion and will be published by Lawrence Erlbaum 
Associates in 2007.  
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grade schools receiving exactly the same type of questionnaire that was used in 1997 showed a 
slightly greater decline of 1.5 percentage points.  
For cigarettes, this change in method appeared to have no effect on self-reported rates of daily 
use or half-pack per day use, and to have had only a very small effect on 30-day prevalence. 
Thus, for example, the 30-day prevalence of cigarette use among all of the 8th graders surveyed 
is shown to have fallen 0.3 percentage points between 1997 and 1998; while the half-sample of 
8th-grade schools receiving exactly the same type of questionnaire as was used in 1997 showed a 
slightly greater decline of 0.6 percentage points. Finally, lifetime cigarette prevalence is shown 
as falling by 1.6 percentage points between 1997 and 1998, but in the half-sample of schools 
with a constant methodology, it fell by 2.6 percentage points. 
We have examined in detail the effects of administration mode in a published journal article, in 
which we use multivariate controls to assess the effects of the change on the 8th-grade self-report 
data. It generally shows even less effect than is to be found without such controls.16 
All tables and figures in Volume I use data from both of the two half-samples of 8th graders 
surveyed in a given year, combined. This is also true for the 10th graders (for whom we found no 
methodological effect) and the 12th graders (for whom it is assumed there is no such effect, since 
none was found among the 10th graders). (See this chapter’s later section entitled 
“Representativeness and Sample Accuracy, School Participation,” for a further discussion of 
half-samples among all three grades.)  
In 1999, the remaining half of the participating schools (all beginning the first of their two years 
of participation) received anonymous questionnaires as well. Thus, from 1999 on, all data from 
8th- and 10th-grade students are gathered using anonymous questionnaires. We continue to use 
confidential questionnaires with 12th graders in order to permit follow-up of the small proportion 
that are randomly selected for the panel studies. 
Questionnaire Forms and Sample Proportions 
Another positive consequence of not interlocking the school samples at 8th and 10th grades was 
that we could consider having more forms of the questionnaire.17 Beginning in 1997, the number 
of forms was expanded to four, but the four forms are not distributed in equal numbers. Forms 1, 
2, 3, and 4 are assigned to one third, one third, one sixth, and one sixth of the students, 
respectively. Thus, if a question appears on only one form, it may be administered to either one 
third or one sixth of the sample. Similarly, a question in two forms may be assigned to one third 
of the sample (one sixth plus one sixth), one half of the sample (one third plus one sixth), or two 
thirds of the sample (one third plus one third). No questions appear on exactly three forms. 
Footnotes to the tables indicate what proportion of all respondents in each grade complete the 
question, if that proportion is other than the entire sample. 
                                                 
16O’Malley, P. M., Johnston, L. D., Bachman, J. G., & Schulenberg, J. E. (2000). A comparison of confidential versus anonymous survey 
procedures: Effects on reporting of drug use and related attitudes and beliefs in a national study of students. Journal of Drug Issues, 30, 35–54. 
 
17Earlier, from 1991 through 1996, two questionnaire forms were used in the surveys of 8th- and 10th-grade students, with a random half-sample 
of students in each grade receiving one form and the remainder receiving the other form. (By having only two forms distributed randomly at each 
grade, we could by chance emerge with half of the students being surveyed both times with the same form, making panel analysis possible.)  
With the constraint of “recapturing” students removed, we could consider having a larger number of forms. 
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The two additional forms were introduced to allow for more questions. The new Forms 1 and 2 
substantially follow the content of the previous Forms 1 and 2, but each was now assigned to a 
third of the sample instead of half. Form 3 builds on Form 1, with some questions omitted to 
make room for more content; and Form 4 builds on the content of Form 2 in a similar manner. 
Much of the new content was placed in both of the new forms (Forms 3 and 4), each of which is 
administered to one sixth of the sample, in order to assign one third of the total sample to those 
new questions. 
 
RESEARCH DESIGN AND PROCEDURES FOR THE FOLLOW-UP SURVEYS OF 
TWELFTH GRADERS 
 
Beginning with the graduating class of 1976, some members of each senior class have been 
selected to be surveyed by mail after high school graduation. From the roughly 13,000 to 17,000 
12th graders originally participating in a given senior class, a representative sample of 2,400 
individuals is chosen for follow-up. In order to ensure sufficient numbers of drug users in the 
follow-up surveys, 12th graders reporting 20 or more occasions of marijuana use in the previous 
30 days (i.e., “daily users”), or any use of the other illicit drugs in the previous 30 days, are 
selected with higher probability (by a factor of 3.0) than the remaining 12th graders. Differential 
weighting is then used in all follow-up analyses to compensate for these differential sampling 
probabilities. Because those in the drug-using stratum receive a weight of only 0.33 in the 
calculation of all statistics to correct for their overrepresentation at the selection stage, there are 
actually more follow-up respondents than are reported in the weighted Ns given in the tables.  
The 2,400 participants selected from each 12th-grade class are randomly split into two matching 
groups of 1,200 each—one group to be surveyed on even-numbered calendar years, and the other 
group to be surveyed on odd-numbered years. This two-year cycle is intended to reduce the 
burden on individual respondents, thus yielding a better retention rate across the years. By 
alternating the two half-samples, we have data from a given graduating class every year, even 
though any given respondent participates only every other year. 
Until 2002, each respondent was surveyed up to seven times; at the seventh follow-up, which 
would occur either 13 or 14 years after graduation, the respondents had reached modal age 31 or 
32. Beginning in 2002, the seventh follow-up was discontinued, and each respondent was 
surveyed up to six times, corresponding to modal age 29 or 30. Additional follow-ups still occur 
at modal ages 35, 40, and 45. (Age 45 follow-ups began in 2003, when the class of 1976 reached 
that age.) We expect to be able to continue follow-ups at five-year intervals beyond age 45. Data 
like these, gathered on representative national samples over such a large portion of the life span, 
are extremely rare and can provide needed insight into the etiology of substance use and related 
behaviors across the life course.  
Follow-Up Procedures 
Using information provided by 12th-grade respondents on a tear-off card (containing the 
respondent’s name, address, and phone number, and the name and address of someone who 
would always know how to reach them), mail contact is maintained with the subset of people 
selected for inclusion in the follow-up panels. Newsletters are sent to them each year, and name 
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and address corrections are requested from both the U.S. Postal Service and the individual. 
Questionnaires are sent to each individual biennially in the spring of each year. A check for $20, 
made payable to the respondent, is attached to the front of each questionnaire.18 Reminder letters 
and postcards are sent at fixed intervals thereafter; finally, those who have not responded receive 
a prompting phone call from the Survey Research Center’s phone interviewing facility in Ann 
Arbor, Michigan. If requested, a second copy of the questionnaire is sent; but no questionnaire 
content is administered by phone. If a respondent asks not to be contacted further, that wish is 
honored. 
Follow-Up Questionnaire Format 
The questionnaires used in the young adult follow-up surveys are very much like those used in 
the senior year. They are optically scanned; all forms contain a common core section that 
includes questions on drug use, background factors, and demographic factors; and they have 
questions about a wide range of topics at the beginning and ending sections, many of which are 
unique to each questionnaire form. Many of the questions asked of 12th graders are retained in 
the corresponding follow-up questionnaires, and respondents are consistently mailed the same 
version (or form) of the questionnaire that they first received in senior year, so that changes over 
time in their behaviors, attitudes, experiences, and so forth can be measured. Questions specific 
to high school status and experiences are dropped in the follow-up, of course, and questions 
relevant to post-high school status and experiences are added. Thus, there are questions about 
college, military service, civilian employment, marriage, parenthood, and so on. Most of these 
are added to the core section. For the 5-year surveys that begin at age 35, the questionnaire 
content is streamlined (only one form is used) and directed at the major family and work issues 
of middle adulthood. Still, many of the questions are ones repeated from the young adult surveys. 
For the early follow-up cohorts, the numbers of cases on single-form questions were one fifth the 
size of the total follow-up sample because five different questionnaire forms were used. 
Beginning with the class of 1989, a sixth form was introduced in the senior year. That new 
questionnaire form was first sent to follow-up respondents in 1990; therefore, single-form data 
since then have Ns one sixth the total follow-up sample size. In the follow-up studies, single-
form samples from a single cohort are too small to make reliable estimates; therefore, in most 
cases where they are reported, the data from several adjacent cohorts are combined or 
concatenated. 
 
REPRESENTATIVENESS AND SAMPLE ACCURACY 
 
School Participation 
Schools are invited to participate in the study for a two-year period. For each school that declines 
to participate, a similar school (in terms of size, geographic area, urbanicity, etc.) is recruited as a 
replacement for that “slot.” In 2005, either an original school or a replacement school was 
obtained in 97% of the sample units, or “slots.” With very few exceptions, each school 
                                                 
18For the class of 1991 and all prior classes, the follow-up checks were for $5. The rate was raised to $10, beginning with the class of 1992, to 
compensate for the effects of inflation over the life of the study. An experiment was first conducted that suggested that the increased payment was 
justified based on the increased panel retention it achieved. Payment increased to $20 in 2004 for much the same reason. 
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participating in the first year has agreed to participate in the second year as well. Figure 3-2 
provides the year-specific school participation rates and the percentage of “slots” filled since 
1977. (The data for the years prior to 1991 are for 12th grade only; beginning in 1991, the data 
are for 8th, 10th, and 12th grades, combined.) As shown in the figure, replacements for declining 
schools are obtained in the vast majority of cases. 
Two questions are sometimes raised with respect to school participation rates: (a) Are 
participation rates so low as to compromise the representativeness of the sample? (b) Does 
variation in participation rates over time contribute to changes in estimates of drug use? 
With respect to the first issue, the selection of replacement schools (which occurs in practically 
all instances of an original school refusal) almost entirely removes problems of bias in region, 
urbanicity, and the like that might result from certain schools refusing to participate. Other 
potential biases could be more subtle, however. If, for example, it turned out that most schools 
with “drug problems” refused to participate, the sample would be seriously biased. And if any 
other single factor were dominant in most refusals, that reason for refusal also might suggest a 
source of serious bias. In fact, however, the reasons given for a school refusing to participate 
tend to be varied and are often a function of happenstance specific to that particular year; only a 
very small proportion specifically object to the drug-related or “sensitive” nature of the content 
of the survey. 
If it were the case that schools differed substantially in drug use, then which particular schools 
participated could have a greater effect on estimates of drug use. However, the great majority of 
variance in drug use lies within schools, not between schools. For example, for 10th graders in 
1992, between-schools variance for marijuana use was 4%–6% of the total variance (depending 
on the specific measure); for inhalant use, 1%–2%; for LSD, 2%–4%; for crack cocaine, 1.0%–
1.5%; for alcohol use, 4%–5%; and for cigarette use, 3%–4%. (Eighth- and 12th-grade values are 
similar.) To the extent that schools tend to be fairly similar in drug use, which particular schools 
participate (within a selection framework that seeks national representation) has a small effect on 
estimates of drug use. The fact that the overwhelming majority of variance in drug use lies 
within schools implies that, at least with respect to drug use, schools are for the most part fairly 
similar.19 Further, some, if not most, of the between-schools variance is due to differences related 
to region, urbanicity, etc.—factors that remain well controlled in the present sampling design 
because of the way in which replacement schools are selected. 
With respect to the second issue, the observed data from the series make it extremely unlikely 
that results have been significantly affected by changes in response rates. If changes in response 
rates seriously affected prevalence estimates, there would be noticeable bumps up or down in 
concert with the changing rates. But in fact this series of surveys produces results that are very 
smooth and change in an orderly fashion from one year to the next. This suggests that the level 
of school-related error in the estimates does not vary much over time. Moreover, the fact that 
                                                 
19Among the schools that actually participated in the study, there is very little difference in substance use rates between the schools that were 
original selections, taken as a set, and the schools that were replacement schools. Averaged over the years 1991 through 2000, for grades 8, 10, 
and 12 combined, the difference between original schools and replacement schools averaged 0.03% in the observed prevalence rates averaged 
across a number of drug use measures: two indexes of annual illicit drug use, the annual prevalence of each of the major illicit drug classes, and 
several measures of alcohol and cigarette use. For the individual drugs and drug indexes, the differences between the original and replacement 
schools, averaged across grades and years, fell within ±0.9%.  
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different substances trend in distinctly different ways further refutes any likelihood that changes 
in response rates are affecting prevalence estimates. We have observed, for example, marijuana 
use decreasing while cocaine use was stable (in the early 1980s); alcohol use declining while 
cigarette use was stable (in the mid- to late 1980s); and marijuana use increasing while inhalant 
use was decreasing (from 1994 to 1997). All of these patterns are explainable in terms of 
psychological, social, and cultural factors (as described in this and previous volumes in this 
series) and cannot be explained by the common factor of changes in response rates. 
Of course, there could be some sort of a constant bias across the years; but even in the unlikely 
event that there is, it seems highly improbable that it would be of much consequence for policy 
purposes, given that it would not affect trends and likely would have a very modest effect on 
prevalence rates. Thus we have a high degree of confidence that school refusal rates have not 
seriously biased the survey results.  
Nevertheless, it is apparent that, for a host of reasons, securing high school cooperation rates has 
become more difficult in recent years. This is a problem common to the field, not specific to 
Monitoring the Future. Therefore, in the study’s most recent proposal for continuation, we 
requested funding to permit the payment of schools as a means of increasing their incentives to 
participate. (Several other ongoing school survey studies already use payments to schools.) Such 
payments were approved and were implemented beginning with the 2003 survey. 
At each grade level, schools are selected in such a way that half of each year’s sample comprises 
schools that started their participation the previous year, and half comprises schools that began 
participating in the current year. (Both samples are national replicates, meaning that each is 
drawn to be nationally representative by itself.) This staggered half-sample design is used to 
check on possible errors in the year-to-year trend estimates due to school turnover. For example, 
separate sets of one-year trend estimates are computed based on students in the half-sample of 
schools that participated in both 2003 and 2004, then based on the students in the half-sample 
that participated in both 2004 and 2005, and so on. Thus, each one-year matched half-sample 
trend estimate derived in this way is based on a constant set of schools (about 65 in 12th grade, 
for example). When the trend data derived from the matched half-sample (examined separately 
for each class of drugs) are compared with trends based on the total sample of schools, the results 
are usually highly similar, indicating that the trend estimates are affected little by turnover or 
shifting refusal rates in the school samples. As would be expected, the absolute prevalence-of-
use estimates for a given year are not as accurate using just the half-sample because the sample 
size is only half as large. 
Student Participation 
In 2005, completed questionnaires were obtained from 90% of all sampled students in 8th grade, 
88% in 10th grade, and 82% in 12th grade. (See Table 3-1 for response rates in earlier years.) 
The single most important reason that students are missed is absence from class at the time of 
data collection; in most cases, for reasons of cost efficiency, we do not schedule special 
follow-up data collections for absent students. Students with fairly high rates of absenteeism also 
report above-average rates of drug use; therefore, some degree of bias is introduced into the 
prevalence estimates by missing the absentees. Much of that bias could be corrected through the 
use of special weighting based on the reported absentee rates of the students who did respond; 
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however, we decided not to use such a weighting procedure because the bias in overall drug use 
estimates was determined to be quite small and because the necessary weighting procedures 
would have introduced greater sampling variance in the estimates. Appendix A in an earlier 
report20 provides a discussion of this point, and appendix A in Volume I of the present 
monograph illustrates the changes in trend and prevalence estimates that would result if 
corrections for absentees had been included. Of course, some students are not absent from class 
but simply refuse, when asked, to complete a questionnaire. However, the proportion of explicit 
refusals amounts to less than 1.5% of the target sample for each grade.   
Sampling Accuracy of the Estimates 
Confidence intervals (95%) are provided in Tables 4-1a through 4-1d (Volume I) for lifetime, 
annual, 30-day, and daily prevalence of use for 8th-, 10th-, and 12th-grade students. As can be 
seen in Table 4-1a, confidence intervals for lifetime prevalence for 12th graders average less 
than ±1.5% across a variety of drug classes. That is, if we took a large number of samples of this 
size from the universe of all schools containing 12th graders in the coterminous United States, 95 
times out of 100 the sample would yield a result that would be less than 1.5 percentage points 
divergent from the result we would get from a comparable massive survey of all 12th graders in 
all schools. This is a high level of sampling accuracy, and it should permit detection of fairly 
small changes from one year to the next. Confidence intervals for the other prevalence periods 
(past 12 months, past 30 days, and current daily use) are generally smaller than those for lifetime 
use. In general, confidence intervals for 8th and 10th graders are very similar to those observed 
for 12th graders. Some drugs (smokeless tobacco, PCP, nitrites, and others, as indicated in Table 
2-1 footnotes) are measured on only one or two questionnaire forms; these drugs will have 
somewhat larger confidence intervals due to their smaller sample sizes. Appendix C of Volume I 
contains information for the interested reader on how to calculate confidence intervals around 
other point estimates; it also provides the information needed to compare trends across time or to 
test the significance of differences between subgroups in any given year. 
 
PANEL RETENTION  
 
We discuss here the nature of the problem of panel attrition generally, the response rates we have 
attained in the Monitoring the Future panel surveys in recent years, and evidence relevant to 
assessing the impact of attrition on the study’s research results. 
The Problem of Panel Attrition 
Virtually all longitudinal studies of drug use, including Monitoring the Future, experience 
attrition, which is often differential with respect to substance use.21 In addition, survey response 
                                                 
20Johnston, L. D., O’Malley, P. M., & Bachman, J. G. (1984). Drugs and American high school students: 1975–1983. DHHS (ADM) 85-1374.  
Washington, DC: U.S. Government Printing Office. 
21McGuigan, K. A., Ellickson, P. L., Hays, R. D., & Bell, R. M. (1997). Adjusting for attrition in school-based samples: Bias, precision, and cost 
trade-off of three methods. Evaluation Review, 21, 554–567. 
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rates in general have been declining over the past few decades,22 highlighting an important 
challenge in the conduct of population-based research. 
A vital feature of the Monitoring the Future panel studies is their very low cost per respondent. 
There are many advantages to collecting panel data through low-cost mail surveys, as we have 
done since the outset of the study. Indeed, given the number of panel surveys we administer each 
year (roughly 15,000) across the entire coterminous United States, using low-cost mail surveys is 
our best (and really the only) cost-effective option. One disadvantage of this mode of data 
collection is that attrition rates tend to be higher than those that might be obtained with much 
more expensive methods, such as intensive personal tracking and interviewing. Certainly there 
exist a few large epidemiological/etiological surveys that have better retention rates, but their 
procedures are extremely expensive and not realistic for an ongoing effort like this one. 
Nevertheless, our retention rates compare reasonably favorably with those of most longitudinal 
studies (including interview studies) reported in the field.  
Response Rates Attained 
We begin with the college student segment in the follow-up sample. The series of survey data on 
American college students now goes back 25 years. We know about our respondents’ actual 
college attendance only from those who are invited and do complete follow-up questionnaires; 
however, we can use senior year questionnaire answers (i.e., college intentions and program of 
study) to predict college attendance with a high degree of accuracy. The study’s retention of 
college-bound 12th graders remains quite good. Among those follow-up respondents who, in 
high school, reported plans to attend college and enrollment in a college-prep curriculum, the 
follow-up retention rates in 2001, for example, for the three most recent classes surveyed at each 
follow-up point were as follows: 70% in the first follow-up, one to two years past high school 
(based on the classes of 1998–2000); 67% in the second follow-up, three to four years past high 
school (based on the classes of 1996–1998); and 65% in the third follow-up, five to six years past 
high school (based on the classes of 1994–1996). To date in Volume II, we have reported only 
on college students who are one to four years past high school graduation. As the average age of 
attendance rises, having the extended age coverage will be of growing importance. The follow-
up participation rates just noted compare favorably with another major national survey of 
substance use among college students, the Harvard College Alcohol Study, which in both its 
1997 and 1999 surveys had cross-sectional response rates of 60%.23 
Retention rates in the biennial follow-ups of all panel members ages 19–30 (corresponding to the 
first six follow-ups) decline with the length of the follow-up interval, of course. For the five-year 
period from 2001 to 2005, the response rate in the first follow-up (corresponding to 1–2 years 
past high school) averaged 59%; and for the second through sixth follow-ups (corresponding to 
3–12 years past high school) response rates averaged 54%. Among the very long-term 
respondents—the 35-, 40-, and 45-year-olds—the retention rates are quite good, apparently 
because some of the decline with age in retention rates reflects cohort differences. Among the 
35-year-old respondents surveyed from 2001 to 2005 (corresponding to 17 years past high 
                                                 
 
22Groves, R. M., Dillman, D. A., Eltinge, J. L., & Little, R. J. A. (Eds.) (2002). Survey nonresponse. New York: Wiley. 
 
23Wechsler, H., Lee, J. E., Kuo, M., & Lee, H. (2000). College binge drinking in the 1990s: A continuing problem. Results of the Harvard School 
of Public Health 1999 College Alcohol Study. Journal of American College Health, 48, 195–198. 
65




school), the average response rate was 50%. Among the 40-year-old respondents surveyed from 
2001 to 2005, corresponding to a 22-year follow-up interval, the average retention rate was 57%. 
Among 45-year-olds surveyed in 2003 to 2005, the average retention rate was 60%.  
In sum, the response rates attained under the current design range from respectable to quite good, 
especially when the low-cost nature of the procedures and the substantial length of the 
questionnaires are taken into account. More importantly, the evidence leaves us confident that 
the data resulting from these follow-up panels are reasonably accurate, which brings us to our 
adjustments for panel attrition and the comparison of our results with those from other sources. 
The Impact of Panel Attrition on Research Results 
An important purpose of the Monitoring the Future follow-ups is to allow estimation of drug 
prevalence rates among American high school graduates at various age levels, as published 
annually in Volume II of this series. Thus, we have always been concerned about making the 
appropriate adjustments to account for panel attrition. In essence, our standard adjustment 
procedure is a poststratification procedure in which we reweight the data from the individuals 
obtained in the follow-up samples so that their reweighted senior year distribution on a given 
drug reproduces the original (senior year) distribution of use originally observed for that drug 
based on all participating seniors. This procedure is carried out (separately) for cigarettes, 
alcohol, and marijuana, as well as other illicit drugs (combined). As expected, this procedure 
produces estimates that are somewhat higher than those uncorrected for attrition, indicating that 
there is indeed some positive association between drug use and panel attrition. However, the 
adjustments are relatively modest, as is documented next.   
One reason the adjustments are modest is that attrition rates do not differ greatly by levels of 
senior year substance use; they do differ, but less than one might expect. For example, among all 
respondents who had never used marijuana, an average of 81% of the classes of 1976–1993 
participated in the first follow-up. The proportion responding is somewhat lower among those 
who had used marijuana once or twice in the past 12 months: 78%. This proportion decreases 
gradually with increasing levels of marijuana use; but even among those who used marijuana on 
20–39 occasions in the past 30 days in their high school senior year, 71% participated in the first 
follow-up. The corresponding participation rates for the same drug-use strata at the fourth 
follow-up (i.e., at ages 25–26) were 68%, 65%, and 60%, respectively. Thus, even among those 
who in high school were quite heavy users of marijuana, response rates at the fourth follow-up 
were only eight percentage points lower than among those who had never used marijuana by 
high school senior year. That is not to say that we assume that all types of drug users remain in 
the panels at comparably high rates. We believe that people who become dependent on, or 
addicted to, heroin or cocaine are unlikely to be retained in reasonable proportions. That is why 
we are careful to not quantify or characterize these special segments of the population. But we 
note that they constitute very low proportions of the drug-using portion of the population, and 
even lower proportions of the entire adult population. Therefore, for a great many purposes, our 
samples are extremely useful. 
The National Survey on Drug Use and Health (NSDUH) would seem to provide the best 
available data against which to validate the estimates generated for adult age groups in 
Monitoring the Future because it is also based on national samples, but uses cross-sectional 
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surveys that do not carry the burden of panel attrition. (Their results, of course, may be affected 
by their own nonresponse rates; but that will be true of any comparison survey. The overall 
response rate for the NSDUH in 2004 was 70.0%.)  
In some earlier analyses we compared the prevalence rates on a set of drugs—cigarettes, alcohol, 
marijuana, and cocaine—for which there was reasonable similarity in question wording across 
the two studies. The comparisons that follow are for the age group 19–28 in the Monitoring the 
Future panel data, and for 19–28 (or 19–29 for 1999 only) in the NSDUH cross-sectional data. 
At that time, the most recent data from NSDUH that were readily available for these 
comparisons were for 1999, so the following comparisons are for that year. (However, similar 
comparisons were run for a number of prior years, and the outcomes were highly consistent.) 
The comparisons are not perfect; most notably, the NSDUH data contain school dropouts and, 
other things equal, this inclusion would lead one to expect its rates of substance use to be higher 
than those from Monitoring the Future. Nevertheless, the Monitoring the Future estimates for the 
30-day prevalence of marijuana are actually higher (14.0% without poststratification and 15.6% 
with it) than the NSDUH estimate (11.0%). The same is true for the 12-month cocaine 
prevalence estimate (4.8% without poststratification and 5.4% with it, vs. 4.3% in the NSDUH).  
The other two comparisons made were for alcohol and cigarettes. Both of these drugs show 
larger differences, with alcohol use consistently higher in Monitoring the Future and cigarette 
use consistently higher in NSDUH. We believe it likely that both are due to definitional 
differences in the exact question wording. In 1999, Monitoring the Future estimates of 30-day 
alcohol prevalence were 68.0% and 68.2% (with poststratification) vs. 59.5% in NSDUH. For 
cigarettes, the 30-day Monitoring the Future prevalence estimates were 28.3% and 30.3%, 
respectively, vs. 37.4% in NSDUH. It is worth noting that the nature and magnitude of the 
differences between Monitoring the Future and NSDUH estimates tend to be quite consistent for 
each of the four drugs at least as far back as 1992. 
The fact that Monitoring the Future estimates for both marijuana and cocaine are higher than 
NSDUH estimates (especially after applying the poststratification reweighting) suggests that 
attrition does not produce substantially lower estimates of drug use than would be obtained if 
response rates were higher. Our estimates come out as high as, and in fact somewhat higher than, 
the best available comparison study for estimating rates using cross-sectional data, and that 
despite our loss of dropouts and absentees (in high school) from the MTF samples. 
It is also worth noting that even with attrition, there remain in the Monitoring the Future follow-
up samples substantial proportions of recent users of the various substances. In recent years, 
about 15%–17% of the 19–28-year-old respondents reported marijuana use in just the prior 30 
days, and about 5%–7% reported past 12-month use of cocaine. These proportions and the 
underlying numbers of actual cases are quite adequate for analytic purposes, particularly given 
that the follow-up surveys over-sample those who reported illicit drug use in the senior year 
surveys. 
An important point worth emphasizing here is that in the present study, attrition is not 
necessarily as great a problem as is nonresponse in a cross-sectional study. This is because we 
already know a great deal about each of the follow-up nonrespondents, including their substance 
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use, based on a lengthy questionnaire in senior year (and, for many, in subsequent years as well). 
Thus, adjustments can be made utilizing data that are highly informative about the missing 
individuals.   
Effects on Relational Analyses  
While differential attrition (uncorrected) may contribute to some bias in point estimates and 
other univariate statistics, such attrition tends to have less influence on bivariate and multivariate 
statistics. This was found to be true in a secondary analysis of data from seven panel studies that 
followed adolescents over time,24 and we have found this to be true in our Monitoring the Future 
panel analyses25 and in analyses with other panel data sets.26 Thus, differential attrition may be of 
less concern in multivariate panel analyses focused on understanding the course, causes, and 
consequences of substance use. Still, as we summarized above, correcting for attrition is 
important, and we continue to do so. 
 
VALIDITY OF THE MEASURES OF SELF-REPORTED DRUG USE 
 
Are sensitive behaviors such as drug use honestly reported? Like most studies dealing with 
sensitive behaviors, we have no direct, totally objective validation of the present measures; 
however, the considerable amount of existing inferential evidence strongly suggests that the 
self-report questions used in Monitoring the Future produce largely valid data. A more complete 
discussion of the contributing evidence that leads to this conclusion may be found in other 
publications;27 Here we only briefly summarize the evidence. 
First, using a three-wave panel design, we established that the various measures of self-reported 
drug use have a high degree of reliability—a necessary condition for validity.28 In essence, 
respondents were highly consistent in their self-reported behaviors over a three- to four-year time 
interval. Second, we found a high degree of consistency among logically related measures of use 
within the same questionnaire administration. Third, the proportion of 12th graders reporting 
some illicit drug use by senior year has reached two-thirds of all respondents in peak years and 
                                                 
24Cordray, S., & Polk, K. (1983). The implication of respondent loss in panel studies of deviant behavior. Journal of Research in Crime and 
Delinquency, 20, 214–242. 
25Bryant, A. L., Schulenberg, J. E., Bachman, J. G., O’Malley, P. M., & Johnston, L. D. (2000). Understanding the links among school 
misbehavior, academic achievement, and cigarette use: A national panel study of adolescents. Prevention Science, 1(2), 71–87; Schulenberg, J. 
E., Bachman, J. G., O’Malley, P. M., & Johnston, L. D. (1994). High school educational success and subsequent substance use: A panel analysis 
following adolescents into young adulthood. Journal of Health and Social Behavior, 35, 45–62. 
26Bachman, J. G., O’Malley, P. M., & Johnston, J. (1978). Youth in Transition: Vol. 6. Adolescence to adulthood: A study of change and stability 
in the lives of young men. Ann Arbor, MI: Institute for Social Research; Schulenberg, J. E., Bryant, A. L., & O’Malley, P. M. (2004). Taking hold 
of some kind of life: How developmental tasks relate to trajectories of well-being during the transition to adulthood. Development and 
Psychopathology, 16, 1119–1140. 
27Johnston, L. D., & O’Malley, P. M. (1985). Issues of validity and population coverage in student surveys of drug use. In B. A. Rouse, N. J. 
Kozel, & L. G. Richards (Eds.), Self-report methods of estimating drug use: Meeting current challenges to validity (NIDA Research Monograph 
No. 57 (ADM) 85-1402). Washington, DC: U.S. Government Printing Office; Johnston, L. D., O’Malley, P. M., & Bachman, J. G. (1984).  
Drugs and American high school students: 1975–1983. DHHS (ADM) 85-1374. Washington, DC: U.S. Government Printing Office; Wallace, J. 
M., Jr., & Bachman, J. G. (1993). Validity of self-reports in student-based studies on minority populations: Issues and concerns. In M. de LaRosa 
(Ed.), Drug abuse among minority youth: Advances in research and methodology. NIDA Research Monograph. Rockville, MD: National Institute 
on Drug Abuse. 
28O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. International Journal of the 
Addictions, 18, 805–824. 
68




over 80% in some follow-up years, constituting prima facie evidence that the degree of 
underreporting must be very limited. Fourth, the 12th graders’ reports of use by their unnamed 
friends—about whom they would presumably have less reason to distort reports of use—have 
been highly consistent with self-reported use in the aggregate, in terms of both prevalence and 
trends in prevalence, as will be discussed later in this report. Fifth, we have found self-reported 
drug use to relate in consistent and expected ways to a number of other attitudes, behaviors, 
beliefs, and social situations—in other words, there is strong evidence of “construct validity.” 
Sixth, the missing data rates for the self-reported use questions are only very slightly higher than 
for the preceding nonsensitive questions, in spite of explicit instructions to respondents 
immediately preceding the drug section to leave blank those drug use questions they felt they 
could not answer honestly. Seventh, an examination of consistency in reporting of lifetime use 
conducted on the long-term panels of graduating seniors found quite low levels of recanting of 
earlier-reported use of the illegal drugs.29 There was a higher level of recanting for the 
psychotherapeutic drugs, which we interpreted as suggesting that adolescents actually may 
overestimate their use of some of these drugs because of misinformation about definitions that is 
corrected as they get older. Finally, the great majority of respondents, when asked, say they 
would answer such questions honestly if they were users.30 
This is not to argue that self-reported measures of drug use are valid in all cases. In the present 
study we have gone to great lengths to create a situation and set of procedures in which students 
recognize that their confidentiality will be protected. We have also tried to present a convincing 
case as to why such research is needed. The evidence suggests that a high level of validity has 
been obtained. Nevertheless, insofar as any remaining reporting bias exists, we believe it to be in 
the direction of underreporting. Thus, with the possible exception of the psychotherapeutic 
drugs, we believe our estimates to be lower than their true values, even for the obtained samples, 
but not substantially so. 
One additional procedure we undertake to help assure the validity of our data is worth noting. 
We check for logical inconsistencies in the triplets of answers about the use of each drug (i.e., 
about lifetime, past year, and past 30-day use), and if a respondent exceeds a minimum number 
of inconsistencies across the drug use questions, his or her record is deleted from the data set. 
Similarly, we check for improbably high rates of use of multiple drugs and delete such cases, on 
the assumption that the respondents are not taking the task seriously. Fortunately, relatively few 
cases have to be eliminated for these reasons. 
Consistency and the Measurement of Trends 
One further point is worth noting in a discussion of the validity of the findings. The Monitoring 
the Future project is designed to be sensitive to changes from one time period to another. A great 
strength of this study, in our opinion, is that the measures and procedures have been standardized 
                                                 
29Johnston, L. D. & O’Malley, P. M. (1997). The recanting of earlier reported drug use by young adults. In L. Harrison (Ed.), The validity of self-
reported drug use: Improving the accuracy of survey estimates (pp. 59–80). (NIDA Research Monograph 167, pp. 59–79). Rockville, MD: 
National Institute on Drug Abuse. 
 
30For a discussion of reliability and validity of student self-report measures of drug use like those used in Monitoring the Future across varied 
cultural settings, see also Johnston, L. D., Driessen, F. M. H. M., & Kokkevi, A. (1994). Surveying student drug misuse: A six-country pilot study.  
Strasbourg, France: Council of Europe. 
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and applied consistently across many years. To the extent that any biases remain because of 
limits in school and/or student participation, and to the extent that there are distortions (lack of 
validity) in the responses of some students, it seems very likely that such problems will exist in 
much the same proportions from one year to the next. In other words, biases in the survey 
estimates will tend to be consistent from one year to another, which means that our measurement 
of trends should be affected very little by any such biases. The smooth and consistent nature of 
most trend curves reported for the various drugs provides rather compelling empirical support for 
this assertion. 
70
Grade: 8th 10th 12th 8th 10th 12th 8th 10th 12th Total 8th 10th 12th Total 8th 10th 12th
1975 — — 111 — — 14 — — 125 — — — 15,791 — — — 78%
1976 — — 108 — — 15 — — 123 — — — 16,678 — — — 77
1977 — — 108 — — 16 — — 124 — — — 18,436 — — — 79
1978 — — 111 — — 20 — — 131 — — — 18,924 — — — 83
1979 — — 111 — — 20 — — 131 — — — 16,662 — — — 82
1980 — — 107 — — 20 — — 127 — — — 16,524 — — — 82
1981 — — 109 — — 19 — — 128 — — — 18,267 — — — 81
1982 — — 116 — — 21 — — 137 — — — 18,348 — — — 83
1983 — — 112 — — 22 — — 134 — — — 16,947 — — — 84
1984 — — 117 — — 17 — — 134 — — — 16,499 — — — 83
1985 — — 115 — — 17 — — 132 — — — 16,502 — — — 84
1986 — — 113 — — 16 — — 129 — — — 15,713 — — — 83
1987 — — 117 — — 18 — — 135 — — — 16,843 — — — 84
1988 — — 113 — — 19 — — 132 — — — 16,795 — — — 83
1989 — — 111 — — 22 — — 133 — — — 17,142 — — — 86
1990 — — 114 — — 23 — — 137 — — — 15,676 — — — 86
1991 131 107 117 31 14 19 162 121 136 419 17,844 14,996 15,483 48,323 90% 87% 83
1992 133 106 120 26 19 18 159 125 138 422 19,015 14,997 16,251 50,263 90 88 84
1993 126 111 121 30 17 18 156 128 139 423 18,820 15,516 16,763 51,099 90 86 84
1994 116 116 119 34 14 20 150 130 139 419 17,708 16,080 15,929 49,717 89 88 84
1995 118 117 120 34 22 24 152 139 144 435 17,929 17,285 15,876 51,090 89 87 84
1996 122 113 118 30 20 21 152 133 139 424 18,368 15,873 14,824 49,065 91 87 83
1997 125 113 125 27 18 21 152 131 146 429 19,066 15,778 15,963 50,807 89 86 83
1998 122 110 124 27 19 20 149 129 144 422 18,667 15,419 15,780 49,866 88 87 82
1999 120 117 124 30 23 19 150 140 143 433 17,287 13,885 14,056 45,228 87 85 83
2000 125 121 116 31 24 18 156 145 134 435 17,311 14,576 13,286 45,173 89 86 83
2001 125 117 117 28 20 17 153 137 134 424 16,756 14,286 13,304 44,346 90 88 82
2002 115 113 102 26 20 18 141 133 120 394 15,489 14,683 13,544 43,716 91 85 83
2003 117 109 103 24 20 19 141 129 122 392 17,023 16,244 15,200 48,467 89 88 83
2004 120 111 109 27 20 19 147 131 128 406 17,413 16,839 15,222 49,474 89 88 82
2005 119 107 108 27 20 21 146 127 129 402 17,258 16,711 15,378 49,347 90 88 82
Source:   The Monitoring the Future Study, the University of Michigan.


















































































































































































































































































Figure 3-2 School Response Rates
77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98
Total 97.8 98.7 96.6 94.9 95.5 97.1 98.6 97.9 96.4 99.3 98.5 97.7 98.5 99.3 98.0 98.0 99.0 97.0 96.0 96.0 98.0 99.0
bottom origin58.5 62.7 61.7 62.5 70.9 70.7 66.4 71.6 67.1 66.4 72.1 71.4 68.1 70.1 59.5 55.3 60.3 53.5 52.0 52.6 51.0 50.6
top repla 39.3 35.9 34.9 32.4 24.6 26.4 32.1 26.2 29.3 32.8 26.5 26.3 30.4 29.2 38.5 42.7 38.7 43.5 44.0 43.4 47.0 48.4
--> Total 98 99 97 95 96 97 99 98 96 99 99 98 99 99 98 98 99 97 96 96 98 99
--> origin 59 63 62 63 71 71 66 72 67 66 72 71 68 70 59 55 60 53 52 53 51 51
delete repla 39 36 35 32 25 26 32 26 29 33 26 26 30 29 39 43 39 44 44 43 47 48
77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98
origin 59 63 62 63 71 71 66 72 67 66 72 71 68 70 59 55 60 53 52 53 51 51
repla 39 36 35 32 25 26 32 26 29 33 26 26 30 29 39 43 39 44 44 43 47 48
total 98 99 97 95 96 97 99 98 96 99 99 98 99 99 98 98 99 97 96 96 98 99
77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05
Original 59 63 62 63 71 71 66 72 67 66 72 71 68 70 59 55 60 53 52 53 51 51 57 62 56 49 53 62 63
Replacements 39 36 35 32 25 26 32 26 29 33 26 26 30 29 39 43 39 44 44 43 47 48 42 35 42 48 45 37 34

































PREVALENCE OF DRUG USE 
IN EARLY AND MIDDLE ADULTHOOD 
 
 
Estimates of drug use in the adult population are most often generated through household survey 
interviews of cross sections of the general population. However, in this study our estimates use data 
from self-completed mail questionnaires from respondents in the follow-up surveys; these consist of 
representative samples of previous classes of high school students, who started their participation in 
the study in their senior year. As described in more detail in chapter 3, the Monitoring the Future 
study has conducted ongoing panel studies on representative samples from each graduating high 
school senior class, beginning with the class of 1976. From each graduating class, two matched 
subpanels of roughly 1,200 students each are randomly selected to comprise long-term follow-up 
panels—one of these two panels is surveyed every even-numbered year after graduation, and the 
other is surveyed every odd-numbered year, up through age 30. (This alternating panel design was 
chosen to reduce the repetitiveness of participating in the panel study, because the questionnaire 
remains the same between ages 19 and 30. So, each respondent participates only every other year.) 
Thus, in a given year, the study encompasses one of the two panels from each of the last 12 senior 
classes previously participating in the study.31 Because the study design calls for an end of the 
biennial follow-ups of these panels after the respondents reach approximately age 30 (i.e., six 
follow-ups for each half panel), in 2005 the (older) classes of 1976 through 1992 were not included 
in the standard, biennial follow-up surveys. Rather, representative samples of the classes of 1993 
through 2004 were surveyed, using the standard young adult survey instruments. For brevity, we 
refer to this 19- through 30-year-old age group as “young adults” in this chapter. 
Additional surveys are conducted at modal age 35 (that is, 17 years after high school graduation) and 
at five-year intervals thereafter. In 2005, the class of 1988 received the “age-35” follow-up 
questionnaire, the class of 1983 received the “age-40” questionnaire, and the class of 1978 received 
the “age-45” questionnaire. The findings from these special five-year follow-up questionnaires are 
included here, so this chapter spans the age interval of 18 (twelfth graders) to 45. 
The results of these 2005 follow-up surveys should accurately characterize approximately 86% of all 
young adults 1 to 12 years beyond high school (modal ages 19 to 30) as well as 86% of adults 17, 
22, and 27 years beyond high school (modal ages 35, 40, and 45). The remaining 14% or so—the 
high school dropout segment—were missing from the senior year surveys and, of course, were 
missing from all of the follow-up surveys as well. Thus, the results presented here are not 
necessarily generalizable to that small segment of the population. The more typical household 
survey approach in theory does not miss this segment, although the segment is probably 
underrepresented to some degree because these respondents tend to be more difficult to locate and 
interview.   
                                                 
31Through 2001, the follow-ups also included modal ages 31 and 32. This seventh follow-up was dropped in 2002 because we believed that the 
marginal costs no longer were justified by the marginal benefits of having this follow-up data, given that an age-35 survey is being conducted. 
Throughout the time between surveys, we send a newsletter to respondents in order to help maintain contact with them. 
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Figures 4-1 through 4-21 contain the 2005 prevalence data by age, corresponding to those 
respondents 1 to 12 years beyond high school (modal ages 19 to 30), as well as 18-, 35-, 40-, and 45-
year-olds. Figures provided in chapter 5 contain the trend data for each age group, including 12th 
graders and high school graduates through age 45. With the exception of the 12th graders, age 
groups have been paired into two-year intervals in both sets of figures in order to increase the 
number of cases, and thus the precision, for each point estimate. The data for ages 35, 40, and 45 are, 
of necessity, based on a single age in each case. Both half samples from a given class cohort are 
included in each year’s samples of 35-, 40-, and 45-year-olds, so in 2005 the two half samples come 
from the graduating classes of 1988, 1983, and 1978, respectively. Their respective weighted 
numbers of cases are 1,030, 968, and 1,042. (Actual, unweighted numbers are somewhat higher.) 
It is worth noting that the pattern of age-related differences showing up in any one year can be 
checked in an adjacent year (i.e., the previous year’s volume or the succeeding year’s) for 
replicability, because two nonoverlapping half samples of follow-up respondents in the 19 to 30 age 
band are surveyed on alternating years. In the case of the 35-, 40-, and 45-year-olds, two entirely 
different graduating classes make up the samples for any two adjacent years. 
 
A NOTE ON ADJUSTED LIFETIME PREVALENCE ESTIMATES 
 
In Figures 4-1 through 4-21, two different estimates of lifetime prevalence are provided. One 
estimate is based on the respondent’s most recent statement of whether he or she ever used the drug 
in question (the light gray bar). The other estimate takes into account the respondent’s answers 
regarding lifetime use gathered in all of the previous data collections in which he or she participated 
(the white bar). To be categorized as one who has used the drug based on all past answers regarding 
that drug, the respondent must have reported either lifetime use in the most recent data collection 
and/or some use in his or her lifetime on at least two earlier occasions. Because respondents in the 
age groups of 18-year-olds and 19- to 20-year-olds cannot have their responses adjusted on the basis 
of two earlier occasions, adjusted prevalence rates are reported only for ages 21 and up. Most 
epidemiological studies can present only an unadjusted estimate because they have data from a 
single cross-sectional survey. An adjusted estimate of the type used here is possible only when panel 
data have been gathered so that a respondent can be classified as having used a drug at some time in 
his or her life, based on earlier answers, even though he or she no longer indicates lifetime use in the 
most recent survey. 
The divergence of these two estimates as a function of age shows that there is more inconsistency as 
time passes. Obviously, there is more opportunity for inconsistency as the number of data collections 
increases. Our judgment is that “the truth” lies somewhere between the two estimates: the lower 
estimate may be depressed by tendencies to forget, forgive, or conceal earlier use, and the upper 
estimate may include earlier response errors or incorrect definitions of drugs that respondents 
appropriately corrected in later surveys as they became more knowledgeable. It should be noted that 
a fair proportion of those giving inconsistent answers across time had earlier reported having used 
the given drug only once or twice in their lifetime.  
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As we have reported elsewhere, the cross-time stability of self-reported usage measures, taking into 
account both prevalence and frequency of self-reported use, is still very high.32 Note that the 
divergence between the two lifetime prevalence estimates is greatest for the psychotherapeutic drugs 
and for the derivative index of “use of an illicit drug other than marijuana,” which is heavily affected 
by the psychotherapeutic estimates. We believe this is due to respondents having greater difficulty 
accurately categorizing psychotherapeutic drugs (usually taken in pill form) with a high degree of 
certainty—especially if such a drug was used only once or twice. We expect higher inconsistency 
across time when the event—and in many of these cases, a single event—is reported with a 
relatively low degree of certainty at quite different points in time. Those who have gone beyond 
simple experimentation with one of these drugs would undoubtedly be able to categorize them with a 
higher degree of certainty. Also, those who have experimented more recently, in the past month or 
year, should have a higher probability of recall, as well as fresher information for accurately 
categorizing the drug. 
We provide both estimates to make clear that a full use of respondent information provides a 
possible range for lifetime prevalence estimates, not a single point. However, by far the most 
important use of the prevalence data is to track trends in current (as opposed to lifetime) use. Thus, 
we are much less concerned about the nature of the variability in the lifetime estimates than we 
might otherwise be. The lifetime prevalence estimates are of importance primarily in showing the 
degree to which a drug class has penetrated the general population overall as well as particular 
cohorts; we believe that the evidence from the lifetime estimates suggests that cross-sectional 
surveys of adults are subject to underreporting, and to a degree such underreporting increases with 
age.33 
The reader is reminded that the reweighting procedures used to correct the panel data for the effects 
of panel attrition are described in chapter 3.  
  
 
PREVALENCE OF DRUG USE AS A FUNCTION OF AGE 
 
Figures 4-1 through 4-21 provide 2005 age comparisons of prevalence rates for each class of drugs, 
covering the age range 18 to 45. For virtually all drugs, available age comparisons show much 
higher lifetime prevalence for the older age groups, as would be expected. In fact, the figures reach 
impressive levels among adults in their early 30s through their mid-40s. 
• The adjusted lifetime prevalence figures are most impressive for today’s 40- and 45-year-
olds, who were passing through adolescence in the peak of the drug epidemic. Some 81% 
and 88% of them, respectively, reported trying an illicit drug (lifetime prevalence, adjusted), 
leaving only 19% and 12% who have reported not doing so. (See Figure 4-1.) Some 75% and 
79% of the 40- and 45-year-olds, respectively, said they had tried marijuana, and about two 
                                                 
32O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1983). Reliability and consistency in self-reports of drug use. International Journal of the 
Addictions, 18, 805–824. 
33For a more detailed analysis and discussion, see Johnston, L. D., & O’Malley, P. M. (1997). The recanting of earlier-reported drug use by young 
adults. In L. Harrison, & A. Hughes (Eds.), The validity of self-reported drug use: Improving the accuracy of survey estimates. (NIDA Research 
Monograph No. 97-4147.) Washington, DC: National Institute on Drug Abuse. 
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thirds (64% and 72%) said they had tried some other illicit drug, including 37% and 44% 
who have tried cocaine specifically. Clearly, the parents of today’s teenagers are themselves 
a very drug-experienced generation. 
 
• In 2005 the adjusted lifetime prevalence figures among 29- to 30-year-olds reach 65% for 
any illicit drug, 60% for marijuana, 46% for any illicit drug other than marijuana, and 
17% for cocaine. Put another way, even among young Americans who graduated from high 
school in 1993 and 1994—after the peak of the larger drug epidemic—only about one third 
(35%) have never tried an illegal drug. 
 
Their 2005 survey responses, unadjusted for previous answers, show somewhat lower 
lifetime prevalence: 60% for any illicit drug, 56% for marijuana, 38% for any illicit drug 
other than marijuana, and 16% for cocaine.  
 
• Despite the higher lifetime prevalence rates among older age groups, these groups generally 
show annual or 30-day prevalence rates that are no higher than they are among today’s 12th 
graders. In fact, for a number of drugs, the levels reported by older respondents are lower, 
suggesting that the incidence of quitting more than offsets the incidence of initiating use of 
these drugs during the years after high school.   
 
In analyses published elsewhere, we looked closely at patterns of change in drug use with 
age and identified some post-high school experiences that contribute to declining levels of 
annual or current use of drugs as respondents grow older. For example, the likelihood of 
marriage increases with age, and we have found that marriage is consistently associated with 
declines in alcohol use in general, heavy drinking, marijuana use, and cocaine use.34 
 
• For the use of any illicit drug (Figure 4-1), lifetime prevalence (unadjusted) is 60% among 
29- to 30-year-olds versus 50% among the 2005 twelfth graders. Annual prevalence, 
however, is highest among the younger respondents (12th graders at 38% and 19–20 at 39%) 
with progressively lower rates among the older age groups, reaching 25% among the 29- to 
30-year-olds. Current (30-day) prevalence shows much the same pattern, with 12th graders 
having the highest rate (23%) and the rate generally declining with age, reaching 15% 
among the 29- to 30-year-olds.  
 
• Among the 35-, 40-, and 45-year-olds lifetime prevalence rates for marijuana, any illicit 
drug, and any illicit drug other than marijuana generally increase with age. (This is also 
true for many of the other specific illicit drugs.) However, annual and 30-day prevalence 
                                                 
34Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates; and Bachman, J. G., O’Malley, P. M., 
Schulenberg, J. E., Johnston, L. D., Bryant, A. L., & Merline, A. C. (2002). The decline of substance use in young adulthood: Changes in social 
activities, roles, and beliefs. Mahwah, NJ: Lawrence Erlbaum Associates. See also Schulenberg, J., O’Malley, P. M., Bachman, J. G., & Johnston, L. D. 
(2000). “Spread your wings and fly”: The course of well-being and substance use during the transition to young adulthood. In L. J. Crockett & R. K. 
Silbereisen (Eds.), Negotiating adolescence in times of social change (pp. 224–255). New York: Cambridge University Press. And see O’Malley, P. 
M., Bachman, J. G., Johnston, L. D., & Schulenberg, J. E. (2004). Studying the transition from youth to adulthood: Impacts on substance use and abuse. 
In J. S. House, F. T. Juster, R. L. Kahn, H. Schuman, & E. Singer (Eds.), A telescope on society: Survey research and social science at the University of 
Michigan and beyond (pp. 305–329). Ann Arbor: The University of Michigan Press. 
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rates generally decline slightly with age from 18 to 45, though declines decelerate after age 
35. Thus, it is clear that greater proportions of the older cohorts have discontinued use.  
  
• Among the young adults, a similar pattern exists for marijuana: a higher lifetime prevalence 
as a function of age, but considerably lower annual and 30-day prevalence rates through the 
late 20s (Figure 4-3). Current daily marijuana use shows the least variation across age (as 
shown in the next chapter in Figure 5-3c). Still, in 2005 it ranges from 5.0% among 12th 
graders down to 3.9% among 29- to 30-year-olds. Daily use in 2005 ranges from 1.9% to 
2.1% for 35-, 40-, and 45-year-olds, indicating that most who were daily users in their 
teenage years are no longer daily users.  
 
• Statistics on the use of any illicit drug other than marijuana (Figure 4-2) have a similar 
pattern. Like marijuana and the any-illicit-drug-use index, adjusted lifetime rates on this 
index also show an appreciable rise with age level, reaching 46% among the 29- to 30-year-
old age group and 72% among the 45-year-olds. In other words, nearly half of today’s 30-
year-olds have tried some illicit drug other than marijuana and nearly three quarters of all 
45-year-olds have done so. Current use shows a decline across the age bands, ranging from 
10% among 12th graders to 7% among 29- to 30-year-olds. After ages 21–22, annual use is 
generally lower with increased age of the respondent. A number of the individual drugs that 
comprise this general category show lower rates of use at higher ages for annual prevalence, 
usually with the highest rate observed at age 18 or ages 19–20. This is particularly true for 
amphetamines, hallucinogens, LSD specifically, inhalants, and sedatives (barbiturates). 
The falloff with age is not as great nor as consistent for cocaine, crack, other cocaine, ice, 
heroin, narcotics other than heroin, tranquilizers, and MDMA (ecstasy), though in general, 
usage rates are somewhat lower among those in their 30s than among those in their early 20s. 
Several classes of drugs are discussed individually next.  
 
• Inhalants show some very interesting differences across the age strata (see Figure 4-13). 
There is little difference across age in contemporaneously reported lifetime prevalence but a 
considerable difference in the lifetime prevalence figure adjusted for previous reporting of 
use. The adjusted pattern—an increase with age—is the one we have come to expect, and we 
believe is the more accurate one. Annual prevalence rates drop off with age, while 30-day 
rates begin fairly low and can drop only a little. Clearly, the use of inhalants is extremely 
low beyond about age 20, and we know from data presented in Volume I that much of the 
decline in use with age has already occurred by the time young people have reached 12th 
grade. Questions on inhalant use are not included in the surveys administered to respondents 
over the age of 30. 
 
• For amphetamines, lifetime prevalence is again much higher among the older age groups—
reflecting the addition of new users who initiate use in their 20s, but also reflecting some 
cohort differences (Figure 4-4). (There is also a considerable divergence between the 
corrected lifetime prevalence versus the contemporaneously reported lifetime prevalence, as 
is true for most of the psychotherapeutic drugs.) However, more recent use, as reflected in 
the annual prevalence figure, is lower among the older age groups. This has not always been 
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true; the present pattern is the result of a sharper decline in use among older respondents than 
has occurred among 12th graders. These trends are discussed in the next chapter.  
 
• Ritalin, a particular amphetamine widely prescribed for the treatment of attention-deficit/ 
hyperactivity disorder (ADHD), shows a drop-off in the annual nonmedically supervised 
prevalence of more than half after age 24, consistent with the interpretation that it is often 
used by college students trying to stay awake and alert for studying and completing 
assignments (see Table 4-3). 
 
• Methamphetamine use is highest among 21- to 22-year-olds, but then declines with age, 
with annual prevalence starting at 3.7% among the 21- to 22-year-olds, and then declining 
fairly steadily to 1.4% by age 29 to 30 (Table 4-3 and Figure 4-5).  
 
• Questions on the use of crystal methamphetamine (ice) are contained in two of the six 
questionnaire forms, making the estimates less reliable than those based on all six forms. (Ice 
use is not asked of the 35-, 40-, or 45-year-old respondents.) Among the 19- to 30-year-old 
respondents combined, 1.6% reported some use in the prior year—lower than the 2.3% 
reported by 12th graders (see Table 4-1 and Figure 4-6).   
 
• Sedatives (barbiturates) show lifetime prevalence rates that are fairly similar across the age 
band 18 through 30, but are appreciably higher among 40- and 45-year-olds. Above age 30, 
however, annual use falls appreciably with age (Figure 4-14). At present, current usage rates 
are quite low in all age groups; therefore, 30-day use varies rather little by age. Because of 
the substantial long-term decline in sedative (barbiturate) use over the life of the study, the 
45-year-olds have, by far, the highest adjusted lifetime prevalence rate (27%).35   
 
• The use of narcotics other than heroin (Figure 4-15) shows age differences that are similar 
in some ways to those seen for sedatives (barbiturates). Lifetime prevalence increases some 
across the early 20s, declines some later in the 20s and in the early 30s, then is fairly 
constant through age 40. The 45-year-olds show the highest lifetime prevalence rate (30%, 
adjusted). Annual prevalence is highest in the 18-to-22 age range (at 9% to 10%), declining 
to 3% among the 45-year-olds. Thirty-day prevalence shows a similar profile across age to 
that for annual prevalence.36  
 
                                                 
35Barbiturates were the dominant form of sedatives in use when these questions were first introduced. In the intervening years, a number of non-
barbiturate sedatives have entered the market and largely displaced barbiturate sedatives. We believe that a number of users of non-barbiturate 
sedatives are reporting them in answer to this question, which also defines them in terms of the conditions for which they are prescribed. In recognition 
of this fact, we now label them as “sedatives (barbiturates).” The rewording of the question was made in half of the questionnaire forms in 2004 and in 
the other half in 2005. 
 
36In 2002 the question text for narcotics other than heroin was changed on three of the six questionnaire forms in order to update the list of examples 
of narcotics other than heroin. Talwin, laudanum, and paregoric—each of which had negligible rates of use by 2001—were replaced by Vicodin, 
OxyContin, and Percocet. As a consequence of this revision, reported use rates increased in 2002 in the half of the questionnaire forms using the new 
question wording; however, it did not increase in those forms using the original wording, as is discussed in the next chapter. Using data from the three 
unchanged questionnaire forms, we derived a best guess as to the actual change in use. We added that change score to the 2001 prevalence rate that 
would have been observed had we not changed the measures. This adjusted value is provided in the relevant tables and figures.   
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• Tranquilizer use shows an increase with age in lifetime prevalence—again, with the oldest 
cohorts having much higher levels of lifetime use—and some modest decrease with age in 
annual prevalence. Thirty-day prevalence is fairly flat across all age groups (Figure 4-16). 
 
• Cocaine generally had presented a unique case among the illicit drugs, in that lifetime, 
annual, and current prevalence rates have all tended to be higher among the older age 
groups. By 1994, however, 30-day cocaine use had reached such low levels that it varied 
rather little by age. Following the resurgence of cocaine use in the 1990s, some differences 
by age in annual prevalence emerged, though there are still rather few differences for current 
prevalence (Figure 4-7). Annual prevalence is now highest among those ages 21 through 26, 
who were 12th graders when the increase in cocaine use occurred in the 1990s. The cohort 
differences in lifetime cocaine use are particularly vivid, with the 40- and 45-year-olds 
showing 37% and 44% adjusted lifetime prevalence rates, respectively, compared to 13% 
among 21- to 22-year-olds in 2005. 
 
• In 2005, lifetime prevalence of crack use (Figure 4-8) is fairly similar among ages 23 
through 35. (Eighteen- through 22-year-olds have lower rates.) Lifetime prevalence is 
highest among 40- and 45-year-olds, no doubt reflecting something of a cohort effect due to 
the rather transient popularity of crack in the early to mid-1980s. Current prevalence is 1% 
or below in all age groups. Annual prevalence is highest among 18-year-olds and 21- to 22-
year-olds, but is lower among 23- to 30-year olds, and lower still among the older strata. 
    
We believe that the omission of high school dropouts is likely to have a greater-than-average 
impact on the prevalence estimates for crack. It also seems likely that any members of the 
panels who are dependent on crack (or other illicit drugs like heroin) would be less likely 
than average to respond to the questionnaires; therefore, such extreme users are no doubt 
underrepresented among the panel respondents. 
 
• MDMA (ecstasy) was added to two of the six forms of the follow-up surveys in 1989 to 
assess how widespread its use had become among young adults. It was added to a third form 
in 2002. Questions about its use were not asked of high school students until 1996, primarily 
because we were concerned that its alluring name might have the effect of stimulating 
interest. We were less concerned about such an effect after the name of the drug had become 
more widely known. (MDMA use is not asked of the 35-, 40-, or 45-year-old respondents.) 
 
Among all 19- to 30-year-olds combined, 15% say they have tried MDMA; among 12th 
graders, 5% say they have used it. The age differences are quite dramatic for this drug, with 
lifetime prevalence now highest at ages 25–26 and generally declining with age thereafter 
(see Figure 4-17). This very likely reflects the fact that ecstasy use rose very rapidly between 
1997 and 2001, and then declined quite sharply; therefore, recent graduating classes report 
less use than their predecessors, and much earlier classes reported less use than their 
successors. Annual prevalence is highest among 19- to 20-year-olds at 4% and is at 2%–3% 
for all other age groups.. Past-month ecstasy use is now at 1% or less for all age bands 
between 18 and 30. 
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• In the case of alcohol, all prevalence rates are higher among those of post-high school age 
than among those in high school, and they generally increase for the first three to five years 
after high school, through age 23 or 24 (Figures 4-20a and b). After that, prevalence rates 
vary only modestly among the different age groups. Lifetime prevalence changes very little 
after ages 23 to 24, due in large part to a “ceiling effect.” Current (30-day) alcohol use is 
considerably higher among those ages 23–24 (71%) than among 12th graders (47%); it drops 
some through age 30 (66%) and is at about the same level among those ages 35, 40, and 45. 
Current daily drinking (Figure 4-20b) is also slightly higher and level among those 21–35 
years old (6%). The highest rate of daily drinking is among those aged 45 (8%).  
 
• Among the various measures of alcohol consumption, occasions of heavy drinking in the 
two weeks prior to the survey show large differences among the age groups (Figure 4-20b). 
There is a fair difference between 18-year-olds (27%) and 21- to 22-year-olds, who have the 
highest prevalence of such heavy drinking (40%). Then there is a falloff at each subsequent 
age level above age 24, reaching 29% by ages 29 to 30. We have interpreted this curvilinear 
relationship as reflecting an age effect—and not a cohort effect—because it seems to 
replicate across different graduating class cohorts and also because it has been linked 
directly to age-related events such as leaving the parental home (which increases heavy 
drinking) and marriage (which decreases it), both of which are, in turn, related to attending 
college.37 Among those aged 35 to 45, about one fifth (20% to 23%) report such heavy 
drinking in the prior two-week interval. 
 
• Cigarette smoking also shows an unusual pattern of age-related differences (Figure 4-21). 
Current (30-day) smoking used to be about the same rate among those in their early 20s as 
among 12th graders, in part reflecting the fact that relatively few new people are recruited to 
smoking after high school. In 2005, however, current smoking is somewhat lower among 
12th graders than among the next several age bands (peaking at 31% among 25- to 26-year-
olds), almost surely due to the sharp drop in smoking that has been occurring among 
secondary school students—a cohort effect. Smoking at heavier levels—such as smoking 
half a pack daily—is (and has been) higher among those in their 20s than among 12th 
graders, reflecting, at least in part, the fact that many light or moderate smokers in high 
school move into a pattern of heavier consumption after high school.38 While less than a third 
(30%) of the current smokers in the 12th grade smoke at the rate of a half-pack per day or 
more, well over one half (60%) of the current smokers in the 29-to-30 age group do so. 
 
• Questions about the use of steroids were added in 1989 to one form only (and to an 
additional form in 1990), making it difficult to determine age-related differences with much 
                                                 
37O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade of 
change, 1976–1986. American Journal of Public Health, 78, 1315–1321. See also Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. 
D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young adulthood: The impacts of new freedoms and new responsibilities. Mahwah, 
NJ: Lawrence Erlbaum Associates. 
38Because age is confounded with class cohort, and because we have established that cigarette smoking shows strong cohort effects (enduring 
differences among cohorts), one must be careful in interpreting age-related differences in a cross-sectional sample as if they were due only to age 
effects—that is, changes with age consistently observable across cohorts. However, multivariate analyses conducted on panel data from multiple 
cohorts do show a consistent age effect of the type mentioned here (see O’Malley, Bachman, & Johnston, 1988, in previous footnote). 
 
82





accuracy due to the limited sample sizes. (Steroid questions are not asked of the 35-, 40-, or 
45-year-old respondents.) Overall, 1.6% of 19- to 30-year-olds in 2005 reported having used 
steroids in their lifetime. Annual and 30-day use levels were very low, at 0.4% and 0.1%, 
respectively. (See Tables 4-2 through 4-4.) The rates among 12th graders tend to be 
considerably higher than the rates among older age groups, reflecting possibly both age and 
cohort effects. (As described in Volume I, the prevalence of steroid use among 12th graders 
rose sharply between 2000 and 2002. At present, the highest annual use among the young 
adults is among 19- to 20-year-olds, at 0.6%.)  
 
In sum, lifetime prevalence rates in some of the older age groups studied here, who passed through 
adolescence in the heyday of the drug epidemic, show impressively high lifetime rates of illicit drug 
use—particularly when lifetime prevalence is corrected for the recanting of earlier reported use. 
However, the current use of most illicit drugs is substantially lower among those in their 30s and 40s 
than among those in their late teens to early 20s. For the two licit drugs, alcohol and cigarettes, the 
picture is a more complicated one. Steroids also present a somewhat complicated picture. 
 
PREVALENCE COMPARISONS FOR SUBGROUPS OF YOUNG ADULTS 
 
Subgroup differences for the group of young adults 1 to 12 years beyond high school (corresponding 
to modal ages 19 to 30) are presented in Tables 4-1 through 4-5. While Table 4-1 provides only 
gender differences, the remaining tables have prevalence rates by gender, age, region of the country, 
and population density. Each of these dimensions is discussed separately below. 
Gender Differences 
In general, most of the gender differences in drug use that were observed in high school students 
may be found in the young adult sample as well. 
• Among young adults, more males than females report using any illicit drug during the prior 
year (34% versus 30%). Males have higher annual prevalence rates for nearly all of the 
specific illicit drugs—with ratios greater than 2 for steroids, PCP, crystal methamphetamine 
(ice), LSD, and hallucinogens other than LSD. For example, among the 19- to 30-year-olds, 
steroids were used by 1.0% of males versus less than 0.1% of females during the prior 12 
months. (See Table 4-1.) 
 
• All forms of cocaine were used in the past year by more males than females (19- to 30-year-
olds). Annual cocaine use was reported by 8.3% of the males and 5.3% of the females, crack 
use by 1.6% of the males and 1.0% of the females, and other cocaine use by 8.1% of the 
males and 4.7% of the females. 
 
• Other large gender differences among the 19- to 30-year-olds are found in daily marijuana 
use (6.6% for males versus 3.5% for females), daily alcohol use (8.4% versus 3.2%), and 
occasions of drinking five or more drinks in a row in the prior two weeks (47% versus 
28%). This gender difference in occasions of heavy drinking is even greater among young 
adults than among 12th graders, where it is 33% for males versus 22% for females. 
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• MDMA (ecstasy) use is only slightly higher among males than among females in the young 
adult sample overall (annual prevalence 3.0% versus 2.7%, respectively). 
 
• The use of narcotics other than heroin outside of medical supervision is fairly close, at 
9.5% annual prevalence for males versus 7.9% for females. Use of Vicodin, one of the most 
widely used drugs in the class, differs a bit more (11.3% versus 7.7%). There is also a gender 
contrast for OxyContin (annual prevalence of 3.8% for males versus 2.4% for females). 
 
• The use of amphetamines, which is now about equivalent among males and females in high 
school, is also fairly similar for both genders in this post-high school period (annual 
prevalence of 5.2% versus 4.4%, respectively). 
 
• In the 1980s, there were few differences between males and females in rate of cigarette use. 
By the early 1990s, however, males had slightly higher rates of use. In 2005 among 12th 
graders, past month prevalence is 25% for males, compared to 21% for females; daily use 
rates are 15% for males and 12% for females; and half-pack or more use rates are 8.0% for 
males and 5.3% for females. But among older respondents, there are little or no gender 
differences among the 19- to 30-year-olds; males are more likely to have smoked in the past 
month (29% versus 27%), but no more likely to have smoked daily (both are between 19% 
and 20%), or to have smoked half a pack or more per day (both at 13%). 
 
• Steroid use among young adults is much more prevalent among males than females, as is 
true for 12th graders. Among 12th graders, 2.6% of the males reported steroid use in the past 
year versus 0.4% of the females. These statistics are much lower among the 19- to 30-year-




Follow-up respondents are asked in what state they currently reside. States are then grouped into the 
same regions used in the analysis of the high school data.39 Tables 4-2 through 4-5 present regional 
differences in lifetime prevalence, annual prevalence, 30-day prevalence, and current daily 
prevalence, for the 19- to 30-year-olds combined. 
• There exist some regional differences in the use of marijuana, with the Northeast and the 
West somewhat higher than the South and the North Central. The Northeast and the West are 
also slightly higher in the proportion using any illicit drug and any illicit drug other than 
marijuana (see Table 4-3). 
 
                                                 
39States are grouped into regions as follows: Northeast—Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, 
New Jersey, and Pennsylvania; North Central—Ohio, Indiana, Illinois, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, 
Nebraska, and Kansas; South—Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, 
Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and Texas; West—Montana, Idaho, Wyoming, Colorado, New Mexico, 
Arizona, Utah, Nevada, Washington, Oregon, and California. 
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• Methamphetamine use is no longer significantly higher in the West (annual prevalence of 
2.7%) than in the South (2.6%) or the North Central (2.2%), but use in those three regions is 
higher than in the Northeast (1.1%) (see Table 4-3). 
 
• The use of crystal methamphetamine (ice) by 19- to 30-year-olds remains considerably 
higher in the West, which has a 3.0% annual prevalence rate in 2005, than in the North 
Central (1.5%), the South (1.4%), and the Northeast (0.7%). Among 12th graders, the West 
also has a higher rate of use than the other three regions. 
 
• The West and the Northeast continue to have higher rates than the other two regions for 
hallucinogen use, though the regional differences are not large.  
 
• Regional differences in MDMA (“ecstasy”) use among young adults are not large at present. 
Use is highest in the West (3.4% annual prevalence) and the South (3.2%) and slightly lower 
in the Northeast and the North Central (2.7% and 2.3%, respectively). 
 
• OxyContin use is higher in the West (3.5%) and the South (3.4%) than in the other two 
regions of the country (2.3% and 2.4%); and Vicodin use is highest in the West (12.8%) and 
lower in the North Central (10.9%), the Northeast (8.1%), and the South (5.9%). 
 
• For the remaining illicit drugs, regional differences are not substantial (see Tables 4-3 and  
4-4).   
 
• Prevalence rates for alcohol use are typically somewhat higher in the Northeast and North 
Central regions than in the South and West regions; this pattern has generally been true 
among 12th graders as well. For binge drinking, the Northeast and North Central have 
prevalence rates of 41% each, whereas the South and West have rates of 30% and 34%, 
respectively. 
 
• As with alcohol, cigarette smoking among young adults is highest in the Northeast and 
North Central. It is lowest in the West. This difference is most pronounced at the current 
half-pack-a-day level (Table 4-5), where the rate in the West (7.4%) is less than half the rate 
in the North Central (17.3%). The Northeast is second highest at 13.6%, followed by the 
South at 11.7%. 
 
Population Density Differences 
Population density is measured by asking respondents to select the response category that best 
describes the size and nature of the community where they lived during March of the year in which 
they were completing the follow-up questionnaire. Various categories are listed in Tables 4-2 
through 4-5, and the population sizes given to the respondent to help define each level are provided 
in a footnote to each table. An examination of the 1987 and 1988 drug use data for the two most 
urban strata revealed that the modest differences in prevalence rates between the suburbs and the 
corresponding cities were not worth the complexity of reporting them separately; accordingly, these 
categories have been merged since then. See Tables 4-3 through 4-5 for the relevant tabular results 
that are discussed below. 
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• Differences in illicit drug use by population density tend to be very modest, perhaps more 
modest than is commonly supposed. Among the general population, use of most illicit drugs 
is fairly broadly distributed among all areas from rural to urban. To the extent that there are 
variations, almost all of the associations are positive, with rural/country areas having the 
lowest levels of use, and small towns having the next lowest. Medium-sized cities, large 
cities, and very large cities tend to be higher, with only small variations among these three 
categories. Positive associations with population density exist for annual prevalence of any 
illicit drug, marijuana, and MDMA (ecstasy). The association is strongest for ecstasy, where 
the annual prevalence rate in the large cities (5.4%) is about twice that in the rural areas and 
small towns (2.8% and 2.2%, respectively). 
 
• Methamphetamine use shows a bimodal relationship between annual prevalence and 
population density, with the rates now highest in the rural/country stratum (2.9%) and the 
very large cities (2.8%). Crystal methamphetamine (ice) shows a similar pattern (Table 4-
3). 
 
• Amphetamines do not show a clearly discernible association with population density.  
 
• Among young adults, the lifetime, annual, and 30-day alcohol use measures all show a 
positive association with population density. Occasions of heavy drinking are fairly similar 
across all strata, although there is some positive ordinal association with urbanicity (see 
Table 4-5). Daily alcohol use falls between 4.3% and 6.8% for all community size strata, 
with no discernible association. 
 
• Contrary to what we find for almost all other substances, there exists a negative association 
between population density and daily cigarette smoking, which is highest in the 
rural/country stratum and lowest in the very large cities (daily prevalence rates of 26% and 
15%, respectively). Smoking at the half-pack-a-day level is more than twice as high in 
rural/country areas (19%) as in very large cities (8%). (See Table 4-5.) 
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Males Females Total
Approx. Weighted N = 2600 3800 6400
Any Illicit Druga
Annual 34.0 30.0 31.6
30-Day 21.3 16.0 18.1
Any Illicit Druga Other Than Marijuana
 Annual 20.1 16.8 18.1
30-Day 8.9 7.3 7.9
Marijuana
Annual 29.7 24.7 26.7
30-Day 18.6 12.9 15.2
Daily 6.6 3.5 4.7
Inhalantsb,c
Annual 1.8 0.9 1.3
30-Day 0.3 0.2 0.2
Hallucinogensb
Annual 5.9 2.9 4.1
30-Day 1.1 0.5 0.7
     LSD
Annual 1.1 0.5 0.8
30-Day 0.2 0.1 0.1
     PCPd
Annual 0.8 0.3 0.5
30-Day 0.0 0.0 0.0
     MDMA (Ecstasy)c
Annual 3.0 2.7 2.9
30-Day 0.9 0.5 0.6
Cocaine
Annual 8.3 5.3 6.5
30-Day 2.5 1.8 2.0
     Cracke
Annual 1.6 1.0 1.2
30-Day 0.5 0.2 0.3
     Other Cocainef
Annual 8.1 4.7 6.0
30-Day 2.3 1.6 1.9
Heroin
Annual 0.6 0.3 0.5
30-Day 0.2 0.1 0.2
Other Narcoticsg
Annual 9.5 7.9 8.5
30-Day 3.8 3.0 3.3
TABLE 4-1
Prevalence of Use of Various Types of Drugs by Gender, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)
(Table continued on next page)
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Males Females Total
Approx. Weighted N = 2600 3800 6400
Amphetamines, Adjustedg,h
Annual 5.2 4.4 4.7
30-Day 2.3 1.7 2.0
Methamphetaminei
Annual 3.1 1.6 2.2
30-Day 0.9 0.6 0.7
Crystal Methamphetamine (Ice)i
Annual 2.4 1.1 1.6
30-Day 0.8 0.5 0.6
Sedatives (Barbiturates)g
Annual 4.3 4.1 4.2
30-Day 1.6 1.7 1.6
Tranquilizersg
Annual 7.5 6.2 6.8
30-Day 2.9 2.4 2.6
Alcohol
Annual 84.5 83.5 83.9
30-Day 73.7 64.4 68.1
Daily 8.4 3.2 5.3
5+ Drinks in a Row in the Last 2 Weeks 47.0 28.1 35.7
     Flavored Alcoholic Beveragesd
Annual 48.3 62.6 56.8
30-Day 20.4 29.6 25.9
Cigarettes
Annual 39.1 37.1 37.9
30-Day 28.7 27.2 27.8
Daily 19.3 19.6 19.5
Half-Pack or More per Day 12.8 12.8 12.8
Steroidsi
Annual 1.0 * 0.4
30-Day 0.3 0.0 0.1
Source :  The Monitoring the Future Study, the University of Michigan.
'*' indicates a prevalence rate of less than 0.05% but greater than true zero.
aUse of  "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other 
narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under a doctor's orders.
bUnadjusted for known underreporting of certain drugs.  See text for details.
cThis drug was asked about in three of the six questionnaire forms.  Total N is approximately 3200.
dThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
eThis drug was asked about in five of the six questionnaire forms.  Total N is approximately 5300.
fThis drug was asked about in four of the six questionnaire forms.  Total N is approximately 4300.
gOnly drug use that was not under a doctor's orders is included here.
hBased on the data from the revised question, which attempts to exclude the inappropriate
reporting of nonprescription amphetamines.
iThis drug was asked about in two of the six questionnaire forms.  Total N is approximately 2100.
TABLE 4-1 (cont.)
Prevalence of Use of Various Types of Drugs by Gender, 2005




Approx. Any Illicit Any Illicit Druga
Weighted N Druga Other Than MJ Marijuana Inhalantsb,c Hallucinogens LSD   PCPd MDMAc Cocaine Cracke Heroin 
Total 6400 60.4 34.6 57.0 10.9 18.1 12.1 2.1 14.5 14.5 4.4 1.9
Gender:
    Male 2600 61.2 37.2 58.8 13.7 22.6 14.9 2.8 15.5 17.3 5.7 2.7
    Female 3800 59.9 32.9 55.7 9.1 15.0 10.2 1.6 13.7 12.7 3.6 1.3
Modal Age:
     19-20 1100 53.6 28.3 49.3 6.6 11.2 3.6 0.8 8.0 10.0 3.1 1.2
     21-22 1100 58.1 31.3 55.3 8.5 14.9 7.6 1.3 12.1 12.4 3.5 1.2
     23-24 1100 61.6 35.9 58.6 12.7 19.1 12.4 1.5 17.0 15.5 4.5 1.8
     25-26 1000 66.0 39.0 62.2 11.4 22.6 17.1 3.7 21.7 17.9 4.6 2.4
     27-28 1100 63.4 35.8 60.6 12.3 20.9 16.0 2.6 16.3 16.3 4.8 2.0
     29-30 1000 60.4 38.1 56.5 14.5 20.5 16.9 2.9 12.0 15.7 6.4 2.8
Region:
    Northeast 1300 64.5 34.7 62.2 9.7 20.0 12.7 3.9 16.9 14.5 3.0 1.9
    North Central 1800 59.4 34.0 55.9 11.1 18.1 12.6 1.7 12.0 13.6 5.0 1.7
    South 2100 58.3 33.6 53.8 10.0 15.3 10.8 1.9 15.3 14.3 4.2 2.1
    West 1200 61.0 37.2 58.0 13.7 20.5 12.6 1.4 14.6 16.3 5.7 1.7
Population Density:f
    Farm/Country 700 56.5 34.0 52.8 10.1 15.7 12.1 4.1 10.4 14.6 7.1 2.8
    Small Town 1700 57.8 32.4 53.7 10.4 16.6 11.2 1.3 13.1 13.2 4.3 1.6
    Medium City 1500 59.3 33.6 56.0 10.7 16.4 10.7 1.6 13.9 13.8 4.0 1.7
    Large City 1500 62.1 35.4 59.0 11.6 18.8 13.0 2.5 15.0 14.5 3.7 1.4
    Very Large City 1000 66.6 39.3 63.8 12.3 23.6 14.4 2.0 19.7 18.3 4.8 2.8
Source :  The Monitoring the Future Study, the University of Michigan.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under 
a doctor's orders.
bUnadjusted for known underreporting of certain drugs.  See text for details.
cThis drug was asked about in three of the six questionnaire forms.  Total N is approximately 3200.
dThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
eThis drug was asked about in five of the six questionnaire forms.  Total N is approximately 5300.
fA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over 
500,000 residents. Within each level of population density, suburban and urban respondents are combined.
TABLE 4-2
Lifetime Prevalence of Use of Various Types of Drugs by Subgroups, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)
(Table continued on next page)89
c d
Flavored
Approx. Other Sedatives  Alcoholic
Weighted N Narcoticsa Amphetaminesa,b Methamphetamine Icec (Barbiturates)a Tranquilizersa Alcohol Beverages Cigarettes Steroidsc
Total 6400 18.0 15.0 8.8 4.6 10.2 14.8 89.7 84.2 NA 1.6
Gender:
    Male 2600 21.3 16.2 11.6 6.4 11.6 16.3 89.3 82.1 NA 3.8
    Female 3800 15.7 14.3 6.9 3.5 9.3 13.9 90.0 85.7 NA 0.3
Modal Age:
     19-20 1100 15.5 12.7 6.0 4.4 9.8 11.5 81.8 76.8 NA 1.0
     21-22 1100 17.4 14.7 7.3 3.0 9.7 14.5 88.8 83.9 NA 1.7
     23-24 1100 17.9 15.6 7.8 4.0 9.9 14.9 90.7 87.9 NA 1.5
     25-26 1000 20.9 15.7 10.6 5.1 11.5 17.6 92.0 86.5 NA 2.4
     27-28 1100 17.7 14.5 10.0 5.5 9.5 14.3 92.9 88.5 NA 2.7
     29-30 1000 18.7 17.3 11.5 6.0 10.9 16.7 92.5 82.0 NA 0.7
Region:
    Northeast 1300 16.7 14.0 5.5 2.8 9.6 13.5 92.8 89.5 NA 1.3
    North Central 1800 18.1 16.0 10.1 5.6 10.3 13.5 91.3 84.6 NA 1.6
    South 2100 17.0 14.8 7.2 3.1 11.1 16.9 87.3 80.5 NA 1.8
    West 1200 20.7 14.7 13.2 7.7 8.5 14.2 88.2 85.7 NA 1.9
Population Density:e
    Farm/Country 700 18.5 15.2 10.2 6.7 11.3 15.3 88.2 77.9 NA 1.2
    Small Town 1700 15.8 15.1 8.2 3.0 10.2 13.5 88.1 84.0 NA 1.4
    Medium City 1500 18.1 15.1 8.4 5.7 9.5 12.9 89.4 82.6 NA 1.7
    Large City 1500 18.3 14.1 7.0 3.9 9.3 14.9 90.6 86.5 NA 1.8
    Very Large City 1000 20.8 15.8 12.2 5.7 12.1 19.8 92.6 87.6 NA 2.1
Source :  The Monitoring the Future Study, the University of Michigan.
'NA' indicates data not available.
aOnly drug use that was not under a doctor's orders is included here.
bBased on the data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
cThis drug was asked about in two of the six questionnaire forms.  Total N is approximately 2100.
dThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over 
500,000 residents. Within each level of population density, suburban and urban respondents are combined.
TABLE 4-2 (cont.)
Lifetime Prevalence of Use of Various Types of Drugs by Subgroups, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)
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Approx. Any Illicit Any Illicit Druga
Weighted N Druga Other Than MJ Marijuana Inhalantsb,c Hallucinogensb      LSD     PCPd MDMAc Cocaine
Total 6400 31.6 18.1 26.7 1.3 4.1 0.8 0.5 2.9 6.5
Gender:
     Male 2600 34.0 20.1 29.7 1.8 5.9 1.1 0.8 3.0 8.3
     Female 3800 30.0 16.8 24.7 0.9 2.9 0.5 0.3 2.7 5.3
Modal Age:
     19-20 1100 38.9 20.2 34.9 1.5 6.4 1.5 0.2 4.1 6.4
     21-22 1100 36.4 20.5 32.6 2.2 5.3 1.0 0.0 3.3 7.5
     23-24 1100 31.9 18.0 26.8 1.0 4.0 0.7 0.0 2.8 6.7
     25-26 1000 32.0 19.7 26.4 0.4 4.3 0.7 2.4 2.3 8.2
     27-28 1100 24.3 14.2 19.7 1.2 2.1 0.1 0.5 2.5 5.7
     29-30 1000 25.2 15.8 18.9 1.4 2.1 0.4 0.0 2.0 4.5
Region:
     Northeast 1300 36.9 18.4 33.6 1.3 4.7 1.1 1.6 2.7 7.6
     North Central 1800 31.1 17.6 25.9 1.1 4.1 0.7 0.7 2.3 6.0
     South 2100 28.1 17.6 22.9 1.2 3.4 0.7 0.0 3.2 6.1
     West 1200 32.7 19.3 27.3 1.8 4.7 0.6 0.2 3.4 6.7
Population Density:e
     Farm/Country 700 25.7 15.7 20.8 1.2 2.6 0.6 0.0 2.8 4.7
     Small Town 1700 29.8 17.4 25.4 1.3 4.0 0.6 0.7 2.2 5.8
     Medium City 1500 32.1 18.2 27.0 1.2 4.3 1.0 0.2 2.4 6.4
     Large City 1500 32.2 17.5 28.0 0.8 3.7 0.6 0.4 2.7 6.5
     Very Large City 1000 36.6 22.0 30.2 2.2 5.6 0.8 0.6 5.4 9.1
Source :  The Monitoring the Future Study, the University of Michigan.
'*' indicates a percentage of less than 0.05% but greater than true zero.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives  (barbiturates), or tranquilizers not under
a doctor's orders.
bUnadjusted for known underreporting of certain drugs.  See text for details.
cThis drug was asked about in three of the six questionnaire forms.  Total N is approximately 3200.
dThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over
500,000 residents. Within each level of population density, suburban and urban respondents are combined.
TABLE 4-3
Annual Prevalence of Use of Various Types of Drugs by Subgroups, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)
(Table continued on next page)
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Approx. Other
Weighted N Cracka Heroin Narcoticsb OxyContinc Vicodinc Amphetaminesb,d Ritalinb,c Methamphetaminec Icec
Total 6400 1.2 0.5 8.5 2.9 9.1 4.7 2.3 2.2 1.6
Gender:   
     Male 2600 1.6 0.6 9.5 3.8 11.3 5.2 2.6 3.1 2.4
     Female 3800 1.0 0.3 7.9 2.4 7.7 4.4 2.1 1.6 1.1
Modal Age:   
     19-20 1100 1.3 0.6 9.9 4.8 11.0 7.0 5.5 2.2 2.4
     21-22 1100 1.8 0.7 10.2 2.6 11.8 6.8 3.0 3.7 1.7
     23-24 1100 1.1 0.3 7.6 2.7 7.5 5.0 2.9 1.9 1.0
     25-26 1000 0.8 0.2 8.8 3.3 8.0 3.8 0.1 2.2 1.7
     27-28 1100 1.0 0.4 6.9 1.8 7.8 2.6 0.5 1.7 1.3
     29-30 1000 1.2 0.5 7.8 2.1 8.4 3.0 1.3 1.4 1.7
Region:   
     Northeast 1300 1.0 0.4 8.1 2.3 8.1 4.0 2.2 1.1 0.7
     North Central 1800 1.3 0.4 9.2 2.4 10.9 5.1 3.1 2.2 1.5
     South 2100 1.1 0.6 7.6 3.4 5.9 5.0 2.2 2.6 1.4
     West 1200 1.6 0.3 9.9 3.5 12.8 4.4 1.4 2.7 3.0
Population Density:e   
     Farm/Country 700 1.6 0.9 7.6 3.7 7.9 4.5 2.3 2.9 2.6
     Small Town 1700 1.3 0.5 8.1 3.0 9.7 6.0 3.5 2.1 0.9
     Medium City 1500 0.8 0.4 8.7 2.8 9.1 4.1 2.1 1.5 1.2
     Large City 1500 1.1 0.3 8.2 3.4 7.3 4.2 2.2 2.0 1.7
     Very Large City 1000 1.5 0.4 10.1 1.9 11.1 4.3 0.5 2.8 2.5
Source :  The Monitoring the Future Study, the University of Michigan.
'*' indicates a percentage of less than 0.05% but greater than true zero.
aThis drug was asked about in five of the six questionnaire forms.  Total N is approximately 5300.
bOnly drug use that was not under a doctor's orders is included here.
cThis drug was asked about in two of the six questionnaire forms.  Total N is approximately 2100.
dBased on the data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over
500,000 residents. Within each level of population density, suburban and urban respondents are combined.
TABLE 4-3 (cont.)
Annual Prevalence of Use of Various Types of Drugs by Subgroups, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)






Weighted N (Barbiturates)a Tranquilizersa Rohypnolb GHBb Ketamineb Alcohol Cigarettes Steroidsb
Total 6400 4.2 6.8 0.1 0.3 0.4 83.9 56.8 37.9 0.4
Gender:   
     Male 2600 4.3 7.5 0.3 0.6 0.6 84.5 48.3 39.1 1.0
     Female 3800 4.1 6.2 * * 0.3 83.5 62.6 37.1 *
Modal Age:   
     19-20 1100 5.1 6.5 0.5 0.7 1.3 77.3 59.6 39.9 0.6
     21-22 1100 5.0 8.5 0.1 0.3 0.5 84.4 60.8 39.6 0.4
     23-24 1100 3.8 6.3 0.0 0.1 0.3 86.6 63.5 41.1 0.6
     25-26 1000 4.0 7.7 0.0 0.4 0.1 85.6 53.6 40.3 0.6
     27-28 1100 2.8 4.3 0.0 0.1 0.3 85.3 53.8 34.9 0.3
     29-30 1000 4.4 7.4 0.1 0.0 0.0 84.8 48.6 31.4 0.0
Region:   
     Northeast 1300 4.2 6.5 0.2 0.4 0.6 88.7 59.9 41.3 0.0
     North Central 1800 4.2 6.1 0.1 0.1 0.4 86.0 60.2 41.8 0.5
     South 2100 4.5 8.2 0.2 0.4 0.4 79.9 51.4 34.7 0.7
     West 1200 3.5 5.3 0.0 0.1 0.5 83.1 59.0 33.9 0.4
Population Density:d   
     Farm/Country 700 4.2 6.3 0.0 0.0 0.2 79.3 52.4 44.6 0.4
     Small Town 1700 4.5 6.6 0.3 0.3 0.4 81.0 55.4 38.5 0.7
     Medium City 1500 3.7 5.8 0.2 0.2 0.4 83.6 60.9 37.4 0.3
     Large City 1500 3.6 6.2 0.0 0.0 0.6 86.6 55.8 35.6 0.4
     Very Large City 1000 5.5 9.5 0.0 1.0 0.6 88.9 56.9 35.6 0.3
Source :  The Monitoring the Future Study, the University of Michigan.
'*' indicates a percentage of less than 0.05% but greater than true zero.
aOnly drug use that was not under a doctor's orders is included here.
bThis drug was asked about in two of the six questionnaire forms.  Total N is approximately 2100.
cThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
dA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over
500,000 residents. Within each level of population density, suburban and urban respondents are combined.
TABLE 4-3 (cont.)
Annual Prevalence of Use of Various Types of Drugs by Subgroups, 2005




Approx. Any Illicit Any Illicit Druga
Weighted N Druga Other Than MJ Marijuana Inhalantsb,c Hallucinogens      LSD     PCPd MDMAc Cocaine Cracke Heroin
Total 6400 18.1 7.9 15.2 0.2 0.7 0.1 0.0 0.6 2.0 0.3 0.2
Gender:
     Male 2600 21.3 8.9 18.6 0.3 1.1 0.2 0.0 0.9 2.5 0.5 0.2
     Female 3800 16.0 7.3 12.9 0.2 0.5 0.1 0.0 0.5 1.8 0.2 0.1
Modal Age:
     19-20 1100 21.3 8.7 18.9 0.4 1.9 0.5 0.0 0.9 1.7 0.3 0.2
     21-22 1100 20.9 9.9 17.9 0.1 1.0 0.1 0.0 0.6 2.3 0.4 0.1
     23-24 1100 17.3 7.9 14.1 0.3 0.5 0.0 0.0 0.3 2.3 0.5 0.2
     25-26 1000 19.3 8.4 15.9 0.1 0.2 * 0.0 0.4 2.8 0.1 0.1
     27-28 1100 14.2 6.1 11.9 0.2 0.4 0.1 0.0 1.0 1.7 0.1 *
     29-30 1000 15.5 6.6 11.9 0.3 0.3 * 0.0 0.8 1.4 0.2 0.3
Region:
     Northeast 1300 20.3 7.6 18.2 0.1 0.6 0.0 0.0 0.6 2.7 0.1 0.1
     North Central 1800 17.6 7.4 14.7 * 0.9 0.2 0.0 0.6 1.7 0.5 0.1
     South 2100 16.9 8.4 13.4 0.3 0.6 0.1 0.0 0.6 1.9 0.2 0.3
     West 1200 18.9 8.3 15.7 0.5 1.0 0.1 0.0 1.0 2.2 0.5 *
Population Density:f
     Farm/Country 700 14.5 6.8 11.7 0.3 0.5 0.2 0.0 1.0 1.2 0.1 0.3
     Small Town 1700 16.7 8.1 14.1 0.1 0.7 0.1 0.0 0.4 1.8 0.3 0.2
     Medium City 1500 18.9 8.5 15.5 0.3 0.9 0.2 0.0 0.6 1.9 0.2 0.1
     Large City 1500 18.3 6.4 16.0 0.1 0.6 0.1 0.0 0.3 1.7 0.4 0.0
     Very Large City 1000 21.9 10.2 17.2 0.6 1.0 0.0 0.0 1.4 3.6 0.4 0.2
Source :  The Monitoring the Future Study, the University of Michigan.
'*' indicates a percentage of less than 0.05% but greater than true zero.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), or tranquilizers not under
a doctor's orders.
bUnadjusted for known underreporting of certain drugs.  See text for details.
cThis drug was asked about in three of the six questionnaire forms.  Total N is approximately 3200.
dThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
eThis drug was asked about in five of the six questionnaire forms.  Total N is approximately 5300.
fA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over 500,000
 residents.  Within each level of population density, suburban and urban respondents are combined.
TABLE 4-4
Thirty-Day Prevalence of Use of Various Types of Drugs by Subgroups, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)




Approx. Other Sedatives  Alcoholic
Weighted N Narcoticsa Amphetaminesa,b Methamphetamine Icec (Barbiturates)a Tranquilizersa Alcohol Beverages Cigarettes Steroidsc
Total 6400 3.3 2.0 0.7 0.6 1.6 2.6 68.1 25.9 27.8 0.1
Gender:   
     Male 2600 3.8 2.3 0.9 0.8 1.6 2.9 73.7 20.4 28.7 0.3
     Female 3800 3.0 1.7 0.6 0.5 1.7 2.4 64.4 29.6 27.2 0.0
Modal Age:   
     19-20 1100 3.5 3.1 0.5 0.4 2.2 2.4 59.0 28.9 27.5 0.1
     21-22 1100 4.6 2.7 0.7 0.6 1.9 2.8 70.1 29.3 29.2 0.0
     23-24 1100 2.9 1.8 0.4 0.5 1.4 2.5 71.2 29.6 29.3 0.1
     25-26 1000 3.9 1.4 1.1 0.8 1.7 2.6 73.0 26.1 30.7 0.4
     27-28 1100 2.4 1.3 0.8 0.6 1.4 2.4 70.3 23.8 26.3 0.0
     29-30 1000 2.6 1.3 0.7 0.8 1.3 3.0 65.7 16.7 23.5 0.0
Region:   
     Northeast 1300 3.6 1.7 0.1 0.5 1.8 2.7 73.6 22.8 30.7 0.0
     North Central 1800 3.2 2.0 0.6 0.6 1.4 1.9 71.9 29.6 32.5 0.0
     South 2100 3.1 2.2 0.8 0.3 1.6 3.5 61.5 25.6 24.8 0.2
     West 1200 3.7 1.8 1.3 1.3 1.7 2.0 68.4 23.8 22.8 0.2
Population Density:e   
     Farm/Country 700 2.9 2.0 1.2 1.0 1.7 2.1 58.0 25.2 34.2 0.2
     Small Town 1700 3.3 2.4 0.6 0.3 1.6 2.7 64.4 26.9 29.0 0.2
     Medium City 1500 4.1 1.6 0.3 0.4 1.7 2.3 67.8 29.8 27.5 0.1
     Large City 1500 2.6 1.9 0.7 0.6 1.3 1.9 73.2 22.3 25.7 0.1
     Very Large City 1000 3.8 1.8 0.9 1.1 2.0 4.3 74.4 24.1 24.4 0.0
Source :  The Monitoring the Future Study, the University of Michigan.
'*' indicates a percentage of less than 0.05% but greater than true zero.
aOnly drug use that was not under a doctor's orders is included here.
bBased on the data from the revised question, which attempts to exclude the inappropriate reporting of nonprescription amphetamines.
cThis drug was asked about in two of the six questionnaire forms.  Total N is approximately 2100.
dThis drug was asked about in one of the six questionnaire forms.  Total N is approximately 1100.
eA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000; and a very large city as having over 500,000 
 residents.  Within each level of population density, suburban and urban respondents are combined.
TABLE 4-4 (cont.)
Thirty-Day Prevalence of Use of Various Types of Drugs by Subgroups, 2005





Approx. in a Row in or More
Weighted N Marijuana Daily Alcohol Daily Past 2 Weeks Cigarettes Daily per Day
Total 6400 4.7 5.3 35.7 19.5 12.8
Gender:
     Male 2600 6.6 8.4 47.0 19.3 12.8
     Female 3800 3.5 3.2 28.1 19.6 12.8
Modal Age:
     19-20 1100 6.4 3.6 36.3 17.6 10.1
     21-22 1100 4.6 6.0 40.4 19.2 12.1
     23-24 1100 4.5 5.8 39.2 20.4 13.9
     25-26 1000 5.9 6.0 37.7 22.5 13.6
     27-28 1100 3.0 4.6 31.5 18.6 13.1
     29-30 1000 3.9 5.8 29.1 18.9 14.1
Region:
     Northeast 1300 4.5 5.4 40.5 21.1 13.6
     North Central 1800 4.8 4.9 40.8 23.5 17.3
     South 2100 4.3 5.1 29.7 18.2 11.7
     West 1200 5.5 5.9 34.0 14.2 7.4
Population Density:a
     Farm/Country 700 3.6 5.0 30.6 26.2 19.1
     Small Town 1700 4.1 4.3 35.0 21.1 14.3
     Medium City 1500 5.4 5.3 36.7 19.8 13.1
     Large City 1500 4.9 5.7 36.7 16.4 10.6
     Very Large City 1000 5.1 6.8 38.0 15.4 8.3
Source :  The Monitoring the Future Study, the University of Michigan.
aA small town is defined as having fewer than 50,000 inhabitants; a medium city as 50,000-100,000; a large city as 100,000-500,000;  and a very large
city as having over 500,000 residents.  Within each level of population density, suburban and urban respondents are combined.
TABLE 4-5
Thirty-Day Prevalence of Daily Use of Various Types of Drugs by Subgroups, 2005
Among Respondents of Modal Ages 19-30
(Entries are percentages)
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See text for discussion.
FIGURE 4-1
 Any Illicit Drug:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group



























































See text for discussion.
Note :  Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time.
FIGURE 4-2
 Any Illicit Drug Other Than Marijuana:  Lifetime, Annual, and Thirty-Day Prevalence




















































See text for discussion.
Note :  Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time.
FIGURE 4-3
Marijuana:  Lifetime, Annual, and Thirty-Day Prevalence

























































See text for discussion.
FIGURE 4-4
Amphetamines:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group


















































See text for discussion.
FIGURE 4-5
Methamphetamine:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45,* 2005
by Age Group
*This specific drug was not included in the age 35, age 40, or age 45 questionnaires.










































See text for discussion.
*This specific drug was not included in the age 35, age 40, or age 45 questionnaires.
FIGURE 4-6
Crystal Methamphetamine ("Ice"):  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45,* 2005
by Age Group


















































See text for discussion.
FIGURE 4-7
Cocaine:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group
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See text for discussion.
FIGURE 4-8
Crack Cocaine:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group














































See text for discussion.
FIGURE 4-9
Other Cocaine:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group






















































See text for discussion.
*Unadjusted for the possible underreporting of PCP.
FIGURE 4-10
Hallucinogens:*  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group






















































See text for discussion.
*This specific drug was not included in the age 40 or age 45 questionnaires.
FIGURE 4-11
LSD:*  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group












































See text for discussion.
*This specific drug was not included in the age 40 or age 45 questionnaires.
FIGURE 4-12
Hallucinogens Other Than LSD:*  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group















































See text for discussion.
*Unadjusted for the possible underreporting of amyl and butyl nitrites. This specific drug was not included in 
the age 35, age 40, or age 45 questionnaires.
FIGURE 4-13
Inhalants:*  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group











































See text for discussion.
FIGURE 4-14
Sedatives (Barbiturates):  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group























































See text for discussion.
FIGURE 4-15
Narcotics Other Than Heroin:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group
























































See text for discussion.
FIGURE 4-16
Tranquilizers:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group






















































See text for discussion.
*This specific drug was not included in the age 35, age 40,  or age 45 questionnaires.
FIGURE 4-17
MDMA:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45,* 2005
by Age Group












































See text for discussion.
*This specific drug was not included in the age 35, age 40, or age 45 questionnaires.
Note :  Lifetime prevalence estimates were adjusted for inconsistency in self-reports of drug use over time.
FIGURE 4-18
Steroids:  Lifetime, Annual, and Thirty-Day Prevalence

















































See text for discussion.
FIGURE 4-19
Heroin:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group
























































See text for discussion.
FIGURE 4-20a
Alcohol:  Lifetime, Annual, and Thirty-Day Prevalence
Among High School Seniors and Adults Through Age 45, 2005
by Age Group























































Alcohol:  Two-Week Prevalence of Five or More Drinks in a Row 
and Thirty-Day Prevalence of Daily Use Among High School Seniors
by Age Group
 and Adults Through Age 45, 2005
For 18-year-olds only:  Due to a coding error, previously released versions of this figure contained values that were 
































5+ Drinks in a Row in Last Two Weeks
Daily in Past 30 Days
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FIGURE 4-21
Cigarettes:  Annual, Thirty-Day, Daily, and Half-Pack-a-Day Prevalence



































































TRENDS IN DRUG USE  
IN EARLY TO MIDDLE ADULTHOOD 
 
 
Longitudinal panel data are typically used to study changes in the behaviors and attitudes of the 
same individuals over time. Although the panel data from the many high school graduating classes 
encompassed in the Monitoring the Future study can be, and frequently are, used for that more 
typical purpose, these data can also be used to track historical trends for fixed age bands across 
years. In other words, they can be used much as we often use the repeated cross-sectional surveys of 
secondary school students. In this chapter, we report historical trends in the use of the various licit 
and illicit drugs by high school graduates for particular age bands between 1 and 27 years beyond 
high school, spanning the modal ages 19 through 45.  
In the early 1990s, we began to document large and important increases among secondary school 
students in the use of several substances, particularly marijuana and cigarettes. The increases 
continued among 12th graders through 1997, as discussed in Volume I. One of the important issues 
addressed in this chapter is whether such increases occurred only among adolescents or whether 
recent graduating classes have carried their higher levels of drug use with them as they have moved 
into young adulthood. In other words, are they exhibiting lasting cohort effects?  
Figures 5-1 through 5-19c plot separate trend lines for two-year age strata (that is, respondents who 
are 1–2 years beyond high school, 3–4 years beyond high school, etc.) We present data in two-year 
age strata in order to damp down the random fluctuations that would be seen with one-year strata. 
(Strictly speaking, these two-year strata are not age strata, because they are based on all respondents 
that year from two adjacent high school classes, and they do not take account of the minor 
differences in individual respondents’ ages within each graduating class; however, they are close 
approximations to age strata, and we characterize them by the modal age of the respondents as ages 
19 to 20, 21 to 22, and so on.) Each data point in these figures is based on approximately 1,200 
weighted cases drawn from two adjacent high school classes; actual (unweighted) numbers of cases 
are somewhat higher. For the 2005 data, the 19- to 20-year-old stratum is composed of participating 
respondents from the high school graduating classes of 2004 and 2003, respectively; the 21- to 22-
year-old stratum contains data from the classes of 2002 and 2001, respectively, and so on. Figures 5-
1 through 5-19c also present some recent trend data from the age-35, age-40, and age-45 follow-ups. 
Each of these is constituted in a slightly different way, in that the two half-samples from a single 
graduating class (which through age 30 had been surveyed in alternating years) are both surveyed in 
the same year. In 2005, the 35-year-olds are graduates from the high school class of 1988 (weighted 
n = 1030), the 40-year-olds are graduates from the high school class of 1983 (weighted n = 968), and 
the 45-year-olds are graduates from the high school class of 1978 (weighted n = 1042).  
Tables 5-1 through 5-5 are derived from the same data but presented in tabular form for 19- to 28-
year-olds combined (i.e., those who graduated from high school 1 to 10 years earlier). Data are given 
for each year in which they are available for that full age band (i.e., from 1986 onward). Those aged 
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29 and over are omitted because their inclusion would shorten the time period over which trends can 
be examined. However, the full data for them are contained in Figures 5-1 through 5-19c. 
 
TRENDS IN PREVALENCE: EARLY AND MIDDLE ADULTHOOD 
 
The trend results are as follows: 
• Longer-term declines among young adults in the annual prevalence of several drugs 
appeared to end in 1992 or 1993 (see Table 5-2). Among the 19- to 28-year-old young adult 
sample this was true for the use of any illicit drug, any illicit drug other than marijuana, 
marijuana, hallucinogens, narcotics other than heroin, crack, amphetamines, sedatives 
(barbiturates), and tranquilizers. In 1994, annual prevalence for most drugs remained 
steady. Cocaine other than crack reached its nadir in 1994 after a period of substantial 
decline. In 1995 there were modest increases (a percentage point or less) in the annual 
prevalence of almost all of the drug classes in Table 5-2, some of which were statistically 
significant. 
 
Thus, it is clear that by 1992 or 1993 the downward secular trend observable in all of these 
age strata (as well as among adolescents) had ended.40 (Such secular trends, in which 
different age groups move in parallel, are also called “period effects.”) What has happened 
since then, however, is quite a different form of change. Rather than being a period effect 
common to all age groups, it is more of a “cohort effect,” reflecting an interaction between 
age and period such that only adolescents showed the increase in illicit drug use initially, and 
then they carried those new (higher) levels of drug use with them as they entered older age 
bands. Figure 5-1 shows the effects due to generational replacement, as the teens of the early 
1990s reached their 20s. It can be seen that, while all age groups moved fairly parallel 
through about 1992, the youngest age bands first showed signs of increase in their overall 
level of illicit drug use. The 18-year-olds shifted up first, followed by the 19- to 20-year-olds 
in 1994, the 21- to 22-year-olds in 1996, the 23- to 26-year-olds in 1999, the 27- to 30-year-
olds in 2000, and the 35- and 40-year-olds in 2004.  
 
To repeat, in the earlier decline phase of the drug epidemic, annual prevalence of use of any 
illicit drug moved in parallel for all of the age strata, as illustrated in Figure 5-1; this pattern 
reflects a secular trend, because a similar change is observed simultaneously across different 
age levels. In what we have called the “relapse phase” of the popular drug epidemic, after 
1992 a quite different pattern emerged, with the 12th graders increasing their drug use first 
(actually the 8th graders showed a rise before they did), and rising fastest; the next oldest age 
group following, but with a little delay; the next oldest then following, but with a longer 
delay; and the oldest groups not yet showing an increase. This pattern reflects a classic 
cohort effect, in which different age groups are not all moving in parallel; rather, different 
age groups show increases when the cohorts (that is, high school classes) having heavier use 
at an earlier stage in development reach the relevant age level. Further, the slopes of the age 
bands are successively less steep in the higher age groups, suggesting that some of the cohort 
                                                 
40Actually, the downturn ended at least a year earlier among the youngest adolescents—the 8th graders—who showed the beginning of an increase in 
1992. (See Table 2-2.) 
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effect may be dissipating with maturation. But we think it unlikely that only cohort effects 
will be occurring (in addition to the long-established age effects); also, no doubt, entering 
into the mix are period effects (i.e., historical effects that have an impact on all age bands in 
a given historical period). 
 
• Use of marijuana, the major component of the illicit drug use index, shows an almost 
identical pattern to the index (Figure 5-3a). After a long and steady decline from the late 
1970s to the early 1990s, use leveled for a while among young adults before beginning a 
gradual increase. Virtually all of this increase was attributable to the two youngest age bands 
(18 and 19 to 20) until 1996, when the third youngest age band (21- to 22-year-olds) began 
to show a rise. The older age bands then tended to show increases fairly sequentially. The 
18-year-olds began a decline after 1997, and later several of the succeeding age bands 
through age 24 have begun to show declines in a pattern that suggests cohort differences. 
   
• A similar pattern emerged for current daily marijuana use (Figure 5-3c). In the mid- to late 
1990s, daily marijuana use among the 35- and 40-year-olds was as high as, or higher than 
use among some younger age groups, suggesting a lasting cohort effect on this behavior. 
However, in recent years, the 35- and 40-year-olds (and now the 45-year-olds) have been 
similar to those ages 27 to 32, who have had among the lowest levels of daily use. An 
important finding shown in Figure 5-3c is that, although the various age groups had been 
moving in parallel for many years at fairly similar levels of prevalence, the trends diverged 
considerably in the 1990s in a staggered fashion, such that now 18- to 30-year-olds have 
distinctly higher levels of daily marijuana use than the older age groups, again reflecting 
stable cohort differences. 
 
• The index of using any illicit drug other than marijuana has shown a similar transition in 
the pattern of change. Period effects seemed to predominate until about 1992, but a cohort-
related pattern of change emerged thereafter (Figure 5-2). And, while use leveled by 1997 
among 18-year-olds, it began rising during that interval among 25- to 26-year-olds and is 
also now rising among 27- to 28-year-olds and 29- to 30-year-olds. The primary difference 
from the picture for marijuana is that the increases were not as sharp in the 1990s for most of 
the age bands for the other illicit drugs taken as a group as they were for marijuana. 
 
• In the 1980s and 1990s, LSD use also increased among those in their teens and early 20s 
more than among the older strata, as Figure 5-6 illustrates. Over the interval 1985 to 1996 
there was a gradual but considerable increase in LSD use among those aged 18 to 24, which 
was sharpest among 12th graders and the 19- to 20-year-olds. (In this case the increase did 
not seem to radiate up the age spectrum beyond age 26.) A turnaround began among the 12th 
graders after 1995 and then among the older age groups in a somewhat staggered fashion, 
again indicative of a cohort effect. The declines in the years since have been greatest among 
the 18- to 24-year-olds, who had attained the highest rates of LSD use. LSD use declined 
considerably from 2001 to 2003 in all age bands (including 8th and 10th graders), and then 
leveled at historically very low rates, suggesting that an important secular trend may have set 
in, quite possibly related to decreased availability of the drug.  
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• Several of these drug classes actually exhibited a faster decline in use among the older age 
groups than among 12th graders during the earlier period of decline. (See Figures 5-1 
through 5-19c.) These included any illicit drug, any illicit drug other than marijuana, 
amphetamines, hallucinogens (until 1987), LSD (through 1989), and methaqualone. 
 
• In fact, there was a crossover for some drugs when 12th graders are compared to young adult 
graduates. In earlier years 12th graders had lower usage levels, but in recent years they have 
tended to have higher ones than post-high school respondents for use of any illicit drug, 
marijuana, any illicit drug other than marijuana, hallucinogens, LSD specifically, 
amphetamines, tranquilizers, narcotics other than heroin, and crystal methamphetamine 
(ice). However, since then, as the next two age strata after high school continued to show 
increases on a number of these drugs, they have closed the gap with 12th graders. This has 
been true for marijuana, hallucinogens, LSD, narcotics other than heroin, and tran-
quilizers. (See, for example, Figure 5-3a for annual marijuana prevalence.) 
 
• Cocaine (Figure 5-9) gives a quite dramatic picture of change. Unlike most of the other 
drugs, active use of cocaine generally has tended to rise with age after high school, usually 
peaking approximately three to four years past graduation. This is a classic example of an 
age-effect. Despite the large age differences in absolute prevalence, all age strata moved in a 
fairly parallel way through 1991, indicating that a secular trend was taking place in addition 
to the age effect. All began a sharp and sustained decline in use after 1986. The two youngest 
strata (12th graders and 19- to 20-year-olds) leveled by 1992, whereas use continued a 
decelerating decline for a few years beyond that in the older age groups, signaling the 
beginning of a cohort effect. From 1994 to 1999, cocaine use rose some in the five youngest 
strata (i.e., those younger than 27) on a somewhat staggered basis, with the three older 
groups still decreasing a bit more over that same period. This, to some degree, reversed the 
age differences that were so prominent in the 1970s and 1980s. Cohort-related change 
appears to have predominated in the 1990s, quite possibly as the result of “generational 
forgetting” of the cocaine-related casualties so evident in the early to mid-1980s. In other 
words, those in the older cohorts retained that learning, but those in the newer cohorts never 
had it. The fact that in recent years the 35- and 40-year-olds had higher lifetime prevalence 
levels of cocaine use than some of the younger age groups also suggests some lasting cohort-
related differences established during the peak years of the cocaine epidemic. 
 
• Crack use was added to the 12th graders’ questionnaires in 1986 and to the follow-up 
questionnaires in 1987. The decline in crack use, which began right after the introduction of 
these questions, ended in 1991 among 12th graders, and by 1994 it had ended among young 
adults (see Figure 5-10 and Table 5-2). Among 19- to 28-year-olds, the annual prevalence 
rate held at about 1%, which was down from the peak levels of just over 3% in 1986 through 
1988. As was true for a number of other drugs, crack use began to rise (in this case after 
1993) among 12th graders but not in the older age strata until later years, when increases 
were observed in a somewhat staggered pattern going up the age scale. Again, a cohort effect 
due to generational replacement seems to have been occurring. Since 1994, the 18-year-olds 
have had the highest reported rates of use, and since 1999 the 19- to 20-year-olds have 
generally had the second highest rates. Importantly, all groups now have annual prevalence 
rates for the most part well below 2.0%. 
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• With regard to inhalants, the large separation of the age band lines in Figure 5-4 shows that, 
across many cohorts, use consistently has dropped sharply with age, particularly in the first 
few years after high school. In fact, of all the populations covered in this study, the 8th 
graders (not shown in Figure 5-4) have had the highest rate of use, indicating that the decline 
in use with age starts at least as early as 8th or 9th grade. Like cocaine, inhalants have shown 
a strong age effect, but unlike cocaine, use of inhalants declines with age. 
 
Figure 5-4 also shows that there was a long-term gradual increase in annual inhalant use 
(unadjusted for underreporting of nitrite inhalants), one which was greatest among 12th 
graders, next greatest among 19- to 20-year-olds, and next greatest among 21- to 22-year-
olds. Respondents more than six years past high school, who historically have had a 
negligible rate of use, did not exhibit the increases in use seen among the younger 
respondents, which began at least as early as 1977 among 12th graders and in 1983 among 
19- to 20-year-olds. There was subsequently some increase among 21- to 22-year-olds and 
later still an increase among 23- to 24-year-olds. After 1995, this long-term trend, reflecting 
a cohort effect, began to reverse in the two youngest age strata and subsequently among the 
next two age strata. The older age strata generally have shown negligible rates of inhalant 
use. A new cohort effect may now be emerging as prevalence increased between 2003 and 
2005 among 8th, 10th, and 12th graders. 
 
• The annual prevalence for MDMA (ecstasy) use among the entire young adult sample (ages 
19 to 28) was at about 1.5% in 1989 and 1990 (Table 5-2 and Figure 5-8). After 1991 it 
dropped to around 0.8% for several years before starting to rise significantly in 1995. Then 
ecstasy use began to rise in all of the young adult age strata but clearly rose the most among 
those in the younger age bands (19 through 26) through 2001. Use among 12th graders, 
which was not measured until 1996, was by then the highest of any of the age groups at 4.6% 
annual prevalence. Twelfth graders’ use slipped by a full percentage point through 1998 
before jumping significantly—by 2 full percentage points—in 1999. (Use by 10th graders 
also jumped significantly in 1999.) Thus it appears that young people from their mid-teens to 
mid-20s had “discovered” ecstasy after some years of low and relatively level use. In 2000 
the sharp increase in use continued among those aged 15 to 16 (10th graders) through age 26 
and also showed up among 8th graders (13- to 14-year-olds) for the first time. By 2001 the 
increase had slowed and even begun to reverse among those aged 18 to 26, even as the 31- to 
32-year-olds showed their first appreciable increase in ecstasy use. We attributed the 
deceleration in 2001 to a fairly sharp increase in perceived risk that year and predicted a 
turnaround in use in 2002. In 2002, and again in 2003, perceived risk increased sharply; and, 
as Figure 5-8 illustrates, all age bands showed a reversal, with a sharp decrease in use. 
Clearly, the decrease has been sharpest in the younger age bands, perhaps because a cohort 
effect is at work in the upper ages, helping to offset a downward secular trend. 
 
• In the late 1970s, amphetamine use rose with age beyond high school; but after a long 
period of decline in use from 1981 to the early 1990s, this relationship had reversed (see 
Figure 5-13). The declines were greatest in the older strata and least among the 12th graders, 
even though use decreased substantially in all groups. As was true for many of the illicit 
drugs, amphetamine use began to rise among the 12th graders after 1992, and eventually 
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among the 19- to 24-year-olds; but there has only recently been a small increase among those 
25- to 30-years-old. In other words, another cohort-related pattern of change seems to have 
emerged in the 1990s for amphetamines, though in this case it may be dissipating quickly 
after respondents reach their early 20s. In fact, in the earlier age strata some decline in 
amphetamine use is observable in the past one or two years. At present the age differences 
through age 45 are of considerable magnitude and mostly ordinal (with the youngest 
showing the highest rates of use). 
 
• Since 1990, when it was first measured, the use of crystal methamphetamine (ice) has 
remained at fairly low rates in this young adult population (Figure 5-14). However, among 
19- to 28-year-olds combined, annual prevalence rose from 0.4% in 1992 to 1.6% by 2005 
(Table 5-2). Use had been rising among 12th graders and 19- to 20-year-olds, specifically, 
between 2000 and 2002, but since then their use fell back to around the 2000 levels. 
Methamphetamine use more generally has only been measured since 1999, and its use since 
then has remained quite stable among 19- to 28-year-olds, fluctuating within a range of 2.4% 
and 2.8% annual prevalence (Table 5-2).   
 
• Use of heroin increased appreciably in 1995 among 12th graders and young adults aged 19 
to 24 but not among the older age bands (Figure 5-11). Among young adults generally, 
annual use had previously been quite stable at least as far back as 1986 (Table 5-2), and it 
stabilized again at a higher level after 1995. Heroin use among 12th graders and 19- to 20-
year-olds has declined slightly since 2000 or 2001, respectively, but the older age groups 
have maintained a fairly stable and low rate of use. 
 
• Among 19- to 28-year-olds, the use of narcotics other than heroin leveled after 1991, 
following a long period of slow, fairly steady decline (Figure 5-12). Twelfth graders showed 
an appreciable increase in use, beginning in 1993, which continued into 2004, while 19- to 
20-year-olds showed some increase after 1994, 21- to 22-year-olds after 1996, 23- to 24-
year-olds after 1997, and the older age groups after 2000. In fact, the 29- to 30-year olds 
showed a significant increase in 2005. Thus, cohort-related change appears to have been 
occurring during the 1990s and beyond for this class of drugs, following a long period of 
secular trends. In 2002, the question text was changed on three of the six questionnaire forms 
to update the list of examples of narcotics other than heroin. Talwin, laudanum, and 
paregoric, each of which had negligible rates of use by 2001, were replaced by Vicodin, 
OxyContin, and Percocet. As a consequence of this revision, reported use rates increased in 
2002. Data presented here for 2002 are from three of the six questionnaire forms with the 
new wording (which showed higher prevalence rates than the older question did). All six 
questionnaire forms contained the new wording beginning in 2003, so the data presented for 
2003 and after are based on all forms. Although the older version of the question showed no 
significant changes occurring in 2002, there was a significant increase in narcotics use 
observed in 2003 (based on the new question). Some turnaround is observed in some of the 
younger age bands in 2005. 
 
• The annual prevalence rates for Vicodin and OxyContin, which were first measured in 2002 
(separately from the general question about narcotics other than heroin), were appreciable 
(8.2% and 1.9%, respectively) for all 19- to 28-year-olds. Increases were observed for these 
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two drugs in the subsequent years. Among 19- to 28-year-olds (see Table 5-2), the annual 
prevalence of OxyContin use rose from 1.9% in 2002 to 3.1% in 2004 and 2005—changes 
that were fairly parallel to those observed among 12th graders over the same interval (when 
their annual prevalence rose from 4.0% to 5.5%). The 2002–2005 increases in OxyContin 
use were significant for both 12th graders and 19- to 28-year-olds. Vicodin use rose by less, 
but started from a higher base, with annual prevalence increasing slightly among 19- to 28-
year-olds, from 8.2% in 2002 to 9.3% in 2005. In sum, the use of these two classes of 
narcotic drugs has been rising over the past several years among high school seniors and 
among young adults. 
 
• Sedative (barbiturate) use (Figure 5-15) showed a long-term parallel decline in all age 
groups covered through the late 1970s and 1980s, leveling by about 1988. While use 
remained low and quite level for most of the age bands for about five years, it began to rise 
by 1993 among 18-year-olds, by 1995 among 19- to 20-year-olds, by 1997 among 21- to 22-
year-olds, by 1998 among 23- to 24-year-olds, by 2001 among 25- to 28-year-olds, and by 
2005 among 29- to 30-year-olds. The same cohort-related pattern of change seen during the 
1990s for many other drugs also exists for sedatives (barbiturates); like most of the other 
drugs, this pattern was preceded by a period of secular change.  
 
• Tranquilizers (Figure 5-16) have a fairly similar picture to that just described for sedatives 
(barbiturates). One difference is that the 12th graders’ annual prevalence rate has not always 
been the highest among the various age groups, as was the case for sedatives (barbiturates), 
although it was highest between 1994 and 2000 as a result of a greater increase in 
tranquilizer use among the 12th graders than in the young adult strata. In the last four years, 
however, as use continued to increase among those in their early 20s, the 12th graders no 
longer stand out as having the highest rate of tranquilizer use. This is another clear example 
of a cohort-related pattern of change.   
 
• The use of anabolic steroids (Figure 5-17) is substantially lower after high school than 
during, and this has been true since measures of steroid use were first introduced into two of 
the follow-up questionnaires in 1991. The age-related differences are not consistent; the 
prevalence rates among the young adult strata are all quite low and do not appear to trend in 
any systematic way. In general, it seems that the rise in steroid use from 1999 to 2003 among 
8th and 10th graders and from 2001 to 2004 among 12th graders seems to have been specific 
to those age groups, at least so far.   
 
• The alcohol trends for the older age groups (see Figures 5-18a-d) have been somewhat 
different than for the younger age groups and in some interesting ways. For 30-day 
prevalence and occasions of heavy drinking, the declines for the two youngest age strata 
(12th graders and those one to two years past high school) during the 1980s were greater 
than for the older age groups. These differential trends were due in part to the effects of 
changes in minimum drinking age laws in many states, changes that would be expected to 
affect primarily the age groups under age 21. However, because similar (though weaker) 
trends were evident among 12th graders in states that maintained a constant minimum 
drinking age of 21, the changed laws cannot account for all the downward trends, suggesting 
that there was also a more general downward trend in alcohol consumption during the 
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1980s.41 By 1994, these declines in 30-day prevalence had slowed or discontinued for 
virtually all age groups until 1997, when they began to turn downward again for 12th 
graders, and 1999, when they started down among the 19- to 20-year-olds. 
 
Those respondents three to four years past high school stand out for showing the smallest 
downward trend in binge drinking since the early 1980s (see Figure 5-18d). One important 
segment of that age stratum is composed of college students, who showed very little 
downward trend (see chapter 9). 
 
The older age groups, in general, have shown only a modest long-term decline in annual 
prevalence rates and no recent decline in binge drinking or in 30-day prevalence rates. Note 
that the binge drinking trend lines for different age groups (Figure 5-18d) are spread out on 
the vertical dimension, reflecting large and persisting age differentials (age effects) in this 
behavior. The relationship with age is curvilinear, however. In recent years the 21- to 22-
year-olds consistently have shown the highest rates of binge drinking, while the two adjacent 
age bands have shown the next highest. Binge drinking appears to have been gradually 
increasing in recent years among the 23- and 24-year-olds and the 25- and 26-year-olds. This 
is perhaps driven in part by the fact that an increasing proportion of them are enrolled in 
college, where binge drinking rates tend to be high. In addition, they tend to be unmarried, 
which also affects rates of binge drinking.42  
 
From the early 1980s through the mid 1990s, rates of daily drinking (Figure 5-18c) fell by 
considerable amounts in all age strata for which we have data, reflecting an important change 
in drinking patterns in the culture. Among 19- to 28-year-olds combined, daily drinking fell 
from 6.6% in 1987 to 3.9% in 1994—a 40% drop—before leveling briefly and then rising to 
5.2% in 2005 (see Table 5-4). Daily drinking rates have generally proven to be highest for 
35-, 40-, and 45-year-olds in recent years, when data on them became available. 
 
It is worth noting that the 35-, 40-, and 45-year-olds have had among the lowest rates of 
binge drinking but among the highest rates of daily drinking in recent years for which we 
have data available. These patterns—particularly the high rate of daily drinking—likely 
reflect age effects as well as perhaps some enduring cohort differences (because these 
cohorts had considerably higher rates of daily drinking when they were in high school). 
 
• The prevalence rates for cigarette smoking show more complex trends than most other 
substances, due to the long-term presence of both cohort and age effects, plus slightly 
different patterns of such effects on different measures of smoking in the past 30 days (one 
or more cigarettes per month, one or more cigarettes per day, and a half-pack or more of 
cigarettes per day). 
 
                                                 
41O’Malley, P. M., & Wagenaar, A. C. (1991). Effects of minimum drinking age laws on alcohol use, related behaviors, and traffic crash involvement 
among American youth: 1976–1987. Journal of Studies on Alcohol, 52, 478–491. 
42Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
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In the earlier years of the study, the curves across time were of the same general shape for 
each age band (Figures 5-19a-c), but each of those curves tended to be displaced to the right 
of the immediately preceding age group, which was two years younger. The pattern is 
clearest in Figure 5-19c (half-pack plus per day). This pattern is very similar to the one 
described in Volume I for lifetime smoking rates for various grade levels below senior year; 
it is the classic pattern exhibited by a cohort effect—that is, when cohorts (in this case, high 
school graduating class cohorts) differ from other cohorts in a consistent way across much or 
all of the life span. We interpret the cigarette data as reflecting just such a cohort effect,43 and 
we believe that the persisting cohort differences are due to the dependence-producing 
characteristics of cigarette smoking. 
 
The declining levels of cigarette smoking across cohorts at age 18, which were observed 
when the classes of 1978 through 1981 became 12th graders, were later observable in the 
early-30s age band, as those same high school graduating classes reached their early 30s (see 
Figures 5-19b and c). This was true at least through about 1991. After that, there was a 
considerable convergence of rates across age groups, largely because there were few cohort 
differences among the senior classes who graduated from the early to mid-1980s through the 
early 1990s—a period of fairly level use among succeeding senior classes. 
 
In addition to these cohort differences, there are somewhat different age trends in which, as 
respondents grow older, the proportion smoking at all in the past 30 days declines some, 
while the proportion smoking a half-pack per day actually increases. Put another way, many 
of the light smokers in high school either become heavy smokers or quit smoking.44 
 
The picture was further complicated in the 1990s, when it appears that a new cohort effect 
emerged, with smoking among adolescents rising sharply (beginning after 1991 for the 8th 
and 10th graders and after 1992 for the 12th graders). The 19- to 20-year-olds also showed a 
rise at the beginning of the 1990s—responding perhaps to some of the same social forces as 
the adolescents (including possibly the Joe Camel advertising campaign); but the 21- to 24-
year-olds did not show an increase until about 1995, and the 25- to 26-year-olds until about 
1996. Those young adults over age 26 have not yet shown much increase, though they may 
well do so as the heavier-smoking senior class cohorts enter those age bands. 
 
After about 1999, smoking rates among virtually all age groups leveled or declined, 
suggesting that general societal forces may be affecting all age groups in a similar way, 
giving rise to some secular trends. Large increases in price and a great deal of adverse 
publicity for the tobacco industry are highly plausible candidates for such forces, as are an 
increase in state and national anti-smoking advertising and the demise of the Joe Camel 
campaign and of billboard advertising.  
 
                                                 
43O’Malley, P. M., Bachman, J. G., & Johnston, L. D. (1988). Period, age, and cohort effects on substance use among young Americans: A decade of 
change, 1976–1986. American Journal of Public Health, 78, 1315–1321. 
44 To illustrate, in the graduating class cohort of 1976, 39% were 30-day smokers in senior year, 39% by ages 19 to 20, but only 28% by age 31 to 32—
a net drop of 11 percentage points over the entire interval. By way of contrast, 19% of that class were half-pack-a-day smokers in senior year, 24% by 
ages 19 to 20, and 21% at ages 31 to 32—a net gain of 2% over the interval. 
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• Apart from cigarettes, none of the other drugs included in the study showed a clear long-term 
pattern of enduring cohort differences in the earlier years of the study (the 1970s and 1980s), 
despite wide variations in their use by different cohorts at a given age. There was one 
exception; a modest cohort effect was observable for daily marijuana use during the late 
1970s and early 1980s. (But as more recent classes leveled at lower rates of use, evidence for 
the cohort effect faded.) The emergence in the 1990s of a new epidemic of marijuana use 
among teens once again yielded a strong pattern of cohort effects. As can be seen in Figure 
5-3c, daily use rose sharply among 12th graders and 19- to 20-year-olds after 1992, among 
21- to 22-year-olds after 1993 with a sharp rise occurring in 1997, among 23- to 24-year-olds 
after 1998, among 25- to 26-year-olds after 2000, among 27- to 28-year-olds in 2003, and 
among 29- to 30-year-olds in 2005. However, among those older than 30, as of yet there has 
been virtually no increase in daily use. This is not unlike the pattern of change for cigarette 
smoking that occurred in the 1990s (Figure 5-19a). The cohort effect for daily marijuana use 
may be attributable, in part, to the very strong association between that behavior and regular 
cigarette smoking. It is noteworthy that even among the 35-, 40-, and 45-year-olds in the 
study, 1.9%–2.1% report that they still currently smoke marijuana on a daily basis. That 
amounts to 1 in every 48 to 53 adults at those ages. And we know from results published in 
the companion volume to this one that many more have been daily marijuana users for at 
least a month at some time in their life. 
 
• In sum, except for cigarettes and alcohol, substance use prior to 1992 among 12th graders 
and young adults had shown longer-term trends that were highly parallel, indicating that 
general secular trends predominated in that period. Since 1992, however, there has been 
some considerable divergence in the trends for different age bands on a number of drugs as 
use among adolescents rose sharply, followed by subsequent rises among the 19- to 20-year-
olds, the 21- to 22-year-olds, and so on. This divergence indicates a new cohort effect, quite 
possibly reflecting a “generational forgetting” of the dangers of drugs by the cohorts who 
reached senior year in the early to mid-1990s. The data discussed in chapter 6, “Attitudes 




TRENDS FOR IMPORTANT SUBGROUPS OF YOUNG ADULTS 
 
Four-year age bands have been used here to examine subgroup trends in order to yield sufficiently 
large numbers of cases to permit reliable estimates for the various subgroups being examined. 
Subgroup data for respondents of each gender and for respondents from communities of different 
sizes are available for 19- to 22-year-olds since 1980, 23- to 26-year-olds since 1984, and 27- to 30-
year-olds since 1988. Beginning with the 1987 follow-up questionnaires, a question about state of 
residence was added to all follow-up questionnaires, permitting trend data to be calculated for the 
four regions of the country since then. These various subgroup data are not presented in tables or 
figures here because of the substantial amount of space they would require. Rather, a verbal synopsis 
of what they contain is presented.  
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Gender Differences in Trends 
• Over the long term, gender differences narrowed for some drugs among young adults, 
primarily because of a steeper decline in use among males (who generally had higher rates of 
use) than among females. The overall picture, though, is one of parallel trends, with use 
among males remaining higher for most drugs, including the indexes of any illicit drug use 
in the prior year and use of any illicit drug other than marijuana (see Table 5-5, for 
example). 
 
• The downward trend in marijuana use among 19- to 22-year-olds between 1980 and 1989 
was a bit sharper among males than females, narrowing the gap between the two groups. 
Annual prevalence fell by 22 percentage points (to 34%) among males, compared to a drop 
of 14 percentage points (to 31%) among females, leaving a difference of 3 percentage points. 
In the late 1990s through 2005, the gap widened a bit, to 7 percentage points (38% versus 
31%). 
 
Similarly, between 1980 and 1993, daily marijuana use for this age group fell more steeply, 
from 12.9% to 2.9% among males, versus from 6.1% to 1.7% among females, narrowing the 
gap considerably. As use began to rise after 1993, the gap widened again. Among 23- to 26-
year-olds, as daily use first began to increase in 1998 and 1999, the gap between the genders 
began to widen. In the oldest age group (aged 27–30), the difference had been fairly 
constant, with daily marijuana use among males generally being two to three times higher 
than among females. After 2001, however, use increased among females, while use among 
males remained relatively steady. 
 
• Males have shown slightly higher proportions using any illicit drug other than marijuana in 
all three age bands, a fact that has not changed appreciably over the years, though the 
differences tended to narrow some as use dropped and to widen as use increased. 
 
• For LSD, males have consistently had higher rates of use than females. Among 19- to 22-
year-olds, the male-female differences tended to diminish as use declined (from 1980 to 
1985 and again from 1999 to 2004) and tended to increase as use increased (1986–1995). In 
the two older age bands there was less change in use, and differences had been relatively 
consistent. In the last few years, however, the pattern was accentuated; LSD use has dropped 
considerably since 1999 among 19- through 26-year-old males (and since 2001 among the 
27- to 30-year-old males), substantially narrowing the gender differences. Males began to 
show these declines first, and both genders have moved to almost no use. 
 
• MDMA (ecstasy) exhibited little or no gender difference in any of the three age bands before 
use began to grow in the late 1990s. Even since then, among the 19- to 22-year-olds there 
has been little gender difference, except that use among males started to decline one year 
ahead of use among females. But in the older age groups a gender difference did open up 
after 1997, with males having higher rates of use among both 23- to 26-year olds and 27- to 
30-year olds. Among these two older age bands, this gender difference had just about 
disappeared by 2005 due to a decline in use among the males since 2001 or 2002. 
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• During the period of sharp decline from the peak levels in annual cocaine prevalence (1986–
1993), use dropped more among males than females, narrowing the gender differences. In 
the 19- to 22-year-old age band, annual prevalence for males declined by 16 percentage 
points (to 4.5%) versus 13 percentage points among females (to 2.8%) in 1993. In the 23- to 
26-year-old age band, there was also a narrowing of the gender difference between 1986 and 
1993, with annual prevalence down 19 percentage points (to 6.9%) among males and 13 
percentage points (to 4.2%) among females. Use in the 27- to 30-year-old group also 
dropped faster among males (down 13.3 percentage points versus 7.1 among females) 
between 1988 (when data were first available) and 1997. In sum, during the period of sharp 
decline in overall cocaine use, the gender differences—which had been fairly large—
narrowed considerably in all three of these age bands. During the more recent resurgence in 
cocaine use, the gap between genders expanded slightly; but males have had higher rates of 
use of this drug throughout the life of the study.  
 
• A similar occurrence happened with crack during the earlier period of decline, though the 
proportional difference between the two genders has consistently been higher than for 
cocaine overall. With crack, though, there was some gender convergence (between 1992 and 
1998) among 19- to 22-year-olds, as use among males declined slightly and use among 
females rose gradually. Since 1999, there has been no consistent change in differences 
between males and females. In the two older age bands, males have fairly consistently had 
somewhat higher crack usage rates. 
 
• As sedative (barbiturate) use declined through the 1980s, the modest gender differences 
(males were higher) were virtually eliminated in all three of the age bands. Since the early 
1990s, there has been some increase in use by both genders among all three age groups, with 
males increasing more than females, thereby opening a difference again in the late 1990s and 
early 2000s. By 2005, the difference had declined to near zero, as a result of increasing use 
among females.  
 
• The annual prevalence figures for heroin dropped among males in the 19- to 22-year-old 
category between 1980 and 1986 (from 0.6% to 0.2%) before leveling through 1994; thus 
most of the decline in use in that interval was among males, mostly eliminating the previous 
gender difference. Rates for both genders remained very low, between 0.1% and 0.3% 
throughout the period 1986 through 1994. In 1995 through 1998, use increased appreciably 
among both males and females in this youngest age group, but a gender difference opened up 
again (with males higher). After 2001, both showed some decline, followed by a gradual rise, 
resulting in respective annual prevalence rates of 0.8% and 0.5% in 2005. Among 23- to 26-
year-olds, use also remained low (0.1% to 0.2%) over the years 1986–1994 for both genders. 
There was an increase from 1995 to 2001 among males, with females remaining relatively 
flat, and more of a gender difference emerged. However, since 2001, males have declined 
and females have remained stable, just about eliminating the gender gap. Among 27- to 30-
year-olds there was some falloff in heroin use between 1988 (when data were first available) 
and 1990 in both genders, as well as a narrowing of gender differences. Use rose slightly in 
the early 2000s among males, and the rates among males have generally been higher than 
among females since 2001 (0.8% and 0.2%, respectively, in 2005).   
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• Among 19- to 22-year-olds, both genders showed some decline in their use of narcotics 
other than heroin between 1980 and 1991, with a near elimination of previous gender 
differences (males had been higher). Beginning in 1994, use by males began to rise in this 
age band, while use by females began to rise a year later. Some gender differences have 
developed as use has increased, with males at 12% and females at 9% in 2004. The picture 
for 23- to 26-year-olds is very similar: the gender difference (males higher) had been 
eliminated by 1988, but reemerged after 1992 as use had increased more among males. Both 
of these younger age bands showed the same development in 2005, in which use among 
males turned down as use among females held steady—once again narrowing the gender 
difference. Among the 27- to 30-year-olds, there has been a smaller gender difference and 
the least increase in use in the 2000s. Still, use has increased in both genders since 1999. 
Males have had slightly higher rates of use since the early 1990s in this age band, and both 
genders have shown a fairly steady increase in use since 1999. 
  
• The use of the specific drugs OxyContin and Vicodin has consistently been higher among 
males than among females for the four years for which we have data.   
 
• Generally, there has been no appreciable gender difference in amphetamine use for some 
years in any of these three age bands. Between 1981 and 1991, rates of amphetamine use 
were similar for males and females and showed substantial and parallel downward trends for 
both genders. Among the 19- to 22-year-olds, use for males dropped 22 percentage points in 
annual prevalence (to 5.2% in 1991), and use for females dropped 21 percentage points (to 
4.7% in 1991). There were small increases in annual prevalence for both genders in the 19- 
to 22-year age group after 1991, in the 23- to 26-year age group after1995, and in the 27- to 
30-year-old age band after 2000, but the genders have diverged only slightly (males higher) 
and use has leveled in all three age bands.  
 
• Crystal methamphetamine (ice) was added to the study in 1990. In the early 1990s, use was 
low and very similar for both genders in all three young adult age bands. Nearly all of the 
increase in use that occurred in the mid-1990s in the younger two age bands occurred among 
males—opening a gender gap. The gap then narrowed, though males were slightly more 
likely to report use of ice up until 2003. While the estimates are a bit “bouncy” due to the 
limited sample sizes for this drug, the gender difference increased in 2004 and 2005 in the 
19- to 20-year-olds, and a similar difference opened in 2005 among the 27- to 30-year-olds. 
 
• For tranquilizers, both genders showed a long, gradual decline (and very similar rates of use) 
from 1980 through about 1993 in all three age bands. Beginning in 1995, use increased for 
both genders in the 19- to 22-year-old group, followed by an increase beginning after 1997 
among the 23- to 26-year-olds and after 1999 among the 27- to 30-year-olds, again reflecting 
cohort effects driven by generational replacement. Some gender difference has emerged in 
this period of increase (and subsequent leveling after 2002 and 2003, respectively), with 
males reporting somewhat higher usage rates. Among the 27- to-30-year-olds, males are 
higher and use is still rising for both genders.  
 
• Inhalant use generally has been quite a bit higher among males than females in all three age 
groups. The 19- to 22-year-old group showed a gradual upward shift from 1980 to 1988, 
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followed by a leveling for some years, in both genders. In 1997, female inhalant use began to 
decline among the 19- to 22-year-olds, followed by males in 2001; however, the gender gap 
did not diminish much with this decline until 2005, when there was a convergence. Among 
23- to 26-year-olds there was a widening gender gap as use by males, but not females, 
increased between 1992 and 1999, though a decline among males since then has narrowed 
the gap, and by 2005 it was eliminated completely. In the oldest age stratum, use among 
males has consistently been slightly higher. 
 
• Use of three “club drugs”—GHB, ketamine, and Rohypnol—tends to be concentrated 
among males in all three age strata, with the single exception that among the 19- to 22-year-
olds, GHB use has been about equivalent for both genders in three of the four years in which 
its use has been measured. 
 
• For alcohol, 30-day prevalence rates have shown a long, gradual, parallel decline from 1981 
through 1992 for both genders in the 19- to 22-year-old age group. Thirty-day prevalence fell 
from 83% to 72% among males and from 75% to 62% among females by 1992. In the two 
older age bands, there had also been a modest, parallel decline for both genders, from 1985 
through 1992 in the case of 23- to 26-year-olds, and at least from 1988 (when data were first 
available) to 1991 or 1992 in the case of 27- to 30-year-olds. Since 1992, both genders in the 
older two age bands have shown fairly level use rates, with males somewhat higher; 
however, among the 19- to 22-year-olds there has been some convergence, because use by 
males has declined slightly while use by females has increased slightly. 
 
There also was a general long-term decline in daily drinking from about 1981 or 1982 
through about 1992, with daily use falling more among males, considerably reducing, but far 
from eliminating, what had been a large gender difference among 19- to 22-year-olds. To 
illustrate, in 1981, 11.8% of the males reported daily use versus 4.0% of the females; the 
comparable 1992 statistics were 5.3% and 2.7%. After 1995, daily drinking began to increase 
among the 19- to 22-year-olds for both genders but leveled a few years later. Since 2002 
daily use by males has been rising, while it has been falling among females. There is still a 
large gender difference for daily drinking among the 19- to 22-year-old age group in 2005—
8.7% for males versus 2.3% for females—but not nearly as large as it had been in 1981 
(11.8% versus 4.0%). The gender differences have been similar for the older age groups (in 
2005, for example, 8.5% versus 4.1% among 23- to 26-year-olds), and there has been little 
evidence of any convergence or divergence. 
 
There also are long-established and large gender differences in all age groups in the 
prevalence of occasional heavy drinking or “binge drinking” (i.e., having five or more 
drinks in a row at least once in the past two weeks). Males in the 19- to 22-year-old band 
showed some longer-term decline in this statistic, from 54% in 1986 to 45% in 1995, thus 
narrowing the gender gap (from 24 percentage points in 1986 to 17 percentage points in 
1995). After 1995 the rates for both genders drifted up a few percentage points. Binge 
drinking among females in the same age band remained quite steady from 1980 through 
2003, before giving some indication of an increase in 2004 (non-significant). In the two older 
age bands (23- to 26-year-olds and 27- to 30-year-olds), both the binge drinking rates and the 
sizable gender differences have been stable for the most part. However, from 1997 to 2002 
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among females, and from 1997 to 2004 among males, there was some increase in binge 
drinking in the 23- to 26-year-old group. The increases were from 22% to 29% among 
females and from 45% to 51% among males across the intervals stated. More recently, since 
about 2002, there has been some gradual increase in binge drinking among 27- to 30-year-
olds of both genders. 
 
• Most striking for cigarette smoking are the similarities between the genders in both absolute 
levels and in trends, though there are some differences. All three age groups showed a long-
term decline in daily smoking rates for both males and females after data were first available 
for each: 19- to 22-year-olds from 1980 to 1990; 23- to 26-year-olds from 1984 to 1992; and 
27- to 30-year-olds from 1988 to 1999. Male and female daily smoking rates have also been 
very close over most of the time for which data are available, particularly in the two older 
age groups. But among the 19- to 22-year-olds there was a crossover after 1993—before that 
point females had slightly higher 30-day prevalence rates, but after that males did. Among 
the 23- to 26-year-olds, males have reported higher 30-day smoking rates during the period 
1998 to 2005. In the oldest age band, males first reported higher rates in 2002; rates 
remained higher through 2004, and then appeared to converge in 2005.   
 
There were some increases in the last decade and a half in 30-day smoking rates among the 
two younger groups and especially among the males. For example, from 1993 to 1999, 19- to 
22-year-old males increased from 29% to 37%, while females increased from 29% to 34%. 
Because smoking rates in high school graduating classes after 1992 had been on the rise, and 
because we know that class cohorts tend to maintain their relative differences over time, we 
had predicted the increase in smoking among 19- to 22-year-olds and eventually in the older 
age bands as the heavier-smoking high school class cohorts grew older. Beginning in 1996, 
smoking began to rise among the 23- to 26-year-olds, before leveling after 1998. Again, it 
rose more among males, opening a small gender gap. In 2004 an unusual increase was 
observed among males in both of the two younger strata, but that did not hold into 2005.  
 
Regional Differences in Trends 
The respondent’s current state of residence was first asked in the 1987 follow-up survey; thus trend 
data by region exist only for the interval since then. In this case, changes have been examined for all 
19- to 28-year-olds combined to increase the reliability of the estimates. Because gender and 
urbanicity crosscut all regions, they have less sampling error than when the sample is divided into 
four separate regions. (All regions are represented by between 1,000 and 2,200 cases in all years.) In 
general, the changes that have occurred since 1987 have been fairly consistent across regions, 
particularly in terms of the direction of the change. By combining the three age strata that we have 
been discussing thus far in this chapter, we are eliminating any ability to see the cohort effects that 
have been observed for so many drugs. Rather, for purposes in this sub-section, we are taking an 
average across the three strata. 
• There were substantial drops among young adults in all four regions of the country—the 
Northeast, West, North Central, and South—between 1987 (the initial measurement point) 
and 1991 for any illicit drug, marijuana, any illicit drug other than marijuana, cocaine, 
crack, and amphetamines. Since 1991 in most or all regions, there has been some increase 
133





and then a leveling in the use of these drugs (except cocaine, which continued to decline 
through the mid-1990s, inched up in the years since, and then leveled in 2005). 
 
• The proportion of 19- to 28-year-olds using any illicit drug has been consistently lowest in 
the South and highest in the West and Northeast. For marijuana use, the South stands out as 
being consistently lowest, and for the most part the North Central has been second lowest. 
Generally, the other two regions have been fairly close to one another. For the use of any 
illicit drug other than marijuana, the West stood out as consistently highest, with the other 
three regions being very similar, at least until 2000; since 2001, use in the Northeast has been 
about as high as in the West. 
 
• From 1991 through 1995 the West had slightly higher annual prevalence rates of LSD use 
than the other three regions among young adults (use dropped in 1995 in the West). 
Otherwise the usage rates have been quite similar in all four regions; all have shown declines 
in LSD use in recent years. 
  
• Questions about MDMA (ecstasy) were added to the follow-up surveys of young adults in 
1989. Through 1993, rates were highest in the West and South and lower in the Northeast 
and North Central regions. Subsequently, use in the Northeast began to increase (as was true 
among 12th graders), exceeding the levels of use found in the South and West from 1999–
2001. The North Central has consistently had a much lower level of ecstasy use than the 
other three regions. In 2000 all four regions showed a sharp and fairly parallel increase in 
ecstasy use; the rise decelerated in 2001 and began to decline thereafter in all regions. As we 
have discussed elsewhere, we believe that this decrease may be caused by a growing 
awareness of the hazards of ecstasy use. By 2003, very little regional difference remained in 
annual prevalence, largely because the declines in use were most pronounced in the 
Northeast and the West. 
 
• The declines in cocaine use, observed in all regions between 1987 and 1991, were greatest in 
the two regions that had attained the highest levels of use by the mid-1980s—the West and 
the Northeast. Thus, regional differences had diminished considerably by 1992. Similar to 
the finding for 12th graders, in 1992 these declines stalled in all regions except the 
Northeast. A gradual further decline then occurred in all regions through 1996 (1997 for the 
West) before a slight rise began to occur, likely reflecting the effects of generational 
replacement. Very little regional variability in cocaine use has existed since the mid-1990s. 
 
• All four regions also exhibited an appreciable drop in crack use between 1987 and 1991, 
again with the greatest declines in the West and Northeast, where prevalence had been the 
highest. Use then generally leveled in all regions except the South, where it continued a 
gradual decline through 1997. As was true for cocaine generally, annual prevalence rates 
among the regions have converged; they now stand between 1.0% in the Northeast and 1.5% 
in the West. (It is worth noting that lifetime use of crack stands out more in the West—and 
has since crack use was first measured in 1987—compared to all other regions.)  
 
• From 1987 (when data were first available) through 1994, rates of inhalant use remained 
relatively stable, quite low, and about equal in all four regions among 19- to 28-year-olds. 
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Annual use then rose in the Northeast in 1995 and 1996 and remained higher than in the 
other regions through 2000, when it dropped back to rates comparable to the other three 
regions. Except for that divergence, the regions have moved very much in parallel for this 
class of drugs. 
 
• The regions have trended fairly similarly in their prevalence of amphetamine use by young 
adults. The only modest exception was that use declined more in the Northeast (which 
started out lowest) in the period 1987 to 1992, giving it a substantially lower rate than the 
other three regions; it remained lowest until 1998. (The West has fairly consistently had the 
highest rate, but not by much.) By the late 1990s, the Northeast had caught up to the North 
Central and South, making the regional differences very small, and there essentially have 
been no regional differences since 2000. 
 
• Methamphetamine use in general has only been measured since 1999 (though crystal 
methamphetamine, discussed next, has been in the study for a longer time). It shows some 
divergence in rates among the regions and some differential trending, with a gradual rise in 
annual prevalence in the West (where use has been highest) and a gradual decline in the 
Northeast, where use is now lowest. Use in the other two regions has remained fairly flat. 
However, in 2005 specifically, use in the West dropped some and use in the Northeast rose 
some, leaving little variability among the regions. Another year’s data are needed to 
determine if this is a real convergence or just a consequence of sampling variability. Lifetime 
prevalence has been particularly high in the West, ranging between 12% and 16% since 
1999. 
 
• The West has consistently had the highest rates for ice (crystal methamphetamine), and the 
regional differences have been very substantial, particularly in terms of lifetime use. The 
Northeast generally has had the lowest rates. In fact, when data were first available on ice in 
1990, the West had a lifetime prevalence of 5.1% versus a range of 1.7% to 2.3% in the other 
three regions. By 2005, the lifetime prevalence rate in the West had increased to 7.9%, and 
use in the North Central and the South grew quite steadily over that interval. This strongly 
suggests that ice use diffused from the West primarily to the South and North Central regions 
but diffused much less to the Northeast. The annual prevalence figures tell a similar story, 
but also show that there was a spike in use in the West from 1994 to 1996 before use there 
declined and then stabilized at around 2%. It then rose again in the West between 2001 and 
2003 and stabilized at a higher level.  
 
• The use of sedatives (barbiturates) remained flat, and at about equivalent levels, in all four 
regions of the country from 1987, when regional data were first available, through 1994. 
Rates then rose gradually in all regions for a number of years, before leveling in all regions 
sometime between 2002 and 2004. 
 
• The picture for tranquilizers is fairly similar to that for sedatives (barbiturates). The regional 
differences have been small, though the South tends to have a slightly higher rate than the 
other regions—a difference that grew a bit larger during the period of increasing use in the 
late 1990s. Use generally declined in all regions from 1987 through 1993. Since then there 
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has been some increase in all regions with the South experiencing the most increase through 
2004, before all regions showed some decline in 2005. 
 
• Levels and trends in heroin use have been quite comparable across the four regions since 
1987. All regions had low and stable rates up into the early 1990s. A gradual increase was 
observed from about 1993 through 2000, and there has been some decline or at least leveling 
since then.  
 
• Trends in the prevalence of the use of narcotics other than heroin have been quite parallel 
for the four regions. A gradual and long-term increase occurred from the mid 1990s through 
2004, and in 2005 use generally leveled. 
 
• The annual prevalence of the specific narcotic drug, OxyContin, has risen some in all four 
regions since it was first measured in 2002. However, a non-significant decline in the 
Northeast in 2005 offset the earlier increase in that one region. Annual prevalence of use for 
Vicodin has shown little net change in use since 2002 in two of the four regions (the South 
and the Northeast), but shows an increase in the West, where annual prevalence is now 
highest at 13%, and the North Central (second highest at 12%). It should be noted that the 
sample sizes are more limited than usual for these two drugs, because questions about them 
occur on only two of the six questionnaire forms. 
 
• The Northeast stood out in 2002, when these drugs were first measured, as having a higher 
rate of use of the two club drugs, ketamine and GHB; but use has dropped in the following 
two years in the Northeast, bringing that region’s usage rates down to the same low levels as 
the other three regions. Rohypnol use has remained very low in all four regions over the 
same interval, not reaching 1% in any region. 
 
• With respect to alcohol use, there were modest declines in 30-day prevalence in all four 
regions between 1987 (when the first measurement was available for 19- to 28-year-olds) 
and 1992. The rates for 30-day prevalence then leveled in all regions. The West and the 
South have consistently had lower rates of 30-day use than the Northeast and North Central, 
(as has generally been true among 12th graders). In 2005, the 30-day prevalence rates for 
each stratum are about where they were in 1992, with all regions showing a very flat pattern 
of prevalence over that 13-year interval. 
 
Current daily use of alcohol also showed a decline from the first (1987) data collection 
through about 1994 or 1995 in all regions. The proportional declines were substantial—on 
the order of 40%–50%. (This decline corresponds to a period of appreciable decline in daily 
drinking among 12th graders, though we can tell from their longer-term data that their 
decline started in 1980; thus the decline may well have started earlier among 19- to 28-year-
olds, as well.) Since the mid-1990s there has been some upward trending in daily prevalence 
in all regions; the rates are all between 4.9% and 5.5% in 2005.   
 
• Occasional heavy drinking (or “binge drinking”) has remained fairly level in all regions 
since it was first measured in 1987. The rates have consistently been appreciably higher in 
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the North Central (43% in 2005) and the Northeast (41%) than in the South and the West 
(31% and 35%, respectively). (Similar regional differences are evident among 12th graders.) 
 
• There have been highly consistent regional differences among young adults in cigarette 
smoking since data were first available in 1987—they exist for monthly, daily, and half-
pack-daily prevalence rates. The West consistently has had the lowest rates (e.g., 15% daily 
prevalence in 2005) and the South the next lowest (18% in 2005); the Northeast and North 
Central have the highest smoking rates at 21% and 24%, respectively, in 2005. After some 
slight decline in 30-day prevalence in all regions between 1987 and 1989, rates leveled off 
for about five years (roughly through 1994). There then followed a very gradual increase of a 
few percentage points through 1998, followed by a leveling. Daily use showed a very similar 
pattern. For half-pack-a-day smoking, the decline phase was longer (from 1987 through 
about 1992 or 1993), likely reflecting the lag between smoking initiation and regular heavy 
smoking. Since 1998, half-pack smoking rates have gradually declined in all four regions. 
While the West has had the lowest rates of smoking throughout the period covered 
(beginning in 1987), 30-day and daily smoking rose in the West in 2004 and 2005, 
narrowing the difference with the other regions.   
 
Population Density Differences in Trends 
The analyses presented here for population density return to the use of four-year age groupings, 
which allows a longer time interval to be examined for the younger strata and for cross-age 
comparisons of the trends. Among the young adults, five levels of population density are 
distinguished based on the respondent’s answer to the question, “In March of this year did you live 
mostly in…”: a very large city (over 500,000 people), a large city (100,000 to 500,000), a medium-
sized city (50,000 to 100,000), a small city or town (under 50,000), or farm/country. Suburbs of 
cities of each size were combined with the city. 
• The proportions of young adults using any illicit drug have moved in parallel among the 
various community size strata. In general, the farm/country stratum has tended to have lower 
use than all of the other strata. The other four strata have tended to differ little from one 
another, though the very large cities have generally ranked at the top. In 2005, the 
proportions of 19- to 22-year-olds reporting use of an illicit drug in the past year were 29% 
for the farm/country strata, 35% for small towns, 39% for medium-sized cities, 41% for 
large-sized cities, and 44% for very large cities.   
 
• The use of any illicit drug other than marijuana tells a similar story. There was a long 
period of fairly parallel decline before leveling, along with some convergence of usage rates 
among the strata at all three age levels. In general, small, large, and very large cities all have 
tended to have about the same rates, and the farm/country stratum has tended to have the 
lowest rates, particularly prior to 1990; the differences by population density have been quite 
small since about 2000, though in 2004 and 2005 the very large cities have tended to have 
the highest rate (annual prevalence of 25% among the 19 to 22 year-olds in 2005) and the 
farm/country areas the lowest (17%). 
 
• Marijuana use has moved pretty much in parallel among the various strata over the time 
intervals for which data exist. Among 19- to 22-year-olds, the rates have been quite close 
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among all the strata, except for the farm/country stratum. The most rural region has 
consistently had the lowest rate of marijuana use, and it fell less in the earlier period and rose 
more slowly in the subsequent increase than it did the other strata. Use also has tended to be 
lower in the more rural areas in the older two age bands, as well. Daily marijuana use also 
has moved very much in parallel among the five population density strata within each age 
band. In 2005 the rates in the more rural strata are lowest among those ages 19 to 26.   
   
• In general there have not been large differences in LSD use among young adults as a 
function of community size since 1983. Among the 19- to 22-year-olds (the young adult age 
group with by far the highest rates of LSD use), use in communities of all sizes declined 
appreciably in the early- to mid-1980s, particularly in the urban strata, eliminating modest 
prior differences by 1984. From around 1989 through 1996, there was some increase in LSD 
use in all strata among the 19- to 22-year-olds, with the most rural region generally 
continuing to have the lowest prevalence (though this has not always been true since 1998). 
Since about 1997, there has been a substantial decline in LSD use in all strata among the 19- 
to 22- year olds. The 23- to 26-year-old respondents had some modest increases after 1989 in 
all strata, though the increases had virtually ended by 1995; since about 1999, there have 
been declines in all strata. In the oldest age group, LSD use has remained very low and for 
the most part quite stable, with a decline in the last few years. 
 
• The use of hallucinogens other than LSD, taken as a class, also has shown considerably 
higher rates in the youngest age band than in the two older ones, suggesting a sharp falloff in 
use with age. Use of this class of drugs fell in communities of all sizes among the young 
adults between 1980 and about 1988. Then there was a leveling of use for a few years, 
followed by an extended increase in use among all strata in the 19- to 22-year-old age band. 
By 2003 the rates attained by each stratum exceeded those originally observed in 1980. The 
23- to 26-year-old group has shown slightly higher rates since 1998 than previously. The 
sharpest increase occurred in the very large cities in 1999 and 2000, possibly as a result of 
growing ecstasy use. Among 27- to 30-year-olds the trend lines have been very flat with only 
minor stratum differences, until 2001 when all strata, especially the very large cities, began 
to increase. In 2004 and 2005 among 19- to 22-year-olds there has been a considerable 
decline observed in four of the five population density strata, at the same time that use in the 
very large cities has risen. In the older age groups there has been little systematic change 
over the past two years. All three age groups have shown higher rates of use than previously 
observed since 1994 in the case of the 19- to 21-year olds, since about 2000 in the case of the 
22- to 26-year olds, and since about 2002 in the case of the 27- to 30-year olds—likely in 
part reflecting a cohort effect in the use of these drugs, but also reflecting the change in the 
wording of the question to include “shrooms” as an example. 
 
• Ecstasy (MDMA) use was first measured in 1989 and since then has shown the largest 
increase among the younger adults of any of the drugs. Use in 1989 was highest among the 
19- to 22-year-olds in the very large cities (5% annual prevalence); but prevalence declined 
in all strata between 1989 and 1994 (to 1.6% or less). By 1998, use had begun to increase in 
all strata within this age band, except among the farm/country stratum. The farm/country 
stratum moved up sharply in 1999, but then the three most urban strata jumped sharply in 
2000, opening a fair gap in use as a function of population density, with the large and very 
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large cities having rates nearly twice as high as any of the other strata in 2002. All strata 
showed large declines in ecstasy use since 2000 or 2001 which lasted through 2004, 
narrowing the differences among them. Among the 23- to 26-year-olds use began to increase 
a little later, and again the most urban strata showed the most increase, particularly in 2000; 
but the medium size cities and the very large cities showed a decline in 2001 (just as 
happened among the 19- to 21-year-olds), followed by a decline in the large cities after 2002, 
which had the effect of narrowing the differences among the strata. All strata have continued 
to decline, or at least remain level, since 2003 with the exception of the very large cities, 
which have a considerably higher annual prevalence rate (5.5%) than the other strata 
(between 0.6% and 2.9%) in 2005. Considerably less increase in ecstasy use occurred among 
27- to 30-year-olds, though there was some increase in the largest cities starting after 1996 
and in the large and medium-sized cities after 1999. In the last one to four years, all strata in 
all three age groups have shown declines in their ecstasy use, again with the exception of the 
very large cities, which also show the highest prevalence in 2005. 
 
Ecstasy use trends in the past five years tell an interesting story. In the very large cities, 
where use had spiked early, use peaked in all three age bands in 2000 and then began to 
decline. The medium-sized cities were beginning to level or decline in all three age bands. 
The small town and farm/country strata peaked in 2001 in all age groups. These data support 
our analysis, based on school-level analyses of the secondary schools, suggesting that the 
presence of this drug was still diffusing geographically—in this case from more urban to 
more rural areas—and, were it not for this continued diffusion, ecstasy use would actually 
have declined nationally a year earlier. The data from 12th graders on perceived risk provide 
the clue as to the most likely cause of this turnaround. They showed a large jump in the level 
of perceived risk associated with ecstasy use in all of the past three years. Unlike most of the 
other drugs that we have been discussing here, the pattern of change since the mid-1990s 
appears to reflect secular trends more than cohort effects. 
 
• In the early 1980s, cocaine use was positively correlated with population density, with the 
highest use in the very large cities. The important drop in cocaine use that began after 1986 
slowed considerably after 1992 or 1993 in all three of the age strata and in communities of 
all sizes, by which time the positive association with population density had been virtually 
eliminated. Among the 19- to 22-year-olds there has been a sustained increase in cocaine use 
among all strata since about 1993 or 1994 and among the 23- to 26-year-olds since about 
1998. As just stated, usage rates among the strata tended to converge considerably during the 
period of decline, and this convergence remains, with the very large cities showing rates of 
cocaine use only slightly higher than the less densely populated areas. In the 27- to 30-year-
old age group, a gradual increase in use has emerged in nearly all strata since 2000, no doubt 
reflecting a cohort effect working its way up the age spectrum. By 2004 all of these strata in 
the oldest age band leveled or declined from their peak rates, the single exception being 
among the farm/country stratum. 
 
• Crack use among all age groups peaked in 1987 or 1988 (strongly suggesting a secular trend 
at work at that time) and, after declining, bottomed out in all population-density strata for 
several years. Among the 19- to 22-year-olds only, it may have made some comeback in the 
rural and small town strata in 1999 and 2000 but not in the larger cities. The crack use 
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reported in these young adult samples at all three age levels has borne practically no 
systematic association with community size, and for the most part the strata have all trended 
in parallel. 
 
• Amphetamine use shows virtually no differences in use associated with urbanicity in any of 
the three age groups, and this has been fairly consistently true since 1983. 
 
• The use of crystal methamphetamine (ice), first measured in 1990, has shown a modest 
increase in use since the early 1990s among the younger two young adult strata, and since 
the late 1990s among the oldest stratum. This has been observable in most population density 
groupings. There have not been any sustained differences in use as a function of population 
density, although over the last several years the annual prevalence levels have tended to be 
highest at the two extremes—the farm/country areas and the very large cities.  
 
• Methaqualone use, which in 1981 was rather strongly positively associated with population 
density, dropped to annual prevalence rates of 0.8% or below in all size strata for all three 
age bands by 1989. For that reason, its use is no longer measured in the study. 
 
• Unlike methaqualone, sedatives (barbiturates) have never shown much correlation with 
urbanicity, at least as far back as 1980. This remains true in all three age bands.  
 
• Tranquilizer use among young adults also has had little or no association with population 
density over this time interval. However, since 2001, tranquilizer use increased in the very 
large cities in all three age groups, opening up some differential.   
 
• From 1980 to 1995, annual heroin prevalence was less than 1.0%—usually much less—in 
all strata for all three of the age bands. After 1994, use among 19- to 22-year-olds in all 
population density strata rose and reached 1.0% in the three most urban strata by 1998. In 
fact, in the very large cities, it reached 1.6% in 1996 (versus 0.3% to 0.7% in the other 
strata). Use of heroin generally has been highest in the very large cities in this age band; but 
an across-the-board decrease by 2002 left rather little difference among the strata. Use levels 
are lower among the 23- to 26-year-olds and lower still among the 27- to 30-year-olds, and it 
is difficult to discern systematic differences among the population density strata in those age 
bands. 
 
• The annual use of narcotics other than heroin had some positive association with degree of 
population density among 19- to 22-year-olds through the early 1990s; however, it has 
shown rather little association since then. Since 1993 in the case of 19- to 22-year-olds, since 
about 1996 in the case of 23- to 26-year-olds, and since about 1998 in the case of the 27- to 
30-year-olds, use of narcotics other than heroin has increased very substantially in all 
community size strata but no systematic differentiation by community size is evident. 
Clearly a cohort effect is at work, and the increased use of these drugs is very widespread. 
The very large cities have had the highest rate of other narcotic use in 2004 and 2005 among 
the 19- to 21-year-olds, and in 2005 among the 22- to 26-year-olds, possibly indicating a 
new divergence emerging among the strata. 
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• Unfortunately, the sample sizes for two of the narcotic drugs of particular interest, 
OxyContin and Vicodin, are not sufficient to estimate population density differences or 
trends with a sufficient degree of accuracy.  
 
• The absolute levels of inhalant use have remained low in these age groups, particularly 
above age 22. However, during the mid- to late 1980s, there was a gradual increase in use 
among 19- to 22-year-olds in all community-size strata. No strong or consistent association 
with population density has appeared, though the very large cities generally have tended to 
have higher rates than the other areas among 19- to 22-year-olds, particularly in the period 
1998 through 2000. 
 
• There have been few differences as a function of population density in the 30-day prevalence 
of drinking alcohol among 19- to 22-year-olds, since data were first available on them in 
1980, except for the fact that the farm/country stratum has tended to have lower-than-average 
use. In the two older age bands, however, there has been a fairly consistent positive 
correlation between urbanicity and use of alcohol in the past 30 days. But there have been no 
consistent differences in current daily drinking associated with urbanicity in any of the three 
age bands. For occasional heavy drinking, all strata have been fairly close across time at all 
three age levels, again with the exception that the farm/country areas have fairly consistently 
shown a slightly lower rate of binge drinking in all three age bands. 
 
• Cigarette smoking has been negatively associated with urbanicity in all three age strata, 
without much evidence of differential trends related to degree of urbanicity, with one 
exception. Among 19- to 22-year-olds, all smoking prevalence measures rose from 1997 
through 1999 in the farm/country and small town strata, while most other strata remained 
level. The differences in 1999 were most striking for half-pack-a-day smoking among the 19- 
to 22-year-olds: farm/country (24%), small town (19%), medium-sized and large cities (both 
15%), and very large cities (10%). This compares with 1985, when there was virtually no 
difference in half-pack-a-day smoking rates among these strata (all were at 18% or 19%). 
Thus, smoking among those in their early 20s has become more concentrated in the non-
urban populations. Among the 19- to 22-year-olds there has been a decline in 30-day 
prevalence in all strata (except for the farm/country) since 2000. Continuing declines in 
smoking among 12th graders would lead us to expect still further declines in the young 
adults, as well. While smoking has been dropping among 19- to 22-year-olds, use generally 
has remained negatively correlated with the degree of urbanicity.  
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Percentage who used in lifetime
'04-'05 
change1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
  Approx. Wtd. N = 6900 6800 6700 6600 6700 6600 6800 6700 6500 6400 6300 6400 6200 6000 5700 5800 5300 5300 5700 5400
Any Illicit Drug a 70.5 69.9 67.9 66.4 64.5 62.2 60.2 59.6 57.5 57.4 56.4 56.7 57.0 57.4 58.2 58.1 59.0 60.2 60.5 60.4 -0.1
Any Illicit Drug a
 Other Than Marijuana 48.4 47.0 44.6 42.7 40.8 37.8 37.0 34.6 33.4 32.8 31.0 30.5 29.9 30.2 31.3 31.6 32.8 33.9 35.2 34.0 -1.2
Marijuana 66.5 66.0 63.8 62.8 60.2 58.6 56.4 55.9 53.7 53.6 53.5 53.8 54.4 54.6 55.1 55.7 56.8 57.2 57.4 57.0 -0.4
Inhalantsb 12.3 12.7 12.6 13.2 12.5 13.4 13.5 14.1 13.2 14.5 14.1 14.1 14.2 14.2 14.3 12.8 12.4 12.2 11.6 10.3 -1.4
  Inhalants, Adj.b,c 18.6 15.7 15.0   NA 13.5 14.1 13.9 14.5 13.5   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
  Nitritesd 2.6 6.9 6.2   NA 1.9 1.4 1.2 1.3 1.0   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Hallucinogens e 18.5 17.1 17.0 15.9 16.1 15.7 15.7 15.4 15.4 16.1 16.4 16.7 17.4 18.0 18.4 18.3 19.6 19.7 19.3 17.6 -1.7 s
  Hallucinogens, Adj.e,f 20.1 17.2 17.2   NA 16.5 16.0 15.9 15.5 15.5 16.2 16.5 16.7 17.5 18.2 18.5 18.4 19.6 20.0 19.6 17.6 -2.0 ss
  LSD 14.6 13.7 13.8 12.7 13.5 13.5 13.8 13.6 13.8 14.5 15.0 15.0 15.7 16.2 16.4 16.0 15.1 14.6 13.4 11.2 -2.2 sss
  PCPg 8.4 4.8 5.0   NA 2.5 3.1 2.0 1.9 2.0 2.2 1.9 2.4 2.7 2.3 2.3 3.1 2.5 3.0 2.7 2.0 -0.8
  MDMA (Ecstasy)h   NA   NA   NA 3.3 3.7 3.2 3.9 3.8 3.8 4.5 5.2 5.1 7.2 7.1 11.6 13.0 14.6 15.3 16.0 14.9 -1.1
Cocaine 32.0 29.3 28.2 25.8 23.7 21.0 19.5 16.9 15.2 13.7 12.9 12.0 12.3 12.8 12.7 13.1 13.5 14.7 15.2 14.3 -0.8
  Cracki   NA 6.3 6.9 6.1 5.1 4.8 5.1 4.3 4.4 3.8 3.9 3.6 3.8 4.3 4.6 4.7 4.3 4.7 4.2 4.1 -0.1
  Other Cocaine j   NA 28.2 25.2 25.4 22.1 19.8 18.4 15.1 13.9 12.4 11.9 11.3 11.5 11.8 11.7 12.1 12.8 13.5 14.4 13.3 -1.1
Heroin 1.3 1.3 1.1 1.0 0.9 0.9 0.9 0.9 0.8 1.1 1.3 1.3 1.6 1.7 1.8 2.0 1.8 1.9 1.9 1.7 -0.2
Other Narcoticsk,l 10.7 10.6 9.8 9.6 9.4 9.3 8.9 8.1 8.2 9.0 8.3 9.2 9.1 9.5 10.0 11.5 13.9 16.8 17.6 17.8 +0.3
Amphetamines, Adj.k,m 32.3 30.8 28.8 25.3 24.4 22.4 20.2 18.7 17.1 16.6 15.3 14.6 14.3 14.1 15.0 15.0 14.8 15.2 15.9 14.6 -1.3 s
  Icen   NA   NA   NA   NA 2.5 2.9 2.2 2.7 2.5 2.1 3.1 2.5 3.4 3.3 3.9 4.0 4.1 4.7 4.7 4.4 -0.3
Sedatives (Barbiturates) k 11.1 9.7 8.9 7.9 8.7 8.2 7.4 6.5 6.4 6.7 6.6 6.5 6.9 7.4 8.1 7.8 8.0 8.7 9.7 10.0 +0.4
  Sedatives, Adj.k,o 16.7 15.0 13.2 12.1   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
  Methaqualone k 13.1 11.6 9.7 8.7   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Tranquilizers e,k 17.6 16.5 15.1 13.5 12.9 11.8 11.3 10.5 9.9 9.7 9.3 8.6 9.6 9.6 10.5 11.9 13.4 13.8 14.9 14.5 -0.4
Alcoholp 94.8 94.9 94.8 94.5 94.3 94.1 93.4 92.1 91.2 91.6 91.2 90.7 90.6 90.2 90.7 89.9 90.2 89.3 89.4 89.1 -0.2
  Flvd. Alcoholic Bvg.d   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 83.2 84.6 +1.4
Cigarettes   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Steroidsq   NA   NA   NA 1.1 1.2 1.7 1.9 1.5 1.3 1.5 1.5 1.4 1.4 1.9 1.4 1.4 1.6 1.8 1.9 1.8 -0.1
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency 
between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
'NA' indicates data not available.
See footnotes on next page.
TABLE 5-1
Trends in Lifetime Prevalence of Various Types of Drugs
Among Respondents of Modal Ages 19-28
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FOOTNOTES FOR TABLES 5-1 THROUGH 5-4
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, 
amphetamines, sedatives (barbiturates), methaqualone (until 1990), or tranquilizers not under a doctor's orders.
bThis drug was asked about in four of the five questionnaire forms in 1986-1989, five of the six questionnaire forms in 
1990-1998, and three of six questionnaire forms in 1999-2005.  Total N in 2005 is approximately 2700.
cAdjusted for underreporting of amyl and butyl nitrites.  Questions about nitrite use were dropped beginning in 
1995.
dThis drug was asked about in one questionnaire form.  Total N in 2005 is approximately is 900.
eIn 2001 the question text was changed on half of the questionnaire forms.  "Other psychedelics" was changed to 
"other hallucinogens," and "shrooms" was added to the list of examples.  For tranquilizers, Miltown was replaced 
with Xanax.  Beginning in 2002 the remaining forms were changed to the new wording. 
fAdjusted for underreporting of PCP.
gThis drug was asked about in one of the five questionnaire forms in 1986-1989, and in one of the six questionnaire 
forms in 1990-2005.   Total N in 2005 is approximately 900.
hThis drug was asked about in two of the five questionnnare forms in 1989, in two of the six questionnaire forms in 
1990-2001, and in three of the six questionnaire forms in 2002-2005. Total N in 2005 is approximately 1800.
iThis drug was asked about in two of the five questionnaire forms in 1987-1989, in all six questionnaire forms in 1990-
2001, and in five of the six questionnaire forms in 2002-2005. Total N in 2005 is approximately 4500.
jThis drug was asked about in one of the five questionnaire forms in 1987-1989, and in four of the six questionnaire 
forms in 1990-2005.  Total N in 2005 is approximately 3600.
kOnly drug use that was not under a doctor's orders is included here.
lIn 2002 the question text was changed on half of the questionnaire forms. The list of examples of narcotics other 
than heroin was updated: Talwin, laudanum, and paregoric--all of which had negligible rates of use by 2001--were 
replaced by Vicodin, OxyContin, and Percocet.  The 2002 data presented here are based on the changed forms 
only; N is one-half of N indicated.  In 2003 the remaining forms were changed to the new wording.  The data are 
based on all forms in 2003 and beyond.
mBased on the data from the revised question, which attempts to exclude the inappropriate reporting of 
nonprescription amphetamines.
nThis drug was asked about in two of the six questionnaire forms in 1990-2005.  Total N in 2005 is approximately 1800.
o"Sedatives, adjusted" data are a combination of barbiturate and methaqualone data.   
pIn 1993 and 1994, the question text was changed slightly in three of the six questionnaire forms to indicate that a 
"drink" meant "more than just a few sips."  Because this revision resulted in rather little change in reported 
prevalence in the surveys of high school graduates, the data for all forms combined are used in order to provide 
the most reliable estimate of change.  After 1994 the new question text was used in all six of the questionnaire 
forms.
qThis drug was asked about in one of the five questionnaire forms in 1989, and in two of the six questionnaire forms 
in 1990-2005. Total N in 2005 is approximately 1800.
rThis drug was asked about in two of the six questionnaire forms. Total N in 2005 is approximately 1800.
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1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
  Approx. Wtd. N = 6900 6800 6700 6600 6700 6600 6800 6700 6500 6400 6300 6400 6200 6000 5700 5800 5300 5300 5700 5400
Any Illicit Drug a 41.9 39.3 36.3 32.8 30.7 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 -0.9
Any Illicit Drug a
 Other Than Marijuana 27.0 23.9 21.3 18.3 16.7 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 -0.2
Marijuana 36.5 34.8 31.8 29.0 26.1 23.8 25.2 25.1 25.5 26.5 27.0 26.8 27.4 27.6 27.9 29.2 29.3 29.0 29.2 28.2 -1.0
Inhalantsb 1.9 2.1 1.8 1.9 1.9 2.0 1.9 2.1 2.1 2.4 2.2 2.3 2.1 2.3 2.1 1.7 1.6 1.4 1.7 1.3 -0.5
  Inhalants, Adj.b,c 3.0 2.8 2.4   NA 2.1 2.2 1.9 2.3 2.2   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
  Nitritesd 2.0 1.3 1.0   NA 0.4 0.2 0.1 0.4 0.3   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Hallucinogens e 4.5 4.0 3.9 3.6 4.1 4.5 5.0 4.5 4.8 5.6 5.6 5.8 5.2 5.4 5.4 5.4 4.7 5.2 4.7 4.5 -0.2
  Hallucinogens, Adj.e,f 4.9 4.1 3.9   NA 4.2 4.6 5.1 4.6 4.9 5.7 5.6 5.9 5.2 5.5 5.5 5.5 4.7 5.2 4.7 4.7 0.0
  LSD 3.0 2.9 2.9 2.7 3.3 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 1.2 0.9 0.8 -0.1
  PCPg 0.8 0.4 0.4   NA 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.5 0.6 0.6 0.3 0.6 0.3 0.3 0.1 0.6 +0.5
  MDMA (Ecstasy)h   NA   NA   NA 1.4 1.5 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 4.5 3.5 3.0 -0.5
Cocaine 19.7 15.7 13.8 10.8 8.6 6.2 5.7 4.7 4.3 4.4 4.1 4.6 4.9 5.4 5.4 5.8 5.8 6.6 7.1 6.9 -0.2
  Crack i 3.2 3.1 3.1 2.5 1.6 1.2 1.4 1.3 1.1 1.1 1.1 1.0 1.1 1.4 1.2 1.3 1.0 1.0 1.3 1.2 -0.1
  Other Cocaine j   NA 13.6 11.9 10.3 8.1 5.4 5.1 3.9 3.6 3.9 3.8 4.3 4.5 4.8 4.8 5.3 5.6 6.1 6.4 6.3 -0.2
Heroin 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.2 0.4 0.3 0.4 +0.1
Other Narcoticsk,l 3.1 3.1 2.7 2.8 2.7 2.5 2.5 2.2 2.5 3.0 2.9 3.3 3.4 3.8 4.1 5.0 7.1 8.5 9.0 8.7 -0.3
  OxyContinr   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 1.9 2.6 3.1 3.1 0.0
  Vicodin r   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 8.2 8.6 8.9 9.3 +0.3
Amphetamines, Adj.k,m 10.6 8.7 7.3 5.8 5.2 4.3 4.1 4.0 4.5 4.6 4.2 4.6 4.5 4.7 5.4 5.8 5.9 5.8 6.2 5.1 -1.2 ss
  Ritalin k,r   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 2.9 2.9 2.7 2.5 -0.3
  Methamphetamine r   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 2.8 2.5 2.8 2.5 2.7 2.8 2.4 -0.4
  Icen   NA   NA   NA   NA 0.4 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 1.3 1.5 1.6 +0.1
Sedatives (Barbiturates) k 2.3 2.1 1.8 1.7 1.9 1.8 1.6 1.9 1.8 2.1 2.2 2.4 2.5 2.8 3.4 3.7 3.9 3.9 4.4 4.2 -0.2
  Sedatives, Adj.k,o 3.0 2.5 2.1 1.8   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
  Methaqualone k 1.3 0.9 0.5 0.3   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Tranquilizers e,k 5.4 5.1 4.2 3.7 3.7 3.5 3.4 3.1 2.9 3.4 3.2 3.1 3.8 3.7 4.6 5.5 7.0 6.8 7.4 6.7 -0.7
Rohypnolr   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 0.3 0.5 0.1 0.1 0.0
GHBr   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 0.8 0.6 0.5 0.3 -0.2
Ketamine r   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 1.2 0.9 0.6 0.5 -0.1
Alcoholp 88.6 89.4 88.6 88.1 87.4 86.9 86.2 85.3 83.7 84.7 84.0 84.3 84.0 84.1 84.0 84.3 84.9 83.3 84.4 83.8 -0.6
  Flvd. Alcoholic Bvg.d   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 62.7 58.4 -4.4  
Cigarettes 40.1 40.3 37.7 38.0 37.1 37.7 37.9 37.8 38.3 38.8 40.3 41.8 41.6 41.1 40.9 41.1 39.1 38.6 39.0 39.1 +0.1
Steroidsq   NA   NA   NA 0.5 0.3 0.5 0.4 0.3 0.4 0.5 0.3 0.5 0.4 0.6 0.4 0.4 0.4 0.5 0.5 0.5 0.0
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency 
between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
'*' indicates a prevalence rate of less than 0.05% but greater than true zero.
'NA' indicates data not available.
See footnotes at end of Table 5-1.
'04-'05 
change
Percentage who used in last 12 months
TABLE 5-2
Trends in Annual Prevalence of Various Types of Drugs
Among Respondents of Modal Ages 19-28
144
3
Percentage who used in last 30 days
'04-'05 
change1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
  Approx. Wtd. N = 6900 6800 6700 6600 6700 6600 6800 6700 6500 6400 6300 6400 6200 6000 5700 5800 5300 5300 5700 5400
Any Illicit Drug a 25.8 23.4 20.5 17.7 15.9 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 -0.5
Any Illicit Drug a
 Other Than Marijuana 13.0 10.7 9.5 7.5 6.0 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8. 8.5 8.2 -0.3
Marijuana 22.0 20.7 17.9 15.5 13.9 13.5 13.3 13.4 14.1 14.0 15.1 15.0 14.9 15.6 16.1 16.7 16.9 17.3 16.5 15.8 -0.7
Inhalantsb 0.4 0.6 0.6 0.5 0.6 0.5 0.6 0.7 0.5 0.7 0.5 0.5 0.7 0.8 0.5 0.4 0.5 0.3 0.3 0.2 -0.1
  Inhalants, Adj.b,c 0.7 0.9 0.9   NA 0.7 0.6 0.7 0.7 0.6   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
  Nitritesd 0.5 0.5 0.4   NA 0.1   * 0.1 0.2 0.1   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Hallucinogens e 1.3 1.2 1.1 1.1 0.9 1.1 1.5 1.2 1.4 1.7 1.2 1.5 1.4 1.3 1.2 1.2 0.9 1.2 0.9 0.8 -0.1
  Hallucinogens, Adj.e,f 1.4 1.2 1.1   NA 1.0 1.2 1.6 1.2 1.4 1.7 1.3 1.5 1.5 1.3 1.2 1.2 0.9 1.2 0.9 0.8 -0.1
  LSD 0.9 0.8 0.8 0.8 0.6 0.8 1.1 0.8 1.1 1.3 0.7 0.9 1.0 0.8 0.8 0.7 0.3 0.2 0.1 0.1 0.0
  PCPg 0.2 0.1 0.3   NA 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.1 0.0 -0.1
  MDMA (Ecstasy)h   NA   NA   NA 0.4 0.2 0.1 0.3 0.3 0.2 0.4 0.3 0.6 0.8 1.3 1.9 1.8 1.3 0.8 0.6 0.6 0.0
Cocaine 8.2 6.0 5.7 3.8 2.4 2.0 1.8 1.4 1.3 1.5 1.2 1.5 1.7 1.9 1.7 2.2 2.2 2.4 2.2 2.2 -0.1
  Crack i   NA 1.0 1.2 0.7 0.4 0.4 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.0
  Other Cocaine j   NA 4.8 4.8 3.4 2.1 1.8 1.7 1.1 1.0 1.3 1.1 1.5 1.5 1.6 1.5 1.8 2.0 2.1 2.1 1.9 -0.1
Heroin 0.1 0.1 0.1 0.1 0.1   * 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 * 0.1 0.1 0.1 0.0
Other Narcoticsk,l 0.9 0.9 0.7 0.7 0.7 0.6 0.7 0.7 0.6 0.9 0.7 0.9 0.9 1.2 1.4 1.7 2.9 2.9 3.0 3.5 +0.5
Amphetamines, Adj.k,m 4.0 3.2 2.7 2.1 1.9 1.5 1.5 1.5 1.7 1.7 1.5 1.7 1.7 1.9 2.3 2.4 2.5 2.5 2.4 2.1 -0.3
  Icen   NA   NA   NA   NA 0.1   * 0.1 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 0.4 0.4 0.6 +0.1
Sedatives (Barbiturates) k 0.7 0.7 0.7 0.5 0.6 0.5 0.5 0.6 0.6 0.8 0.8 0.9 0.9 1.1 1.3 1.7 1.5 1.5 1.8 1.7 -0.1
  Sedatives, Adj.k,o 0.9 0.8 0.7 0.5   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
  Methaqualone k 0.3 0.2 0.1 0.0   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Tranquilizers e,k 1.8 1.6 1.4 1.2 1.1 0.9 1.0 1.0 0.8 1.1 0.7 1.1 1.2 1.3 1.8 2.1 2.8 2.4 2.7 2.6 -0.1
Alcoholp 75.1 75.4 74.0 72.4 71.2 70.6 69.0 68.3 67.7 68.1 66.7 67.5 66.9 68.2 66.8 67.2 68.3 67.0 68.4 68.6 +0.2
  Flvd. Alcoholic Bvg.d   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA 29.5 27.6 -1.9
Cigarettes 31.1 30.9 28.9 28.6 27.7 28.2 28.3 28.0 28.0 29.2 30.1 29.9 30.9 30.3 30.1 30.2 29.2 28.4 29.2 28.6 -0.7
Steroidsq   NA   NA   NA 0.2 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.1 +0.1
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency 
between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
'*' indicates a prevalence rate of less than 0.05% but greater than true zero.
'NA' indicates data not available.
See footnotes at end of Table 5-1.
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Percentage who used daily in last 30 days
'04-'05 
change1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
  Approx. Wtd. N = 6900 6800 6700 6600 6700 6600 6800 6700 6500 6400 6300 6400 6200 6000 5700 5800 5300 5300 5700 5400
Marijuana 4.1 4.2 3.3 3.2 2.5 2.3 2.3 2.4 2.8 3.3 3.3 3.8 3.7 4.4 4.2 5.0 4.5 5.3 5.0 4.9 -0.1
Cocaine 0.2 0.1 0.2 0.1   * 0.1   * 0.1   * 0.1   *   *   * 0.1 * 0.1 * * 0.1 0.1 0.0
Amphetamines, Adj.k,m 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.0
Alcohol
  Dailyo 6.1 6.6 6.1 5.5 4.7 4.9 4.5 4.5 3.9 3.9 4.0 4.6 4.0 4.8 4.1 4.4 4.7 5.1 4.5 5.2 +0.6
  5+ Drinks in a Row 
     in Last 2 Weeks 36.1 36.2 35.2 34.8 34.3 34.7 34.2 34.4 33.7 32.6 33.6 34.4 34.1 35.8 34.7 35.9 35.9 35.8 37.1 37.0 -0.2
Cigarettes
  Daily 25.2 24.8 22.7 22.4 21.3 21.7 20.9 20.8 20.7 21.2 21.8 20.6 21.9 21.5 21.8 21.2 21.2 20.3 20.8 19.6 -1.2
  Half-Pack or More
     per Day 20.2 19.8 17.7 17.3 16.7 16.0 15.7 15.5 15.3 15.7 15.3 14.6 15.6 15.1 15.1 14.6 14.2 13.9 13.5 12.5 -1.0
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency 
between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
The illicit drugs not listed here show a daily prevalence of 0.2% or less in all years.
'*' indicates a prevalence rate of less than 0.05% but greater than true zero.
See footnotes at end of Table 5-1.
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'04-'05 
change1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Percentage who used in past year
Any Illicit Drug 41.9 39.3 36.3 32.8 30.7 27.0 28.3 28.4 28.4 29.8 29.2 29.2 29.9 30.3 30.8 32.1 32.4 33.0 33.7 32.8 -0.9
   Males 45.3 42.6 39.5 35.7 33.6 30.0 31.4 31.1 32.3 32.1 31.6 31.9 33.6 33.9 34.4 34.9 35.6 36.0 37.0 35.3 -1.8
   Females 39.0 36.5 33.6 30.5 28.3 24.5 25.8 26.1 25.3 28.1 27.3 27.1 27.1 27.6 28.2 30.1 30.2 31.0 31.4 31.1 -0.3
Any Illicit Drug
 Other Than Marijuana 27.0 23.9 21.3 18.3 16.7 14.3 14.1 13.0 13.0 13.8 13.2 13.6 13.2 13.7 14.9 15.4 16.3 18.1 18.8 18.5 -0.2
   Males 30.4 26.5 23.8 21.0 19.1 16.4 16.3 14.7 16.2 16.2 15.4 15.6 16.2 16.7 17.8 17.2 18.9 19.8 21.3 20.4 -0.9
   Females 24.0 21.6 19.4 16.2 14.7 12.5 12.2 11.6 10.5 12.0 11.4 12.0 11.0 11.5 12.9 14.1 14.6 17.0 17.1 17.3 +0.3
Percentage who used in past 30 days
Any Illicit Drug 25.8 23.4 20.5 17.7 15.9 15.1 14.8 14.9 15.3 15.8 15.8 16.4 16.1 17.1 18.1 18.8 18.9 19.9 19.1 18.6 -0.5
   Males 29.9 27.1 23.7 21.1 18.8 18.3 17.9 17.4 19.5 18.6 19.0 19.8 20.1 20.0 21.5 21.9 22.8 22.4 23.1 22.0 -1.1
   Females 22.2 20.2 17.8 15.0 13.5 12.5 12.4 12.9 12.1 13.5 13.3 13.8 13.2 15.0 15.6 16.6 16.3 18.3 16.3 16.4 +0.1
Any Illicit Drug
 Other Than Marijuana 13.0 10.7 9.5 7.5 6.0 5.4 5.5 4.9 5.3 5.7 4.7 5.5 5.5 6.0 6.4 7.0 7.7 8.3 8.5 8.2 -0.3
   Males 15.2 12.3 10.6 9.1 6.8 6.6 6.5 5.9 7.1 6.8 5.7 6.8 7.1 7.3 7.8 8.1 8.5 9.2 10.6 9.2 -1.4
   Females 11.0 9.4 8.7 6.2 5.3 4.4 4.7 4.0 3.9 4.8 4.0 4.5 4.4 5.1 5.4 6.3 7.1 7.7 7.1 7.6 +0.5
Approximate Weighted N
All Respondents 6900 6800 6700 6600 6700 6600 6800 6700 6500 6400 6300 6400 6200 6000 5700 5800 5300 5300 5700 5400
   Males 3200 3100 3000 2900 3000 3000 3000 3000 2900 2800 2700 2800 2700 2600 2400 2400 2200 2200 2300 2200
   Females 3700 3700 3700 3700 3700 3600 3700 3700 3600 3600 3600 3600 3500 3400 3300 3400 3100 3100 3400 3200
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency
between the change estimate and the prevalence estimates for the two most recent years is due to rounding.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines,
sedatives (barbiturates), methaqualone (until 1990), or tranquilizers not under a doctor's orders.
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FIGURE 5-1
Any Illicit Drug:  Trends in Annual Prevalence Among 
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 48.1 51.1 53.8 54.2 53.1 52.1 49.4 47.4 45.8 46.3 44.3 41.7 38.5 35.4 32.5 29.4 27.1 31.0 35.8 39.0 40.2 42.4 41.4 42.1 40.9 41.4 41.0 39.3 38.8 38.4
19-20 Years 55.8 54.5 54.5 53.4 50.2 47.4 45.9 45.7 42.6 39.5 39.4 35.7 32.3 28.1 29.7 30.5 32.2 35.6 36.1 36.7 40.6 40.4 39.3 38.4 39.4 38.1 38.0 38.9
21-22 Years 55.3 55.4 51.2 49.9 47.3 46.3 45.8 42.3 38.2 35.0 32.7 29.9 30.0 30.2 31.6 31.9 33.0 33.5 34.1 33.3 36.9 40.2 36.7 38.3 36.5 36.4
23-24 Years 51.7 48.9 44.0 47.8 42.8 37.9 36.6 31.4 30.7 27.0 29.2 29.8 27.3 28.5 27.6 27.3 27.4 31.1 29.6 31.1 35.2 34.6 34.5 31.9
25-26 Years 44.0 45.2 39.3 40.1 34.4 30.5 29.6 25.2 26.4 25.6 25.5 27.3 23.4 25.4 23.9 24.5 25.5 27.4 27.6 27.5 31.6 32.0
27-28 Years 38.4 36.2 32.5 30.9 27.4 23.9 25.3 24.6 23.6 23.9 23.7 20.7 22.0 20.8 21.4 22.9 22.9 26.3 26.8 24.3
29-30 Years 30.5 28.9 23.0 24.5 23.1 21.7 22.4 21.3 22.7 22.2 19.6 19.0 20.3 21.1 20.9 20.6 22.0 25.2
31-32 Years* 23.7 23.8 21.9 22.3 22.4 19.8 21.7 21.2 19.3 17.7 17.6 20.2 NA NA NA NA
35 Years 19.5 21.6 21.2 20.3 18.1 17.7 19.1 17.8 18.1 17.9 18.5 18.2
40 Years 20.3 16.7 17.2 15.8 18.2 15.8 17.5 19.1
45 Years 17.8 15.8 15.3
































Any Illicit Drug Other than Marijuana: Trends in Annual Prevalence
Among High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 25.4 26.0 27.1 28.2 30.4 34.0 30.1 28.4 28.0 27.4 25.9 24.1 21.1 20.0 17.9 16.2 14.9 17.1 18.0 19.4 19.8 20.7 20.2 20.7 20.4 21.6 20.9 19.8 20.5 19.7
19-20 Years 28.6 30.2 33.3 34.2 32.4 29.8 27.5 26.9 24.7 22.2 21.3 17.6 16.5 13.8 13.4 13.5 14.6 18.6 17.4 17.6 17.3 18.7 19.6 18.0 19.6 19.9 20.2 20.2
21-22 Years 35.5 37.0 34.2 33.7 31.6 29.5 29.1 25.6 22.8 19.4 17.4 14.9 15.4 13.5 14.1 15.2 13.7 17.7 15.3 14.1 17.0 20.0 18.9 20.7 21.2 20.5
23-24 Years 35.4 33.2 29.4 33.4 29.3 22.6 21.1 18.8 17.5 14.6 14.8 12.9 12.9 11.5 13.1 12.1 12.9 14.8 15.0 14.1 17.2 20.1 21.2 18.0
25-26 Years 30.2 30.3 25.5 25.7 21.0 17.6 16.6 14.4 13.4 13.0 12.0 11.6 10.0 10.7 10.8 11.6 12.5 13.3 14.6 14.5 16.3 19.7
27-28 Years 26.5 23.3 20.4 18.2 15.2 13.6 13.2 11.5 11.1 10.9 10.7 8.4 8.9 8.6 9.9 11.4 11.4 15.1 14.6 14.2
29-30 Years 20.0 17.4 12.4 13.2 11.6 9.9 10.8 11.0 10.3 11.0 7.8 8.1 7.4 9.9 10.9 11.6 11.8 15.8
31-32 Years* 13.8 13.1 10.7 9.5 11.5 8.2 10.2 10.8 9.6 8.3 7.4 9.7 NA NA NA NA
35 Years 11.2 10.4 11.4 10.0 8.2 9.3 9.3 8.8 9.6 9.5 11.0 10.5
40 Years 9.3 7.9 7.7 7.3 9.7 6.7 8.3 9.4
45 Years 8.9 9.3 8.4
































Marijuana:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 44.5 47.6 50.2 50.8 48.8 46.1 44.3 42.3 40.0 40.6 38.8 36.3 33.1 29.6 27.0 23.9 21.9 26.0 30.7 34.7 35.8 38.5 37.5 37.8 36.5 37.0 36.2 34.9 34.3 33.6
19-20 Years 52.8 51.0 49.7 49.0 44.9 43.0 41.4 40.3 39.1 35.8 36.2 32.2 28.4 25.4 26.9 27.9 29.3 31.8 34.2 34.8 37.2 37.9 37.0 35.4 36.4 35.9 34.5 34.9
21-22 Years 50.1 51.1 45.8 45.4 42.1 40.9 39.6 37.4 33.7 31.6 28.2 26.8 26.9 26.1 29.2 28.1 30.6 30.6 31.9 31.5 33.2 37.5 34.3 33.1 32.5 32.6
23-24 Years 46.0 43.8 38.6 42.0 36.6 33.7 32.0 27.3 26.6 23.2 26.6 26.5 24.6 25.8 25.8 25.1 25.5 27.4 26.9 28.3 31.8 30.0 27.7 26.8
25-26 Years 38.3 39.2 34.1 35.4 29.7 26.2 24.1 21.8 23.5 22.2 22.6 24.4 21.7 23.3 21.2 21.8 22.7 25.0 24.5 24.3 27.6 26.4
27-28 Years 32.5 31.4 26.7 26.8 22.6 20.9 21.2 21.3 20.1 20.4 20.6 18.0 19.9 18.2 18.8 19.4 19.4 21.2 22.4 19.7
29-30 Years 25.4 24.7 20.0 21.0 20.1 18.8 19.0 18.2 19.5 18.0 16.9 16.0 18.4 17.1 17.5 17.0 16.4 18.9
31-32 Years* 19.8 19.9 17.7 19.9 18.6 17.2 18.6 16.7 15.8 14.8 14.5 16.7 NA NA NA NA
35 Years 14.5 17.2 16.3 17.5 14.9 14.7 13.8 14.8 13.7 13.0 13.0 12.9
40 Years 17.1 13.8 13.7 12.5 14.6 13.4 13.9 14.3
45 Years 14.0 11.9 11.7
































Marijuana:  Trends in Thirty-Day Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 32.2 35.4 37.1 36.5 33.7 31.6 28.5 27.0 25.2 25.7 23.4 21.0 18.0 16.7 14.0 13.8 11.9 15.5 19.0 21.2 21.9 23.7 22.8 23.1 21.6 22.4 21.5 21.2 19.9 19.8
19-20 Years 38.0 37.5 33.9 34.2 28.6 25.7 24.6 22.8 22.9 20.4 20.1 16.3 15.2 13.2 14.1 14.6 15.3 18.7 19.9 19.9 20.1 23.1 22.3 21.0 22.2 22.5 20.7 18.9
21-22 Years 35.9 35.3 29.1 29.3 26.4 25.2 23.3 21.8 18.5 15.9 14.3 14.7 14.7 13.8 16.5 15.4 16.4 18.9 17.5 17.8 19.8 22.9 20.1 18.2 18.3 17.9
23-24 Years 30.3 29.7 25.4 26.8 23.0 19.6 17.4 15.6 13.4 13.0 12.5 13.6 13.3 12.2 14.2 14.0 13.8 15.3 14.7 14.9 17.2 18.9 15.6 14.1
25-26 Years 24.9 24.8 19.9 21.5 17.2 14.7 13.4 13.0 12.6 12.4 12.9 11.7 12.6 10.5 11.8 12.0 12.5 14.5 14.8 14.5 15.1 15.9
27-28 Years 20.7 20.3 16.1 14.7 12.9 13.5 12.0 12.3 11.6 10.4 11.0 10.1 10.5 8.9 10.7 10.3 9.9 12.2 12.0 11.9
29-30 Years 15.4 15.0 11.5 12.7 12.2 11.2 11.4 10.8 10.5 9.4 9.0 9.3 9.8 8.3 9.0 8.9 8.5 11.9
31-32 Years* 11.5 12.1 11.3 11.7 10.8 11.1 10.9 10.0 8.7 8.5 7.7 9.6 NA NA NA NA
35 Years 8.7 11.1 8.8 10.7 9.1 8.8 8.3 8.8 8.9 7.1 7.8 7.0
40 Years 10.5 8.3 8.5 8.3 8.1 8.2 8.3 8.1
45 Years 8.4 6.5 7.2
































Marijuana:  Trends in Thirty-Day Prevalence of Daily Use
Among High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 8.2 9.1 10.7 10.3 9.1 7.0 6.3 5.5 5.0 4.9 4.0 3.3 2.7 2.9 2.2 2.0 1.9 2.4 3.5 4.6 4.9 5.8 5.6 6.0 6.0 5.8 6.0 6.0 5.6 5.0
19-20 Years 10.5 10.9 8.1 7.9 6.6 5.2 4.7 4.6 3.5 3.4 3.5 2.8 2.3 2.1 1.4 2.3 3.1 4.7 4.9 5.4 5.2 6.2 6.0 6.1 6.0 6.5 6.0 6.4
21-22 Years 10.9 9.4 6.4 6.2 5.3 4.5 4.1 3.9 3.5 3.1 2.5 2.4 2.6 2.3 2.9 3.4 3.2 5.3 5.2 4.6 5.5 7.0 6.0 6.0 5.1 4.6
23-24 Years 8.1 6.7 5.5 5.8 4.9 4.3 3.1 3.0 2.7 2.1 2.3 2.7 3.1 3.3 2.3 2.6 3.1 5.1 3.8 4.7 5.5 6.6 5.3 4.5
25-26 Years 6.0 6.1 3.6 5.0 3.4 3.3 2.7 2.5 2.6 2.5 2.7 2.3 3.1 2.5 2.4 3.1 3.4 4.6 2.7 3.5 5.5 5.9
27-28 Years 4.8 4.6 3.0 4.1 2.4 2.6 2.5 2.3 2.2 2.5 2.5 2.7 2.3 2.8 2.0 2.3 2.5 4.0 2.9 3.0
29-30 Years 3.2 3.2 2.2 2.6 2.9 2.7 2.4 2.5 2.2 2.3 2.4 2.5 2.2 2.6 2.3 1.9 2.0 3.9
31-32 Years* 2.2 2.5 2.1 2.6 2.7 3.1 2.8 2.8 2.8 2.1 2.6 2.9 NA NA NA NA
35 Years 2.3 2.6 2.3 3.5 2.7 1.9 2.7 2.3 3.0 2.1 2.5 2.1
40 Years 3.2 2.1 2.6 1.8 3.0 2.4 1.8 1.9
45 Years 2.6 2.0 2.1

























Inhalants:*  Trends in Annual Prevalence Among 
High School Seniors and Adults Through Age 45 
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 3.0 3.7 4.1 5.4 4.6 4.1 4.5 4.3 5.1 5.7 6.1 6.9 6.5 5.9 6.9 6.6 6.2 7.0 7.7 8.0 7.6 6.7 6.2 5.6 5.9 4.5 4.5 3.9 4.2 5.0
19-20 Years 2.6 2.4 2.5 2.2 2.7 3.0 2.9 3.4 3.5 4.2 4.4 3.7 4.0 4.0 3.5 3.6 3.1 5.0 4.2 4.7 4.1 3.1 3.2 3.4 2.8 2.2 3.1 1.5
21-22 Years 1.8 2.0 1.9 2.0 1.7 1.8 2.6 3.0 2.7 2.1 2.3 2.3 3.0 2.8 3.3 2.1 2.7 2.8 2.4 3.3 3.0 2.4 1.9 1.4 2.1 2.2
23-24 Years 1.9 1.4 1.5 2.1 1.2 1.4 1.0 1.9 1.4 1.0 1.3 1.9 1.9 2.1 1.8 1.6 1.1 3.0 2.4 0.9 1.9 0.9 1.6 1.0
25-26 Years 0.6 0.8 1.2 0.9 0.5 0.5 0.5 1.2 0.6 0.7 0.7 1.7 0.9 1.0 1.7 0.4 1.0 0.8 0.8 1.3 1.2 0.4
27-28 Years 0.8 0.7 0.1 0.8 0.7 0.6 0.4 0.8 0.6 0.7 0.7 0.5 0.9 1.2 0.9 1.0 0.6 1.0 0.3 1.2
29-30 Years 0.5 0.4 0.3 0.6 0.6 0.4 0.6 0.8 0.0 1.0 0.1 0.5 0.1 0.7 0.5 0.5 0.6 1.4
31-32 Years** 0.3 0.4 0.6 0.5 0.3 0.9 0.2 0.4 0.8 0.3 0.5 0.5 NA NA NA NA
35 Years - - - - - - - - - - - -
40 Years - - - - - - - -
45 Years - - -
*Unadjusted for the possible underreporting of amyl and butyl nitrites.  Chapter 5, Volume I, shows that such an adjustment would flatten the trend for seniors considerably 
because the line was adjusted up more in the earlier years, when nitrite use was more prevalent.  Questions about nitrite use were dropped from the follow-up questionnaires 
beginning in 1995. Questions about the use of inhalants were not included in the questionnaires for the 35-, 40-, and 45-year-olds.






















Hallucinogens:*  Trends in Annual Prevalence Among 
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 9.4 8.8 9.6 9.9 9.3 9.0 8.1 7.3 6.5 6.3 6.0 6.4 5.5 5.6 5.9 5.8 5.9 7.4 7.6 9.3 10.1 9.8 9.0 9.4 8.1 9.1 6.6 5.9 6.2 5.5
19-20 Years 9.5 10.9 9.7 8.6 9.9 7.2 6.0 5.1 6.3 5.9 5.8 5.8 6.3 6.2 6.7 6.9 6.7 9.6 10.1 9.6 8.1 9.4 8.0 9.0 7.3 7.7 6.3 6.4
21-22 Years 10.1 10.9 9.3 7.4 7.5 5.7 5.7 5.2 5.8 4.3 5.0 5.7 7.2 5.0 6.8 6.6 6.2 8.0 6.7 6.8 7.4 8.1 5.8 7.1 6.7 5.3
23-24 Years 8.1 7.4 5.4 4.9 4.6 3.7 3.8 3.8 4.4 4.4 4.2 4.7 4.3 4.9 5.4 5.0 5.2 5.9 4.9 4.6 5.2 5.8 4.4 4.0
25-26 Years 4.7 4.7 3.0 2.4 2.5 2.0 2.3 3.2 3.7 3.0 3.0 3.7 3.2 3.7 3.2 2.7 3.9 3.1 2.8 2.8 3.2 4.3
27-28 Years 2.4 2.7 1.3 1.7 1.8 2.4 2.2 2.1 2.4 2.3 2.2 1.8 2.0 1.7 2.6 1.8 2.2 2.5 2.6 2.1
29-30 Years 2.1 1.4 1.2 1.5 1.9 1.3 1.5 1.9 1.4 1.6 1.4 1.4 1.7 1.7 2.0 1.5 1.4 2.1
31-32 Years** 1.0 1.3 1.2 0.9 1.0 1.3 0.9 1.6 0.9 1.3 0.9 1.5 NA NA NA NA
35 Years 0.8 0.7 0.5 1.0 0.6 0.8 0.5 0.8 0.3 0.6 1.0 0.3
40 Years 0.8 0.5 0.9 0.2 0.7 0.5 0.5 0.4
45 Years 0.6 0.3 0.1
*Unadjusted for the possible underreporting of PCP.

























LSD:  Trends in Annual Prevalence Among 
High School Seniors and Adults Through Age 45 
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 6.4 5.5 6.3 6.6 6.5 6.5 6.1 5.4 4.7 4.4 4.5 5.2 4.8 4.9 5.4 5.2 5.6 6.8 6.9 8.4 8.8 8.4 7.6 8.1 6.6 6.6 3.5 1.9 2.2 1.8
19-20 Years 6.2 8.1 7.2 6.4 7.7 5.4 4.3 3.3 4.5 4.7 4.9 4.5 5.3 5.4 6.3 6.2 6.2 8.2 8.7 7.8 5.9 7.7 6.3 6.4 3.3 1.9 1.5 1.5
21-22 Years 7.9 8.0 6.9 4.9 5.1 3.3 4.4 3.7 4.2 3.2 4.0 5.0 6.0 4.3 5.7 5.5 4.9 5.5 4.4 4.5 4.9 4.7 1.8 1.2 1.4 1.0
23-24 Years 6.0 4.6 3.1 2.9 2.7 2.2 2.9 2.7 3.5 3.8 3.5 3.5 3.2 4.1 4.6 4.0 3.5 4.3 2.6 2.5 2.2 1.4 0.7 0.7
25-26 Years 2.7 2.9 1.5 1.6 1.6 1.4 1.8 2.5 3.2 2.4 2.4 2.6 2.0 2.6 2.1 1.9 2.5 1.7 1.0 0.6 0.5 0.7
27-28 Years 1.6 1.8 0.8 1.1 1.5 1.9 1.6 1.8 1.6 1.7 1.6 1.3 1.0 1.2 1.6 1.3 0.7 0.6 0.3 0.1
29-30 Years 1.5 0.8 0.8 1.0 1.4 1.0 1.0 1.4 1.0 0.8 1.0 0.8 1.0 1.1 0.9 0.4 0.2 0.4
31-32 Years* 0.6 0.8 1.0 0.7 0.6 1.1 0.5 1.0 0.7 0.9 0.2 0.7 NA NA NA NA
35 Years 0.6 0.4 0.5 0.5 0.3 0.6 0.3 0.5 0.0 0.0 0.4 0.1
40 Years* - - - - - - - -
45 Years* - - -
*Beginning in 2002, respondents were followed through age 30 (instead of 32, as in past years).  Questions about LSD use were not included in the questionnaires administered























Hallucinogens Other Than LSD:  Trends in Annual Prevalence
Among High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 7.0 6.9 7.3 6.8 6.2 5.6 4.7 4.1 3.8 3.6 3.0 3.2 2.1 2.2 2.1 2.0 1.7 2.2 3.1 3.8 4.4 4.6 4.6 4.3 4.4 5.9 5.4 5.4 5.6 5.0
19-20 Years 7.1 7.3 5.4 4.6 6.1 3.9 3.2 3.2 3.6 2.5 2.4 3.0 2.6 2.6 1.9 2.8 2.2 3.9 4.4 5.1 4.8 4.2 4.6 5.5 6.5 7.3 6.0 6.2
21-22 Years 5.8 6.5 5.2 4.3 4.1 3.7 2.6 2.7 3.2 2.0 2.4 2.2 3.1 1.9 3.1 3.2 3.5 5.2 3.7 4.2 4.7 5.9 5.2 6.9 6.3 5.0
23-24 Years 4.0 4.2 3.5 2.8 2.7 2.4 1.8 1.9 1.6 1.4 1.9 2.2 2.0 1.9 2.8 2.3 3.1 3.6 3.7 3.0 4.1 5.5 4.0 3.7
25-26 Years 3.0 2.7 2.0 1.3 1.2 1.2 1.0 1.3 1.5 1.4 1.3 1.8 1.6 1.6 1.8 1.5 2.1 1.9 2.5 2.5 3.1 4.0
27-28 Years 1.4 1.5 0.7 0.8 0.7 1.0 0.8 0.9 1.2 1.1 0.9 1.0 1.4 0.9 1.6 0.9 1.7 2.2 2.4 2.1
29-30 Years 0.9 0.9 0.6 0.6 0.8 0.8 0.9 0.7 0.7 1.1 0.7 0.8 1.1 1.0 1.6 1.3 1.4 1.9
31-32 Years* 0.5 0.8 0.4 0.3 0.5 0.5 0.6 0.8 0.4 0.6 0.6 1.1 NA NA NA NA
35 Years 0.5 0.3 0.1 0.6 0.5 0.4 0.3 0.4 0.3 0.6 0.8 0.2
40 Years* - - - - - - - -
45 Years* - - -
*Beginning in 2002, respondents were followed through age 30 (instead of 32, as in past years).  Questions about the use of hallucinogens other than LSD were not included in 
























7 8 8 3
3 3 0 8 3
8 4 3 4
3 8
0 7 4 4
8 3 4
FIGURE 5-8
MDMA:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 4.6 4.0 3.6 5.6 8. 9. 7. 4.5 4.0 3.0
19-20 Years 1.9 2.2 0.6 1.8 1.1 0.6 2.2 3.7 3.1 4. 4.9 9.1 11. 6. 5.3 4.2 4.1
21-22 Years 2.1 2.0 1.1 1.7 0.5 1.4 2.1 1.9 3.9 3. 4.6 9. 10. 9. 5.3 2.4 3.3
23-24 Years 1.3 1.5 1.0 0.4 1.2 0.9 1.3 1.1 1.3 2. 3. 7. 6. 8. 5.2 3.2 2.8
25-26 Years 0.3 1.0 0.6 0.8 0.5 0.2 1.2 1.1 1.6 1. 3. 6.9 4. 4. 3.4 4.0 2.3
27-28 Years 1.0 0.7 0.6 0.4 0.7 0.4 1.4 0.7 0.5 2. 1. 2.6 4.1 2.6 3.1 3.7 2.5
29-30 Years 0.1 0.3 0.7 0.0 0.0 0.3 0.3 0.5 1.4 0. 0. 2. 2.6 2. 1.2 0.9 2.0
31-32 Years* 0.5 0.2 0.4 0.2 0.2 0.2 0.1 0.6 0.9 0. 0. 1. NA NA NA NA
35 Years* - - - - - - - - - - - -
40 Years* - - - - - - - -
45 Years* - - -
*Beginning in 2002, respondents were followed through age 30 (instead of 32, as in past years).  Questions about use of MDMA were not included in the questionnaires






















7 2 0 8 0 8 3
3 7 8 0 3 3
0 3 0 4
2 8 3 4 0 3 4
7 0 8 4 4 7
8 0 2
7 7 8 4





Cocaine:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 6.0 7.2 9.0 12.0 12.3 12.4 11.5 11.4 11.6 13.1 12.7 10.3 7.9 6.5 5.3 3.5 3.1 3.3 3.6 4.0 4.9 5.5 5. 6. 5. 4. 5. 4. 5. 5.1
19-20 Years 11.8 15.0 16.3 15.9 16.9 13.8 14.6 15.4 15.9 13.4 10.6 7.6 5.6 3.8 3.7 3.2 3.2 3.9 3.7 4.5 5. 5. 5. 6. 6.5 6. 6. 6.4
21-22 Years 19.8 20.5 21.6 21.2 20.6 19.2 20.4 16.0 14.1 11.8 8.7 6.1 5.1 4.1 3.9 4.3 4.2 5.8 6. 5.6 6. 7.5 7. 7. 8.6 7.5
23-24 Years 22.9 20.8 20.2 23.5 22.8 16.2 15.1 12.0 9.5 7.2 6.5 4.6 4.8 4.5 4.8 4.9 5. 6. 6. 5. 6. 8. 8. 6.7
25-26 Years 21.1 21.6 19.7 17.4 15.2 10.7 9.9 7.4 6.6 6.3 4.2 4.6 3.8 4.3 3. 5. 4. 5. 5.6 5. 6. 8.2
27-28 Years 19.9 15.6 14.2 12.2 9.9 6.9 7.2 5.8 5.4 4.6 4.3 3.7 3.9 3.9 3.6 4. 4. 5.5 5. 5.7
29-30 Years 14.0 11.6 8.1 6.7 6.7 4.7 6.0 4.5 4.3 4.3 3. 3.6 2. 2. 4. 4.9 3.6 4.5
31-32 Years* 8.9 6.8 5.7 5.1 5.5 3.8 5.0 5.1 4. 4.1 3. 3.5 N N N NA
35 Years 4.7 4.3 5.1 4.1 4. 4.6 3.9 3.5 3.6 2. 3. 2.8
40 Years 4.5 4.1 3.5 3. 3. 3.1 3. 2.8
45 Years 3. 3.9 2.9
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FIGURE 5-10
Crack Cocaine:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 4.1 3.9 3.1 3.1 1.9 1.5 1.5 1.5 1.9 2.1 2.1 2.4 2.5 2. 2. 2.1 2. 2. 2. 1.9
19-20 Years 2.7 2.7 1.8 1.0 0.6 1.3 1.2 1.2 1.0 1.3 1.3 1. 2. 1.6 1. 1. 1. 1.6 1.3
21-22 Years 4.1 2.9 3.6 1.6 1.3 1.3 1.1 1.1 1.3 1.4 1.2 1. 1. 1.6 1. 1. 1. 1. 1.8
23-24 Years 3.4 4.0 3.1 2.1 1.4 1.3 1.2 0.8 1.0 1.2 1.0 1. 1.5 1. 1.1 1.1 1.1 1. 1.1
25-26 Years 2.4 2.7 1.9 2.3 1.5 1.3 1.3 1.0 1.1 0.7 0.7 0. 0.9 1.1 1. 0. 0.5 1.1 0.8
27-28 Years 3.0 3.0 2.0 1.3 1.6 1.6 1.7 1.5 0.9 0.8 0.6 0. 0. 0.6 1. 0.6 0.6 0. 1.0
29-30 Years 3.2 2.8 1.7 1.1 0.9 1.0 1.5 1.5 1.0 1.5 0. 1. 0.5 0. 0.9 0. 0.6 1.2
31-32 Years* 1.5 1.3 1.1 0.9 1.0 1.0 1.3 0.7 0.9 0. 0. 1. N N N NA
35 Years 1.0 1.0 1.5 0.8 1. 1.1 0. 0. 1. 0. 0.5 0.7
40 Years 1.5 1. 0.5 0.6 1. 0. 0. 0.8
45 Years 1.1 1. 0.6

























Heroin:  Trends in Annual Prevalence Among 
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 0.8 0.8 0.8 0.5 0.5 0.5 0.6 0.6 0.5 0.6 0.5 0.5 0.5 0.6 0.5 0.4 0.6 0.5 0.6 1.1 1.0 1.2 1.0 1.1 1.5 0.9 1.0 0.8 0.9 0.8
19-20 Years 0.4 0.3 0.2 0.5 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.5 0.7 0.4 1.1 0.6 0.7 1.0 0.4 0.4 0.4 0.6
21-22 Years 0.6 0.4 0.4 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.5 0.7 0.4 0.4 0.5 0.5 0.1 0.4 0.5 0.7
23-24 Years 0.2 0.6 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.3 0.1 0.2 0.5 0.4 0.5 0.3 0.5 0.3 0.3
25-26 Years 0.2 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.1 0.2 0.2
27-28 Years 0.3 0.3 0.3 0.2 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.1 0.6 0.1 0.4
29-30 Years 0.2 0.3 0.0 0.2 0.1 0.0 0.3 0.4 0.2 0.3 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.5
31-32 Years* 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.1 0.2 0.2 0.0 NA NA NA NA
35 Years 0.3 0.2 0.2 0.1 0.1 0.4 0.1 0.1 0.2 0.3 0.1 0.0
40 Years 0.4 0.0 0.1 0.1 0.3 0.2 0.0 0.0
45 Years 0.2 0.2 0.0
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FIGURE 5-12
Narcotics Other Than Heroin:  Trends in Annual Prevalence Among
 High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02* '03* '04 '05
18 Years 5.7 6.4 6.0 6.2 6.3 5.9 5.3 5.1 5.2 5.9 5.2 5.3 4.6 4.4 4.5 3.5 3.3 3.6 3.8 4.7 5.4 6.2 6. 6. 7. 6. 9. 9. 9.5 9.0
19-20 Years 4.7 4.7 5.6 4.9 4.4 4.2 3.9 3.4 4.2 3.7 3.1 3.0 3.9 3.2 2.2 2.5 2.7 4.7 4.7 4.3 4. 5.5 6. 7. 8. 9.9 10. 9.9
21-22 Years 4.9 5.0 3.5 4.0 3.3 3.8 3.8 3.6 3.6 3.4 2.7 2.4 3.4 2.9 2.9 3.1 2.6 5.0 4. 4. 5. 6. 8.9 9.6 9. 10.2
23-24 Years 4.4 3.3 3.5 3.8 2.7 2.4 2.3 2.4 2.7 2.4 2.2 2.0 2.6 2.5 2.9 2.7 3.5 4.1 4. 4. 8. 9. 9.5 7.6
25-26 Years 2.7 3.4 2.0 2.5 2.5 2.4 2.3 2.4 2.6 2.0 1.8 1.8 2.1 2.2 3. 3. 2.9 3. 6. 6. 7.9 8.8
27-28 Years 2.7 3.0 1.6 2.9 1.5 1.8 1.7 1.4 2.1 2.4 2.0 2.0 1.9 1. 2.1 3.1 4. 6. 7.5 6.9
29-30 Years 2.2 2.1 1.5 1.8 1.9 1.3 1.7 1.9 2.1 2.6 1.5 1. 2.5 2.9 4. 5.1 5. 7.8
31-32 Years** 1.4 1.7 1.5 1.5 1.9 1.8 1.5 2.2 2. 2. 1. 2.9 N N N NA
35 Years 1.7 1.6 1.8 2.0 1. 2.1 2.1 2. 4. 3. 4. 4.3
40 Years 1. 1. 1. 1.6 3. 2. 2.9 3.4
45 Years 2. 3. 3.1
*In 2002 the question text was changed on half of the questionnaire forms for 18-30-year-olds. The list of examples of narcotics other than heroin was updated.  Talwin, 
laudanum, and paregoric—all of which had negligible rates of use by 2001—were replaced by Vicodin, OxyContin, and Percocet.  The 2001 data presented here are based 
on all forms.  The 2002 data are based on the changed forms only.  In 2003 the remaining forms were changed to the new wording.  The data are based on all forms in 2003. 
Beginning in 2002 data were based on the changed question text for 35- and 40-year-olds.
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FIGURE 5-13
Amphetamines:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 15.8 16.3 17.1 18.3 20.8 26.0 20.3 17.9 17.7 15.8 13.4 12.2 10.9 10.8 9.1 8.2 7.1 8.4 9.4 9.3 9.5 10. 10.1 10. 10.5 10.9 11.1 9.9 10. 8.6
19-20 Years 18.2 21.5 23.8 25.5 23.9 19.7 15.8 14.5 11.0 9.1 9.2 6.9 6.6 4.9 5.6 5.4 5.4 7.2 6.5 5.9 7.5 7.9 9. 8. 9.1 8.6 8.5 7.0
21-22 Years 25.5 26.7 22.4 19.9 17.4 13.0 13.0 9.9 8.1 6.8 5.5 4.9 4.3 4.8 5.3 5.7 4.9 7.3 5. 5. 6. 7.9 7.1 7.5 6. 6.8
23-24 Years 21.8 18.3 14.0 14.1 11.4 7.9 7.6 5.1 5.3 3.8 4.0 3.8 4.5 3.0 4.1 3.8 4. 4.5 4. 5. 5. 5. 7.1 5.0
25-26 Years 14.9 12.5 8.6 8.3 6.4 5.5 4.0 3.4 2.7 2.9 3.9 3.5 2.5 3.2 2.9 3. 3.6 3.6 3.9 3.1 4.6 3.8
27-28 Years 9.1 7.9 5.0 4.3 4.3 4.0 3.5 2.6 2.9 2.7 2.5 2.0 2. 2.6 2. 3. 3. 3.6 3.9 2.6
29-30 Years 5.5 5.0 2.7 2.9 3.3 2.4 2.6 2.5 2.6 2.7 1. 2. 1. 1.9 2.1 2.6 2. 3.0
31-32 Years* 3.7 3.7 2.6 2.4 2.5 1.5 2.7 2.6 2.6 1.9 1.9 1.5 N N N NA
35 Years 2.4 1.9 1.9 1.7 1. 1.9 1. 1.9 1. 2. 1.5 1.2
40 Years 1. 1. 1. 1. 1. 1. 1.1 0.8
45 Years 1. 0.9 0.5
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FIGURE 5-14
Crystal Methamphetamine ("Ice"):  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 1.3 1.4 1.3 1.7 1.8 2.4 2.8 2.3 3. 1.9 2. 2.5 3. 3. 2. 2.3
19-20 Years 0.3 0.4 0.3 1.4 1.3 1.1 1.5 0.7 2. 1. 1. 1.9 2.6 2.6 1. 2.4
21-22 Years 0.7 0.5 0.1 1.0 0.4 2.2 0.7 1.5 1.1 0.6 1. 0.9 1. 1. 1. 1.7
23-24 Years 0.4 0.4 0.7 0.9 1.7 0.8 1.4 1.3 1. 1.5 2. 0.6 1.6 1.6 1.1 1.0
25-26 Years 0.3 0.2 0.8 0.1 0.6 0.2 0.1 0.4 0.6 0. 0. 1.1 0.9 0.9 0.9 1.7
27-28 Years 0.5 0.0 0.3 0.6 0.3 0.8 0.5 0.3 0. 0. 0. 0. 0. 0. 1. 1.3
29-30 Years 0.3 0.1 0.4 0.3 0.7 0.6 0.2 0.7 0. 0. 0. 0. 0. 0. 0.1 1.7
31-32 Years* 0.3 0.2 0.2 0.2 0.3 0.0 0.4 0.7 1. 0. 0. 0. N N N NA
35 Years* - - - - - - - - - - - -
40 Years* - - - - - - - -
45 Years* - - -
*Beginning in 2002, respondents were followed through age 30 (instead of 32, as in past years). Questions about the use of ice were not included in the questionnaires 
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FIGURE 5-15
Sedatives (Barbiturates):  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 9.6 9.3 8.1 7.5 6.8 6.6 5.5 5.2 4.9 4.6 4.2 3.6 3.2 3.3 3.4 3.4 2.8 3.4 4.1 4.7 4.9 5.1 5.5 5. 6. 5. 6. 6. 6.5 7.2
19-20 Years 6.4 6.9 4.5 4.7 4.4 3.5 3.5 2.0 2.2 1.9 2.2 1.6 1.7 1.8 1.7 1.9 2.3 3.4 3.3 4.0 3. 5. 4.9 5. 5. 5. 6. 5.1
21-22 Years 5.7 5.8 4.1 3.1 2.5 2.3 2.9 2.7 1.9 1.8 1.7 1.4 1.8 1.6 2.2 2.6 2.4 3.5 3.1 2.5 3.9 4. 3. 4. 4. 5.0
23-24 Years 4.1 3.7 2.6 3.0 2.3 1.5 2.1 1.8 2.3 2.0 1.7 1.7 1.7 1.4 2.2 1.5 2. 3. 4. 3. 4. 3.9 5. 3.8
25-26 Years 3.3 3.4 1.8 2.1 1.7 1.3 2.2 2.5 1.5 1.8 1.1 1.2 1.0 1.5 1. 1. 2. 2. 2.9 2.5 3. 4.0
27-28 Years 2.4 2.3 1.2 1.7 1.8 1.4 1.4 2.3 1.6 1.4 1.7 1.0 1.5 1.1 1. 2.1 2. 3.1 2. 2.8
29-30 Years 2.1 1.4 1.6 1.6 2.0 1.1 1.4 1.7 1.6 1.8 1. 1. 0.9 1. 1. 1.5 1.9 4.4
31-32 Years* 2.2 2.2 1.7 1.5 1.2 1.1 1.4 0.8 1. 0.9 0.9 1.1 N N N NA
35 Years 1.9 1.7 1.6 1.3 1.1 1.6 0.9 1. 1. 1. 1. 1.4
40 Years 0.9 1.5 1.6 1. 1. 0. 1. 1.3
45 Years 1. 1. 1.4


























Tranquilizers:  Trends in Annual Prevalence Among 
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 10.3 10.8 9.9 9.6 8.7 8.0 7.0 6.9 6.1 6.1 5.8 5.5 4.8 3.8 3.5 3.6 2.8 3.5 3.7 4.4 4.6 4.7 5.5 5.8 5.7 6.9 7.7 6.7 7.3 6.8
19-20 Years 9.4 9.8 8.8 7.4 5.6 5.1 5.4 4.4 4.2 4.0 3.5 3.4 3.0 2.7 2.2 2.1 1.9 3.7 3.5 4.7 4.2 4.1 5.5 6.1 8.8 8.0 8.0 6.5
21-22 Years 9.0 7.3 7.2 5.8 5.4 4.5 5.4 5.5 4.5 3.5 3.6 3.2 3.8 3.1 2.9 3.5 3.7 3.6 4.5 4.2 5.3 7.1 7.8 7.0 8.1 8.5
23-24 Years 8.6 6.6 5.6 6.2 5.2 4.1 4.2 3.8 3.8 4.0 3.4 3.2 3.1 3.0 3.0 2.9 3.7 4.2 5.3 5.4 6.4 7.2 8.3 6.3
25-26 Years 6.7 7.1 5.4 5.8 4.3 2.9 5.0 3.9 4.5 3.7 3.3 3.1 2.4 1.9 3.6 3.5 3.7 5.3 7.0 6.3 6.8 7.7
27-28 Years 6.8 6.2 4.8 4.6 3.3 3.8 3.4 3.8 3.6 3.4 2.9 2.0 2.9 2.6 3.0 3.9 4.9 5.2 5.6 4.3
29-30 Years 4.6 4.1 3.9 4.2 3.7 2.7 3.2 3.5 3.1 4.1 2.4 2.1 2.7 4.2 5.0 4.3 4.8 7.4
31-32 Years* 3.8 4.1 4.1 2.7 3.8 1.8 3.2 4.1 3.8 2.7 2.6 3.0 N N N NA
35 Years 3.1 3.6 3.6 3.0 2.2 3.4 3.2 4.3 4.0 3.8 3.6 4.4
40 Years 3.0 2.0 3.0 3.7 4.2 2.2 3.5 3.8
45 Years 2.9 3.1 2.9


























Steroids:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 1.9 1.7 1.4 1.1 1.2 1.3 1.5 1.4 1.4 1.7 1.8 1.7 2.4 2.5 2.1 2.5 1.5
19-20 Years 0.4 0.5 0.0 0.5 0.4 0.3 0.6 0.8 0.5 0.1 0.4 1.0 0.5 0.8 0.6
21-22 Years 0.3 0.1 0.9 0.6 0.6 0.1 0.2 0.2 1.1 0.4 0.9 0.3 0.8 0.2 0.4
23-24 Years 0.4 0.7 0.4 0.0 0.8 0.3 0.9 0.2 0.1 0.3 0.0 0.4 0.2 0.5 0.6
25-26 Years 0.5 0.4 0.0 0.2 0.2 1.0 0.5 0.3 1.0 0.2 0.0 0.3 0.5 0.5 0.6
27-28 Years 0.8 0.0 0.2 0.5 0.0 0.0 0.2 0.4 0.1 0.9 0.6 0.0 0.3 0.3 0.3
29-30 Years 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.1 0.0 0.0
31-32 Years* 0.1 0.0 0.0 0.4 0.2 0.5 0.0 0.5 0.0 0.2 0.0 N N N NA
35 Years* - - - - - - - - - - - -
40 Years* - - - - - - - -
45 Years* - - -
*Beginning in 2002, respondents were followed through age 30 (instead of 32, as in past years), then again at ages 35 and 40.  The 45-year-olds were added in 2003.  Questions
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FIGURE 5-18a
Alcohol:  Trends in Annual Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 85.7 87.0 87.7 88.1 87.9 87.0 86.8 87.3 86.0 85.6 84.5 85. 85. 82. 80.6 77. 76. 76. 73. 73. 72.5 74. 74. 73. 73. 73. 71.5 70.1 70.6 68.6
19-20 Years 89.8 90.6 89.0 90.6 88.6 88.5 88.7 88.5 88. 88. 86.6 87.5 85.6 84.6 81.9 80.6 78. 78. 79.6 79. 79. 79.6 79. 77.6 78. 75. 75. 77.3
21-22 Years 90.2 91.6 91.8 91.8 89.1 89. 90.1 90. 89.5 89.1 89.6 89. 87.9 85.9 84. 85. 84. 85.1 86. 85.5 86. 87. 85. 84. 86. 84.4
23-24 Years 90.0 91.7 90.4 91.6 88.1 89. 89. 88. 88. 88.1 89.1 87. 86.6 87. 85. 85. 84.9 85. 87. 86. 88. 87.6 87. 86.6
25-26 Years 88.2 89.9 88. 90.5 89. 87.5 87.5 87. 86. 87. 86. 86. 85.9 86. 83. 85. 84. 86. 88. 86. 87.9 85.6
27-28 Years 87. 87. 87. 88. 86. 85. 85.6 85. 84.5 85. 85. 85.9 85. 85. 82.9 84. 84. 83.6 86.1 85.3
29-30 Years 87. 86. 86.9 85. 84.5 83. 82.6 83. 84. 83. 84. 85. 83. 84. 83.6 83.9 83.5 84.8
31-32 Years* 84. 83. 85. 83.6 83.6 81. 82. 83. 83. 85.1 82.9 84. N N N NA
35 Years 82.5 82.1 83.5 82. 82. 81. 81. 82. 85.1 82.6 86. 85.8
40 Years 77. 80. 80. 81.5 80. 81.6 79. 81.6
45 Years 78.9 79. 80.3
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FIGURE 5-18b
Alcohol:  Trends in Thirty-Day Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 68.3 71.2 72.1 71.8 72.0 70.7 69.7 69.4 67.2 65.9 65. 66. 63.9 60. 57.1 54. 51. 51. 50.1 51. 50. 52. 52. 51. 50. 49. 48.6 47.5 48. 47.0
19-20 Years 75.8 76.5 76.6 77.0 75.7 73.9 73.6 73. 72.9 72.5 69.6 69. 66.6 64.5 61. 60.5 59.9 59. 58.1 59. 59. 62. 59.1 59. 59. 56. 56. 59.0
21-22 Years 78.3 80.5 79.9 79.3 78.1 75.9 77. 77. 76. 73. 74.1 75. 72. 71.6 70. 70. 69.5 69.1 69. 69. 70.5 71. 71.9 69.5 72. 70.1
23-24 Years 77.9 78.9 77.6 79. 75. 74.9 75.9 72. 73.6 72. 73. 73.1 70.1 72. 69. 69. 70. 70. 71.5 70.6 71.9 72. 72. 71.2
25-26 Years 75.2 76. 76. 77. 74.1 72.5 71. 71.6 69. 69.9 70. 71. 68.5 70.9 66. 70. 68. 68. 71. 69.1 72. 73.0
27-28 Years 73.6 75. 74.6 73.9 70.9 69. 69.1 68. 69.9 68. 69. 70. 68. 70. 64.6 66.5 67.9 67. 68. 70.3
29-30 Years 72.1 72. 70. 69.6 69. 66. 67. 67. 68. 65. 66.1 67. 65. 66. 65. 66.5 64.5 65.7
31-32 Years* 68. 68.5 67. 66. 67. 67.6 65.5 65. 65. 66. 66. 67. N N N NA
35 Years 65.1 66. 64. 65. 62.9 64. 64. 63. 67. 63. 70. 68.5
40 Years 59. 64. 63.1 65.6 65. 66. 63. 65.1
45 Years 62. 65. 65.4































Alcohol:  Trends in Thirty-Day Prevalence of Daily Use Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 5.6 6.1 5.7 6.9 6.0 6.0 5.7 5.5 4.8 5.0 4.8 4.8 4.2 4.2 3.7 3.6 3.4 2.5 2.9 3.5 3.7 3.9 3.9 3.4 2.9 3.6 3.5 3.2 2.8 3.1
19-20 Years 7.6 7.7 7.0 7.2 7.5 5.3 5.8 5.6 5.3 5.7 4.8 4.7 4.0 3.7 3.3 3.2 3.3 3.1 2.7 4.8 3.6 4.1 3.9 3.6 3.9 3.6 3.7 3.6
21-22 Years 8.4 7.7 7.8 8.0 7.7 6.4 6.3 7.0 7.2 5.0 4.9 4.9 4.4 5.1 3.9 3.5 5.1 4.6 5.7 5.9 5.3 6.2 5.6 5.7 5.7 6.0
23-24 Years 8.2 8.5 6.8 7.3 6.2 6.1 6.2 5.1 5.3 5.4 4.2 4.9 3.7 4.1 4.8 4.5 3.9 4.7 4.2 4.6 5.0 6.5 5.5 5.8
25-26 Years 7.5 7.5 5.3 6.9 6.3 6.0 4.8 4.9 6.1 5.1 3.3 4.4 3.7 5.1 3.4 5.1 3.8 5.0 5.4 4.6 4.3 6.0
27-28 Years 7.3 7.2 5.7 6.9 4.9 6.2 4.4 4.7 5.4 4.7 3.6 4.2 3.1 4.3 3.5 2.7 3.7 5.1 3.5 4.6
29-30 Years 7.6 5.6 5.6 5.9 5.8 4.6 5.0 4.1 5.1 5.9 3.4 5.2 3.9 4.3 3.8 3.5 3.8 5.8
31-32 Years* 6.4 5.2 6.0 5.7 4.7 4.9 5.1 5.0 4.8 4.4 4.2 4.7 NA NA NA NA
35 Years 7.2 5.5 7.5 4.8 6.0 5.2 5.2 5.8 4.8 3.9 6.3 6.1
40 Years 6.9 7.5 6.5 7.5 6.6 7.8 6.6 7.2
45 Years 7.8 9.0 8.5
























Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 37.1 39.4 40.3 41.2 41.2 41.4 40.5 40.8 38.7 36.7 36.8 37.5 34.7 33.0 32.2 29.8 27.9 27.5 28.2 29.8 30.2 31.3 31.5 30.8 30.0 29.7 28.6 27.9 29.2   27.1**
19-20 Years 41.1 42.1 42.7 43.1 41.7 40.9 41.0 41.2 41.2 37.2 37.3 36.9 36.0 37.0 34.0 34.6 34.5 31.7 32.7 36.5 34.5 35.3 35.3 36.3 36.0 33.6 35.5 36.3
21-22 Years 40.7 43.6 41.6 42.3 40.4 40.4 40.8 41.0 42.0 39.3 38.1 40.3 39.9 40.3 40.5 38.5 38.2 40.2 39.7 40.2 40.6 42.4 40.7 39.9 41.7 40.4
23-24 Years 37.1 39.3 35.1 37.3 35.8 36.6 37.0 35.4 35.5 34.4 34.9 35.0 32.9 35.6 36.3 33.4 35.3 38.1 37.0 38.2 39.4 39.3 40.4 39.2
25-26 Years 33.7 33.3 31.5 33.3 30.7 31.7 32.0 31.5 31.8 32.1 30.9 28.7 30.0 31.5 31.3 33.0 31.5 33.7 34.9 35.1 36.4 37.7
27-28 Years 30.1 32.2 28.0 29.8 28.9 28.8 29.2 29.0 28.5 26.9 29.7 29.3 28.9 32.0 29.1 29.2 28.9 31.1 31.3 31.5
29-30 Years 26.7 26.3 25.2 24.3 25.7 25.1 27.5 26.3 24.9 26.5 26.6 26.9 24.0 27.3 25.8 26.4 26.9 29.1
31-32 Years* 25.4 25.1 23.7 24.8 24.6 24.7 24.3 24.7 22.8 24.1 24.1 24.3 NA NA NA NA
35 Years 21.1 20.0 21.9 22.3 20.4 21.4 22.2 20.6 22.9 22.4 21.6 23.0
40 Years 19.7 20.5 18.3 21.3 20.8 20.7 20.2 22.2
45 Years 20.1 19.2 19.6
** For 18-year-olds only:  Due to a coding error, previously released versions of this figure contained values for 2005 that were slighly off for this measure.  This has been corrected here. 
h
*Beginning in 2002, respondents were followed through age 30 (instead of 32, as in past years).
FIGURE 5-18d
Alcohol:  Trends in Two-Week Prevalence of Having Five or More Drinks 

































Cigarettes:  Trends in Thirty-Day Prevalence Among
High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 38.8 38.4 36.7 34.4 30.5 29.4 30.0 30.3 29.3 30.1 29.6 29.4 28.7 28.6 29.4 28.3 27.8 29.9 31.2 33.5 34.0 36.5 35.1 34.6 31.4 29.5 26.7 24.4 25.0 23.2
19-20 Years 39.3 39.3 36.0 34.9 32.1 32.5 31.5 30.9 30.0 30.1 28.4 27.7 27.2 27.6 29.5 29.0 31.3 33.4 34.0 34.0 33.9 36.1 32.2 32.8 29.8 27.0 27.9 27.5
21-22 Years 37.9 37.5 36.2 33.5 32.2 32.4 32.0 32.4 29.8 29.4 28.6 28.3 29.0 29.2 28.8 31.8 32.3 32.3 33.7 33.4 33.6 34.0 32.6 30.5 31.3 29.2
23-24 Years 36.7 36.5 33.6 31.9 29.9 31.7 29.9 29.4 27.8 28.5 28.4 28.1 27.0 28.0 30.1 29.1 30.9 32.4 29.5 31.1 31.9 31.0 31.5 29.3
25-26 Years 33.7 35.3 31.3 28.2 27.3 29.5 28.4 28.3 26.3 27.7 26.4 25.7 26.8 27.6 29.9 25.6 28.2 28.6 27.3 27.0 29.6 30.7
27-28 Years 32.5 32.3 29.1 27.2 26.5 28.2 27.8 25.4 25.0 26.8 26.0 24.9 25.6 22.9 26.5 24.2 24.7 26.3 25.9 26.3
29-30 Years 28.9 30.2 27.8 24.4 23.8 25.8 25.5 25.2 23.4 24.6 23.1 22.7 21.2 20.4 24.4 22.0 21.9 23.5
31-32 Years* 28.3 28.1 27.5 25.3 24.9 25.0 23.8 24.3 22.5 24.0 22.7 21.2 NA NA NA NA
35 Years 24.8 26.1 25.4 22.3 23.6 22.6 24.0 20.4 21.9 20.1 20.0 19.1
40 Years 24.3 23.5 23.5 22.9 18.9 21.9 20.0 21.4
45 Years 20.7 20.2 22.1



























Cigarettes:  Trends in Thirty-Day Prevalence of Daily Use
Among High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 28.8 28.8 27.5 25.4 21.3 20.3 21.1 21.2 18.7 19.5 18.7 18.7 18.1 18.9 19.1 18.5 17.2 19.0 19.4 21.6 22.2 24.6 22.4 23.1 20.6 19.0 16.9 15.8 15.6 13.6
19-20 Years 31.0 31.2 29.3 26.0 23.9 24.4 24.1 23.2 21.9 22.5 19.5 18.9 19.2 19.4 20.5 21.1 21.9 22.2 22.5 22.7 23.8 25.6 22.7 21.9 20.6 18.8 18.2 17.6
21-22 Years 31.1 31.4 28.6 26.0 25.3 25.3 24.4 24.2 22.3 22.5 20.2 20.6 21.2 20.5 21.1 24.0 22.8 21.4 22.8 24.2 25.1 23.6 23.9 20.8 21.5 19.2
23-24 Years 30.1 30.6 27.8 25.1 25.2 26.0 24.0 23.3 22.2 22.5 20.9 20.1 19.9 20.0 22.8 21.5 21.2 21.4 21.2 22.4 23.5 21.5 23.3 20.4
25-26 Years 28.7 30.4 27.3 23.7 22.9 25.0 23.3 22.8 20.3 21.9 19.8 19.2 21.1 19.2 21.9 19.6 20.1 20.9 19.8 20.4 22.7 22.5
27-28 Years 27.6 27.9 25.0 22.9 22.2 23.9 21.8 20.1 20.5 20.9 19.4 17.6 19.5 16.0 19.7 17.2 18.1 19.8 18.2 18.6
29-30 Years 25.4 26.4 24.2 21.0 20.3 21.7 20.9 20.1 18.6 19.7 17.2 17.2 15.8 14.4 17.4 16.4 16.7 18.9
31-32 Years* 23.9 24.9 22.8 21.4 20.9 21.2 19.8 19.1 17.9 18.9 18.1 16.1 NA NA NA NA
35 Years 22.5 23.0 22.1 18.3 20.4 19.7 20.1 16.4 18.2 16.3 14.8 14.5
40 Years 21.7 20.9 20.8 20.1 16.7 19.0 16.6 18.5
45 Years 19.0 17.8 20.1


























Cigarettes:  Trends in Thirty-Day Prevalence of Smoking a Half-Pack or More Daily 
Among High School Seniors and Adults Through Age 45
by Age Group
Age '76 '77 '78 '79 '80 '81 '82 '83 '84 '85 '86 '87 '88 '89 '90 '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05
18 Years 19.2 19.4 18.8 16.5 14.3 13.5 14.2 13.8 12.3 12.5 11.4 11.4 10.6 11.2 11.3 10.7 10.0 10.9 11.2 12.4 13.0 14.3 12.6 13.2 11.3 10.3 9.1 8.4 8.0 6.9
19-20 Years 23.8 24.6 21.9 19.3 18.0 17.2 17.2 16.6 16.2 15.6 13.8 13.0 14.3 12.7 14.5 14.5 15.0 15.2 14.7 15.4 16.9 16.3 14.6 13.9 12.8 11.7 11.6 10.1
21-22 Years 25.2 25.3 23.0 19.7 21.2 20.4 19.3 19.3 17.3 16.4 15.0 14.1 15.1 14.5 15.6 18.1 15.7 14.7 16.2 16.4 17.2 15.9 14.4 13.8 12.7 12.1
23-24 Years 24.6 25.1 22.8 20.8 21.1 21.6 18.4 18.6 17.4 17.4 15.5 15.2 15.0 15.3 16.1 16.4 14.5 14.8 14.1 15.8 15.9 15.4 15.2 13.9
25-26 Years 24.1 24.8 22.0 19.9 18.6 20.6 19.6 18.2 15.8 17.4 15.0 14.2 15.0 13.2 15.5 15.0 14.8 15.1 14.1 14.0 15.6 13.6
27-28 Years 23.2 23.3 20.6 19.0 18.2 19.0 17.9 16.3 15.9 16.3 14.8 12.8 14.8 12.4 14.7 12.6 13.9 14.8 12.8 13.1
29-30 Years 22.3 22.0 20.5 16.7 17.0 17.9 16.8 16.5 15.2 15.9 12.2 13.2 12.5 11.4 14.0 12.7 12.5 14.1
31-32 Years* 20.8 20.8 19.3 17.8 17.8 17.6 16.1 16.1 14.3 14.8 12.8 11.9 NA NA NA NA
35 Years 19.1 19.1 18.5 15.4 16.3 17.3 15.7 13.4 13.0 12.4 10.9 11.3
40 Years 18.7 17.2 17.2 15.9 13.6 14.9 14.2 16.0
45 Years 16.8 15.4 16.4

































ATTITUDES AND BELIEFS ABOUT DRUGS 
AMONG YOUNG ADULTS 
 
 
One of the most important theoretical and practical contributions of this study has been to 
demonstrate the extent to which attitudes and beliefs about drugs determine use of the various drugs. 
Earlier volumes in this monograph series, as well as other publications from the study, have 
demonstrated that shifts in certain attitudes and beliefs—in particular the degree of risk of harm 
perceived to be associated with use of a particular drug—are important in explaining changes in 
actual drug-using behavior. Indeed, on a number of occasions we have predicted changes that later 
occurred.45 In this chapter, we review trends since 1980 in the same attitudes and beliefs among the 
young adult samples that were considered in Volume I for secondary school students. 
 
PERCEIVED HARMFULNESS OF DRUGS 
 
Table 6-1 provides trends in the percentages of young adults who perceive a “great risk” of harm 
associated with differing usage levels of various licit and illicit drugs. These questions are contained 
in one questionnaire form only, limiting the numbers of follow-up cases; accordingly, we use four-
year age bands in order to increase the available sample size (to about 300–600 weighted cases per 
year for each age band) and, thus, to improve the reliability of the estimates. (The numbers of 
weighted cases are given at the end of Table 6-1. The actual numbers of respondents are somewhat 
larger.) Still, these are relatively small sample sizes compared to those available for 8th, 10th, and 
12th graders, and thus the change estimates may be relatively more labile. Because of the nature of 
the Monitoring the Future design, trend data are available for a longer period for 19- to 22-year-olds 
(since 1980) than for 23- to 26-year-olds (since 1984) or for 27- to 30-year-olds (since 1988). Also 
displayed in this table are comparison data for 12th graders, shown here as 18-year-olds, from 1980 
onward. (See also Table 8-3 in chapter 8 of Volume I for the longer-term trends in 12th graders’ 
levels of perceived risk.) Questions about these attitudes and beliefs are not included in the 
questionnaires for 35-, 40-, and 45-year-old respondents. 
• Table 6-1 illustrates considerable differences in the degree of risk young adults associate 
with various drugs. In general, the results closely parallel the distinctions made by 12th 
graders. 
                                                 
45Bachman, J. G., Johnston, L. D., O’Malley, P. M., & Humphrey, R. H. (1988). Explaining the recent decline in marijuana use: Differentiating the 
effects of perceived risks, disapproval, and general lifestyle factors. Journal of Health and Social Behavior, 29, 92–112; Bachman, J. G., Johnston, L. 
D., & O’Malley, P. M. (1990). Explaining the recent decline in cocaine use among young adults: Further evidence that perceived risks and disapproval 
lead to reduced drug use. Journal of Health and Social Behavior, 31, 173–184; Bachman, J. G., Johnston, L. D., & O’Malley, P. M. (1998). Explaining 
recent increases in students’ marijuana use: Impacts of perceived risks and disapproval, 1976 through 1996. American Journal of Public Health, 88, 
887–892; Johnston, L. D. (1981). Characteristics of the daily marijuana user. In R. de Silva, R. L. DuPont, & G. K. Russell (Eds.), Treating the 
marijuana-dependent person (pp. 12–15). New York: The American Council on Marijuana; Johnston, L. D. (1985). The etiology and prevention of 
substance use: What can we learn from recent historical changes? In C. L. Jones & R. J. Battjes (Eds.), Etiology of drug abuse: Implications for 
prevention (NIDA Research Monograph No. 56, pp. 155–177). (DHHS Publication No. (ADM) 85-1335). Rockville, MD: National Institute on Drug 
Abuse. 
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• Marijuana is seen as the least risky of the illicit drugs, although sharp distinctions are made 
between different levels of marijuana use. In 2005, experimental use of marijuana is 
perceived as being of “great risk” by only about one seventh  (13%–16%) of all high school 
graduates in the age band 19 to 30, whereas regular use is perceived to carry great risk by 
over half (54%–57%) of them. 
 
It is interesting to note that in the mid-1980s and early 1990s, fewer of the older age groups 
attached great risk to marijuana use than did the younger age bands. Indeed, there was a 
quite regular negative ordinal relationship between age and perceived risk for some years 
after 1980, when the first comparisons were available. Although this may have first looked 
like an age effect, our study design allowed us to recognize it as a cohort effect: the younger 
cohorts initially perceived marijuana as more dangerous than the older cohorts and persisted 
in such beliefs as they grew older. Newer cohorts, however, have shown lower levels of 
perceived risk. Twelfth graders from the class of 2005 are much less likely to perceive 
regular marijuana use as dangerous as did 12th-grade cohorts in the late 1980s and early 
1990s. This reflects what we have interpreted as “generational forgetting,” a phenomenon 
wherein younger replacement cohorts no longer carry the knowledge—and perhaps the direct 
or vicarious experience on which the knowledge is based—that the older cohorts had at that 
age.   
 
The decline in perceived risk that began in the 1990s was greater in the younger age bands, 
including grades 8 and 10, and was least among the 27- to 30-year-olds. We believe that 
much of the decline in perceived risk that occurred in the older age bands resulted directly 
from generational replacement of earlier cohorts by later, less concerned ones. The 
credibility of this view is strengthened by the 1995–1997 reversal of the relationship 
between age and perceived risk of regular use. This reversal is consistent with an underlying 
cohort effect and could not simply reflect an association between age and a regular change in 
these attitudes (i.e., an “age effect”). The decline in perceived risk for regular marijuana 
ended in a somewhat staggered fashion—among 12th graders in 1999, among 19- to 22-year-
olds in 2001, among 23- to 26-year-olds in 2002, and among 27- to 30-year-olds in 2004.  
 
• Young adults view use of any of the other illicit drugs as distinctly more risky than use of 
marijuana. Even the experimental use of amphetamines and sedatives (barbiturates) is 
perceived as risky by about 27%–39% of young adults aged 19 to 30, and 39%–54% think 
trying LSD or MDMA (ecstasy) involves great risk. Trying cocaine powder is seen as 
dangerous by 50%–53%, while trying crack or heroin once or twice is seen as dangerous by 
57%–74%. 
 
• In recent years, the older age groups have been more likely than the younger age groups to 
see LSD as dangerous. Indeed, there is now a substantial age-related difference. The age 
distinctions for LSD use have become sharper in recent years as perceived risk has declined 
more in the younger age groups than in the older ones—again indicating some important 
cohort changes in these attitudes, quite likely as a result of the process we have labeled 
“generational forgetting” (see above). 
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• Young adults report somewhat higher perceived risk with respect to cocaine use than the 
12th graders, who have had less experience with cocaine. Among 12th graders and the young 
adult age groups, the danger associated with using cocaine on a regular basis grew 
considerably (by 13 and 17 percentage points, respectively) between 1980 and 1986. 
However, these changed beliefs did not translate into changed behavior until the perceived 
risk associated with experimental and occasional use began to rise sharply after 1986. When 
these two measures rose, a sharp decline in actual use occurred.   
 
We hypothesized that respondents saw only these lower levels of use as relevant to them 
and, therefore, saw themselves as vulnerable to the dangers only of such use. (No one starts 
out planning to be a heavy user; further, in the early 1980s, cocaine was not believed to be 
addictive.) Based on this hypothesis, we included the additional question about occasional 
use in 1986, just in time to capture a sharp increase in perceived risk later that year. This 
increase occurred largely in response to the growing media frenzy about cocaine—and crack 
cocaine, in particular—and to the widely publicized, cocaine-related deaths of several public 
figures (most notably, Len Bias, a collegiate basketball star and top National Basketball 
Association draft pick). After stabilizing for a few years, perceived risk began to fall off 
among 12th graders after about 1991 but not among the older age groups—once again 
suggesting that lasting cohort differences were emerging, quite possibly as a result of 
“generational forgetting” of the dangers of cocaine. A decline in perceived risk began among 
the 19- to 22-year-olds starting after 1994, among the 23- to 26-year-olds after 1997, and 
among the 27- to 30-year-olds after 2001, all likely reflecting generational replacement with 
the 12th graders who earlier had come to see cocaine as less dangerous than did their 
predecessors.  
 
• A similar situation also now exists for crack, for which perceived risk is highest in the oldest 
age band and lowest among 12th graders. Trend data (available since 1987) on the risks 
perceived to be associated with use of crack show increases in the 1987–1990 interval for all 
age groups, followed by relatively little change in the older age strata. Since 1990, the 12th 
graders have shown decreases in the perceived risk of experimental use of crack—perhaps 
reflecting the onset of “generational forgetting” of its dangers—leaving them as perceiving 
considerably less risk than the older groups. The young adult age groups have shown a 
staggered decline in this measure, with the 19- to 22-year-olds showing a decline after 1994, 
the 23- to 26-year-olds since 1996, and the 27- to 30-year-olds after 2001. As a result, the 
different ages have spread out more in recent years in their levels of perceived risk of crack 
use. 
 
• Questions about perceived risk of crystal methamphetamine (ice) use were introduced in 
1990, and the results show what may be an important reason for its lack of rapid spread. 
More than half of all 12th graders and young adults perceived it as a quite dangerous drug 
even to try, perhaps because it was likened to crack in many media accounts. (Both drugs 
come in crystal form, both are burned and the fumes inhaled, both are stimulants, and both 
can produce a strong dependence.) There was rather little age-related difference in perceived 
risk associated with use of ice in 1990 and 1991 (although the two youngest age groups were 
somewhat higher). But as perceived risk fell considerably among 12th graders (and 
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eventually among 19- to 22-year-olds) and held steady or rose in the oldest two age groups, 
an age-related difference emerged. Now perceived risk has risen some among the 19- to 22-
year-olds, narrowing the age-related differences that had emerged for a few years. Still, 12th 
graders are less likely to see risk attached to trying ice (55%) than are 27- to 30-year-olds 
(63%), again very likely due to generational forgetting.    
 
• MDMA (ecstasy) questions were introduced in the follow-up surveys in 1989 but were not 
asked of 12th graders until 1997. At the beginning of the 1990s, all young adult age bands 
viewed it as a fairly dangerous drug, even for experimentation. But, again, the different age 
bands had diverging trends during the 1990s, with the oldest two age bands continuing to see 
ecstasy as quite dangerous but the 19- to 22-year-olds (and very likely the 12th graders, for 
whom we did not have data until 1997) coming to see it as less so. In 2000, 38% of the 12th 
graders saw great risk in trying ecstasy versus 49% of the 27- to 30-year-olds; in 2001, the 
corresponding figures were 46% and 54%. In fact, three of the four age bands showed 
appreciable increases in perceived risk for ecstasy in 2001, which led us to state four years 
ago in this corresponding chapter that “a turnaround in the use of this drug may be about to 
occur.” The increase in perceived risk continued in 2002 in the two youngest age strata, and 
their use of ecstasy did, indeed, begin to decline—and decline sharply (see chapter 5). At 
present there is rather limited age-related difference in perceived risk for this drug, and what 
difference there is derives from the 23- to 26-year-olds having the lowest level of perceived 
risk (which may originate in part from the fact that they have had the most experience with 
this drug). Until they caught up in 2005, that age band had not shown the increase in 
perceived risk that the younger two age bands have shown in recent years.    
 
• Young adults have been more cautious about heroin use than have 12th graders. In general, 
there has been relatively little change over the years in the proportions of all age groups 
seeing regular heroin use as dangerous; the great majority of each group (over 86%) 
consistently held this viewpoint. With regard to heroin experimentation, from 1975 to 1986 
there had been a downward shift among the 12th graders in the proportion seeing great risk 
associated with trying heroin. Following this decline (although their data do not extend back 
as far) young adults showed an increased caution about heroin use in the latter half of the 
1980s—possibly due to the association of heroin injection with the spread of HIV 
infection—followed by a leveling through most of the 1990s. In 1996 and 1997, young 
adults’ perceived risk increased some, as happened among the 12th graders (as well as 
among the 8th and 10th graders). These various trends may reflect, respectively, (a) the 
lesser attention paid to heroin by the media during the late 1970s and early 1980s as cocaine 
took center stage; (b) the subsequent great increase in attention paid to intravenous heroin 
use in the latter half of the 1980s because of its important role in the spread of HIV/AIDS; 
(c) the emergence in the 1990s of heroin so pure that people no longer needed to use a needle 
to administer it, resulting in lower perceived risk; and (d) the subsequent increased attention 
given to heroin by the media (partly as a result of some overdose deaths by public figures 
and partly prompted by the emergence of “heroin chic” in the design industry), as well as 
through an anti-heroin campaign in the media launched by the Partnership for a Drug-Free 
America in June 1996. At present the young adults still see heroin use as more dangerous 
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than do the 12th graders (Table 6-1); the differences generally have been largest for 
experimental and occasional use. 
 
• A large minority of young adults see heavy drinking on weekends as dangerous (37%–
44%), which is true for 12th graders as well (45%). The belief that heavy drinking carries 
great risk has increased over the years in all of these age groups, rising among 12th graders 
from 36% in 1980 to 49% in 1992. Among 19- to 22-year-olds it rose from a low of 30% in 
1981 to 42% in 1992; the increases among the older groups were smaller. The increase in 
this belief may well help to explain the important decline in actual heavy drinking and may 
in turn be explained by the media campaigns against drunk driving and by the increase in the 
drinking age in a number of states.46 After reaching peaks in the early 1990s, perceived risk 
for this behavior eased back some in all age strata, following a staggered pattern in which 
perceived risk peaked among 18-year-olds in 1992, among 19- to 22-year-olds in 1993, 
among 23- to 26-year-olds in 1994, and among 27- to 30-year-olds in 1995.  
 
• Between 1980 and 1991, a gradually increasing proportion of all four age groups viewed 
drinking one or two drinks per day as dangerous; but then they all showed a parallel 
decrease in perceived risk for this behavior through 2000, at least. It seems likely that the 
earlier increase was due to the general rising concern about the consequences of alcohol use, 
particularly drunk driving, and that the subsequent decline was due to increasing reports of 
cardiovascular health benefits of light-to-moderate daily alcohol consumption. In recent 
years there has been little systematic change in this belief in any of the age strata, nor has 
there been much difference by age. 
 
• About four fifths (81%-84%) of young adults perceive regular pack-a-day cigarette smoking 
as entailing high risk, higher than the 77% of 12th graders who hold that belief and much 
higher than the 62% of 8th graders who do so. In recent years, the 18-year-olds have 
consistently shown lower perceived risk than young adults, while 10th graders have been 
still lower and 8th graders lowest. Clearly, there is an age effect in young people coming to 
understand the dangers of smoking. Unfortunately, it appears that much of the learning about 
the risks of smoking happens after a great deal of smoking initiation has occurred and many 
young people already have become addicted. These beliefs about smoking risks have 
strengthened very gradually in all age groups from senior year forward during the years we 
have monitored them. (See Table 6-1.) The parallel changes in these beliefs across the 
different age groups indicate a period effect, rather than a cohort effect, suggesting that all of 
these age groups were responding to common influences in the larger culture. These 
influences are discussed at some length in the chapter on attitudes and beliefs in Volume I.  
In the past three or four years, the rise in perceived risk appears to have ended in the several 
young adult strata, while there has been some slight further increase among 12th graders. 
 
• The regular use of smokeless tobacco is seen as dangerous by only 48%–59% of young 
adults and by even fewer 12th graders (44%). However, these beliefs have also gradually 
                                                 
46See O’Malley, P. M., & Johnston, L. D. (1999). Drinking and driving among U.S. high school seniors: 1984–1997. American Journal of Public 
Health, 89, 678–684. See also O’Malley, P. M., & Johnston, L. D. (2003). Unsafe driving by high school seniors: National trends from 1976 to 2001 in 
tickets and accidents after use of alcohol, marijuana and other illegal drugs. Journal of Studies on Alcohol, 64, 305–312.  
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strengthened in all age groups over the intervals covered (Table 6-1). As with cigarettes, the 
change appears to reflect a secular trend or period effect, because it has been occurring in 
parallel for all age groups.  Also like cigarettes, smokeless tobacco has seen the degree of 




PERSONAL DISAPPROVAL OF DRUG USE 
 
The questions asked of 12th graders concerning the extent to which they personally disapprove of 
various drug-using behaviors among “people (who are 18 or older)” are also asked of follow-up 
respondents in one of the six questionnaire forms. Trends in the answers of young adults aged 19 to 
22, 23 to 26, and 27 to 30 are contained in Table 6-2. Comparison data for 12th graders are also 
provided for 1980 onward. (See Table 8-6 in chapter 8, Volume I, for the longer-term trends in 12th 
graders’ levels of disapproval associated with using the various drugs.) 
• In general, disapproval levels of adult use of the various drugs rank similarly across 
substances for both 12th graders and young adults. The great majority of young adults 
disapprove of using, or even experimenting with, all of the illicit drugs other than 
marijuana. For example, 95% or more of young adults in 2005 disapprove regular use of 
each of the following drugs: LSD, cocaine, amphetamines, sedatives (barbiturates), and 
heroin. In fact, fully 79% to 99% of young adults disapprove experimentation with each of 
these drugs. Many of these attitudes differ rather little as a function of age, at present; when 
there is a difference, the younger age groups are usually the least disapproving. 
 
• Even for marijuana, about half of young adults now disapprove of experimentation (from 
48% to 52%). In 2005, about two thirds (between 66% and 68%) disapproved of occasional 
use, and the great majority (84% to 86%) disapproved of regular use. 
 
Marijuana shows the widest fluctuations in disapproval over time—generally, fluctuations 
that parallel the changes in perceived risk (though sometimes with a one-year time lag, with 
the change in perceived risk coming first). The most fluctuation has occurred among 12th 
graders, nearly as much among 19- to 22-year-olds, and the least among 27- to 30-year-olds 
(Table 6-2). Among 12th graders, disapproval of regular marijuana use increased 
substantially in the 1980s, peaked in the early 1990s, declined through much of the 1990s, 
and then leveled around 1998 with little change since then. The 19- to 22-year-olds had a 
quite similar pattern, though the decline continued a year longer, likely due to generational 
replacement. Among 23- to 26-year-olds, there were some declines starting later in the 
1990s, but the declines have been very modest. 
 
• The great majority of all age groups have disapproved of even experimenting with LSD 
since 1980, when these data were first available.  Beginning around 1990, all age groups 
decreased some in their disapproval of trying LSD (from high levels of disapproval, all at 
90% or 91%). The decline was steepest among 12th graders, but there was a reversal of the 
decline among 12th graders in 1997, and their disapproval of using LSD has increased some 
since then. Disapproval in the older age groups declined less, and in a staggered fashion; this 
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trend has shown some evidence of a reversal among 19- to 22-year-olds and 23- to 26-year-
olds since 2001 and 2002, respectively. This pattern again suggests some lasting cohort 
differences in these attitudes. 
 
• Most of the disapproval statistics for heroin use, with regard to all three levels of use, have 
remained very high and stable throughout the life of the study. There was, however, a little 
slippage in heroin disapproval rates among 12th graders from 1991 through 1996 (from 96% 
to 92% for disapproval of experimental use)—a period during which heroin usage rates 
began to rise.   
 
• Disapproval of regular cocaine use rose gradually among 19- to 22-year-olds, from 89% in 
1981 to 99% in 1990, about where it has remained since. All three young adult age bands are 
now near the ceiling of 100%. Disapproval of experimental use of cocaine increased during 
the 1980s, peaking first among the 12th graders at 94% in 1991. It then peaked among 19- to 
22-year-olds (at 94%) and 23- to 36-year-olds (at 92%) in 1995. Finally, it peaked among 
27- to 30-year-olds at 90% in 1999. All age groups have had some modest falloff in 
disapproval of cocaine use since reaching their peak levels of disapproval in the 1990s. 
Again, the lag in inflection points between the successive age groups suggests some lasting 
cohort differences in these attitudes that show up as each cohort makes its way through the 
successive age bands. For the last few years, all age groups’ disapproval of experimental 
cocaine use has hovered around 90%.  
 
• Disapproval of experimental use has moved very much in parallel for amphetamines and 
sedatives (barbiturates).  Disapproval of both drugs increased significantly during the 1980s, 
accompanied by declining use. Trying amphetamines once or twice was disapproved of by 
73%–74% of 19- to 26-year-olds in 1984, compared to 84% by 1990. The corresponding 
figures for disapproval of trying sedatives were 84%–85% in 1984 compared to 89%–91% 
by 1990. Disapproval of amphetamine and sedative use slipped some among 12th graders 
after 1992 and among 19- to 22-year-olds after 1994, with the 23- to 26-year-olds following 
suit after 1996, and the 27- to 30-year-old stratum in 2004. This pattern of staggered change 
again suggests cohort effects, reflecting lasting cohort differences in these attitudes. 
 
• The story for alcohol is quite an interesting one, in that changes in the minimum drinking 
age law may have led to modest changes in norms for the affected cohorts. Between 1980 
and 1992, an increasing proportion of 12th graders favored total abstention, with the percent 
who disapproved even drinking only once or twice rising from 16% in 1980 to 33% in 1992. 
(This figure has fallen back some, to 26% as of 2005.) Among 19- to 22-year-olds, there was 
a modest increase from 15% to 22% disapproving any use between 1985 and 1989; this 
figure remains at 22% in 2005. For the two oldest age groups, there has been rather little 
change in these attitudes so far. These differing trends may reflect the fact that during the 
1980s, the drinking age in a number of states was raised so that by 1987 it was 21 in all 
states; this change would have had the greatest effect on 12th graders, who may have 
incorporated the legal restrictions into their normative structure and, as they entered the 
second age band, brought these new norms with them. Put another way, these changes could 
reflect a cohort effect resulting from the laws that were prevailing when the cohort passed 
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through late adolescence. But the changes may be exhibited only when the respondents are in 
the age bands directly impacted by the law.   
 
Disapproval of daily drinking (of one or two drinks) has not shown any such cohort effects, 
because all age groups have moved in parallel, at similar levels of disapproval. The three 
youngest age bands (which include 12th graders through 26-year-olds) showed an increase in 
disapproval of daily drinking up until about 1990 (there was little data yet available on the 
oldest age group), but disapproval has declined a fair amount in all of the age groups since 
then. This pattern of cross-time change closely parallels what was observed for perceived 
risk of light daily drinking, discussed previously; the decline in both variables may well be 
due  to widely publicized reports that some cardiovascular benefits result from having one or 
two drinks per day.   
 
There was a considerable increase in disapproval of heavy drinking on weekends from the 
early 1980s for the two youngest age groups, and this continued through 1992 for 12th 
graders (who then showed some drop-off) and through 1996 among 19- to 22-year-olds (who 
also then showed some drop-off). As Figure 5-18d illustrates, the prevalence of occasional 
heavy drinking declined substantially among 12th graders and 19- to 22-year-olds between 
1981 and the early 1990s, as norms became more restrictive. There was little or no change in 
the older age strata, either in their levels of disapproval or in their rates of occasional heavy 
drinking, until the early 2000s, when disapproval began to drop some in both strata. 
 
At present, the 12th graders are most likely to disapprove of trying alcoholic beverages (as 
has been the case for some years) but are the least disapproving of heavy daily drinking. 
Weekend binge drinking is least disapproved by 19- to 22-year-olds, who report the highest 
levels of such behavior. 
 
• Some fluctuations in the disapproval of cigarette smoking have occurred over the intervals 
covered by the study. Twelfth graders showed some increase in disapproval of pack-a-day-
or-more smoking between 1982 (69%) and 1992 (74%). Their disapproval then fell through 
1997 (to 67%) before increasing in the last several years, to 80% in 2005. The 19- to 22-
year-olds showed a similar increase from 1982 (66%) to 1989 (76%), holding fairly level 
through 2004, followed by a significant increase to 82% in 2005. All four age strata showed 
some upward drift in their level of disapproval of smoking since about 1999, suggesting a 
secular change in these attitudes during this historical period.    
 
 
A FURTHER COMMENTARY: COHORT DIFFERENCES AND THEIR IMPLICATIONS 
FOR PREVENTION AND THEORY 
 
One theoretical point to be made—based on the strong evidence reported here for cohort effects in 
perceived risk and disapproval of many of the drugs under study—is that one cause for cohort 
effects in actual use is lasting cohort differences in these critical attitudes and beliefs. The attitudes 
and beliefs brought into adulthood from adolescence tend to persevere. 
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The second point has to do with the causes of the cohort effects in attitudes and beliefs. We noted 
earlier that the older respondents are more likely than the younger ones to see the use of marijuana, 
LSD, heroin, amphetamines, MDMA, ice, cocaine, crack, and sedatives (barbiturates) as 
dangerous. We have offered the framework for a theory of drug epidemics in which direct learning 
(from personal use) and vicarious learning (from observing use by others in both the immediate and 
mass media environments) play important roles in changing these key attitudes.47 To the extent that 
the data on perceived risk represent cohort effects (enduring differences between class cohorts), 
these findings would be consistent with this theoretical perspective. Clearly, use of these particular 
drugs was greater when the older cohorts were growing up, and public attention and concern 
regarding the consequences of these drugs were greatest in the 1970s and early 1980s. In the early 
1970s, LSD was alleged to cause brain damage and chromosomal damage, as well as bad trips, 
flashbacks, and behavior that could prove dangerous. Methamphetamine use was discouraged with 
the slogan “speed kills.” In addition, there was a serious epidemic of heroin use in the early 1970s. 
More recent cohorts in our study (through the mid-1990s, at least) were not exposed to those 
experiences. While there may have been a secular trend toward greater perceived risk for drugs in 
general, in the case of LSD there may also have been an operating cohort effect (with younger 
cohorts seeing less danger) offsetting the secular trend among 12th graders; the net effect was a 
decrease in 12th graders’ perceived risk of LSD use after 1980. 
This vicarious learning process has a very practical importance for national strategy for preventing 
future epidemics. As future cohorts of youth grow up with less opportunity for such vicarious 
learning, because fewer in their immediate social circles and fewer public role models are using  
these drugs and exhibiting the adverse consequences of use, these youth will have less opportunity to 
learn about the adverse consequences of these drugs in the normal course of growing up. Unless 
those hazards are convincingly communicated to them in other ways—for example, through school 
prevention programs, by their parents, and through the mass media, including public service 
advertising—they will become more susceptible to a new epidemic of use of the same or similar 
drugs. 
Volume I, the companion volume to the present one, reported an increase in use of several drugs in 
8th, 10th, and 12th grades in 1994 through 1997. This increase suggests that this form of 
“generational forgetting”—in which replacement cohorts lose some of the knowledge held by their 
predecessors and thus become more vulnerable to using drugs—may well have been taking place 
during those years. For the cohorts that follow such a rise in use, there is once again an increased 
opportunity for vicarious learning from the adverse experiences of those around them, but by that 
time members of affected cohorts have had to learn the hard way what consequences await those 
who become involved with the various drugs. 
 
                                                 
47Johnston, L. D. (1991). Toward a theory of drug epidemics. In L. Donohew, H. E. Sypher, & W. J. Bukoski (Eds.), Persuasive communication and 






Q.  How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they. . . 
Percentage saying “great risk” a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Try marijuana 18 10.0 13.0 11.5 12.7 14.7 14.8 15.1 18.4 19.0 23.6 23.1 27.1 24.5 21.9 19.5 16.3 15.6 14.9 16.7 15.7 13.7 15.3 16.1 16.1 15.9 16.1 +0.2
  once or twice  19-22 8.3 7.8 9.7 9.7 12.8 11.2 13.0 12.9 16.8 16.9 17.8 19.1 19.7 19.4 18.8 13.3 16.9 14.8 13.4 12.5 14.3 11.9 13.3 17.1 15.3 15.6 +0.3
23-26 9.6 10.0 12.4 14.5 16.0 14.0 17.7 14.0 15.0 13.0 15.0 15.8 18.5 15.1 16.7 16.4 13.1 13.0 15.1 15.3 13.6 13.0 -0.6
27-30 14.6 16.0 17.0 15.7 15.1 14.0 14.8 16.1 16.2 16.1 16.4 16.1 14.4 17.3 16.2 18.0 13.8 14.5 +0.7
Smoke marijuana  18 14.7 19.1 18.3 20.6 22.6 24.5 25.0 30.4 31.7 36.5 36.9 40.6 39.6 35.6 30.1 25.6 25.9 24.7 24.4 23.9 23.4 23.5 23.2 26.6 25.4 25.8 +0.  
  occasionally  19-22 13.9 14.2 16.9 16.7 21.7 20.6 22.4 23.0 28.7 29.1 30.1 30.2 29.5 30.3 31.3 25.5 25.6 22.0 22.0 19.8 25.8 18.0 21.0 24.1 23.2 24.3 +1.1
23-26 15.8 16.3 20.9 20.8 26.8 25.3 30.4 26.2 27.4 24.0 25.5 27.7 27.3 26.4 26.8 26.4 24.9 20.5 24.5 22.2 22.7 21.6 -1.1
27-30 24.2 25.7 28.7 27.4 27.5 26.8 28.1 28.3 28.1 26.0 25.8 25.3 25.8 25.0 30.2 27.9 25.1 24.8 -0.4
Smoke marijuana  18 50.4 57.6 60.4 62.8 66.9 70.4 71.3 73.5 77.0 77.5 77.8 78.6 76.5 72.5 65.0 60.8 59.9 58.1 58.5 57.4 58.3 57.4 53.0 54.9 54.6 58.0 +3.  
  regularly  19-22 43.9 47.8 52.4 58.4 62.2 66.8 67.6 69.4 72.4 74.9 73.0 75.0 69.3 69.2 65.0 62.1 61.3 60.7 53.4 55.2 58.0 49.6 56.7 57.8 57.2 55.3 -1.9
23-26 52.9 57.5 59.4 65.3 68.3 72.1 71.0 70.9 67.3 64.1 63.2 64.2 62.7 64.1 62.7 60.1 60.3 55.1 53.7 56.7 54.2 53.6 -0.6
27-30 67.5 69.1 69.2 67.5 68.8 69.4 65.6 69.2 67.3 65.0 63.6 66.1 64.0 61.7 63.5 64.7 59.3 57.0 -2.3
Try LSD once or twice  18 43.9 45.5 44.9 44.7 45.4 43.5 42.0 44.9 45.7 46.0 44.7 46.6 42.3 39.5 38.8 36.4 36.2 34.7 37.4 34.9 34.3 33.2 36.7 36.2 36.2 36.5 +0.  
19-22 44.8 44.4 45.0 44.7 46.0 44.3 47.6 49.4 49.2 49.5 49.3 48.0 45.6 42.4 42.3 40.3 44.4 40.1 38.7 38.1 37.9 37.5 35.3 39.7 39.2 38.7 -0.5
23-26 48.3 46.9 47.9 51.5 53.7 50.7 52.0 50.1 49.7 49.0 46.8 45.8 46.1 46.6 45.7 49.3 44.9 48.5 45.7 43.8 40.7 39.9 -0.8
27-30 53.3 55.6 54.6 52.5 53.0 51.5 53.5 52.5 50.1 52.0 52.0 49.9 46.4 46.7 44.9 47.5 47.2 47.9 +0.7
Take LSD regularly  18 83.0 83.5 83.5 83.2 83.8 82.9 82.6 83.8 84.2 84.3 84.5 84.3 81.8 79.4 79.1 78.1 77.8 76.6 76.5 76.1 75.9 74.1 73.9 72.3 70.2 69.9 -0.4
19-22 83.4 85.3 86.2 86.0 84.5 86.4 87.1 85.6 85.4 85.5 85.8 86.6 87.0 81.3 81.0 80.5 82.4 83.6 78.6 82.2 81.6 79.2 81.1 78.6 78.4 77.8 -0.6
23-26 89.0 86.6 88.7 90.0 89.2 89.0 88.2 89.1 87.3 85.3 87.5 86.3 84.7 85.6 82.1 85.4 84.1 86.0 85.3 84.3 83.5 80.8 -2.7
27-30 89.1 91.2 92.0 87.1 88.5 89.0 89.2 88.4 87.0 87.2 90.5 87.8 85.3 86.9 85.3 87.5 83.9 87.9 +4.0
Try PCP once or twice  18 55.6 58.8 56.6 55.2 51.7 54.8 50.8 51.5 49.1 51.0 48.8 46.8 44.8 45.0 46.2 48.3 45.2 47.1 46.6 -0.5
19-22 63.6 63.8  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
23-26 64.8 63.2  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
27-30 65.9  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
Try MDMA (ecstasy) 18 33.8 34.5 35.0 37.9 45.7 52.2 56.3 57.7 60.1 +2.  
  once or twice  19-22 45.2 47.1 48.8 46.4 45.0 51.1 48.3 46.7 45.5 42.7 37.6 37.9 40.5 46.8 50.1 52.3 53.8 +1.5
23-26 49.5 47.2 47.4 45.5 41.9 50.6 49.3 50.4 50.5 47.7 50.0 46.7 45.7 45.6 45.9 44.9 51.2 +6.3
27-30 44.9 48.7 47.7 44.2 51.7 47.3 50.0 50.6 48.8 50.4 50.9 48.9 53.6 52.0 58.8 49.1 50.2 +1.0
Try MDMA (ecstasy) 18  NA  NA  NA  NA  NA —
  occasionally  19-22 72.5 77.8 81.7 78.3 80.0 +1.7
23-26 72.5 71.9 73.6 77.4 77.2 -0.2
27-30 75.2 76.5 79.9 76.9 74.7 -2.3
Try cocaine 18 31.3 32.1 32.8 33.0 35.7 34.0 33.5 47.9 51.2 54.9 59.4 59.4 56.8 57.6 57.2 53.7 54.2 53.6 54.6 52.1 51.1 50.7 51.2 51.0 50.7 50.5 -0.2
  once or twice 19-22 31.4 30.4 33.3 28.7 33.1 33.2 35.5 45.9 51.9 51.5 58.1 58.7 56.1 60.5 63.8 57.7 61.9 55.5 55.4 52.8 56.7 48.9 55.5 55.0 55.5 55.6 +0.1
23-26 31.3 31.1 35.9 48.0 47.1 51.3 51.5 50.5 53.5 54.1 56.0 58.7 57.2 63.1 60.2 62.6 63.1 62.4 61.0 55.4 52.1 53.0 +0.9
27-30 45.3 53.0 51.6 52.6 51.8 54.7 53.5 56.4 53.6 54.6 60.5 61.7 59.9 60.9 58.8 56.4 61.4 56.5 -4.9
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Q.  How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they. . .
Percentage saying “great risk” a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Take cocaine occasionally 18 54.2 66.8 69.2 71.8 73.9 75.5 75.1 73.3 73.7 70.8 72.1 72.4 70.1 70.1 69.5 69.9 68.3 69.1 67.2 66.7 -0.5
19-22 53.8 61.3 67.1 72.6 74.6 72.6 74.9 75.4 78.0 73.4 76.6 76.1 71.2 68.0 72.4 70.0 69.9 70.3 70.2 72.1 +1.9
23-26 50.9 62.6 63.2 69.9 69.9 70.3 69.9 72.8 70.3 76.0 71.3 76.5 74.2 77.8 76.2 74.2 75.4 68.3 74.1 70.4 -3.7
27-30 62.6 66.6 66.6 69.1 69.9 69.1 69.9 70.0 67.8 73.8 73.2 75.4 76.5 78.1 74.3 72.6 75.3 76.2 +0.9
Take cocaine regularly  18 69.2 71.2 73.0 74.3 78.8 79.0 82.2 88.5 89.2 90.2 91.1 90.4 90.2 90.1 89.3 87.9 88.3 87.1 86.3 85.8 86.2 84.1 84.5 83.0 82.2 82.8 +0.6
19-22 65.2 69.3 71.5 75.2 75.1 82.9 82.0 88.0 90.3 89.1 93.9 93.5 92.9 91.7 92.2 91.5 92.2 91.6 88.7 88.5 90.7 85.1 88.3 87.4 87.1 89.2 +2.2
23-26 75.6 76.9 83.0 88.9 90.9 91.2 91.2 92.7 89.9 91.9 92.6 93.3 90.6 93.2 92.9 92.7 92.9 91.1 91.5 88.5 91.5 88.0 -3.5
27-30 88.9 92.0 91.4 90.9 92.0 91.6 92.1 91.3 91.6 92.7 93.0 92.4 92.3 94.5 91.2 92.9 91.3 94.0 +2.6
Try crack once or twice  18 57.0 62.1 62.9 64.3 60.6 62.4 57.6 58.4 54.6 56.0 54.0 52.2 48.2 48.4 49.4 50.8 47.3 47.8 48.4 +0.7
19-22 59.4 67.3 68.5 69.4 66.9 65.4 63.5 70.1 61.9 65.2 62.0 59.3 56.1 52.9 54.1 54.1 55.1 56.8 56.6 -0.3
23-26 59.1 63.5 69.8 67.3 66.9 67.1 64.2 69.3 64.8 68.6 64.7 67.3 64.6 63.2 59.8 60.9 58.5 56.4 60.6 +4.2
27-30 66.5 64.9 68.7 66.8 64.3 68.8 65.6 66.4 66.7 68.5 66.5 65.0 62.9 69.3 67.4 66.0 62.6 61.9 -0.7
Take crack occasionally  18 70.4 73.2 75.3 80.4 76.5 76.3 73.9 73.8 72.8 71.4 70.3 68.7 67.3 65.8 65.4 65.6 64.0 64.5 63.8 -0.7
19-22 75.0 77.3 81.8 82.3 82.7 81.9 83.6 84.3 78.8 83.5 79.1 79.1 75.5 74.9 72.3 75.3 75.3 76.0 75.0 -1.0
23-26 70.3 74.0 79.9 81.1 83.9 84.4 81.6 83.2 81.4 85.9 80.8 84.2 81.6 84.0 80.1 82.2 77.1 76.4 78.6 +2.2
27-30 76.4 76.7 82.6 81.8 79.1 83.6 78.6 81.1 81.3 85.3 81.7 79.8 81.6 84.4 81.5 81.9 82.1 79.5 -2.6
Take crack regularly  18 84.6 84.8 85.6 91.6 90.1 89.3 87.5 89.6 88.6 88.0 86.2 85.3 85.4 85.3 85.8 84.1 83.2 83.5 83.3 -0.2
19-22 89.6 91.1 94.1 94.9 95.6 93.4 96.2 96.0 94.2 94.7 93.3 92.8 92.3 91.1 89.6 91.1 93.8 93.3 92.5 -0.8
23-26 88.0 89.2 91.5 94.2 95.4 94.1 93.4 94.9 95.5 96.1 91.4 95.6 94.4 95.6 93.4 94.7 92.2 92.5 93.1 +0.6
27-30 89.6 89.5 95.3 94.4 93.3 93.5 93.0 94.0 94.3 96.0 94.3 95.2 93.5 96.8 94.2 94.4 94.0 95.2 +1.2
Try cocaine powder 18 45.3 51.7 53.8 53.9 53.6 57.1 53.2 55.4 52.0 53.2 51.4 48.5 46.1 47.0 49.0 49.5 46.2 45.4 46.2 +0.9
  once or twice 19-22 44.0 48.6 51.1 54.5 52.7 56.2 49.7 62.0 55.8 57.1 53.8 53.0 47.9 48.0 47.1 47.9 49.4 48.7 50.2 +1.6
23-26 41.0 43.6 48.4 48.9 47.4 45.9 45.6 52.5 48.9 57.2 53.6 54.1 53.8 53.2 53.9 52.5 50.8 46.0 53.3 +7. s
27-30 42.0 45.1 46.2 43.3 42.3 49.9 47.1 48.2 48.9 49.1 49.8 49.7 52.2 53.3 54.4 56.6 52.5 52.9 +0.4
Take cocaine powder 18 56.8 61.9 65.8 71.1 69.8 70.8 68.6 70.6 69.1 68.8 67.7 65.4 64.2 64.7 63.2 64.4 61.4 61.6 60.8 -0.8
  occasionally 19-22 58.0 59.0 63.2 70.0 69.9 72.6 70.6 75.4 73.0 77.4 70.7 73.0 69.3 69.3 64.4 68.9 69.3 68.6 68.1 -0.5
23-26 50.0 53.2 62.2 63.3 67.0 65.8 64.0 68.8 68.8 76.1 72.8 77.0 70.8 76.0 70.5 73.7 67.9 64.6 69.9 +5.4
27-30 53.6 52.7 60.9 59.2 61.2 64.3 61.0 65.9 68.2 69.7 68.5 70.1 71.3 73.5 71.9 71.7 71.5 71.7 +0.3
Take cocaine powder  18 81.4 82.9 83.9 90.2 88.9 88.4 87.0 88.6 87.8 86.8 86.0 84.1 84.6 85.5 84.4 84.2 82.3 81.7 82.7 +1.0
  regularly 19-22 86.6 87.6 91.3 92.5 93.8 92.1 94.0 94.9 93.5 93.8 92.8 91.5 92.4 90.7 89.8 91.0 92.0 91.6 90.7 -0.9
23-26 82.9 84.1 88.5 92.4 93.8 91.3 92.4 92.8 92.1 94.8 90.8 93.7 93.6 94.2 92.2 93.4 89.1 89.4 91.2 +1.7
27-30 85.1 86.7 92.7 91.1 91.5 92.5 90.7 92.7 91.7 93.0 92.3 93.1 91.5 94.0 93.3 94.1 93.1 93.9 +0.7
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Q.  How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they. . .
Percentage saying “great risk” a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Try heroin once or twice  18 52.1 52.9 51.1 50.8 49.8 47.3 45.8 53.6 54.0 53.8 55.4 55.2 50.9 50.7 52.8 50.9 52.5 56.7 57.8 56.0 54.2 55.6 56.0 58.0 56.6 55.2 -1.4
19-22 57.8 56.8 54.4 52.5 58.7 51.0 55.5 57.9 58.9 59.6 58.3 59.9 59.8 58.9 60.8 58.9 61.0 63.9 60.7 63.5 63.2 64.0 63.1 64.6 67.3 66.5 -0.8
23-26 58.2 59.2 60.8 66.6 65.4 62.3 64.1 62.4 63.7 65.0 63.3 64.1 63.5 67.3 67.3 68.0 70.7 71.9 69.8 70.6 67.5 69.2 +1.7
27-30 66.0 69.7 67.5 66.1 66.5 69.3 69.6 66.4 66.4 67.9 69.7 70.1 67.4 68.2 70.9 72.3 68.4 74.4 +5.9
Take heroin occasionally  18 70.9 72.2 69.8 71.8 70.7 69.8 68.2 74.6 73.8 75.5 76.6 74.9 74.2 72.0 72.1 71.0 74.8 76.3 76.9 77.3 74.6 75.9 76.6 78.5 75.7 76.0 +0.3
19-22 77.5 77.8 73.6 74.5 74.9 73.6 77.2 77.6 77.5 79.8 80.8 80.2 81.6 78.8 79.0 77.9 82.1 84.7 80.4 82.5 82.0 83.6 82.2 84.9 85.1 83.8 -1.3
23-26 81.2 80.7 78.9 84.5 82.4 80.8 83.4 84.4 81.5 82.1 80.8 85.3 82.4 86.5 83.9 88.5 86.6 88.4 90.0 88.3 86.7 87.5 +0.7
27-30 86.0 86.8 85.3 84.3 84.9 86.2 86.8 83.1 83.8 85.8 86.6 87.1 86.5 86.4 87.9 87.4 88.6 91.2 +2.6
Take heroin regularly  18 86.2 87.5 86.0 86.1 87.2 86.0 87.1 88.7 88.8 89.5 90.2 89.6 89.2 88.3 88.0 87.2 89.5 88.9 89.1 89.9 89.2 88.3 88.5 89.3 86.8 87.5 +0.  
19-22 87.2 89.9 87.5 88.6 86.8 90.2 90.7 90.2 89.6 90.8 91.2 91.5 92.2 89.2 91.2 89.9 94.0 93.7 92.4 92.8 94.0 91.3 92.6 93.9 94.3 94.9 +0.5
23-26 92.0 90.1 90.6 92.8 91.5 91.3 91.0 92.6 91.3 91.6 93.0 93.5 92.7 94.4 93.4 93.7 94.8 95.9 96.3 96.5 96.0 94.8 -1.2
27-30 92.7 93.5 93.0 90.7 91.3 92.6 93.8 92.4 92.1 93.8 95.0 93.7 94.2 94.5 95.9 94.9 95.0 97.3 +2.3
Try amphetamines  18 29.7 26.4 25.3 24.7 25.4 25.2 25.1 29.1 29.6 32.8 32.2 36.3 32.6 31.3 31.4 28.8 30.8 31.0 35.3 32.2 32.6 34.7 34.4 36.8 35.7 37.7 +2.0
  once or twice 19-22 24.6 24.6 27.8 24.8 26.9 23.9 27.1 27.4 31.7 28.9 35.6 32.8 34.5 33.3 36.3 32.9 36.8 30.1 31.7 33.7 35.0 34.2 38.1 40.2 36.8 38.3 +1.5
23-26 29.6 29.4 29.4 34.1 33.2 32.5 35.3 31.0 32.7 32.6 32.9 34.3 34.9 37.8 40.9 41.8 39.9 41.6 38.0 38.3 33.2 39.1 +5.9
27-30 35.2 37.5 36.9 36.5 36.2 34.0 37.5 36.0 36.2 34.5 37.6 36.3 39.4 38.5 39.0 40.5 39.2 38.2 -1.0
Take amphetamines 18 69.1 66.1 64.7 64.8 67.1 67.2 67.3 69.4 69.8 71.2 71.2 74.1 72.4 69.9 67.0 65.9 66.8 66.0 67.7 66.4 66.3 67.1 64.8 65.6 63.9 67.1 +3.2
  regularly 19-22 71.9 69.9 68.3 69.9 68.4 68.5 72.3 72.0 73.9 71.3 74.0 77.1 73.5 73.5 71.6 72.2 75.8 72.3 71.9 72.4 73.4 71.1 72.7 75.0 72.4 74.1 +1.7
23-26 75.8 77.2 75.6 78.2 77.4 76.7 77.8 79.4 76.4 76.2 73.6 80.5 78.5 79.1 77.5 78.7 79.0 77.7 77.9 80.1 75.1 80.1 +5.0
27-30 80.6 82.9 83.3 79.4 80.3 79.8 78.4 77.7 75.6 77.4 81.1 82.6 80.8 79.9 79.8 81.5 77.6 78.9 +1.3
Try crystal meth (ice) 18 61.6 61.9 57.5 58.3 54.4 55.3 54.4 52.7 51.2 51.3 52.7 53.8 51.2 52.4 54.6 +2.3
19-22 57.8 58.6 57.7 57.5 61.4 58.9 61.1 56.4 55.8 50.6 49.2 52.5 56.5 60.0 60.3 63.1 +2.8
23-26 56.5 56.0 55.6 52.0 61.0 57.8 64.1 60.7 58.2 61.3 60.1 59.2 57.7 58.6 55.9 63.9 +8. s
27-30 59.6 57.2 52.7 60.3 57.9 58.5 59.1 59.8 59.9 61.0 59.7 66.4 62.5 66.6 62.8 62.6 -0.2
Try sedatives/barbituratesb 18 30.9 28.4 27.5 27.0 27.4 26.1 25.4 30.9 29.7 32.2 32.4 35.1 32.2 29.2 29.9 26.3 29.1 26.9 29.0 26.1 25.0 25.7 26.2 27.9 24.9 24.7 -0.2
  once or twice 19-22 27.6 26.4 30.5 25.4 29.9 25.0 30.7 29.6 32.7 30.5 36.4 33.5 33.5 33.4 35.0 30.5 34.1 31.4 27.7 28.5 30.3 30.0 30.7 32.7 26.7 26.9 +0.2
23-26 32.2 29.9 30.2 35.5 35.8 32.9 37.9 31.8 33.5 32.8 34.0 34.8 35.8 37.3 40.3 39.4 37.0 38.5 34.7 36.5 22.2 29.8 +7. s
27-30 37.2 38.7 39.0 37.0 38.2 36.5 40.5 36.6 37.2 35.7 36.7 35.2 36.3 40.9 37.3 38.6 31.4 31.7 +0.3
Take sedatives/barbituratesb 18 72.2 69.9 67.6 67.7 68.5 68.3 67.2 69.4 69.6 70.5 70.2 70.5 70.2 66.1 63.3 61.6 60.4 56.8 56.3 54.1 52.3 50.3 49.3 49.6 54.0 54.1 +0.1
  regularly 19-22 74.0 73.3 72.7 71.3 71.6 71.7 74.5 73.0 74.0 71.7 75.5 75.5 73.6 71.1 69.4 66.4 70.7 69.5 65.1 64.7 64.6 61.8 64.5 63.8 60.2 64.4 +4.1
23-26 77.4 77.0 74.9 79.9 79.8 76.6 80.5 77.7 76.3 75.0 74.3 77.6 77.1 75.2 73.9 75.1 73.8 73.1 73.1 72.8 63.9 67.0 +3.2
27-30 81.5 83.7 84.0 79.6 78.6 80.2 78.3 77.7 74.1 77.1 79.9 80.7 75.5 78.2 75.4 79.0 70.1 75.2 +5.1
TABLE 6-1 (cont.)
Trends in Perceived Harmfulness of Drugs
High School Seniors (Age 18) and Young Adults in Modal Age Groups of 19-22, 23-26, and 27-30
(Table continued on next page)
186
e
Q.  How much do you think 
people risk harming 
themselves (physically or in 
other ways), if they. . .
Percentage saying “great risk” a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Try one or two drinks of an  18 3.8 4.6 3.5 4.2 4.6 5.0 4.6 6.2 6.0 6.0 8.3 9.1 8.6 8.2 7.6 5.9 7.3 6.7 8.0 8.3 6.4 8.7 7.6 8.4 8.6 8.5 -0.1  
  alcoholic beverage 19-22 3.0 3.4 3.1 2.3 4.7 3.1 5.4 3.5 3.9 5.9 6.1 5.4 5.8 6.6 6.5 4.5 3.3 3.2 4.2 5.7 5.4 4.8 6.6 7.5 5.1 3.8 -1.4
  (beer, wine, liquor) 23-26 5.5 3.0 6.5 6.6 4.2 5.1 5.7 4.4 5.6 3.2 4.5 4.3 4.8 4.4 4.4 6.6 3.5 5.5 5.1 5.7 4.7 5.3 +0.6
27-30 5.0 6.3 4.4 6.6 5.6 4.7 4.1 6.7 4.7 4.0 6.2 5.9 4.7 5.5 3.1 6.9 4.6 7.3 +2.7
Take one or two drinks nearly 18 20.3 21.6 21.6 21.6 23.0 24.4 25.1 26.2 27.3 28.5 31.3 32.7 30.6 28.2 27.0 24.8 25.1 24.8 24.3 21.8 21.7 23.4 21.0 20.1 23.0 23.7 +0.7  
  every day 19-22 22.7 22.9 23.2 23.2 25.0 26.3 27.3 26.1 26.5 28.1 30.1 29.1 30.2 28.0 27.5 24.0 23.0 24.2 22.1 23.9 22.1 19.6 22.7 19.8 21.3 22.1 +0.9
23-26 27.8 27.4 26.9 30.2 29.1 27.8 31.1 30.4 31.6 25.9 26.2 26.1 22.0 20.2 21.0 26.0 21.7 23.5 23.4 19.1 22.9 19.9 -2.9
27-30 27.4 31.7 32.2 31.7 30.9 28.0 27.4 27.2 24.0 24.8 20.8 25.3 22.0 22.7 21.7 21.4 21.8 23.7 +1.9
Take four or five drinks nearly 18 65.7 64.5 65.5 66.8 68.4 69.8 66.5 69.7 68.5 69.8 70.9 69.5 70.5 67.8 66.2 62.8 65.6 63.0 62.1 61.1 59.9 60.7 58.8 57.8 59.2 61.8 +2.6
  every day 19-22 71.2 72.7 73.3 72.7 76.2 74.1 74.0 76.4 72.8 75.7 76.1 75.5 71.8 72.1 70.3 72.5 68.5 71.4 70.4 69.9 69.9 64.5 71.1 66.4 65.3 63.0 -2.2
23-26 76.7 77.9 80.1 77.2 81.8 76.9 79.7 80.2 78.0 76.7 77.5 75.2 72.0 75.1 69.3 72.8 71.7 75.8 74.9 71.1 74.2 71.2 -3.0
27-30 79.3 81.7 84.7 79.1 79.9 79.1 76.6 82.2 76.1 79.3 75.7 75.1 77.4 72.8 76.2 70.6 72.1 77.5 +5.4
Have five or more drinks onc 18 35.9 36.3 36.0 38.6 41.7 43.0 39.1 41.9 42.6 44.0 47.1 48.6 49.0 48.3 46.5 45.2 49.5 43.0 42.8 43.1 42.7 43.6 42.2 43.5 43.6 45.0 +1.4
  or twice each weekend 19-22 34.2 30.1 33.5 36.6 37.9 40.2 34.6 36.7 36.9 42.4 40.6 40.8 41.8 42.4 41.9 39.9 40.7 36.6 42.0 37.2 38.9 37.2 37.8 40.4 38.1 37.5 -0.6
23-26 38.4 39.7 39.1 39.8 35.8 37.7 40.2 39.3 37.6 36.2 40.2 37.9 39.1 37.4 41.1 40.2 34.9 39.0 36.8 36.3 37.9 36.8 -1.1
27-30 41.0 42.3 44.1 42.2 45.1 42.9 43.2 44.6 41.5 40.0 40.2 41.9 37.9 41.6 40.6 42.5 40.5 44.0 +3.5
Smoke one or more packs of 18 63.7 63.3 60.5 61.2 63.8 66.5 66.0 68.6 68.0 67.2 68.2 69.4 69.2 69.5 67.6 65.6 68.2 68.7 70.8 70.8 73.1 73.3 74.2 72.1 74.0 76.5 +2.5
  cigarettes per day 19-22 66.5 61.7 64.0 62.1 69.1 71.4 70.4 70.6 71.0 73.4 72.5 77.9 72.6 76.0 71.2 71.6 73.8 76.3 77.2 75.7 77.1 76.6 80.6 77.8 81.1 80.5 -0.6
23-26 71.1 70.1 75.7 73.6 75.5 71.4 78.5 75.3 76.3 78.4 76.4 76.0 76.0 77.6 76.5 80.9 79.7 83.9 85.1 83.6 84.1 81.6 -2.5
27-30 72.8 75.2 77.8 75.4 77.6 75.0 75.3 75.6 73.0 80.3 80.9 80.7 78.4 82.7 80.6 82.0 81.7 84.1 +2.4
Use smokeless tobacco 18 25.8 30.0 33.2 32.9 34.2 37.4 35.5 38.9 36.6 33.2 37.4 38.6 40.9 41.1 42.2 45.4 42.6 43.3 45.0 43.6 -1.4
  regularly 19-22 29.7 34.1 31.1 37.1 33.5 38.9 40.1 43.3 37.6 42.3 40.9 46.5 47.4 47.0 52.0 48.4 53.6 50.8 49.9 47.6 -2.2
23-26 37.0 38.5 35.8 37.9 40.1 38.9 41.6 44.6 42.9 46.6 47.2 46.2 48.4 53.1 49.8 59.8 61.4 58.9 57.8 55.8 -2.0
27-30 42.8 42.8 43.8 44.3 44.1 47.3 46.3 44.2 43.6 50.2 52.6 53.6 49.9 53.2 56.7 58.2 55.7 58.9 +3.3
Approximate Weighted  N= 18 3234 3604 3557 3305 3262 3250 3020 3315 3276 2796 2553 2549 2684 2759 2591 2603 2449 2579 2564 2306 2130 2173 2198 2466 2491 2512
19-22 590 585 583 585 579 547 581 570 551 565 552 533 527 480 490 500 469 464 431 447 424 430 395 402 447 412
23-26 540 512 545 531 527 498 511 505 518 503 465 446 438 420 413 418 400 392 382 401 426 408
27-30 513 587 490 486 482 473 443 450 422 434 416 400 377 384 369 380 388 374
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05,  ss = .01,  sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding.
'NA' indicates data not available.
aAnswer alternatives were:  (1) No risk, (2) Slight risk, (3) Moderate risk, (4) Great risk, and (5) Can't say, drug unfamiliar.
bIn 2004 the question text was changed from "barbiturates" to "sedatives/barbiturates" and the list of examples was changed from "downers, goofballs, reds, yellows, etc." to just "downers." These 
changes likely explain the discontinuity in the 2003 and 2004 results.
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Q.  Do you disapprove of 
people (who are 18 or 




Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Try marijuana 18 39.0 40.0 45.5 46.3 49.3 51.4 54.6 56.6 60.8 64.6 67.8 68.7 69.9 63.3 57.6 56.7 52.5 51.0 51.6 48.8 52.5 49.1 51.6 53.4 52.7 55.0 +2.3
  once or twice 19-22 38.2 36.1 37.0 42.0 44.1 46.6 51.6 52.8 55.8 62.4 59.6 60.4 57.8 60.6 63.5 57.1 55.4 56.2 55.9 54.0 55.2 49.3 48.7 54.2 48.3 50.3 +1.9
23-26 41.2 38.6 42.6 49.1 48.7 52.5 57.5 58.8 55.0 54.6 52.3 51.9 56.3 54.5 55.3 55.7 54.8 51.2 52.4 47.8 53.4 47.7 -5.7
27-30 49.0 50.9 53.8 54.6 51.9 56.8 55.7 57.5 54.1 59.0 55.7 52.6 58.0 54.4 56.9 54.9 55.4 52.1 -3.3
Smoke marijuana  18 49.7 52.6 59.1 60.7 63.5 65.8 69.0 71.6 74.0 77.2 80.5 79.4 79.7 75.5 68.9 66.7 62.9 63.2 64.4 62.5 65.8 63.2 63.4 64.2 65.4 67.8 +2.4
  occasionally 19-22 49.6 49.1 51.3 56.0 60.4 62.6 66.7 67.2 69.5 77.3 76.3 77.0 74.8 75.8 76.9 70.4 68.9 70.2 67.8 66.4 70.7 64.6 62.3 68.0 64.3 67.9 +3.7
23-26 54.8 52.8 57.0 64.9 63.4 69.4 73.7 73.3 74.0 71.9 70.9 68.1 72.5 69.2 70.4 71.1 68.6 67.4 64.0 63.8 69.3 65.6 -3.7
27-30 65.3 67.1 68.9 73.0 67.2 72.2 69.4 72.5 70.5 74.5 72.4 71.5 72.2 70.9 69.1 71.2 69.1 68.2 -0.9
Smoke marijuana  18 74.6 77.4 80.6 82.5 84.7 85.5 86.6 89.2 89.3 89.8 91.0 89.3 90.1 87.6 82.3 81.9 80.0 78.8 81.2 78.6 79.7 79.3 78.3 78.7 80.7 82.0 +1.3
  regularly 19-22 74.3 77.2 80.0 81.8 84.9 86.7 89.2 88.7 89.1 91.2 93.1 91.3 89.5 90.2 90.1 86.8 87.7 88.1 85.3 84.5 86.6 84.5 82.8 84.8 82.7 84.4 +1.7
23-26 80.6 81.3 83.3 87.4 86.9 90.4 91.0 89.6 90.2 92.1 90.3 90.1 88.9 88.1 87.5 86.1 83.9 86.4 81.7 82.3 87.4 84.3 -3.1
27-30 87.6 87.5 89.7 89.6 87.2 89.4 88.7 91.9 89.9 92.1 89.2 90.0 89.5 89.3 88.8 87.7 88.6 86.3 -2.4
Try LSD once or twice 18 87.3 86.4 88.8 89.1 88.9 89.5 89.2 91.6 89.8 89.7 89.8 90.1 88.1 85.9 82.5 81.1 79.6 80.5 82.1 83.0 82.4 81.8 84.6 85.5 87.9 87.9 0.  
19-22 87.4 84.8 85.9 88.4 88.1 89.1 90.4 90.0 90.9 89.3 90.5 88.4 84.6 88.5 86.8 84.2 83.0 83.1 80.8 83.2 82.3 81.4 83.7 86.2 85.0 87.6 +2.6
23-26 87.3 87.1 88.0 89.9 91.4 91.0 90.7 89.1 88.8 86.9 87.3 87.1 86.7 87.9 84.1 84.8 80.3 83.0 79.2 80.1 84.0 84.0 +0.1
27-30 91.0 87.2 89.7 87.9 85.6 88.8 88.2 87.4 88.7 88.7 87.3 86.6 87.2 85.7 82.7 85.6 82.5 82.2 -0.3
Take LSD regularly 18 96.7 96.8 96.7 97.0 96.8 97.0 96.6 97.8 96.4 96.4 96.3 96.4 95.5 95.8 94.3 92.5 93.2 92.9 93.5 94.3 94.2 94.0 94.0 94.4 94.6 95.6 +1.0
19-22 98.2 97.4 97.7 97.6 97.6 98.8 98.5 98.0 98.1 97.5 99.1 97.5 97.0 97.8 97.7 96.8 97.0 97.4 96.3 97.0 96.8 96.5 96.9 98.4 97.3 98.9 +1.5
23-26 99.2 98.0 98.5 99.0 98.0 98.4 98.3 98.4 98.3 98.1 97.7 96.7 97.7 96.1 97.6 98.0 97.0 97.1 97.9 96.9 97.1 98.7 +1.7
27-30 98.8 97.1 98.9 98.9 97.5 98.5 98.7 98.6 98.1 97.5 97.4 97.9 98.6 98.2 98.0 98.2 98.2 97.2 -1.0
Try MDMA (ecstasy) 18 82.2 82.5 82.1 81.0 79.5 83.6 84.7 87.7 88.4 +0.  
  once or twice 19-22 81.5 80.3 87.2 83.5 90.3 +6. ss
23-26 80.6 80.6 80.2 83.1 83.9 +0.8
27-30 84.2 84.0 86.3 83.2 82.4 -0.8
Try MDMA (ecstasy) 18  NA  NA  NA  NA  NA —
  occasionally 19-22 92.8 91.8 95.6 93.8 96.7 +2.9 s
23-26 90.5 91.8 92.1 93.3 94.4 +1.2
27-30 91.7 93.0 94.3 91.0 92.1 +1.1
Try cocaine once or twice 18 76.3 74.6 76.6 77.0 79.7 79.3 80.2 87.3 89.1 90.5 91.5 93.6 93.0 92.7 91.6 90.3 90.0 88.0 89.5 89.1 88.2 88.1 89.0 89.3 88.6 88.9 +0.3
19-22 73.0 69.3 69.9 74.1 72.5 77.6 78.9 82.3 85.3 88.8 90.1 91.2 90.6 92.7 93.9 94.2 92.0 91.7 89.9 90.9 89.9 87.7 87.9 89.3 87.7 92.3 +4. s
23-26 70.2 70.5 72.1 80.0 82.9 85.5 88.3 88.0 87.3 89.2 89.2 91.8 90.7 91.5 89.0 91.3 87.1 90.1 85.8 86.4 87.4 88.3 +0.9
27-30 82.1 81.0 85.5 86.9 83.9 85.7 86.6 86.6 88.3 89.2 90.3 90.4 89.4 90.3 88.5 91.5 88.0 87.0 -1.0
Take cocaine regularly 18 91.1 90.7 91.5 93.2 94.5 93.8 94.3 96.7 96.2 96.4 96.7 97.3 96.9 97.5 96.6 96.1 95.6 96.0 95.6 94.9 95.5 94.9 95.0 95.8 95.4 96.0 +0.6
19-22 91.6 89.3 91.9 94.6 95.0 96.3 97.0 97.2 97.9 97.4 98.9 97.9 98.4 97.8 98.8 98.2 97.9 98.0 97.8 97.6 98.0 97.2 97.0 98.2 98.5 98.7 +0.2
23-26 95.7 95.3 97.3 98.1 97.6 98.3 98.4 98.5 98.7 98.4 98.8 97.7 97.8 96.9 98.5 98.3 97.8 97.5 97.5 97.6 98.1 98.9 +0.7
27-30 98.1 97.0 99.3 99.0 97.2 98.7 99.0 98.9 98.5 97.9 97.8 98.8 98.7 98.4 97.8 98.8 98.8 97.8 -1.0
TABLE 6-2
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Q.  Do you disapprove of 
people (who are 18 or 




Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Try heroin once or twice 18 93.5 93.5 94.6 94.3 94.0 94.0 93.3 96.2 95.0 95.4 95.1 96.0 94.9 94.4 93.2 92.8 92.1 92.3 93.7 93.5 93.0 93.1 94.1 94.1 94.2 94.3 0.0
19-22 96.3 95.4 95.6 95.2 95.1 96.2 96.8 96.3 97.1 96.4 98.3 95.9 95.9 96.3 96.6 95.6 95.2 95.6 95.1 95.5 94.1 94.2 95.0 96.4 95.9 98.8 +2. s
23-26 96.7 94.9 96.4 97.1 97.4 96.7 96.8 96.9 96.3 95.4 96.5 95.9 96.1 95.2 94.6 96.3 93.1 95.0 94.8 95.0 95.0 96.1 +1.1
27-30 97.9 95.8 97.5 96.6 94.8 97.3 94.7 96.3 96.0 96.9 95.9 96.7 95.9 96.4 94.4 97.6 94.9 95.6 +0.6
Take heroin occasionally  18 96.7 97.2 96.9 96.9 97.1 96.8 96.6 97.9 96.9 97.2 96.7 97.3 96.8 97.0 96.2 95.7 95.0 95.4 96.1 95.7 96.0 95.4 95.6 95.9 96.4 96.3 -0.1
19-22 98.6 97.8 98.3 98.3 98.6 98.7 98.3 98.3 98.3 97.9 99.2 98.2 98.1 98.1 98.3 97.7 97.9 97.8 98.2 97.2 98.0 97.9 97.9 98.3 98.9 99.4 +0.5
23-26 99.2 98.2 98.8 99.1 98.4 98.3 98.1 99.0 98.7 98.4 98.6 97.7 98.7 97.4 97.5 98.5 98.2 97.8 97.5 97.2 98.5 98.3 -0.2
27-30 99.2 97.3 99.0 98.9 97.0 98.9 98.7 98.9 98.0 98.7 97.6 98.8 98.6 98.4 98.6 98.7 98.1 97.7 -0.3
Take heroin regularly  18 97.6 97.8 97.5 97.7 98.0 97.6 97.6 98.1 97.2 97.4 97.5 97.8 97.2 97.5 97.1 96.4 96.3 96.4 96.6 96.4 96.6 96.2 96.2 97.1 97.1 96.7 -0.4
19-22 99.2 98.5 98.6 98.7 98.7 99.1 98.9 98.6 98.4 98.3 99.5 98.5 98.3 98.4 98.8 98.4 98.3 98.1 98.3 98.2 98.5 98.2 98.3 98.8 99.0 99.2 +0.2
23-26 99.4 98.8 99.1 99.4 98.7 98.7 98.5 99.3 99.2 98.9 98.8 98.7 98.9 97.6 98.5 98.7 98.8 98.4 98.3 98.6 98.9 98.9 0.0
27-30 99.4 97.6 99.4 99.0 97.8 99.0 99.4 99.1 98.6 98.4 98.1 98.8 98.7 98.7 98.4 99.3 98.8 99.1 +0.2
Try amphetamines 18 75.4 71.1 72.6 72.3 72.8 74.9 76.5 80.7 82.5 83.3 85.3 86.5 86.9 84.2 81.3 82.2 79.9 81.3 82.5 81.9 82.1 82.3 83.8 85.8 84.1 86.1 +2.0
  once or twice 19-22 74.5 70.5 68.9 74.0 73.0 75.6 78.9 79.9 81.8 85.3 84.4 83.9 83.8 87.2 88.3 85.0 84.4 83.3 84.6 84.9 83.8 82.1 81.4 86.3 82.1 88.2 +6.1 s
23-26 74.2 74.2 74.6 80.3 83.5 83.3 84.1 84.8 83.4 84.8 82.7 86.0 86.4 85.7 83.5 84.5 82.4 83.9 83.5 79.9 81.6 81.3 -0.3
27-30 83.5 81.0 84.3 83.7 80.9 83.5 82.0 83.1 85.8 86.3 85.9 86.4 84.5 86.0 86.4 84.9 82.4 81.3 -1.1
Take amphetamines 18 93.0 91.7 92.0 92.6 93.6 93.3 93.5 95.4 94.2 94.2 95.5 96.0 95.6 96.0 94.1 94.3 93.5 94.3 94.0 93.7 94.1 93.4 93.5 94.0 93.9 94.8 +0.9
  regularly 19-22 94.8 93.3 94.3 93.4 94.9 96.6 96.9 95.1 97.5 96.8 97.5 97.7 96.7 97.3 97.9 96.8 97.2 97.8 96.7 97.5 96.1 97.3 96.4 97.1 97.1 98.4 +1.3
23-26 96.6 95.9 96.6 97.0 97.2 98.1 97.9 97.9 97.7 98.4 97.7 97.0 97.9 97.0 98.0 97.0 97.6 96.8 96.3 97.2 95.9 98.3 +2.  
27-30 98.1 96.5 98.6 97.8 96.8 97.7 99.0 98.9 98.2 98.1 97.7 98.2 98.5 97.6 97.4 98.1 98.0 97.6 -0.4
Try sedatives/barbituratesb 18 83.9 82.4 84.4 83.1 84.1 84.9 86.8 89.6 89.4 89.3 90.5 90.6 90.3 89.7 87.5 87.3 84.9 86.4 86.0 86.6 85.9 85.9 86.6 87.8 83.7 85.4 +1.7
  once or twice 19-22 83.5 82.3 83.8 85.1 85.2 86.1 88.3 87.5 90.1 92.0 91.1 90.4 88.8 90.7 91.1 90.5 89.1 86.6 85.8 86.6 84.2 85.2 84.2 87.7 81.8 86.6 +4.9
23-26 84 84.5 84.4 89.8 90.7 89.4 88.8 87.9 88.8 88.5 88.0 89.3 88.3 88.3 87.4 87.3 85.2 86.9 86.8 81.8 80.3 81.6 +1.3
27-30 90.5 88.3 88.4 88.8 86.6 88.9 87.6 88.0 89.4 88.8 88.4 87.6 87.3 88.5 86.9 89.2 81.8 78.7 -3.1
Take sedatives/ 18 95.4 94.2 94.4 95.1 95.1 95.5 94.9 96.4 95.3 95.3 96.4 97.1 96.5 97.0 96.1 95.2 94.8 95.3 94.6 94.7 95.2 94.5 94.7 94.4 94.2 95.2 +1.0
   barbituratesb 19-22 96.6 95.6 97.3 96.5 96.6 98.1 98.0 97.0 97.9 97.7 98.7 98.0 97.9 98.2 98.7 97.7 97.9 97.7 97.7 97.3 97.4 96.9 97.8 98.5 96.6 98.3 +1.7
   regularly 23-26 98.4 98.5 97.7 98.6 98.3 98.3 98.5 98.5 98.6 98.5 98.5 97.4 98.4 97.4 98.5 97.6 97.4 97.0 97.1 97.1 96.1 98.0 +2.0
27-30 98.4 97.1 99.1 98.5 97.7 98.4 99.1 99.0 98.5 97.9 97.7 98.5 98.1 98.4 97.2 98.4 98.1 96.5 -1.7
Try one or two drinks of  18 16.0 17.2 18.2 18.4 17.4 20.3 20.9 21.4 22.6 27.3 29.4 29.8 33.0 30.1 28.4 27.3 26.5 26.1 24.5 24.6 25.2 26.6 26.3 27.2 26.0 26.4 +0.4
  an alcoholic beverage 19-22 14.8 14.5 13.9 15.5 15.3 15.4 16.9 16.0 18.4 22.4 17.6 22.2 16.9 20.8 22.2 22.0 22.0 18.3 21.5 18.3 18.4 16.3 18.3 20.1 20.7 22.3 +1.6
  (beer, wine, liquor) 23-26 17.4 16.1 13.2 17.7 13.7 17.5 18.6 19.5 17.4 18.1 17.6 16.5 18.0 15.8 18.6 19.1 19.9 15.9 18.1 13.0 16.3 13.5 -2.8
27-30 19.5 19.1 18.7 18.8 17.9 19.5 18.6 18.2 16.1 17.4 15.2 15.9 14.8 15.9 18.4 15.4 18.8 16.1 -2.7
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Q.  Do you disapprove of 
people (who are 18 or 




Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Take one or two drinks  18 69.0 69.1 69.9 68.9 72.9 70.9 72.8 74.2 75.0 76.5 77.9 76.5 75.9 77.8 73.1 73.3 70.8 70.0 69.4 67.2 70.0 69.2 69.1 68.9 69.5 70.8 +1.3
  nearly every day 19-22 67.8 69.7 71.3 73.3 74.3 71.3 77.4 75.3 76.5 80.0 79.7 77.1 76.0 75.0 78.0 74.7 73.5 73.2 70.3 67.3 66.7 68.3 63.9 66.9 68.1 64.6 -3.6
23-26 71.4 73.7 71.6 72.7 74.6 74.4 77.6 76.9 75.5 74.2 73.3 69.7 70.6 68.4 70.2 73.4 66.3 66.5 62.7 65.0 61.7 64.4 +2.7
27-30 76.0 73.9 73.3 76.1 69.5 73.5 72.4 71.8 71.4 71.8 69.8 67.9 65.9 68.9 70.9 63.1 66.7 60.5 -6.2
Take four or five drinks 18 90.8 91.8 90.9 90.0 91.0 92.0 91.4 92.2 92.8 91.6 91.9 90.6 90.8 90.6 89.8 88.8 89.4 88.6 86.7 86.9 88.4 86.4 87.5 86.3 87.8 89.4 +1.6
  nearly every day 19-22 95.2 93.4 94.6 94.6 94.6 94.8 94.9 95.7 94.8 96.1 95.8 96.4 95.5 95.1 96.2 95.5 94.2 93.9 92.4 92.4 92.8 94.2 92.6 92.5 92.2 93.2 +1.1
23-26 96.2 95.0 95.5 96.9 94.3 95.9 96.9 96.1 95.7 95.7 95.7 95.2 96.5 93.8 96.1 95.1 94.3 93.5 93.7 92.6 93.1 94.8 +1.8
27-30 97.4 94.6 96.1 95.3 94.8 94.8 96.4 96.7 96.4 96.2 95.0 97.2 95.3 96.1 95.4 95.6 96.0 92.8 -3.2
Have five or more drinks 18 55.6 55.5 58.8 56.6 59.6 60.4 62.4 62.0 65.3 66.5 68.9 67.4 70.7 70.1 65.1 66.7 64.7 65.0 63.8 62.7 65.2 62.9 64.7 64.2 65.7 66.5 +0.8
  once or twice 19-22 57.1 56.1 58.2 61.0 59.7 59.4 60.3 61.6 64.1 66.3 67.1 62.4 65.6 63.5 68.1 66.0 69.2 66.5 63.2 63.5 65.1 58.3 57.5 61.9 59.4 60.1 +0.7
  each weekend 23-26 66.2 68.3 66.5 67.5 65.2 63.2 66.9 64.6 69.6 66.8 66.9 65.3 70.9 66.6 69.5 68.1 66.2 66.0 61.2 65.5 60.9 64.5 +3.7
27-30 73.9 71.4 73.1 72.1 68.4 73.4 73.5 73.7 72.4 73.0 71.1 73.1 73.1 73.0 70.9 71.5 73.8 67.5 -6.2
Smoke one or more packs 18 70.8 69.9 69.4 70.8 73.0 72.3 75.4 74.3 73.1 72.4 72.8 71.4 73.5 70.6 69.8 68.2 67.2 67.1 68.8 69.5 70.1 71.6 73.6 74.8 76.2 79.8 +3.6 s
  of  cigarettes per day 19-22 68.7 68.1 66.3 71.6 69.0 70.5 71.4 72.7 73.8 75.6 73.7 73.2 72.6 72.8 75.3 69.8 72.2 74.3 72.3 70.1 73.1 73.2 73.4 73.4 74.8 81.5 +6.7 s
23-26 69.9 68.7 67.5 69.7 66.4 71.1 71.5 77.2 73.6 72.9 70.3 72.2 73.0 71.7 73.9 73.8 72.7 77.3 74.8 75.7 76.2 74.8 -1.4
27-30 72.8 69.4 73.5 71.2 70.7 73.8 72.3 73.9 72.7 74.3 71.7 71.0 78.6 75.2 78.8 76.2 77.6 77.3 -0.4
Approximate Wtd.  N= 18 3261 3610 3651 3341 3254 3265 3113 3302 3311 2799 2566 2547 2645 2723 2588 2603 2399 2601 2545 2310 2150 2144 2160 2442 2455 2460
19-22 588 573 605 579 586 551 605 587 560 567 569 533 530 489 474 465 480 470 446 449 416 413 402 396 431 378
23-26 542 535 560 532 538 516 524 495 538 514 475 466 449 423 401 397 389 404 346 385 403 374
27-30 526 509 513 485 512 462 442 450 430 453 449 429 395 368 359 346 370 367
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05,  ss = .01,  sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most  recent years is due to rounding.
'NA' indicates data not available.
aAnswer alternatives were: (1) Don't disapprove, (2) Disapprove, and (3) Strongly disapprove.  Percentages are shown for categories (2) and (3) combined.
bIn 2004 the question text was changed from "barbiturates" to "sedatives/barbiturates" and the list of examples was changed from "downers, goofballs, reds, yellows, etc." to just "downers." These 
changes likely explain the discontinuity in the 2003 and 2004 results.
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THE SOCIAL MILIEU FOR ADULTS 
 
 
The individual’s social environment can influence their likelihood of using drugs in a number of 
ways. It can bring about an awareness of new drugs (knowledge of their existence and potential for 
altering mood and consciousness) and provide the social norms for the individual regarding drug 
use. It can also provide social modeling of either use, or abstention from use, and influence the 
availability of drugs (through friends and friends’ contacts). Since its inception, this study has 
measured three important features of the social environment: (1) peer groups’ norms about drug use, 
(2) the amount of direct exposure to use of the various drugs through friends and others, and (3) the 
perceived availability of the various drugs. All three factors are measured by self-reports and are, 
therefore, measures of the perceived environment, though they clearly bear a strong correlation with 
the actual environment. We believe that these three factors are important influences on substance 
use, at both the individual (micro) level and the aggregate (macro) level. In Volume I, we examined 
these factors among secondary school students. In this chapter, we examine them for the young (and 
sometimes middle) adult population, whose social environments for the large majority differ 
considerably from what they were in high school. Most high school graduates today enter college, a 
good number get civilian jobs, and some enter military service. These transitions almost always 
change the circles of people to whom young adults are exposed and with whom they develop 
friendships.  
Each of the question sets discussed here is contained in only one of the six questionnaire forms, so 
the case counts are lower than those presented in most chapters in this volume. (Also, in comparison 
to the secondary school samples covered in Volume I, follow-up samples are necessarily much 
smaller.) Therefore, the prevalence and trend estimates are more subject to fluctuation due to 
relatively greater sampling error. 
 
PEER NORMS AS PERCEIVED BY ADULTS 
 
Table 7-1 provides current levels and trends in perceived friends’ disapproval of drug use among 
12th graders, 19- to 22-year-olds, 23- to 26-year-olds, and 27- to 30-year-olds. (These are the same 
age groupings used in chapter 6.) Trend data are available since 1980, 1984, and 1988, respectively, 
for these three four-year age groupings. 
The questions regarding friends’ disapproval include the same answer scale (stated in terms of 
disapproval rates associated with different use levels of the various drugs) as the questions that ask 
about the respondents’ own attitudes about those behaviors (discussed in chapter 6). The list of drug-
using behaviors is shorter here, and the questions appear on a different questionnaire form and, 
therefore, have a different set of respondents. However, because the questionnaire forms are 
distributed randomly in senior year, there are no systematic sample differences across forms. 
Furthermore, the results for perceived peer norms are generally quite consistent with those for 
personal disapproval in the aggregate; that is, the proportion saying that they personally disapprove 
of a drug-using behavior tends to be similar to the proportion saying that their close friends would 
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disapprove of that same behavior.48 Exceptions are trying marijuana once or twice and smoking one 
or more packs of cigarettes per day, to which respondents have consistently reported their friends’ 
attitudes as more disapproving than their own attitudes (especially in the oldest age band), and heavy 
weekend drinking, to which friends’ attitudes are seen as less disapproving than their own.   
Current Perceptions of Friends’ Attitudes 
Table 7-1 provides trends for each age band in the proportions of respondents indicating how their 
close friends would feel about the respondent engaging in various drug-using behaviors. For 
purposes of simplification, we begin by addressing results across the entire 19- to 30-year age band 
(tabular data for the entire age band are not presented). Then we distinguish among the three age 
bands: 19 to 22, 23 to 26, and 27 to 30. 
 
• It turns out that the peer norms reported by young adults 1 to 12 years past high school are 
quite similar to those reported by 12th graders. That is, for each of the illicit drugs other 
than marijuana, the great majority of young adults think that their close friends would 
disapprove of their even trying such drugs once or twice (88% for LSD, amphetamines, and 
cocaine). 
 
• Well over half of the young adults (over 58%) now think their friends would disapprove of 
their even trying marijuana, while 68% think their friends would disapprove of occasional 
use and about 84% think they would disapprove of regular use. So, clearly the norms differ 
as a function of level of marijuana use, but for all levels of use they tend to be restrictive for 
the majority of young adults.  
 
• About two thirds (65%) of young adults say their friends would disapprove if they were daily 
drinkers, and 9 out of 10 (90%) if they were heavy daily drinkers, defined as having four or 
five drinks nearly every day. 
 
• Friends’ disapproval of heavy drinking on weekends is distinctly lower. Only 52% to 57% 
of any age group think that their friends would disapprove of their having five or more 
drinks once or twice each weekend. The 19- to 22-year-olds and the 23- to 26-year-olds have 
lower levels of disapproval (53% and 52%) than the 18-year-olds (60%) or the 27- to 30-
year-olds (57%). 
 
• Peer disapproval of cigarette smoking is reasonably high in all four age bands: 81% of 12th 
graders say their friends would disapprove of pack-a-day smoking, 83% of the 19- to 22-
year-olds, 77% of the 23- to 26-year-olds, and 82% of the 27- to 30-year-olds.  
 
Trends in Peer Norms 
• Important changes in the social acceptability of drug-using behaviors among both 12th 
graders’ and young adults’ peers have occurred over the life of this study. (See Table 7-1.) 
Among 12th graders, the proportion who said that their friends would disapprove of their 
trying marijuana rose from 41% in 1979 to 73% in 1992—a period of substantial decline in 
                                                 
48The question reads, “How do you think your close friends feel (or would feel) about you… [smoking marijuana once or twice]?” The answer 
categories are “don’t disapprove,” “disapprove,” and “strongly disapprove.” Percentages discussed are for the last two categories combined. 
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use. Friends’ disapproval also grew substantially stronger in all of the young adult age bands 
in the years for which data are available. For example, among the 19- to 22-year-olds, the 
proportion thinking their friends would disapprove if they even tried marijuana rose from 
41% in 1981 to 65% in 1992. A similar peaking occurred for the 23- to 26-year-olds in 1992 
and 1993, and among 27- to 30-year-olds in 1994 and 1995—at 66% for both age bands. In 
all age groups, disapproval subsequently declined, though the declines were earliest and 
greatest among 12th graders. Among the 12th graders the decline ended in 1997 and began 
to reverse, but the decline continued through 2002 among the 19- to 26-year-olds. Perceived 
peer disapproval of trying marijuana increased over the past several years in the younger age 
groups but there was little systematic change in the two oldest age bands. 
 
Among those under age 18, friends’ disapproval of more frequent use of marijuana also rose 
until the early 1990s and then declined between 1992 and 1997. It declined through 1999 
among the 19- to 22-year-olds and continues to decline among the 23- to 30-year-olds. In 
essence, peer norms have moved in a way consistent with the existence of some lasting 
cohort differences.  
 
• There was a more gradual increase in peer disapproval levels of amphetamine use for all age 
groups through 1991, followed by definite declines evident among the 12th graders through 
1997. But this weakening of norms against use occurred primarily among adolescents. Since 
1997, levels among the 18- to 30-year-olds have increased again.  
 
• Through 1991, peer disapproval of trying LSD showed very little change in any of the age 
bands, but it fell some in the 1990s, especially among the 18-year-olds and subsequently the 
19- to 22-year-olds. These declines bottomed out in a staggered fashion, beginning with the 
12th graders in 1997 (who have since shown a nine-percentage-point increase in peer 
disapproval). Since 2000 there has been an eight-percentage-point increase among the 19- to 
22-year-olds. 
 
• Perceived peer norms regarding cocaine use were first measured in 1986. During the next 
eight years, self-reported cocaine use declined substantially as peer norms in all age bands 
shifted considerably toward disapproval. For example, by 1994, 95% of the 19- to 22-year-
olds thought their friends would disapprove of their even trying cocaine. After 1994, peer 
norms against use continued to strengthen a bit in the upper age bands, perhaps through 
generational replacement, but weakened slightly in the younger age bands, likely reflecting a 
new cohort effect. In recent years there has not been much difference by age in peer norms 
against cocaine use. 
 
• Peer norms regarding occasional heavy drinking (five or more drinks once or twice each 
weekend) have tended to be weakest among the 19- to 22-year-old age stratum (where such 
behavior is most common) and strongest among the 27- to 30-year-old stratum. Since 2002, 
however, the 23- to 26-year-olds were also low relative to the two other age bands in their 
disapproval of weekend binge drinking. Among 12th graders, friends’ attitudes became 
somewhat more restrictive between 1981 and 1992 as binge drinking declined, but they have 
been fairly level since then. There was a similar upward trend in disapproval among the 
various young adult age bands that followed a staggered pattern, likely reflecting a cohort 
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effect. However, between 1997 and 2000 the 19- to 22-year-old age group became somewhat 
less disapproving of occasional binge drinking; this was followed by a decline in peer 
disapproval between 2001 and 2004 among the 23- to 26-year-olds, and a significant decline 
in 2005 among the 27- to 30-year-olds. 
 
• Peer norms regarding cigarette smoking (at the rate of one or more packs per day) became 
somewhat more restrictive among 12th graders in the early years of this study; peer 
disapproval rose from 64% in 1975 to 73% in 1979. There was little further net change for 
13 years (through 1992), when friends’ disapproval stood at 76%. However, peer disapproval 
of smoking slipped some in the 1990s. Between 1992 or 1993 and 1997 or 1998, all age 
groups showed a decrease in perceived peer disapproval of smoking. Since then the two 
younger strata have shown some strengthening of norms against smoking. Between 1998 and 
2005, the proportion saying that their close friends would disapprove of their smoking a pack 
or more of cigarettes per day rose from 69% to 81% among the 18-year-olds and from 69 % 
to 83% among the 19- to 22-year-olds. The two older strata have not seen a comparable 
change, however.   
 
 
EXPOSURE TO DRUG USE BY FRIENDS AND OTHERS 
 
Exposure to drug use is important because it provides both the modeling of the behavior by peers 
(possibly including direct encouragement to use), and also immediate access. Exposure is measured 
by two sets of questions, each appearing on a (different) single questionnaire form. The first set asks 
the respondent to estimate what proportion of his or her friends use each drug, while the second asks, 
“During the LAST TWELVE MONTHS how often were you around people who were using each of 
the following to get high or for ‘kicks’?” The same questions are asked of 12th graders, and their 
results are included for comparison purposes in Tables 7-2 and 7-3. (Questions about exposure to 
drug use were not included in the questionnaires for 35-, 40-, and 45-year-olds, so they could not be 
included in Table 7-3.) We continue to deal with four-year age bands to increase the reliability of the 
estimates. (Ages 35, 40, and 45 are included as one-year age bands, but those years have larger 
numbers of cases than single years at the earlier ages. Both half samples from those cohorts are 
surveyed, and only one questionnaire form is administered to those respondents.) At the bottom of 
each table is a summary of the weighted number of cases upon which each annual estimate is based. 
(The actual numbers of cases are somewhat higher.) 
Exposure to Drug Use Among Adults 
• Relatively high proportions of young adults in all of these age bands have at least some 
friends who use some illicit drug (Table 7-2). In recent years, the proportion has declined 
considerably with age, although this was not always the case. The differences opened up 
considerably in the 1990s as use rose among the younger strata. In 2005 the proportion is 
highest for 12th graders (80%) and falls to 64% among 27- to 30-year-olds and then down to 
40% among 35-year-olds, and 34% among 45-year-olds. The proportions who say that most 
or all of their friends use one or more of the illicit drugs fall from 20% for 12th graders, to 
5% among 27- to 30-year-olds, and between 1.4% and 2.5% for the 35-, 40-, and 45-year-
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olds—quite a dramatic difference, and one that is consistent with the large differences in 
their own self-reported current use. 
 
• With regard to illicit drugs other than marijuana, taken as a whole, considerably fewer 
report any of their friends who use: 51% for 12th graders, 55% for 19- to 22-year-olds, 33% 
for 27- to 30-year-olds, 19% for 35-year-olds, and 21% for 40- and 45-year-olds. These age 
differences are considerably greater than they were throughout the 1980s. During the period 
of increasing drug use in the 1990s, primarily among adolescents, the 12th graders reported 
having the highest proportion of friends using drugs. However, as those 12th graders have 
aged, it is now the young adults aged 19 to 22 who are showing the highest proportion of 
friends using drugs, as well as the highest proportion of any of the age strata. The 
proportions saying that most or all of their friends use illicit drugs other than marijuana in 
2005 are 7%, 5%, and 3%, respectively, for the three youngest age bands, with fewer than 
1% of respondents over the age of 26 reporting such high proportions of their friends using 
other illicit drugs. Thus, relatively few of these age groups appear to be deeply immersed in 
a drug culture that involves illicit drugs beyond marijuana. 
 
• With respect to individual illicit drugs, exposure among all of the age groups is greatest for 
marijuana, with 77% of the 12th graders, 76% of the 19- to 22-year-olds, 61% of the 27- to 
30-year-olds, and 26%–37% of the 35-, 40-, and 45-year-olds reporting that at least some of 
their friends use the drug. The next highest exposures are for ecstasy (23% among 12th 
graders, 28% among 19- to 22-year-olds, 25% among the 23- to 26-year-olds, declining to 
16% among 27- to 30-year-olds), amphetamines (29% among 12th graders and 26% among 
19- to 22-year-olds, declining to 12% among 27- to 30-year-olds), hallucinogens other than 
LSD (31% among 12th graders and 25% among 19- to 22-year-olds, declining to 9% among 
27- to 30-year-olds), and LSD (20% among 12th graders and 14% among 19- to 22-year-
olds, declining to 7% among 27- to 30-year-olds). Because of the dramatic increase in its use 
during the 1990s and early 2000s, MDMA, or ecstasy, surpassed a number of the more 
traditional drugs, though its use has declined sharply in recent years.   
 
The proportion of young adults who have some friends who use the other illicit drugs is 10% 
or higher in at least one of the young adult age groups for the following drugs: cocaine 
(18%–27%), narcotics other than heroin (13%–20%), sedatives (barbiturates) (11%–20%), 
steroids (7%–20%), crack cocaine (9%–15%), tranquilizers (10%–13%), and inhalants 
(3%–11%). See Table 7-2 for specifics. 
 
• For most illicit drugs, the proportion of young adults having any friends who use them 
decreases with age, consistent with the age differentials in self-reported use. The steepest 
declines occur with inhalants (18.1% of 18-year-olds down to 3.2% of 27- to 30-year-olds). 
(Inhalant use is not asked of the 35-, 40-, and 45-year-olds, precisely because of this sharp 
decline in use with age.) 
 
• For some years, cocaine showed significantly higher rates of active use among adults 
compared to 12th graders. That is no longer true, although there is rather little drop-off with 
age in early adulthood; consequently, there is not a great difference associated with age in 
195





having friends who use cocaine (18% to 28% for all four of the younger age groups). (The 
35-, 40-, and 45-year-olds are asked separately about cocaine powder and crack use; far 
fewer, but still a fair proportion, report having friends who use cocaine powder—7% to 9% 
in 2005 for all three groups.) 
 
• For crack, however, the story is different. Reported friends’ use of crack now descends 
sharply with age, although this was not true in the mid-1980s, when measures of crack use 
were first included in the surveys. In 2005, 23% of 12th graders report having any friends 
using crack, versus 2%–3% of the 35-, 40- and 45-year-olds.   
 
• The proportion reporting that they have any friends who use heroin also decreases sharply 
with age, from 13.1% among 12th graders to 3.8% among 27- to 30-year-olds. Narcotics 
other than heroin also follow a similar pattern, though the decline with age is not as sharp. 
(Older respondents are not asked these questions.) 
 
• In general, it appears that some respondents who report that their friends use illicit drugs are 
not directly exposed to that use themselves, judging by the differences in proportions saying 
they have some friends who use (Table 7-2) and the proportions who say they have not been 
around people who were using during the prior year (Table 7-3).  
 
• With respect to alcohol use, the great majority of young adults have at least some friends 
who get drunk at least once a week, although this differs by age: 79% of the 12th graders, 
85% of the 19- to 22-year-olds, 81% of the 23- to 26-year-olds, 72% of the 27- to 30-year-
olds, 51% of the 35-year-olds, 48% of the 40-year-olds, and 42% of the 45-year-olds. Given 
the potential serious consequences of this behavior, these rates are impressively high across a 
wide age range. The proportions who say most or all of their friends get drunk once a week 
differ more substantially by age: 29% of the 12th graders and 31% of the 19- to 22-year-olds, 
declining sharply to 11% of the 27- to 30-year-olds and 3% of the 45-year-olds. Note in 
particular how high these rates are among the high school and college-aged populations. In 
terms of direct exposure during the past year to people who were drinking alcohol “to get 
high or for ‘kicks,’” having some such exposure is almost universal in the three four-year 
age groups of young adults: 93%, 90%, and 92%, respectively. (See Table 7-3.) 
 
• From ages 18 through 30, nearly all respondents (81%–89%) have at least a few friends who 
smoke cigarettes, with considerable falloff by age 35. In fact, 17%–20% of the 12th graders 
and 19- to 22-year-olds state that most or all of their friends smoke. Above those ages the 
proportions decline to 13% of the 27- to 30-year-olds, and 6%–7% for those 35 years of age 
and older. This increase in the segregation of smokers from nonsmokers likely reflects the 
stratification of young people after high school as a function of educational attainment, 
which is highly correlated with cigarette smoking. Also, it can be seen in Table 7-2 that there 
was much less age-related difference in the late 1980s, suggesting that the sharp rise in 
smoking among high school students during much of the 1990s accentuated the age 
differentials and that those differentials remain, reflecting lasting cohort effects.  
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Trends in Exposure to Drug Use Among Adults 
Tables 7-2 and 7-3 also provide trend data on the proportions of respondents’ friends using drugs 
and the proportion of respondents directly exposed to drug use by others. Both of these measures of 
exposure to use will be discussed in this section. Once again, trends are available for the 19- to 22-
year-olds since 1980, for the 23- to 26-year-olds since 1984, and for the 27- to 30-year-olds since 
1988. Data for 35-, 40-, and 45-year-olds are available for friends’ use since 1994, 1998, and 2003, 
respectively. (Questions about frequency of being around drug users were not included in the 
questionnaires administered to the 35-, 40-, and 45-year-old respondents, so those age bands are not 
included in Table 7-3.) Data for 12th graders since 1980 have also been included in these tables for 
comparison purposes. 
• An examination of Table 7-3 shows that exposure to illicit drug use (in the 12 months 
preceding the survey) declines with age for any illicit drug, marijuana, and any illicit drug 
other than marijuana, as well as for nearly all of the specific illicit drugs. In general, these 
differences replicate across different historical periods, with the exception of cocaine, which 
began to show a decline in exposure with increasing age after 1996. These declines reflect 
age effects in both exposure to use and in personal use of most drugs.  
 
• Until 1992, young adults’ trends in exposure to use tended to parallel those observed for 12th 
graders. Over the 12-year period of 1980 to 1992, that meant a decreasing number of 
respondents were exposed to any illicit drug use (Table 7-3) or reported any such use in their 
own friendship circle (Table 7-2). After 1992, however, an important divergence in trends 
among age groups emerged: 12th graders showed a substantial increase in both friends’ use 
and exposure to use (and in self-reported use); the 19- to 22-year-olds showed a similar rise, 
but lagged by a few years; the 23- to 26-year-olds subsequently showed some rise; while the 
27- to 30-year-old age band did not show a rise until 2002. As is discussed in earlier 
chapters, this pattern no doubt reflects the emergence of lasting cohort differences driven by 
the process of generational replacement. 
 
• Marijuana showed a very similar pattern of change. In addition, returning to the measures of 
friends’ use, it is particularly noteworthy that, while 34% of the 19- to 22-year-olds in 1980 
said most or all of their friends used marijuana, only 9% said the same in 1993. Clearly, the 
number of friendship groupings in which marijuana use was widespread dropped 
dramatically over that interval. The figure increased to 19% by 1999, where it remained for a 
couple of years. Friends’ use has declined some in the past few years for the two youngest 
strata, but only recently leveled among the older strata. 
 
• The proportion reporting having any friends who use any illicit drugs other than marijuana 
began to decline after 1982. By 1991 or 1992 there had been a considerable drop in all four 
age groups. This drop appears to be due particularly to decreases in friends’ use of cocaine 
and amphetamines, although there were decreases for sedatives (barbiturates) and 
tranquilizers as well. The levels then began to rise in the two youngest age bands in the early 
1990s, while at the same time they continued to decline in the two oldest age bands, opening 
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up a large age-related difference in exposure to use. Since 2001 there has been some decline 
in friends’ use in the two youngest age strata, narrowing the age differences some. 
 
• Between 1987 and about 1992, there was a considerable drop in the proportion of all four 
age groups who said they had any friends who used crack. (Self-reported use declined in the 
same period.) After that decline, the rates of friends’ use increased some in the two youngest 
age bands and decreased some in the four oldest ones, resulting in a large age difference in 
the proportion of friends using crack. Of course, some of that apparent age difference could 
be due to a greater amount of cumulative attrition of the most drug-prone members of our 
panels, and crack users would certainly be among the most drug-prone. In 2004 there was a 
significant 3.8 percentage-point increase in the proportion of 12th graders saying they had 
any friends using crack (to 22.5%) and a nonsignificant 4.2-percentage point-increase among 
the 19- to 22-year-olds who had friends using crack. However, reported friends’ use in 2005 
leveled off in both of these age bands, suggesting that a serious rise in use is not occurring.  
 
• It is noteworthy that there has been a substantial increase since the early 1990s in the 
proportion of 12th graders and 19- to 22-year-olds reporting that they have friends using 
narcotics other than heroin (though the increase was greater among the 12th graders, where 
it began earlier). Increases within the two older age strata began later, and have been more 
modest; however, unlike the case with the younger strata, increases seem to be underway 
still.  
 
• The proportions of friends reported using ecstasy (MDMA) increased sharply in recent years 
in all age groups for which data are available, though in a staggered fashion. Twelfth graders 
showed the first sharp increase beginning after 1992, 19- to 22-year-olds after 1994, 23- to 
26-year-olds after 1996, and 27- to 30-year-olds after 1997. These sharp increases ended 
among 12th graders in 2001 and among 19- to 30-year-olds a year later. Since those peak 
levels there have been considerable declines in all four age strata in the proportions saying 
that they had any friends using ecstasy, which corresponds to the sharp declines in self-
reported use. These declines continued into 2005 for three of the four age strata. 
    
• For all four age groups there were modest declines between 1987 and 1992 in the proportion 
saying that most or all of their friends drink alcohol. Since 1992, there has been very little 
change in the lower four age bands, though a drop among 12th graders in 2002 began to 
open a difference before all of the older age strata showed a similar drop in 2003. The 35-, 
40- and 45-year-olds report fewer friends who drink and substantially fewer who get drunk 
on a weekly basis than do the younger age bands; this is an age-difference that has been 
constant, consistent with it reflecting an age effect. 
 
• Among 12th graders, the proportion who said most or all of their friends smoked cigarettes 
declined appreciably between 1975 and 1981 during the same period that self-reported use 
declined. Neither measure showed much change until about 1992. Thereafter, substantial 
increases in both measures occurred. By 1997 fully one third (34%) of 12th graders reported 
that most or all of their friends smoked cigarettes (up from 21% in 1992); since then, friends’ 
use has declined (to 17% in 2005). Among 19- to 22-year-olds a decline in friends’ use 
198





occurred between 1980 (or possibly earlier) and 1985, followed by a leveling through 1994. 
The percentage of them saying most friends smoke increased from 22% in 1994 to 29% in 
2000, before beginning to decline. Among 23- to 26-year-olds, a downturn was evident 
between at least 1984 (the first year for which data are available) and 1988, and then 
reported friends’ use leveled. Since about 2002, some slight increase is evident. These 
staggered changes until about 1998 illustrate that the cohort effects were moving up the age 
spectrum (as the cohorts themselves aged). Since 1998 (or the earliest year available for the 
age bands above 30) there has been some decline in the proportions saying that any of their 
friends smoke but little or no change in the proportions of friends reported as smoking 
among the 23- to 30-year-olds (which now contain the heavier-smoking senior classes of the 
mid-1990s).  
 
Nearly all of these changes in exposure to drug use across the various drugs parallel changes in self-
reported use by these four age groups. This pattern reinforces our trust in the validity of the self-
report data, because there would presumably be less motivation to distort answers about the 
proportion of an unnamed set of friends who use a drug than about one’s own use of it. Also 
reassuring is the systematic nature of the patterns of change across age strata (whether in terms of 
parallel trends consistent with a secular trend or staggered ones consistent with a cohort-related 
trend).  
 
PERCEIVED AVAILABILITY OF DRUGS BY ADULTS 
 
Young and middle adults participating in the follow-up surveys receive survey questions identical to 
those asked of 12th graders regarding how difficult they think it would be to get each of the various 
drugs if they wanted them. The questions are contained in only one of the six questionnaire forms. 
The data for the follow-up samples, which are grouped into the same four-year age bands, are 
presented in Table 7-4, along with the data for the 12th graders and the 35-, 40-, and 45-year-olds. 
Sample sizes are presented at the bottom. 
Perceived Availability  
As is true with the 12th graders, substantial proportions of the American adult population have 
access to various illicit drugs. (We do not ask about access to alcohol and cigarettes, because we 
assume access to be universal.)  
 
• Marijuana is the most available illicit drug, with 85%–88% of the young adult age strata 
saying it would be “fairly easy” or “very easy” to get. Access generally decreases with age 
after age 26; but even at age 45, 70% of respondents say they can get it fairly easily. 
  
• Ecstasy (MDMA) is among the most widely available of all of the illicit drugs other than 
marijuana. Its availability is now greatest among 23- to 26-year-olds (46%). It used to be 
greatest for 12th graders (now 40%) and 19- to 22-year-olds (now at 44%). This reversal 
may reflect the aging of the heavier using cohorts, who knew how to acquire ecstasy. 
Availability then falls off among 27- to 30-year-olds (to 38%). (The question is not asked of 
those 35, 40, or 45 years of age.) 
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• Amphetamines are also among the most available of the illicit drugs (45% to 57% among 
young adults and 35% to 41% among 35-, 40-, and 45-year-olds). Note that there is a fair 
difference among the age bands, with those above age 26 reporting amphetamines to be less 
available. 
 
• Sedatives (barbiturates)are about as available as amphetamines to these age groups (43% to 
48%), whereas tranquilizers are reported as available by considerably fewer (30% to 34%).  
 
• Cocaine is reported as readily available by a significant proportion of young adults, with 
43%–50% saying it would be fairly easy to get. Powdered cocaine availability does not 
differ much by age (36%–45%). Crack is available to somewhat smaller proportions than 
powdered cocaine—34%–35% for all three post-high school young adult age strata and 
34%–41% for 35-, 40-, and 45-year-olds. Cocaine was considerably more available to the 
older age groups in the 1980s (up through age 30, at least) but is now about equally available 
across all four lower age bands, including 12th graders. 
 
• Hallucinogens other than LSD are reported as available by 45%–49% of 12th graders and 
19- to 22-year-olds. Availability is lower among the 23- to 30-year-olds at 31%–39%. 
 
• LSD now shows only a moderate degree of availability for all ages (24%–29%).  
 
• More than a third of young adults (38%–45%) say they can get narcotics other than heroin 
fairly easily, as do 39% of 12th graders.  
  
• Steroids show some declines in perceived availability with increasing age, as has generally 
been the case, ranging from 40% among 12th graders down to 32% among the 27- to 30-
year-olds. (The question is not asked of respondents above age 30.) 
 
• About a quarter (23%–28%) of young adults and 12th graders say that they could get heroin 
fairly easily; yet a far smaller proportion of them report having used heroin.   
 
• Crystal methamphetamine (ice) is perceived to be available by just above a quarter of each 
age group (27%–29%). 
Trends in Perceived Availability 
• Marijuana has been almost universally available to the adolescent and young adult age 
groups throughout the historical periods covered by the data (since 1975 in the case of 12th 
graders). There was a slight decrease through 1991 among 12th graders since the peak year 
of 1979, a slightly larger decrease from 1980 through 1991 among 19- to 20-year olds. 
Availability rose by a few percentage points in nearly all strata between about 1993 and 
2001, and since then has slipped back a few percentage points in the two younger strata. 
Perceived availability is now a bit higher for the younger age groups (between 85% and 88% 
for 12th graders through 27- to 30-year-olds versus 70% to 74% for those aged 35 to 45). In 
general their trends in availability have been quite parallel, though. 
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• Cocaine availability increased among all three younger age strata over the 1984–1988 
interval, reaching historic highs in 1988 and 1989. (Twelfth graders showed a rise in 
availability in earlier years—from 1975 to 1980—followed by a leveling between 1980 and 
1984. Availability was also level during the latter period among 19- to 22-year-olds.) From a 
policy perspective, it is worth noting that in all three age bands for which we have data, the 
perceived availability of cocaine increased in 1987—the same year that use actually dropped 
sharply. Between 1988 and 1989, in the two younger age strata (aged 18, and 19 to 22) the 
proportions reporting that they could get cocaine fairly easily were still increasing, whereas 
in the older age strata the proportions were beginning to decrease. In 1990 and 1991, all four 
groups reported decreased availability—quite parallel to the number who had friends who 
were users and to personal use, both of which dropped substantially in these years and then 
leveled in 1992. Perceived availability of cocaine dropped to between 49% and 57% for all 
four age groups by 1993, with the absolute declines ranging from four to seven percentage 
points. After that there has been some falloff in perceived availability in all age strata 
through age 30—particularly among those ages 23 through 30—and an increasing 
convergence. However, in the past year or two there has been an increase in cocaine 
availability in all four age groups. 
 
• Crack availability peaked in 1988–1989 for all age groups (it was first assessed in 1987) and 
declined through 1992, with little further change until 1995. Since 1995, crack availability 
has declined some in all strata.  
 
• The trends in LSD availability among young adults have some parallels to those for 12th 
graders. Among 12th graders, there was a drop of about ten percentage points in the mid-
1970s and a later drop in the interval 1980 to 1986. The latter drop, at least, was paralleled in 
the data from 19- to 22-year-olds. After 1986, availability increased considerably in all age 
bands, reaching its peak levels (the highest we have recorded since these questions were 
introduced) by 1995, with a considerable difference by age developing (with availability 
lower with increases in age); since 1995, availability has fallen considerably in the youngest 
two age strata and by less in the older strata, once again narrowing the differences among the 
age groups. Indeed, the drop-off in availability of LSD to 12th graders and 19- to 22-year-
olds was quite sharp in 2002, possibly contributing to the steep decline in use that year. 
Availability among 35- and 40-year-olds is the lowest—it has decreased slightly since data 
were first available. In 2005, between 24% and 29% of each age group say they could get 
LSD fairly easily. 
 
• In the early 1980s, there was a fair decline among all age groups in the availability of 
hallucinogens other than LSD; there was little additional change through 1992. From 1992 
to 1995 the three youngest age groups all showed an increase in availability, with 12th 
graders showing the largest increase. From 1996 to 2000, availability was fairly steady. All 
age groups showed substantial increases in 2001, but this was presumably due to the changed 
question wording in which, among other things, “shrooms” was added to the examples of 
hallucinogens. Since 2001 the general pattern has been one of stability but with the levels of 
availability more differentiated by age. Generally, the lower the age stratum the higher the 
reported availability. 
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• The availability of MDMA (ecstasy) rose very substantially in all of these age groups during 
the 1990s and early 2000s. (The questions were first introduced in 1989 and 1990.) Among 
the 12th graders, reported availability nearly tripled, from 22% in 1989 to 62% in 2001—the 
peak year for 12th graders. All four age groupings showed sharp increases in 2000 and 2001, 
with the oldest groups continuing to increase through 2002—their peak year. The 27- to 30-
year-olds are the least likely to say that ecstasy is readily available to them; still, 38% of 
them say it would be fairly easy to get. In fact, the two youngest strata have shown 
considerable declines since 2002, and all strata showed some decline in 2005. 
 
• Heroin availability varied within a fairly narrow range from 1980 to 1986 but then showed a 
fair-sized increase among both 12th graders and young adults through 1990. It then rose 
further among 12th graders and 19- to 22-year-olds through 1995 before declining a bit. In 
the older two of the four age groups, heroin availability remained fairly flat from 1990 to 
1995, and then increased some through 1999, and declined thereafter. What is clear is that 
heroin was much more available to all of these age groups in the 1990s than it was in the 
1980s. It was this increase in the availability of heroin, and also the purity, that most likely 
led to the evolution of non-injection forms of administration during this period. All age 
groups have shown some decline in heroin availability over the last several years, during 
which there has been only modest variability in heroin availability across the 18-to-30 age 
range. 
 
• The availability of narcotics other than heroin slowly rose among all age groups between 
1980 and 1989, followed by considerable stability from 1989 through 1994. After 1994, 
availability increased modestly, accompanied by steadily rising use. But in the past few years 
there has been some falloff in availability among all age strata. For the most part, there has 
not been a consistent difference by age in the availability of narcotics other than heroin.  
 
• The reported availability of amphetamines peaked in 1982 for both 12th graders and 19- to 
22-year-olds; since then it has fallen by 20 percentage points among 12th graders and 17 
percentage points among 19- to 22-year-olds. Since 1984, when data were first available, 
there has been a decline of 14 percentage points among 23- to 26-year-olds, as well. For 27- 
to 30-year-olds, reported availability decreased by nine percentage points between 1988 (the 
first measurement point) and 2005. There have been decreases among 35-year-olds as well. 
In general, the age groups above age 30 have reported somewhat lower availability than the 
younger strata. These differential rates of availability across the age groups emerged after 
1992, when prevalence of use began to rise among 12th graders 
 
• By way of contrast, crystal methamphetamine or “ice” exhibited an increase in availability 
in the 1990s, rising for all four age strata from 1991 to 1998 or 1999, before stabilizing with 
similar rates of availability from age 18 to age 30. 
 
• Sedatives (barbiturates) exhibited a long-term decline in availability from about 1981 or 
1982 through 2003 in the two younger groups—a 20-percentage-point drop among 12th 
graders and 23-percentage-point drop among 19- to 22-year-olds. All groups showed an 
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increase in 2004 no doubt due primarily to a change in the question wording, and no further 
systematic change in 2005. 
 
• Tranquilizer availability has declined long-term by almost two thirds among 12th graders, 
from 72% in 1975 to 26% in 2005. Since 1980, when data were first collected for 19- to 22-
year-olds, tranquilizer availability among adults declined sharply (from 67% in 1980 to 30% 
in 2005), such that previous differences in availability between these two groups were 
eliminated by 1992. The older age groups also showed a considerable decline in the 
availability of tranquilizers through 2003 or 2004. For the most part the trend lines for the 
different age groups have been quite parallel, as was true for sedatives (barbiturates). This 
class of drugs has shown the most consistent pattern of change in perceived availability over 
the 30-year life of the study. 
 
• Data on steroid availability were first gathered in 1990, and although there has not been 
much change in availability since then, availability did appear to peak in 1992 in all age 
strata. This was followed by a modest decline in all age groups. Twelfth graders showed 
some increase between 1996 and 2002, and 19- to 22-year-olds showed a very modest 






Q.  How do you think 
your close friends feel 
(or would feel) about 
you...
Percentage saying friends disapprove a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Trying marijuana once  18 42.6 46.4 50.3 52.0 54.1 54.7 56.7 58.0 62.9 63.7 70.3 69.7 73.1 66.6 62.7 58.1 55.8 53.0 53.8 55.1 58.1 57.6 54.1 58.4 59.5 60.9 +1.  
  or twice 19-22 41.0 40.6 46.9 47.1 51.6 54.5 55.2 54.7 58.7 63.0 63.6 64.7 64.7 63.4 63.7 58.5 64.3 58.4 57.0 56.5 56.0 54.2 53.4 56.5 61.0 57.9 -3.1
23-26 47.7 47.0 49.1 53.9 58.2 62.6 61.3 64.5 65.6 65.5 63.2 63.8 61.2 59.3 66.5 62.6 64.6 55.2 53.8 51.4 57.7 55.9 -1.8
27-30 58.6 58.7 61.4 64.6 63.5 64.4 66.3 66.1 65.8 65.0 65.4 61.8 63.9 64.9 67.1 61.9 67.2 61.2 -6.0
Smoking marijuana  18 50.6 55.9 57.4 59.9 62.9 64.2 64.4 67.0 72.1 71.1 76.4 75.8 79.2 73.8 69.1 65.4 63.1 59.9 60.4 61.6 63.9 64.3 60.3 64.2 65.0 67.6 +2.  
 occasionally 19-22 50.9 49.2 54.0 57.9 59.4 64.6 64.4 65.1 69.8 71.5 74.1 73.9 74.3 73.1 73.0 66.6 71.3 65.1 65.1 64.6 61.8 61.0 62.6 63.3 70.1 67.2 -2.9
23-26 54.3 56.4 57.1 63.1 68.1 73.2 71.8 72.5 75.3 73.5 72.2 70.7 70.8 68.5 73.6 70.2 70.9 63.9 64.5 61.6 63.5 65.5 +1.9
27-30 67.8 69.4 71.9 73.7 76.0 75.1 76.4 73.8 75.6 72.4 74.9 74.5 75.0 74.2 72.9 71.4 76.9 70.4 -6.5 s
Smoking marijuana  18 72.0 75.0 74.7 77.6 79.2 81.0 82.3 82.9 85.5 84.9 86.7 85.9 88.0 83.5 80.6 78.9 76.1 74.1 74.7 74.5 76.1 77.8 75.3 77.0 77.3 79.5 +2.2
  regularly 19-22 70.3 75.2 75.7 79.5 80.0 82.7 83.5 84.8 86.9 87.5 89.1 88.4 89.1 87.6 85.9 83.9 84.5 83.3 81.1 78.2 78.5 80.0 80.5 79.1 84.4 82.2 -2.2
23-26 77.8 78.4 80.9 82.0 85.8 89.2 88.1 87.9 90.3 89.1 88.8 84.9 89.5 85.6 87.1 86.8 86.9 83.7 82.8 80.0 79.2 82.7 +3.6
27-30 85.4 86.0 88.4 89.2 88.7 88.2 88.9 89.7 89.6 87.8 90.8 89.2 91.6 90.1 87.9 87.2 88.0 87.7 -0.3
Trying LSD once or 18 87.4 86.5 87.8 87.8 87.6 88.6 89.0 87.9 89.5 88.4 87.9 87.9 87.3 83.5 83.4 82.6 80.8 79.3 81.7 83.2 84.7 85.5 84.9 87.5 87.3 88.4 +1.2
  twice 19-22 87.4 90.5 88.0 89.3 89.3 91.1 90.5 91.8 90.8 91.2 89.1 89.9 87.2 87.7 87.9 84.6 85.3 83.6 81.7 82.0 82.1 85.2 86.9 86.9 88.6 90.5 +1.8
23-26 87.4 90.8 88.6 89.8 88.9 91.0 90.1 92.4 88.9 87.7 86.3 85.3 88.5 85.4 87.6 84.5 85.3 82.8 83.6 79.3 82.4 85.6 +3.2
27-30 88.8 89.7 92.3 91.1 91.4 89.9 91.2 89.7 89.3 88.5 88.7 88.4 85.6 87.4 86.3 87.1 87.7 86.9 -0.8
Trying cocaine once or 18 79.6 83.9 88.1 88.9 90.5 91.8 92.2 91.1 91.4 91.1 89.2 87.3 88.8 88.7 90.2 89.3 89.1 91.2 87.9 89.0 +1.1  
  twice 19-22 76.4 NA 84.8 87.7 89.2 92.3 91.9 92.4 94.7 91.7 91.5 91.8 90.0 91.2 89.4 89.1 91.7 90.6 90.3 90.3 +0.1
23-26 70.8 NA 81.4 84.5 84.1 86.7 87.4 87.7 87.9 90.4 90.0 91.1 92.0 89.6 90.5 88.0 88.5 83.6 84.2 84.6 +0.4
27-30 81.8 81.1 83.7 83.5 84.4 86.1 87.8 87.5 88.7 89.4 89.3 90.5 90.4 89.3 88.8 89.9 91.8 89.5 -2.3
Taking cocaine 18 87.3 89.7 92.1 92.1 94.2 94.7 94.4 93.7 93.9 93.8 92.5 90.8 92.2 91.8 92.8 92.2 92.2 93.0 91.0 92.3 +1.3
  occasionally 19-22 84.9 NA 91.0 93.8 94.2 95.6 95.9 95.6 97.5 95.6 95.7 96.6 93.1 95.7 94.7 94.5 95.6 95.1 96.0 95.3 -0.7
23-26 81.7 NA 88.2 91.5 92.4 94.1 93.8 93.5 94.3 94.6 95.4 95.1 95.2 95.2 96.7 94.7 93.2 91.2 90.1 93.0 +2.9
27-30 87.7 89.5 90.0 92.2 92.3 92.8 94.6 94.1 94.6 94.2 96.1 95.4 95.9 94.2 94.0 95.1 96.3 94.5 -1.7
Trying an amphetamine  18 78.9 74.4 75.7 76.8 77.0 77.0 79.4 80.0 82.3 84.1 84.2 85.3 85.7 83.2 84.5 81.9 80.6 80.4 82.6 83.0 84.1 83.8 83.3 85.9 84.7 86.1 +1.5
  once or twice 19-22 75.8 76.7 75.3 74.3 77.0 79.7 81.5 81.3 83.0 83.5 84.5 86.5 83.8 85.0 87.2 83.1 86.0 84.5 84.0 85.8 81.6 84.5 87.6 87.6 89.4 88.9 -0.5
23-26 78.4 79.1 76.7 81.7 83.0 85.6 84.3 85.0 83.6 84.2 84.7 87.6 86.5 83.3 87.0 85.9 85.1 83.1 83.9 81.5 82.7 86.2 +3.4
27-30 82.7 84.1 84.9 84.6 84.7 84.1 85.9 85.5 85.6 85.9 85.8 87.2 87.8 86.4 86.0 87.9 88.9 87.5 -1.3
Taking one or two drinks 18 70.5 69.5 71.9 71.7 73.6 75.4 75.9 71.8 74.9 76.4 79.0 76.6 77.9 76.8 75.8 72.6 72.9 71.5 72.3 71.7 71.6 73.4 71.6 74.7 72.8 74.0 +1.1
  nearly every day 19-22 71.9 72.1 68.6 73.5 71.6 72.2 72.7 70.2 73.9 77.1 73.3 73.7 74.0 71.2 73.0 68.3 68.9 73.5 67.3 68.6 66.6 64.9 68.5 64.4 72.4 68.3 -4.1
23-26 63.6 66.8 67.7 68.3 69.2 70.8 72.7 72.5 72.1 67.6 71.5 68.2 72.8 68.1 66.9 66.1 65.4 64.4 61.6 62.1 61.8 62.3 +0.5
27-30 71.0 68.0 70.4 71.9 68.8 73.2 70.9 68.8 65.7 67.3 66.7 64.3 67.3 67.1 64.0 64.5 65.0 62.8 -2.2
TABLE 7-1
Trends in Proportions of Friends Who Disapprove of Drug Use
High School Seniors (Age 18) and Young Adults in Modal Age Groups of 19-22, 23-26, and 27-30
(Table continued on next page)
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Q.  How do you think 
your close friends feel 
(or would feel) about 
you...
Percentage saying friends disapprove a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Taking four or five drinks 18 87.9 86.4 86.6 86.0 86.1 88.2 87.4 85.6 87.1 87.2 88.2 86.4 87.4 87.2 85.2 84.1 82.6 82.5 82.8 82.2 82.8 84.4 80.1 83.1 82.9 82.7 -0.2
  nearly every day 19-22 93.7 91.7 89.9 91.9 91.7 92.5 91.5 90.8 90.4 92.5 89.9 91.7 92.6 89.6 90.1 88.8 88.1 90.0 85.9 87.9 86.6 84.6 87.7 86.8 89.8 86.8 -2.9
23-26 90.8 90.2 92.5 92.8 93.7 92.1 92.1 92.4 91.1 93.1 92.1 92.2 92.6 90.7 93.7 89.9 92.5 91.1 88.1 89.3 87.8 89.1 +1.3
27-30 92.8 92.0 92.9 92.7 92.7 93.9 94.0 92.9 91.9 93.8 92.1 95.3 92.4 91.2 92.7 92.6 92.5 93.4 +0.9
Having five or more   18 50.6 50.3 51.2 50.6 51.3 55.9 54.9 52.4 54.0 56.4 59.0 58.1 60.8 58.5 59.1 58.0 57.8 56.4 55.5 57.6 57.7 57.8 55.6 60.3 59.4 59.9 +0.5  
  drinks once or twice 19-22 53.5 51.7 51.7 53.3 50.8 53.3 47.0 49.4 50.5 56.8 53.1 51.4 53.6 51.9 54.4 55.5 52.1 56.4 52.8 51.8 45.2 47.4 50.4 47.9 52.4 53.2 +0.8
  each weekend 23-26 53.8 57.3 61.0 57.2 58.8 57.5 55.1 56.8 58.4 57.6 61.4 58.9 58.4 55.6 60.0 54.5 56.6 56.9 52.9 49.5 49.5 51.9 +2.4
27-30 61.9 65.1 66.3 68.2 66.2 66.7 63.7 64.6 61.6 64.0 63.0 57.7 65.8 58.8 63.3 59.6 64.6 56.9 -7.7 s
Smoking one or more 18 74.4 73.8 70.3 72.2 73.9 73.7 76.2 74.2 76.4 74.4 75.3 74.0 76.2 71.8 72.4 69.2 69.3 68.5 69.0 71.2 72.6 74.5 75.7 79.2 78.6 81.1 +2.5  
  packs of cigarettes 19-22 75.6 75.1 75.4 78.5 76.2 79.7 77.7 78.6 80.2 78.4 77.5 78.3 79.0 76.0 73.8 70.9 73.9 76.5 69.2 73.9 71.1 74.3 77.3 78.3 82.1 82.7 +0.6
  per day 23-26 73.9 77.3 80.3 80.5 79.5 80.5 78.5 83.3 82.3 77.4 80.1 78.8 78.3 75.8 76.5 78.0 79.9 77.0 75.4 78.3 77.6 77.4 -0.1
27-30 81.2 80.9 82.9 84.5 83.1 86.8 82.5 83.4 81.9 80.5 81.9 82.6 84.0 83.6 86.1 84.0 84.6 82.2 -2.5
Approx. Weighted  N= 18 2766 3120 3024 2722 2721 2688 2639 2815 2778 2400 2184 2160 2229 2220 2149 2177 2030 2095 2037 1945 1775 1862 1820 2133 2208 2183
19-22 569 597 580 577 582 556 577 595 584 555 559 537 520 510 470 480 471 466 436 430 379 402 361 399 427 395
23-26 510 548 549 540 510 513 516 516 507 481 463 445 436 419 425 394 398 378 366 363 377 361
27-30 483 518 479 480 451 451 457 439 439 422 440 397 394 374 364 346 408 362
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding.
aAnswer alternatives were:  (1) Don't disapprove, (2) Disapprove, and (3) Strongly disapprove.  Percentages are shown for categories (2) and (3) combined.
TABLE 7-1 (cont.)
Trends in Proportions of Friends Who Disapprove of Drug Use
High School Seniors (Age 18) and Young Adults in Modal Age Groups of 19-22, 23-26, and 27-30
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Q.  How many of 
your friends would 
you estimate...
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Take any illicit druga
   % saying any 18 87.5 85.4 86.3 82.6 81.0 82.4 82.2 81.7 79.1 76.9 71.0 69.1 67.3 71.0 78.3 78.6 80.6 83.4 84.6 82.0 82.0 82.8 81.8 80.7 81.2 79.8 -1.4
19-22 90.2 88.0 86.8 85.0 82.3 82.9 80.5 76.7 77.2 78.4 72.7 71.5 66.8 71.7 71.6 71.6 76.2 77.2 79.8 77.3 83.1 81.1 78.3 79.4 78.1 78.6 +0.6
23-26 83.6 82.7 80.3 80.9 74.4 73.8 65.8 63.0 67.3 64.6 66.7 65.3 64.6 67.0 67.6 67.9 67.8 66.9 73.4 70.8 70.8 74.2 +3.4
27-30 74.8 72.9 69.6 67.1 61.5 60.2 57.1 58.5 59.1 60.9 58.3 59.6 55.6 57.2 61.8 58.6 63.1 63.7 +0.6
35 38.1 37.4 39.7 39.2 38.4 36.3 37.7 39.1 40.9 37.5 37.9 40.0 +2.1
40 39.2 38.2 38.0 38.4 36.2 36.5 34.6 36.2 +1.6
45 37.8 38.3 34.3 -4.0  
   % saying most or all 18 32.5 29.8 26.5 23.8 20.9 22.7 21.5 18.6 15.8 15.7 11.6 11.7 12.0 15.5 20.3 21.7 23.8 23.7 25.9 25.5 24.5 25.2 23.1 23.5 23.0 20.2 -2.8
19-22 34.9 32.8 28.1 22.4 21.9 18.2 16.2 14.0 13.5 10.9 10.5 8.8 9.0 10.4 14.9 13.1 17.3 16.2 16.8 20.6 18.9 20.3 20.2 17.3 14.7 15.8 +1.0
23-26 19.6 15.4 16.2 11.7 9.5 9.7 9.5 7.4 6.2 6.4 8.7 7.6 8.8 10.5 9.6 8.4 9.7 10.4 10.3 10.3 11.7 9.7 -1.9
27-30 8.6 6.4 5.9 2.9 5.8 5.0 5.6 6.1 3.6 4.5 5.3 5.7 5.3 7.1 6.9 6.9 3.9 4.7 +0.8
35 2.1 1.9 2.0 3.0 3.1 2.8 3.1 3.2 2.9 3.2 2.8 2.5 -0.3
40 2.3 2.0 2.0 1.6 2.2 1.6 1.6 2.1 +0.5
45 2.2 1.5 1.4 -0.1
Take any illicit druga
 other than marijuana 18 62.4 63.3 64.7 61.2 61.3 61.8 63.3 62.4 56.5 56.2 50.1 46.3 47.1 48.7 53.7 53.7 54.5 55.1 55.6 51.2 52.5 55.0 54.3 50.0 51.4 51.3 -0.1  
   % saying any 19-22 67.9 67.8 66.7 65.2 60.8 62.1 61.0 57.3 53.5 60.8 53.4 51.5 45.3 51.4 46.3 46.4 46.5 49.7 53.3 54.8 56.1 60.0 57.2 50.8 53.4 54.9 +1.5
23-26 63.7 64.0 59.0 61.1 55.1 54.2 47.8 41.8 46.1 42.3 39.4 40.3 32.8 35.1 35.4 41.1 42.5 42.6 49.4 42.3 47.1 46.6 -0.5
27-30 55.9 55.0 49.7 47.2 37.7 38.5 33.9 37.7 36.4 33.9 34.1 35.2 31.7 33.5 36.0 34.7 35.8 33.1 -2.8
35 21.4 21.6 22.1 19.2 19.3 19.0 17.9 18.7 20.4 18.5 20.2 18.5 -1.8
40 20.9 21.0 21.9 21.4 21.0 20.2 18.5 21.0 +2.5
45 23.4 25.1 20.8 -4.3 s
   % saying most or all 18 11.1 11.9 10.9 11.0 10.3 10.4 10.3 9.2 6.9 7.7 5.1 4.6 5.3 7.1 7.1 7.7 8.9 7.0 8.9 7.4 7.4 7.0 6.1 6.7 7.3 6.7 -0.7
19-22 9.8 12.9 11.8 9.8 9.3 8.6 7.6 5.0 5.3 4.0 3.2 2.6 3.3 4.0 4.4 3.5 6.2 4.1 4.3 5.1 7.7 8.0 5.7 5.1 3.5 4.8 +1.2
23-26 10.6 6.6 8.6 5.2 3.9 4.2 3.4 1.6 1.8 2.8 2.5 1.9 1.9 2.6 2.8 2.2 3.8 3.7 2.8 3.7 3.1 3.2 +0.1
27-30 4.6 3.0 2.8 1.0 1.4 1.5 1.5 1.5 0.9 1.2 0.9 1.3 1.5 2.6 2.3 0.7 0.8 0.9 0.0
35 0.8 0.5 0.7 0.5 0.7 0.9 1.0 0.9 0.6 0.6 0.4 0.5 +0.2
40 0.4 0.8 0.7 0.5 0.3 0.3 0.2 0.5 +0.3
45 0.7 0.7 0.4 -0.3
TABLE 7-2
Trends in Proportions of Friends Using Drugs
High School Seniors (Age 18) and Adults in Modal Age Groups of 19-22, 23-26, 27-30, 35, 40, and 45
(Entries are percentages)




Q.  How many of 
your friends would 
you estimate...
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Smoke marijuana  
   % saying any 18 86.4 83.0 84.4 80.3 77.7 79.5 79.2 78.4 75.3 72.5 68.3 65.8 63.1 67.4 75.6 76.1 78.0 81.4 83.2 80.7 80.5 81.2 79.4 78.9 79.5 77.4 -2.1
19-22 88.8 86.4 85.2 83.8 81.6 81.1 78.5 75.3 75.1 73.8 67.6 68.0 63.5 67.6 67.4 68.8 74.9 74.7 77.2 73.9 81.2 78.4 77.2 76.5 75.6 75.8 +0.2
23-26 82.0 80.8 77.7 79.4 71.6 69.8 61.8 59.6 61.3 61.2 62.6 63.2 62.6 63.5 65.0 64.4 64.8 64.5 68.8 67.7 68.4 70.7 +2.2
27-30 71.8 68.2 65.1 62.6 58.0 57.4 52.3 55.7 55.1 58.3 55.5 57.0 51.7 56.5 59.0 55.8 60.4 60.8 +0.5
35 36.9 36.3 36.3 35.0 34.6 33.3 34.9 35.6 37.4 32.9 34.7 37.2 +2.4
40 34.6 32.5 32.3 31.8 31.4 30.7 29.9 30.4 +0.6
45 31.1 29.4 26.3 -3.1
   % saying most or all 18 31.3 27.7 23.8 21.7 18.3 19.8 18.2 15.8 13.6 13.4 10.1 10.0 10.3 13.9 18.9 20.7 22.2 22.5 23.8 24.2 23.2 24.0 21.4 21.7 21.1 17.9 -3.2 s
19-22 34.1 30.6 25.6 20.6 19.4 16.0 13.3 12.5 12.2 9.0 9.2 8.3 8.2 8.5 13.0 12.5 16.3 16.2 16.4 19.4 16.6 18.5 18.6 16.0 15.0 13.4 -1.6
23-26 17.0 14.3 13.7 10.4 7.8 8.6 8.3 6.9 5.6 5.6 7.5 6.6 8.2 9.8 9.0 8.5 8.2 9.0 8.7 9.3 9.8 8.0 -1.9
27-30 6.8 4.4 4.0 2.8 5.1 5.2 5.0 5.6 3.5 3.9 4.8 5.5 4.9 6.3 6.2 6.7 3.5 4.3 +0.8
35 3.0 2.5 2.9 2.9 2.8 2.6 2.8 2.6 2.7 3.1 2.7 2.3 -0.4
40 2.1 1.4 1.9 1.2 2.0 1.4 1.6 1.8 +0.2
45 1.9 0.9 1.3 +0.4
Use inhalants
   % saying any 18 17.8 16.5 18.4 16.1 19.3 21.2 22.4 24.7 20.8 22.1 20.0 19.2 22.2 23.7 26.5 27.5 27.2 27.4 25.9 21.6 23.5 22.2 21.0 17.5 17.9 18.1 +0.  
19-22 11.9 13.2 13.8 12.3 11.7 9.6 10.9 12.7 10.9 11.7 13.0 12.2 12.6 13.8 14.0 14.2 16.2 13.7 16.2 16.3 13.7 13.7 10.4 10.0 9.5 11.1 +1.6
23-26 7.7 6.7 7.2 6.1 6.2 5.9 6.1 4.4 5.1 6.3 7.0 9.3 5.6 7.5 6.2 7.9 6.9 7.5 7.4 7.9 6.2 5.8 -0.4
27-30 4.6 3.5 2.9 2.5 3.3 2.9 3.5 4.0 4.1 3.6 3.8 4.2 3.6 6.0 4.5 3.2 2.6 3.2 +0.6
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.2 0.9 1.3 1.1 1.1 1.5 2.0 1.9 1.2 1.9 1.0 0.7 1.8 1.8 2.0 2.0 2.4 1.9 2.7 1.8 1.4 1.4 1.2 1.1 1.2 2.0 +0.8
19-22 0.5 0.4 0.7 0.3 0.5 0.6 0.7 0.7 0.7 0.4 0.6 0.2 0.8 0.7 0.7 0.6 1.1 0.7 1.3 0.8 0.6 1.2 0.4 0.6 0.0 0.1 +0.1
23-26 0.6 0.2 0.6 0.1 0.2 0.4 0.4 0.1 0.0 0.1 0.2 0.7 0.5 0.8 0.0 0.1 0.7 0.1 0.4 0.3 0.0 0.1 +0.1
27-30 0.3 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.  
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
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0
Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 19.0 17.4 17.5 14.5 15.0 15.6 18.0 18.3 13.6 13.3 10.4 8.9 9.0 10.7 10.0 10.7 11.2 11.9 12.9 10.9 11.0 11.9 11.2 8.5 9.4 9.1 -0.3  
19-22 18.4 16.0 14.2 13.8 8.9 9.9 11.7 13.2 10.2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 10.8 7.8 8.0 7.9 5.2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 6.6 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.3 1.2 0.9 0.7 1.2 1.0 1.2 1.3 0.7 0.9 0.6 0.4 0.7 0.7 0.8 0.8 0.8 0.7 1.0 0.7 1.0 0.6 0.8 1.0 1.2 1.0 -0.2
19-22 0.3 0.4 0.9 0.6 0.6 0.6 0.4 0.4 0.2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 0.8 0.3 0.4 0.3 0.1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 0.5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Take LSD
   % saying any 18 28.1 28.5 27.8 24.0 23.9 24.4 24.5 25.3 24.1 25.2 25.0 23.4 28.1 31.3 34.1 36.9 37.9 36.5 36.8 32.2 31.9 32.2 28.6 21.9 23.5 19.5 -4.0 ss
19-22 30.9 25.9 26.5 22.6 21.6 18.8 18.7 18.2 19.0 20.1 20.1 22.0 22.2 28.8 23.8 26.9 28.6 24.7 29.4 28.2 27.8 28.4 24.0 15.4 15.9 13.9 -2.0
23-26 21.5 17.2 15.4 15.9 13.3 14.1 12.3 12.5 15.0 17.2 17.3 21.5 15.3 18.2 15.2 18.1 19.3 16.8 15.8 16.1 14.4 12.0 -2.4
27-30 10.4 7.7 9.1 8.6 10.9 8.7 8.1 12.0 11.6 12.3 12.6 13.4 11.8 12.5 13.1 11.4 8.9 6.6 -2.4
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.8 2.2 2.4 1.4 2.0 1.5 1.8 1.6 1.5 2.4 1.9 1.7 2.4 3.8 4.2 4.8 5.0 3.7 4.7 3.9 3.1 2.9 1.7 1.9 1.5 1.5 0.  
19-22 1.2 0.8 0.9 1.0 0.6 0.8 0.9 0.6 1.3 0.4 1.2 1.4 1.9 2.1 2.5 2.3 3.8 1.4 2.5 1.8 2.1 2.7 1.6 0.8 0.3 0.3 -0.1
23-26 0.8 0.5 1.0 0.2 0.6 0.5 0.6 0.2 0.4 0.7 1.1 0.7 0.7 0.6 1.0 1.5 0.9 0.3 0.4 0.8 0.4 0.2 -0.2
27-30 0.3 0.2 0.3 0.3 0.0 0.3 0.4 0.3 0.4 0.4 0.1 0.6 0.4 0.4 0.3 0.1 0.0 0.3 +0.3
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
(Table continued on next page)
TABLE 7-2 (cont.)
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Q.  How many of 
your friends would 
you estimate...
Age 




 hallucinogensb 18 28.2 26.3 25.6 22.1 21.3 22.0 22.3 21.7 17.8 18.1 15.9 15.1 17.0 19.3 21.4 23.8 26.4 26.3 27.4 22.5 24.0 35.4 33.6 30.1 31.9 31.0 -0.9  
   % saying any 19-22 33.4 25.5 25.1 21.0 20.2 16.6 15.8 15.0 16.1 13.9 15.3 14.2 12.0 15.0 13.8 14.9 17.2 17.2 19.1 18.9 20.9 33.6 33.5 24.8 26.8 25.1 -1.7
23-26 20.0 16.7 13.2 13.2 11.7 9.6 8.7 8.5 9.8 9.4 10.3 11.7 10.4 13.0 11.7 9.6 11.3 18.6 22.4 20.2 24.5 18.5 -6.0 s
27-30 10.6 7.4 7.1 6.8 7.9 7.1 6.6 7.9 7.5 6.8 7.8 9.4 8.0 14.6 14.9 13.5 12.4 9.4 -2.9
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 2.2 2.1 1.9 1.6 1.9 1.4 1.3 1.2 0.9 1.4 1.0 0.8 1.0 1.7 2.2 2.2 2.3 2.6 3.1 2.4 2.4 2.9 2.3 2.4 2.6 2.2 -0.4
19-22 1.5 0.9 1.1 1.2 0.7 1.0 0.7 0.6 0.9 0.2 0.5 0.8 0.7 0.9 1.6 1.5 1.0 1.1 1.7 0.8 2.0 2.3 2.2 1.5 1.1 0.6 -0.5
23-26 0.8 0.3 0.5 0.3 0.2 0.3 0.8 0.1 0.4 0.7 0.6 0.8 0.1 0.8 0.7 0.8 0.3 0.6 0.7 1.0 0.8 0.7 -0.1
27-30 0.2 0.1 0.3 0.2 0.0 0.2 0.3 0.1 0.2 0.3 0.2 0.2 0.4 0.6 1.0 0.1 0.0 0.4 +0.4
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Take PCP
   % saying any 18 22.2 17.2 17.3 14.2 14.2 15.9 16.1 15.5 13.5 14.7 13.0 12.0 12.7 15.6 15.5 18.3 20.3 19.7 20.2 16.8 17.5 19.1 17.2 13.6 11.8 10.1 -1.  
19-22 24.1 15.3 15.3 12.6 9.5 8.9 10.1 9.7 10.1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 11.6 6.8 7.4 6.9 5.1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 6.7 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.6 0.9 0.9 1.1 1.1 1.2 1.2 1.1 0.8 1.2 0.5 0.5 0.9 1.9 1.2 1.2 1.3 1.4 1.6 1.5 1.7 1.3 1.0 1.5 1.1 1.0 -0.1
19-22 0.5 0.3 0.3 0.5 0.7 0.7 0.2 0.1 0.3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 0.6 0.0 0.4 0.0 0.2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 0.4 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
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Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 12.4 11.9 10.7 12.8 15.9 20.7 24.2 27.7 24.5 26.7 37.3 41.9 38.0 34.2 28.9 23.1 -5.8 sss
19-22 16.3 14.3 12.0 12.9 13.7 11.3 17.2 20.7 21.4 26.0 30.7 42.4 43.3 43.4 31.3 27.6 28.3 +0.7
23-26 7.6 9.0 9.5 11.0 9.8 11.4 11.2 11.3 15.1 13.7 15.2 25.9 29.4 36.8 27.0 31.2 25.3 -5.9
27-30 5.6 6.3 5.4 4.6 6.6 5.8 6.9 10.1 7.4 8.5 12.4 13.1 17.8 20.6 19.4 20.6 15.6 -5.0
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 2.2 1.7 2.1 1.2 1.7 2.8 3.0 2.6 2.5 2.7 4.8 5.2 3.7 2.7 3.2 2.5 -0.7
19-22 0.4 0.7 0.2 0.7 0.7 0.5 0.5 0.8 1.7 2.0 2.9 4.9 5.8 2.7 1.9 1.9 1.1 -0.8
23-26 0.5 0.2 0.1 0.1 0.5 0.1 0.4 0.1 0.8 0.8 0.4 2.9 1.7 1.2 2.0 1.1 1.3 +0.2
27-30 0.5 0.3 0.0 0.1 0.3 0.2 0.5 0.1 0.3 0.0 0.8 0.4 0.3 0.9 0.5 0.6 0.2 -0.3
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Take cocaine
   % saying any 18 41.6 40.1 40.7 37.6 38.9 43.8 45.6 43.7 37.7 37.4 31.7 26.8 26.3 24.5 26.1 24.8 28.1 28.2 31.2 27.8 27.2 27.1 26.8 23.8 29.3 28.1 -1.2  
19-22 51.0 48.9 49.8 46.5 47.6 45.9 48.3 45.7 42.0 42.7 33.2 29.7 22.8 24.3 21.5 22.0 19.4 22.2 26.8 25.7 24.8 27.4 28.2 25.5 26.2 27.2 +1.0
23-26 52.4 53.2 51.6 50.7 47.1 40.8 34.8 29.0 28.8 27.1 22.3 24.4 18.1 19.7 18.7 20.1 20.3 19.4 23.7 21.9 27.4 25.6 -1.7
27-30 47.9 43.3 38.3 35.7 29.9 27.6 22.6 26.2 20.8 21.5 18.6 20.7 16.5 19.7 16.0 17.0 17.0 17.9 +0.9
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 6.1 6.3 4.9 5.1 5.1 5.8 6.2 5.1 3.4 3.7 2.1 1.5 1.5 2.1 1.5 2.0 2.2 2.0 3.2 2.9 2.0 1.7 1.7 2.4 2.3 2.3 0.0
 19-22 7.0 8.6 7.8 6.1 6.3 6.1 6.1 3.3 3.5 2.1 1.2 1.1 1.0 0.5 1.5 0.9 1.0 0.8 1.5 1.1 1.0 1.8 1.0 1.4 0.7 2.1 +1.4
23-26 9.1 5.3 7.0 4.1 3.1 2.7 2.1 0.6 0.9 0.8 1.0 0.3 0.4 1.1 0.9 0.5 0.8 1.6 1.0 1.6 1.0 1.5 +0.6
27-30 3.8 2.0 2.3 0.9 1.2 0.8 0.8 0.4 0.4 0.6 0.1 0.4 0.4 0.5 0.6 0.3 0.3 0.0 -0.3
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
TABLE 7-2 (cont.)
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4
Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 27.4 25.4 26.1 19.2 17.6 17.8 17.9 20.0 19.2 21.6 22.2 24.4 19.0 21.4 23.4 21.5 18.7 22.5 22.9 +0.  
19-22 23.8 21.8 20.6 14.6 14.3 11.8 13.6 13.8 14.0 9.4 13.1 16.4 15.7 16.5 17.4 18.0 11.8 16.0 14.9 -1.1
23-26 26.4 22.4 19.8 14.4 10.8 10.8 8.8 8.8 11.1 8.2 8.3 8.3 8.8 7.9 8.6 10.1 10.4 10.8 10.8 +0.1
27-30 22.1 18.4 16.6 11.6 10.3 10.2 10.4 10.3 8.6 6.3 6.4 8.7 6.0 7.1 6.4 6.5 5.2 8.5 +3.3
35 4.5 5.1 4.4 3.1 2.8 3.2 3.9 2.8 3.2 2.8 3.1 2.6 -0.5
40 3.8 3.0 2.9 3.5 2.6 2.7 2.6 2.8 +0.2
45 3.7 3.3 2.4 -0.9
   % saying most or all 18 2.2 1.1 2.1 0.6 0.6 0.7 0.9 1.0 1.1 0.9 1.1 1.7 1.5 1.4 0.8 0.8 1.4 1.6 1.6 0.0
19-22 0.7 0.8 1.0 0.6 0.2 0.1 0.3 0.4 0.3 0.5 0.3 0.9 0.9 0.5 0.3 0.2 0.4 0.1 1.0 +0.9
23-26 0.8 0.9 0.8 0.5 0.1 0.1 0.5 0.2 0.0 0.3 0.5 0.4 0.0 0.5 0.3 0.0 0.3 0.5 0.2 -0.3
27-30 1.2 0.9 0.9 0.3 0.0 0.6 0.3 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 +0.1
35 0.6 0.3 0.4 * 0.1 0.3 0.5 0.2 0.3 0.3 0.1 0.2 +0.1
40 * 0.2 0.2 0.1 * 0.0 0.0 0.1 +0.1
45 0.4 0.3 0.2 -0.1
Take cocaine powder
   % saying any 18 NA NA 25.3 24.6 19.8 19.7 18.1 20.7 19.2 22.8 24.8 22.9 22.0 21.3 20.1 22.4 23.2 25.4 23.2 -2.2
19-22 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 14.2 12.9 15.4 11.1 10.4 10.0 10.3 9.4 9.4 8.2 9.2 8.3 -0.9
40 10.8 8.9 8.8 8.8 8.5 7.6 7.6 8.9 +1.3
45 8.3 8.0 7.0 -1.0
   % saying most or all 18 NA NA 2.3 2.5 1.8 2.0 1.6 1.9 1.7 1.9 2.0 1.9 1.9 1.8 1.5 1.9 1.9 3.3 1.7 -1.6 ss
19-22 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 0.8 0.3 0.6 0.4 0.4 0.6 0.7 0.4 0.4 0.4 0.2 0.2 +0.1
40 0.2 0.2 * 0.2 0.1 0.1 0.1 0.2 +0.1
45 0.5 0.5 0.2 -0.3
(Table continued on next page)
TABLE 7-2 (cont.)
Trends in Proportions of Friends Using Drugs






Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 13.0 12.5 13.2 12.0 13.0 14.5 15.3 13.9 12.4 14.0 11.4 11.4 13.2 13.3 14.3 14.5 15.6 15.6 16.5 12.7 14.9 13.1 12.9 10.3 12.7 13.1 +0.  
19-22 11.0 8.1 9.4 7.5 7.1 6.5 8.5 8.5 7.8 6.8 6.5 6.1 4.7 7.0 8.1 10.4 6.7 7.4 9.4 9.7 7.7 8.7 8.9 5.3 7.0 6.4 -0.6
23-26 6.1 4.4 4.3 6.5 3.6 5.2 4.2 3.6 3.8 4.5 4.9 5.8 4.0 6.2 5.8 4.8 4.7 5.0 5.2 6.1 2.9 5.1 +2.2
  27-30 3.8 2.8 4.5 2.7 3.1 3.6 4.2 3.6 4.4 4.2 3.5 3.8 2.8 4.3 3.9 3.4 3.0 3.8 +0.8
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.0 0.5 0.7 0.8 0.8 0.9 1.1 0.9 0.7 1.1 0.4 0.4 0.7 1.1 1.0 1.1 0.9 0.8 1.3 1.0 1.1 0.9 0.7 0.9 0.9 1.1 +0.1
19-22 0.3 0.5 0.1 0.2 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.1 0.2 0.4 0.4 0.4 0.2 0.5 0.1 0.3 0.6 0.0 0.3 0.0 0.3 +0.3
23-26 0.4 0.2 0.2 0.0 0.2 0.4 0.2 0.3 0.4 0.1 0.2 0.2 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 +0.3
27-30 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.  
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Take other narcotics
   % saying any 18 22.4 23.1 23.9 20.8 21.4 22.8 21.8 23.2 19.2 19.2 17.2 13.7 14.9 16.1 18.5 19.5 21.8 22.2 24.8 22.9 23.1 24.0 27.5 21.6 24.6 21.4 -3.2 s
19-22 22.8 20.4 21.9 17.9 17.4 16.9 14.6 15.4 14.1 15.0 12.9 14.1 10.8 13.2 10.5 15.9 13.4 13.2 15.2 19.8 23.2 23.0 21.8 21.9 22.6 19.9 -2.7
23-26 16.0 14.9 14.0 13.0 10.6 10.8 10.5 8.5 8.4 8.7 8.0 10.5 8.9 9.9 9.4 10.4 11.2 13.5 14.6 18.4 16.8 18.3 +1.5
27-30 12.1 8.6 9.1 9.3 7.5 8.2 8.0 7.7 9.5 7.9 8.3 7.2 8.4 11.2 11.8 11.0 12.0 12.5 +0.5
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.7 1.5 1.4 1.4 1.6 1.4 1.8 1.4 1.2 1.4 0.9 0.5 1.1 1.2 1.0 1.6 1.5 1.4 2.9 1.8 2.0 2.0 2.1 2.4 2.4 1.9 -0.5
19-22 0.9 0.7 0.6 0.5 0.8 1.0 0.5 0.4 0.9 0.1 0.6 0.4 0.5 0.6 0.6 0.6 0.4 0.4 0.8 0.4 1.2 1.8 1.3 1.0 0.5 1.0 +0.5
23-26 0.4 0.3 0.7 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.3 0.0 0.4 0.5 0.6 0.6 0.5 0.8 +0.3
27-30 0.3 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.  
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
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Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 43.9 48.8 50.6 46.1 45.1 43.3 41.8 39.5 33.4 33.5 28.7 24.3 24.3 27.5 28.1 30.3 32.2 32.7 33.8 30.8 32.9 33.2 34.4 28.1 31.4 28.8 -2.6  
19-22 54.1 52.2 51.3 49.7 46.1 42.1 38.5 34.5 26.8 29.6 23.3 26.2 19.5 21.0 20.9 21.7 21.6 21.1 24.4 25.5 28.4 28.0 28.6 24.0 23.5 25.9 +2.5
23-26 45.6 40.1 33.5 32.1 28.4 23.1 20.6 17.1 15.1 16.8 16.2 18.2 12.5 14.4 14.1 14.2 14.5 17.5 18.4 18.0 18.8 18.4 -0.4
27-30 26.1 21.6 19.3 17.0 15.3 14.0 13.1 13.7 15.5 12.9 11.0 11.8 11.9 12.9 12.3 12.0 13.5 11.8 -1.8
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 4.8 6.4 5.4 5.1 4.5 3.4 3.4 2.6 1.9 2.6 1.9 1.3 1.3 2.0 1.8 2.0 2.8 2.4 3.4 2.8 3.1 2.2 2.4 2.1 2.9 2.2 -0.7
19-22 3.8 5.7 4.6 3.8 3.3 2.9 1.3 1.9 1.4 0.7 1.0 0.6 0.9 0.2 1.1 1.2 0.7 0.7 1.2 0.7 1.7 1.6 1.3 1.2 0.5 0.7 +0.2
23-26 1.9 1.8 1.7 1.2 0.3 0.6 0.7 0.8 0.4 1.5 0.9 0.5 0.2 0.8 0.5 0.6 0.3 0.5 0.3 0.7 0.1 0.3 +0.1
27-30 0.6 0.4 0.5 0.5 0.1 0.5 0.5 0.3 0.3 0.1 0.3 0.6 0.1 0.5 0.9 0.1 0.0 0.4 +0.4
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Take sedatives/barbituratesc
   % saying any 18 30.5 31.1 31.3 28.3 26.6 27.1 25.6 24.3 19.7 20.3 17.4 14.8 16.4 17.8 18.2 17.8 21.6 20.4 22.8 20.9 21.6 22.1 25.3 18.1 25.2 22.3 -2.9  
19-22 33.2 27.9 27.7 23.6 22.0 17.2 18.8 15.5 14.0 14.1 11.9 12.8 10.7 11.7 9.7 13.3 11.6 12.1 14.8 16.0 15.2 18.6 17.1 14.4 18.8 19.6 +0.8
23-26 22.2 18.7 16.3 14.1 11.2 10.4 8.9 8.3 8.7 8.2 7.6 9.6 6.9 8.4 7.9 8.3 6.6 11.1 10.9 12.9 16.7 15.7 -1.0
27-30 12.0 8.5 8.8 7.1 6.6 6.7 7.4 7.2 6.7 6.5 6.1 5.7 6.4 7.9 7.4 7.3 11.5 10.5 -1.0
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 2.6 2.1 1.8 1.7 1.7 1.6 1.4 1.1 1.1 1.4 0.6 0.5 0.6 1.0 1.1 1.4 1.6 1.1 2.5 1.4 1.7 1.1 1.7 1.9 2.0 1.8 -0.3
19-22 1.1 1.3 1.0 0.8 0.8 0.5 0.3 0.4 0.8 0.1 0.2 0.3 0.1 0.1 0.3 0.8 0.2 0.7 0.4 0.4 1.0 0.9 0.8 0.7 0.3 0.3 -0.1
23-26 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.4 0.0 0.2 0.4 0.2 -0.2
27-30 0.2 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.6 0.1 0.0 0.5 +0.5
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
TABLE 7-2 (cont.)
Trends in Proportions of Friends Using Drugs
High School Seniors (Age 18) and Adults in Modal Age Groups of 19-22, 23-26, 27-30, 35, 40, and 45
(Entries are percentages)




Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 32.5 35.0 35.5 29.7 26.1 26.0 23.5 22.0 17.1 16.6 14.3 12.0 13.1 14.2 14.2 15.5 18.1 16.1 17.4 15.5 16.2 17.8 18.0 14.2 16.6 13.6 -3.0 s
19-22 38.3 36.2 35.4 30.5 24.6 19.9 20.3 16.9 12.5 10.9 10.0 10.6 9.2 10.0 7.8 11.5 10.1 9.3 10.6 11.4 13.1 14.6 13.0 10.3 8.3 8.2 -0.1
23-26 25.7 21.0 17.4 15.0 12.1 10.3 8.6 5.9 6.4 7.6 7.7 9.0 6.3 6.5 6.6 6.4 4.9 7.7 8.5 8.9 6.5 7.7 +1.2
27-30 11.8 7.9 8.2 7.0 7.1 6.5 6.6 4.5 6.9 4.9 4.1 5.1 5.0 4.9 6.6 4.3 4.4 3.6 -0.7
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 3.6 3.6 2.6 2.6 1.7 1.3 1.6 1.0 1.0 1.3 0.8 0.5 0.8 1.1 1.1 1.3 1.7 1.1 2.0 1.4 1.4 1.2 1.2 1.2 1.6 1.3 -0.3
19-22 1.9 2.7 1.2 1.3 1.2 0.6 0.2 0.4 0.4 0.2 0.6 0.2 0.1 0.1 0.2 0.7 0.1 0.6 0.5 0.4 0.9 0.8 0.1 0.4 0.0 0.4 +0.4
23-26 0.6 0.3 0.7 0.2 0.2 0.4 0.2 0.1 0.2 0.6 0.2 0.2 0.0 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.1 0.2 0.0
27-30 0.5 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.3 +0.3
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Take tranquilizers 
   % saying any 18 29.7 29.5 29.9 26.7 26.6 25.8 24.2 23.3 19.9 18.0 14.9 13.5 14.6 15.5 16.5 15.8 18.1 17.9 19.7 16.4 19.4 18.6 21.2 17.2 18.3 16.9 -1.  
19-22 37.5 33.9 28.7 22.9 22.0 19.7 20.6 18.0 16.4 14.8 13.4 13.0 11.3 11.9 9.5 13.6 10.5 11.7 13.7 16.2 16.7 21.3 18.1 14.5 12.3 11.5 -0.8
23-26 29.3 26.3 22.3 20.8 15.5 13.1 14.8 12.1 12.5 11.0 13.4 10.4 10.7 9.6 8.5 9.8 11.2 12.4 14.9 12.9 15.1 13.1 -2.0
27-30 20.1 16.6 16.9 14.9 12.0 12.5 13.9 11.9 11.0 10.8 12.6 10.4 10.6 9.6 10.6 10.4 9.9 9.7 -0.2
35 14.3 12.2 13.1 10.8 10.7 11.4 10.8 12.2 12.5 11.4 12.7 12.4 -0.3
40 13.7 14.8 15.2 15.1 15.6 15.0 13.6 14.1 +0.5
45 17.3 19.8 15.4 -4. ss
   % saying most or all 18 1.9 1.4 1.1 1.2 1.5 1.2 1.3 1.0 0.7 1.5 0.5 0.4 0.7 0.9 0.9 1.1 1.4 0.8 2.3 1.3 2.1 1.3 1.6 1.5 1.7 1.6 -0.1
19-22 0.7 0.9 0.5 0.8 0.3 0.7 0.3 0.6 0.4 0.1 0.4 0.5 0.1 0.1 0.2 0.7 0.7 0.8 0.6 0.3 0.6 0.9 0.4 0.4 0.3 0.3 -0.1
23-26 0.4 0.3 0.5 0.0 0.3 0.4 0.2 0.3 0.1 0.4 0.2 0.0 0.0 1.1 0.1 0.0 0.5 0.8 0.1 0.0 0.5 0.7 +0.2
27-30 0.5 0.3 0.4 0.2 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.4 0.6 0.1 0.0 0.2 +0.2
35 0.5 0.3 0.3 0.1 0.2 0.6 0.6 0.2 0.1 0.2 0.3 0.5 +0.2
40 0.0 0.4 0.1 0.3 0.2 * 0.2 0.2 0.0
45 0.3 0.2 0.2 0.0
(Table continued on next page)
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Trends in Proportions of Friends Using Drugs






Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 96.1 94.7 95.7 95.5 94.6 94.6 95.6 95.4 95.7 95.1 92.0 91.2 90.5 88.9 90.1 90.9 89.6 90.7 91.2 90.2 89.8 89.2 88.0 87.9 87.8 87.2 -0.6
19-22 96.3 96.7 96.6 97.3 96.8 95.8 96.9 95.6 97.0 97.6 96.1 95.2 93.1 95.1 92.5 94.8 93.7 94.5 94.5 92.8 95.2 93.4 94.5 92.5 90.4 95.0 +4. s
23-26 96.8 96.8 96.2 95.9 95.3 95.4 94.7 93.9 95.1 94.4 94.0 94.1 92.7 95.4 95.5 93.3 94.5 93.1 95.3 92.8 94.9 91.6 -3.3
27-30 96.1 96.0 95.2 94.4 95.6 93.4 93.3 93.3 93.1 95.1 93.1 94.4 92.7 91.4 92.8 90.5 94.4 93.7 -0.7
35 89.6 89.9 90.3 89.5 88.1 88.7 89.6 89.3 90.1 87.4 93.4 91.3 -2.1
40 88.4 88.9 90.7 89.6 90.5 89.2 90.5 92.1 +1.6
45 87.9 90.3 89.8 -0.6
   % saying most or all 18 68.9 67.7 69.7 69.0 66.6 66.0 68.0 71.8 68.1 67.1 60.5 58.6 56.9 57.0 59.6 56.4 56.4 60.9 61.0 58.2 57.2 59.2 53.7 53.1 53.9 55.3 +1.  
19-22 76.6 77.6 75.2 75.1 74.9 71.9 74.2 71.3 73.4 74.1 70.0 71.4 67.4 66.5 68.7 63.9 67.0 63.8 69.4 67.8 70.1 65.4 68.8 63.9 66.4 71.8 +5.3
23-26 73.2 74.4 69.5 74.9 68.9 69.8 67.1 69.3 68.8 68.7 70.7 67.0 68.9 66.6 67.4 63.6 70.8 65.7 73.4 66.0 71.3 69.3 -2.0
27-30 66.7 67.8 62.0 62.7 63.3 61.3 63.2 62.6 64.1 66.6 62.9 64.4 64.8 64.9 66.3 61.5 69.0 66.2 -2.8
35 43.8 45.1 49.5 46.6 47.1 46.0 49.1 48.4 52.9 51.6 53.7 55.5 +1.9
40 37.7 41.4 42.5 44.7 44.8 47.2 43.3 47.2 +3.9
45 38.9 41.7 42.4 +0.7
Get drunk at least 
 once a week
   % saying any 18 83.1 81.8 83.1 83.9 81.5 82.5 84.7 85.6 84.4 82.8 79.2 79.8 79.9 79.2 81.4 78.9 78.5 82.4 81.1 81.5 79.5 79.6 78.3 77.3 79.0 78.7 -0.3
19-22 80.9 79.9 80.0 80.4 79.8 76.7 82.0 81.1 80.6 80.4 80.1 80.8 76.5 81.1 79.6 83.2 80.9 79.2 82.3 82.8 82.2 81.9 81.5 81.5 80.5 85.1 +4.6
23-26 73.1 72.7 73.5 73.7 72.1 73.1 72.2 74.0 73.1 74.3 72.1 73.1 74.5 71.9 74.1 71.0 76.5 74.7 81.0 76.4 75.8 80.7 +4.9
27-30 66.3 61.8 65.4 65.2 65.5 64.5 62.7 67.1 66.7 65.4 65.5 65.9 64.3 64.7 68.9 66.5 73.8 72.4 -1.4
35 44.3 43.2 44.9 42.9 46.1 44.5 46.9 47.6 48.3 47.9 52.0 50.7 -1.3
40 41.6 40.6 42.2 41.3 42.6 42.9 43.2 48.4 +5. s
45 41.6 42.2 41.6 -0.6
   % saying most or all 18 30.1 29.4 29.9 31.0 29.6 29.9 31.8 31.3 29.6 31.1 27.5 29.7 28.6 27.6 28.4 27.4 29.0 30.9 31.7 30.1 32.4 32.7 28.3 27.1 27.6 28.5 +0.9  
19-22 21.9 23.3 22.0 20.2 22.7 21.7 20.8 21.3 24.0 22.6 23.6 24.9 22.6 28.8 26.3 28.2 26.0 26.6 29.8 29.3 28.1 30.2 31.0 29.6 29.0 31.2 +2.2
23-26 11.4 11.6 12.5 11.9 12.8 12.0 13.9 11.6 14.6 13.2 15.2 15.2 14.0 17.0 16.0 16.8 17.4 19.1 19.2 18.3 24.0 24.0 0.0
27-30 5.2 6.3 6.7 6.6 5.9 6.7 6.4 7.9 8.6 7.7 9.3 12.1 9.8 11.7 8.9 13.0 9.4 11.2 +1.8
35 3.6 3.6 5.4 3.2 4.4 4.9 4.6 4.8 4.5 5.2 5.3 5.3 0.0
40 2.8 3.0 2.5 2.9 3.8 3.9 3.0 3.6 +0.5
45 3.6 2.7 2.7 0.0
(Table continued on next page)
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Q.  How many of 
your friends would 
you estimate...
Age 




   % saying any 18 90.6 88.5 88.3 87.0 86.0 87.0 87.8 88.3 87.7 86.5 84.9 85.7 84.4 84.8 88.1 87.9 88.3 89.9 89.5 89.3 87.2 86.8 85.4 83.3 83.7 81.8 -1.9
19-22 94.4 94.3 93.4 93.1 91.9 91.6 91.1 90.3 89.3 90.0 86.1 86.1 86.7 86.7 86.1 88.8 89.2 91.3 92.6 91.0 90.9 90.9 89.7 86.5 89.7 89.3 -0.4
23-26 93.9 95.0 91.6 92.1 89.8 90.1 88.7 89.6 85.6 88.3 86.4 86.8 85.3 85.4 88.7 84.1 86.5 86.7 86.4 86.5 87.0 87.3 +0.3
27-30 92.6 89.8 90.7 90.4 88.0 85.8 84.8 84.9 85.4 84.1 81.1 86.3 85.1 84.9 87.0 82.8 83.5 81.0 -2.4
35 72.7 71.7 71.7 72.4 71.8 69.9 70.8 69.2 66.6 67.0 67.7 65.5 -2.2
40 70.2 70.0 67.8 64.3 65.5 65.1 62.4 63.8 +1.4
45 66.1 67.0 62.9 -4.1 s
   % saying most or all 18 23.3 22.4 24.1 22.4 19.2 22.8 21.5 21.0 20.2 23.1 21.4 21.8 21.4 25.0 25.3 27.5 30.4 34.4 33.9 31.1 28.2 25.0 23.0 19.6 20.6 16.7 -3.9 ss
19-22 31.8 27.6 25.6 25.2 25.6 22.7 21.9 22.5 19.3 19.9 19.2 20.2 20.3 22.2 21.7 28.4 24.0 25.1 28.8 26.8 29.4 27.0 25.7 20.2 20.7 20.4 -0.4
23-26 25.6 22.7 19.7 18.5 16.5 20.5 16.9 18.1 16.0 15.5 16.6 13.9 17.6 17.0 16.8 17.5 17.0 15.5 15.1 18.3 19.8 19.6 -0.2
27-30 15.8 14.2 11.6 12.9 11.9 14.3 10.9 12.3 10.4 12.1 12.3 13.4 11.7 10.2 12.9 12.2 9.2 12.6 +3.4
35 7.9 7.2 9.3 7.2 8.0 9.0 6.7 8.8 6.6 6.3 6.9 6.0 -0.9
40 8.1 7.4 6.8 5.7 5.8 5.9 6.0 7.0 +0.9
45 5.7 5.9 6.1 +0.2
Take steroids
   % saying any 18 25.9 24.7 21.5 19.0 18.1 19.5 17.9 18.9 18.3 20.0 19.8 21.7 21.6 21.1 22.8 19.1 -3.6 s
19-22 23.4 21.5 22.2 19.7 20.7 16.8 16.6 16.1 16.8 20.0 20.6 18.9 20.0 19.3 17.1 21.4 20.1 -1.3
23-26 15.3 15.0 12.3 14.5 11.1 10.5 12.4 7.3 13.0 9.2 15.0 12.2 13.6 14.3 12.9 12.4 11.6 -0.8
27-30 9.9 10.5 7.5 8.0 8.0 8.0 8.0 10.2 9.1 7.0 11.2 9.3 10.7 6.4 11.6 10.1 7.4 -2.8
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
   % saying most or all 18 1.8 1.0 1.7 0.9 1.2 1.3 0.8 1.7 1.4 0.9 1.9 1.2 1.5 1.5 2.6 1.5 -1.1 s
19-22 0.2 0.6 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.3 0.1 0.3 0.7 0.7 0.4 0.0 0.1 +0.1
23-26 0.4 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.3 +0.2
27-30 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 +0.1
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
TABLE 7-2 (cont.)
Trends in Proportions of Friends Using Drugs
High School Seniors (Age 18) and Adults in Modal Age Groups of 19-22, 23-26, 27-30, 35, 40, and 45
(Entries are percentages)
(Table continued on next page)
216
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Approx. Weighted 
N= 18 2987 3307 3303 3095 2945 2971 2798 2948 2961 2587 2361 2339 2373 2410 2337 2379 2156 2292 2313 2060 1838 1923 1968 2233 2271 2266
19-22 576 592 564 579 543 554 579 572 562 579 556 526 510 468 435 470 469 467 437 426 402 402 375 388 443 395
23-26 527 534 546 528 528 506 510 507 516 495 449 456 416 419 394 414 387 403 358 362 411 361
27-30 516 507 499 476 478 461 419 450 464 454 428 424 363 359 348 369 396 363
35 1200 1187 1187 1209 1067 1071 1033 1005 918 968 985 1041
40 1098 1156 1144 1119 1083 945 1004 975
45 976 1074 1052
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:   s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding.  
'NA' indicates data not available.
'*' indicates a prevalence rate of less than 0.05% but greater than true zero.
aThese estimates were derived from responses to the questions listed above.  For the young adult sample, "any illicit drug" includes all of the drugs listed except cigarettes and alcohol. For the 
35-, 40-, and 45-year-olds, "any illicit drug" includes marijuana, tranquilizers, crack, cocaine powder, and "other illicit drugs."
bIn 2001 the question text was changed from "other psychedelics" to "other hallucinogens," and "shrooms" was added to the list of examples. These changes likely explain the discontinuity in 
the 2001 results.
cIn 2004 the question text was changed from "barbiturates" to "sedatives/barbiturates" and the list of examples was changed from "downers, goofballs, reds, yellows, etc." to just "downers." 
These changes likely explain the discontinuity in the 2004 results.
TABLE 7-2 (cont.)
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Q.  During the LAST 12 MONTHS 
how often have you been 
around people who were
taking each of the 
following to get high or 
for "kicks"?
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Any illicit druga  
  % saying any exposure 18 84.3 82.7 81.4 79.4 77.9 77.7 75.5 73.9 71.3 68.6 67.6 64.2 61.3 66.1 70.8 75.3 78.0 78.8 77.2 77.9 76.0 76.5 76.5 73.6 74.3 73.0 -1.3
19-22 80.6 81.0 81.5 76.5 76.3 77.4 74.6 72.7 69.5 61.5 60.8 58.9 58.6 58.4 60.7 66.4 67.2 65.3 69.1 65.8 64.7 69.7 65.7 68.0 67.6 68.8 +1.2
23-26 68.9 70.2 68.0 62.4 62.7 58.3 54.6 52.1 48.2 49.9 47.1 54.2 50.3 55.4 50.6 50.5 55.1 56.4 56.5 57.0 53.5 53.9 +0.4
27-30 52.4 50.2 47.0 39.6 41.7 38.9 45.6 42.4 44.9 41.6 37.5 41.1 40.8 42.2 47.0 46.7 43.3 45.7 +2.4
  % saying often exposed 18 36.3 36.1 31.4 29.8 28.3 27.2 26.3 23.3 20.8 22.0 20.7 18.2 18.0 24.0 29.3 32.3 33.8 34.7 33.2 35.6 32.6 33.6 32.6 31.8 30.4 29.9 -0.4
19-22 34.6 34.0 32.1 24.4 24.4 23.7 21.1 18.9 19.9 16.2 16.4 17.6 21.4 16.1 18.1 23.7 20.4 25.3 24.2 24.0 21.3 26.1 25.2 26.5 26.8 25.2 -1.6
23-26 20.7 23.3 18.5 17.4 18.2 13.8 13.7 13.3 12.2 11.1 11.1 12.5 12.8 14.3 14.2 15.0 15.9 16.4 15.9 17.8 15.1 18.7 +3.7
27-30 13.7 12.0 10.8 8.2 10.5 9.0 12.5 8.5 10.1 10.3 8.5 9.6 9.4 10.4 13.8 13.9 10.3 14.5 +4.1
Any illicit druga other 
than marijuana
  % saying any exposure 18 58.5 62.6 62.5 59.4 59.8 59.3 55.3 51.7 47.8 47.1 45.4 40.0 41.6 42.6 45.3 47.2 49.7 47.9 47.3 46.5 47.2 49.9 49.3 46.3 48.3 45.9 -2.5
19-22 56.9 58.4 61.6 54.9 57.1 53.3 53.4 48.5 46.4 36.5 39.4 33.8 37.1 29.4 33.9 36.8 36.5 39.4 40.0 36.4 38.1 39.2 38.0 40.2 40.9 41.1 +0.2
23-26 51.5 51.9 51.5 43.6 42.9 36.8 34.0 30.0 27.3 27.8 24.9 26.8 23.2 25.6 27.1 28.0 31.0 31.4 31.5 32.2 32.6 32.3 -0.3
27-30 35.8 33.7 31.5 25.8 26.6 24.2 25.8 21.1 21.8 21.4 15.4 19.5 17.2 22.2 23.1 26.1 23.2 27.1 +3.9
  % saying often exposed 18 14.1 17.1 16.6 14.2 14.6 12.9 12.1 10.2 9.6 10.7 9.2 7.9 7.5 9.6 9.4 11.1 12.1 11.7 9.9 11.7 10.5 11.9 12.6 10.8 11.4 10.6 -0.8
19-22 11.8 15.6 13.5 11.1 10.7 10.2 8.2 8.1 7.5 6.7 4.5 4.4 5.5 4.1 5.1 7.7 3.9 7.6 7.0 4.8 6.4 7.8 8.6 5.2 7.9 8.0 +0.1
23-26 9.0 10.4 9.3 8.5 6.7 5.0 5.1 3.5 2.6 3.0 2.2 3.5 3.4 3.1 3.1 4.3 3.5 3.4 5.0 5.4 5.4 4.0 -1.3
27-30 6.0 4.7 4.1 3.2 3.7 2.4 3.4 2.9 3.4 3.2 1.0 2.5 1.6 3.7 4.7 4.9 2.4 5.6 +3. s
Marijuana 
  % saying any exposure 18 82.0 80.2 77.9 76.2 74.4 73.5 72.0 70.4 67.0 64.8 63.4 59.6 56.8 61.0 67.2 72.7 75.6 76.8 75.5 75.8 73.8 74.9 74.2 71.4 72.2 70.8 -1.4
19-22 79.8 79.8 78.7 72.7 74.1 75.5 72.4 70.5 66.3 59.3 57.5 55.0 56.4 55.4 56.8 64.0 64.8 63.4 67.1 63.5 63.9 68.0 64.6 64.8 65.1 66.8 +1.8
23-26 65.3 66.0 64.1 59.0 57.6 55.0 50.6 47.9 44.6 45.9 44.4 51.0 47.8 53.1 48.8 48.1 51.8 54.2 53.5 54.4 50.6 49.7 -0.9
27-30 49.1 47.4 42.1 36.0 38.2 35.3 41.9 38.3 41.8 39.1 35.7 38.7 38.8 37.0 44.6 44.1 40.4 42.4 +2.0
  % saying often exposed 18 33.8 33.1 28.0 26.1 24.8 24.2 24.0 20.6 17.9 19.5 17.8 16.0 15.6 20.9 27.6 30.7 31.8 32.9 31.4 34.4 30.3 30.8 30.7 30.4 28.0 27.0 -1.0
19-22 32.6 30.5 30.3 21.1 21.9 20.3 18.6 16.4 18.3 14.2 14.7 15.9 19.9 14.7 17.0 22.1 20.3 23.7 22.8 23.0 20.4 24.5 24.8 24.2 24.5 23.6 -0.9
23-26 17.5 20.6 14.6 14.8 15.6 11.6 11.2 11.6 10.9 10.4 10.4 11.1 11.5 12.9 13.6 13.2 15.2 15.6 14.9 16.2 13.7 17.8 +4.0
27-30 10.9 9.8 8.5 6.7 8.9 7.6 10.7 7.4 9.1 8.9 8.1 8.8 8.6 8.4 11.7 11.7 9.6 12.2 +2.6
TABLE 7-3
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Q.  During the LAST 12 MONTHS 
how often have you been 
around people who were
taking each of the 
following to get high or 
for "kicks"?
Age 




  % saying any exposure 18 17.2 17.4 16.1 13.8 12.5 13.2 13.1 12.9 13.4 15.0 14.9 15.7 17.8 21.0 24.2 26.1 27.6 25.9 23.1 23.6 22.0 21.6 17.2 14.2 12.4 10.8 -1.6  
19-22 17.4 15.8 16.0 13.5 12.8 12.7 10.8 10.9 12.0 12.0 12.1 13.1 19.3 13.4 16.5 18.6 20.7 22.3 21.0 20.1 15.9 15.2 13.6 10.0 8.5 7.2 -1.2
23-26 8.3 9.3 8.8 7.3 6.3 6.7 8.4 8.6 8.8 7.8 8.4 9.9 8.6 7.6 9.8 9.4 9.8 11.1 9.3 5.5 4.4 4.7 +0.3
27-30 3.6 3.2 3.3 3.6 3.9 4.9 5.3 5.5 4.3 3.9 3.2 3.7 3.2 4.3 4.8 3.0 4.7 4.0 -0.8
  % saying often exposed 18 1.4 2.0 1.9 1.4 1.5 1.3 1.6 1.8 1.6 2.2 2.6 2.9 3.0 3.9 4.2 6.1 4.7 5.1 3.2 4.1 3.3 2.8 2.6 1.8 1.6 1.5 -0.1
19-22 1.4 1.5 1.4 0.6 0.8 0.7 0.5 1.2 0.6 1.1 1.2 1.0 2.0 1.1 0.4 3.6 1.4 1.8 2.0 1.7 1.4 2.4 0.9 0.2 0.1 0.7 +0.6
23-26 0.3 0.4 0.4 0.7 0.6 0.3 0.5 0.2 0.8 0.3 0.5 0.5 0.4 0.2 0.1 0.3 0.2 0.0 0.3 0.3 0.0 0.3 +0.3
27-30 0.3 0.2 0.5 0.2 0.2 0.5 0.5 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.6 +0.3
Other psychedelics/
 hallucinogensb 18 20.4 17.6 16.8 13.1 12.7 12.5 11.8 10.0 9.0 8.8 9.4 9.4 9.7 12.1 14.0 15.8 16.6 17.8 15.9 17.7 16.3 28.1 26.4 25.8 24.8 24.3 -0.4
  % saying any exposure 19-22 18.3 16.3 16.3 12.5 10.5 11.0 9.2 9.1 7.7 8.4 8.3 8.9 10.6 6.7 8.3 12.8 13.1 15.0 15.0 12.4 11.8 22.8 23.4 18.9 18.7 19.5 +0.8
23-26 8.4 8.9 9.1 6.0 5.1 4.8 5.7 5.5 5.1 5.7 5.2 5.5 6.9 5.6 8.7 5.8 8.9 14.8 14.7 11.9 10.1 11.3 +1.1
27-30 5.0 3.4 3.4 3.4 2.1 3.7 3.4 4.2 3.2 2.9 2.6 3.0 3.0 6.4 7.7 6.3 7.9 8.8 +0.9
  % saying often exposed 18 2.2 2.0 2.6 1.1 1.7 1.4 1.5 1.2 1.1 1.3 1.2 1.3 1.1 1.9 2.3 2.5 2.7 2.8 1.7 2.7 2.1 3.6 4.5 3.2 3.2 2.6 -0.6
19-22 1.1 0.9 0.9 0.7 0.8 0.8 0.2 0.8 0.3 0.4 0.4 0.5 0.7 0.4 0.2 1.6 0.7 0.7 0.5 0.6 0.8 2.6 2.4 0.4 0.7 1.2 +0.5
23-26 0.1 0.3 0.5 0.6 0.8 0.1 0.4 0.4 0.0 0.2 0.4 0.3 0.3 0.2 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.5 +0.5
27-30 0.2 0.4 0.5 0.3 0.1 0.5 0.2 0.3 0.2 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.6 +0.3
Cocaine
  % saying any exposure 18 37.7 36.3 34.9 33.3 35.6 38.3 37.4 34.9 30.2 30.2 27.7 21.3 19.8 19.2 18.8 21.6 25.0 25.6 26.6 25.8 24.2 24.5 24.9 24.8 24.4 25.7 +1.3
19-22 37.6 42.3 43.6 36.6 38.9 39.4 41.5 37.0 36.2 26.6 24.0 18.5 19.8 13.5 14.7 14.1 19.3 18.8 21.6 18.5 19.1 20.6 22.5 18.4 23.6 22.7 -0.9
23-26 38.5 40.6 42.0 34.5 35.9 28.0 24.0 19.9 16.7 14.6 14.3 14.1 12.5 14.0 16.0 18.2 16.4 16.9 18.3 17.4 18.7 19.2 +0.5
27-30 28.9 28.3 24.2 18.6 19.4 16.6 14.3 11.4 12.1 11.4 8.6 11.6 10.2 11.6 12.2 12.6 13.0 15.8 +2.7
  % saying often exposed 18 5.9 6.6 6.6 5.2 6.7 7.1 7.8 5.9 5.1 5.4 4.7 3.4 2.7 2.9 2.5 3.2 4.0 4.2 3.7 4.6 4.6 4.5 5.3 5.0 4.7 4.2 -0.5
19-22 5.8 7.6 6.5 4.3 6.5 7.0 5.4 5.2 4.8 4.3 2.2 1.6 1.7 1.7 1.8 1.7 1.2 2.4 3.2 1.4 3.8 3.0 4.1 1.6 2.6 4.0 +1.4
23-26 5.3 8.5 7.0 6.0 5.4 3.5 2.5 1.7 1.4 1.7 1.0 1.7 1.3 1.8 1.5 2.2 1.8 1.0 2.5 1.9 2.9 1.8 -1.1
27-30 4.4 3.9 2.9 2.2 2.0 1.2 1.5 1.4 1.9 1.6 0.8 1.5 0.3 1.6 2.4 1.7 0.7 2.4 +1.6
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Q.  During the LAST 12 MONTHS 
how often have you been 
around people who were
taking each of the 
following to get high or 
for "kicks"?
Age 




  % saying any exposure 18 7.4 6.6 7.1 5.1 6.0 5.5 6.0 5.8 5.7 6.5 5.4 5.1 5.4 5.7 7.3 7.9 8.6 9.1 8.7 8.1 9.1 8.7 8.3 7.3 6.6 7.3 +0.8
19-22 4.4 3.3 4.1 2.9 3.1 4.8 2.9 2.9 2.9 2.9 2.5 3.0 2.7 2.0 3.7 3.8 3.6 3.7 6.4 3.2 5.2 3.2 5.3 3.4 3.0 3.2 +0.2
23-26 2.3 3.3 3.2 2.9 1.7 2.3 2.3 1.8 1.7 1.5 1.9 2.8 2.9 2.7 3.1 2.9 2.6 2.4 3.8 2.0 3.1 2.6 -0.5
27-30 2.1 1.4 1.5 0.9 1.0 2.0 2.0 1.7 1.5 1.3 1.4 1.9 1.9 2.3 2.7 1.3 3.2 2.9 -0.2
  % saying often exposed 18 0.4 0.6 1.0 0.7 1.1 0.5 1.0 0.9 0.8 1.0 0.5 0.9 0.7 1.1 0.7 1.2 1.6 1.2 0.9 1.3 1.5 0.7 1.3 1.2 1.2 0.8 -0.  
19-22 0.2 0.3 0.3 0.1 0.2 0.5 0.2 0.1 0.2 0.1 0.2 0.4 0.6 0.4 0.6 1.2 0.2 0.4 0.7 0.8 0.7 0.8 0.6 0.2 0.0 0.8 +0.8
23-26 0.0 0.7 0.3 0.6 0.4 0.3 0.6 0.3 0.0 0.0 0.0 0.2 0.2 0.3 0.5 1.0 0.0 0.0 0.8 0.5 0.5 0.3 -0.2
27-30 0.3 0.3 0.5 0.2 0.2 0.9 0.3 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.0 0.4 +0.4
Other narcotics
  % saying any exposure 18 19.6 17.5 18.5 17.3 18.0 18.4 15.6 14.4 14.8 13.8 14.2 11.3 11.1 12.4 14.9 15.5 18.5 20.4 20.7 21.9 21.1 21.6 22.5 21.8 20.3 19.0 -1.3
19-22 14.4 14.4 15.2 10.9 12.4 13.7 9.8 12.2 11.2 9.0 9.4 9.2 8.5 6.8 10.1 12.1 11.5 14.5 15.3 13.9 17.0 18.3 18.7 13.6 14.5 16.8 +2.2
23-26 9.0 12.3 9.2 9.7 7.4 8.0 5.9 8.3 7.0 4.6 6.9 7.8 7.4 6.5 8.1 9.4 10.9 12.2 12.0 12.6 12.6 12.4 -0.2
27-30 6.5 6.5 5.8 5.5 3.7 5.6 5.9 5.7 4.7 4.9 3.6 5.2 6.5 9.0 7.9 9.5 8.8 11.6 +2.8
  % saying often exposed 18 1.7 1.7 2.4 2.2 2.0 1.8 2.1 1.7 1.7 1.7 1.6 1.4 1.3 1.7 1.7 2.1 3.4 2.5 2.8 3.9 2.9 3.0 3.8 3.0 3.3 2.6 -0.7
19-22 0.7 0.5 0.5 0.9 0.7 1.0 0.5 0.4 0.9 0.3 0.2 1.0 0.9 0.6 0.8 1.4 0.7 1.5 1.7 1.1 2.4 1.6 3.0 1.2 0.8 2.4 +1.6
23-26 0.4 0.5 1.3 0.8 0.8 0.5 1.6 0.7 0.1 0.3 0.1 0.1 0.3 0.7 0.5 1.1 0.7 1.0 0.9 1.6 1.4 1.3 0.0
27-30 0.7 0.5 1.0 0.3 0.8 1.2 0.8 0.8 0.7 0.5 0.0 0.2 1.1 1.0 0.7 1.2 0.1 1.7 +1. s
Amphetamines
  % saying any exposure 18 40.8 49.5 50.2 46.1 45.0 41.0 36.5 31.7 27.9 27.4 28.3 23.6 24.5 24.7 28.2 28.1 31.5 31.0 29.9 30.1 29.5 31.5 30.6 27.4 27.2 26.4 -0.8
19-22 42.3 48.6 48.4 39.7 41.3 35.9 31.3 26.7 21.2 18.5 19.5 17.4 21.3 15.1 20.3 21.0 22.3 24.6 24.8 21.2 24.8 23.3 25.5 21.6 23.7 22.2 -1.4
23-26 32.3 30.5 29.1 20.9 18.8 14.0 16.8 14.6 11.8 13.2 11.2 13.0 11.1 11.7 14.6 12.3 18.5 18.2 17.9 15.4 18.8 15.6 -3.2
27-30 15.6 14.3 13.5 10.7 11.4 11.3 11.0 10.6 7.6 9.1 6.6 10.4 7.4 11.1 11.5 12.2 11.4 12.2 +0.8
  % saying often exposed 18 8.3 12.1 12.3 10.1 9.0 6.5 5.8 4.5 4.1 4.7 4.1 3.1 3.0 3.9 4.1 4.5 5.6 5.2 4.7 6.3 4.4 6.0 6.4 4.9 5.3 4.1 -1.2
19-22 7.4 9.9 7.7 6.9 5.4 4.4 3.1 3.3 2.2 1.5 1.1 1.9 2.6 1.5 3.3 5.0 1.3 4.1 2.9 2.2 2.4 2.6 5.6 1.7 4.1 3.1 -0.9
23-26 3.9 3.2 2.2 3.3 1.9 0.7 2.0 1.3 0.2 0.8 0.9 1.6 1.3 1.4 2.2 1.7 1.4 2.2 0.7 1.3 1.7 1.6 -0.1
27-30 2.0 2.0 1.2 0.8 0.8 1.3 0.7 1.6 1.8 1.0 0.2 1.1 0.4 0.6 1.5 1.0 1.2 1.0 -0.2
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Q.  During the LAST 12 MONTHS 
how often have you been 
around people who were
taking each of the 
following to get high or 
for "kicks"?
Age 




  % saying any exposure 18 25.2 25.9 25.7 22.5 21.2 18.9 15.8 13.1 12.4 11.8 13.3 10.0 10.2 11.9 13.0 14.5 15.5 16.1 16.1 17.1 16.3 17.1 17.7 14.8 21.5 20.4 -1.2  
19-22 25.6 23.1 21.8 18.3 15.7 14.7 12.8 12.0 8.2 8.3 6.5 7.9 7.3 7.2 7.4 10.1 8.8 11.7 13.4 11.6 13.1 13.1 16.0 11.9 17.2 17.8 +0.6
23-26 16.1 13.1 11.0 7.1 7.1 6.6 6.9 5.9 6.5 3.8 4.2 5.7 6.6 4.9 8.5 7.1 9.3 9.0 9.8 7.9 15.9 12.5 -3.4
27-30 8.0 6.8 5.9 5.4 5.2 5.7 4.5 5.2 3.5 3.8 2.7 4.1 2.9 5.3 6.0 6.1 9.2 12.4 +3.3
  % saying often exposed 18 3.4 4.0 4.3 3.0 2.7 1.7 2.1 1.5 1.4 1.7 1.7 1.2 1.1 1.6 1.7 2.0 2.9 2.5 2.7 3.8 2.7 2.7 4.6 2.8 4.1 3.7 -0.  
19-22 2.5 2.8 1.1 1.4 0.7 1.3 0.5 0.7 0.7 0.3 0.7 0.4 0.7 0.7 1.3 1.3 0.4 0.9 1.4 0.9 1.6 1.2 1.8 0.8 1.7 2.1 +0.4
23-26 0.7 0.9 1.7 0.8 0.6 0.3 1.1 0.3 0.3 0.0 0.0 0.2 0.3 0.8 0.5 0.9 0.7 0.2 0.3 0.4 0.7 1.1 +0.4
27-30 0.7 0.4 0.6 0.2 0.4 1.2 0.2 0.6 0.5 0.2 0.0 0.6 0.2 0.9 0.4 0.6 0.4 1.7 +1.3
Tranquilizersb
  % saying any exposure 18 29.1 29.0 26.6 23.5 23.1 23.4 19.6 18.4 18.2 15.1 16.3 14.2 12.7 13.8 16.5 15.7 17.9 18.9 17.3 18.2 17.7 23.8 22.7 21.0 22.1 20.9 -1.1
19-22 29.6 26.9 28.5 19.5 21.2 19.5 16.4 18.5 13.8 12.0 12.7 12.6 11.0 10.0 12.0 11.8 10.7 15.6 16.9 14.3 18.5 21.3 23.6 20.0 21.9 20.6 -1.2
23-26 23.1 21.0 16.9 15.9 13.4 12.9 12.0 10.4 9.7 10.9 9.8 10.3 10.1 9.4 10.9 10.8 12.3 16.4 20.1 18.7 19.9 20.1 +0.2
27-30 15.0 11.6 11.1 9.7 10.3 10.4 9.0 11.2 9.6 9.6 6.1 8.8 7.6 12.6 13.6 15.3 14.6 18.1 +3.6
  % saying often exposed 18 3.2 4.2 3.5 2.9 2.9 2.2 2.5 2.6 2.2 2.1 1.9 1.4 1.9 1.7 1.8 2.3 3.5 3.2 2.8 3.7 3.5 4.9 5.8 4.2 4.1 4.5 +0.4
19-22 3.2 2.6 1.8 2.1 1.5 1.7 0.9 1.1 1.8 1.0 1.1 1.1 1.5 1.1 1.3 1.5 0.5 1.3 1.6 1.5 1.7 3.1 3.6 2.3 2.7 2.7 0.0
23-26 2.0 1.6 2.6 1.8 1.2 0.8 0.5 1.0 0.6 0.7 0.1 1.1 1.5 0.7 1.1 1.5 1.7 1.3 2.1 1.6 2.0 1.3 -0.7
27-30 1.4 0.3 1.7 0.8 1.3 1.3 1.0 1.1 0.8 1.2 0.2 0.9 0.4 1.6 1.6 1.9 0.8 3.5 +2. s
Alcoholic beverages
  % saying any exposure 18 94.7 94.0 94.0 94.0 94.0 94.0 94.1 93.9 93.1 92.3 93.6 91.7 90.6 91.8 90.0 91.2 91.5 91.4 92.2 91.8 90.7 90.8 89.5 88.3 87.6 87.4 -0.2
19-22 94.3 93.8 94.5 93.4 94.2 92.7 93.6 94.4 92.5 91.8 92.4 94.0 93.3 92.9 93.7 93.1 93.7 93.1 91.8 91.0 93.3 94.3 93.7 93.6 92.5 92.7 +0.2
23-26 90.3 92.7 91.4 90.6 91.1 92.9 91.3 91.0 91.4 90.3 89.5 91.9 89.6 93.1 89.1 91.5 92.1 90.1 91.9 91.8 92.2 90.0 -2.2
27-30 87.1 88.4 86.2 87.7 87.3 86.6 86.2 89.3 89.2 86.4 88.4 88.7 89.8 91.2 89.0 90.0 85.3 92.2 +7. ss
  % saying often exposed 18 60.2 61.0 59.3 60.2 58.7 59.5 58.0 58.7 56.4 55.5 56.1 54.5 53.1 51.9 54.0 54.0 54.5 53.9 54.5 53.5 50.2 52.7 50.8 49.0 48.2 49.1 +0.9
19-22 59.6 61.2 62.5 56.6 59.3 61.8 59.9 61.4 55.4 53.8 56.0 53.9 56.1 56.8 57.0 56.3 52.3 54.2 57.9 54.7 54.3 53.4 54.9 55.7 54.3 58.9 +4.6
23-26 52.1 54.8 51.4 53.0 48.1 50.9 49.7 48.4 45.4 45.4 43.3 47.5 44.8 49.8 44.6 45.7 49.6 48.8 46.3 50.5 48.3 46.4 -1.9
27-30 39.9 39.5 38.7 38.0 39.9 38.1 39.3 38.0 34.7 37.1 36.6 38.3 34.4 40.0 39.6 40.6 36.8 43.6 +6.  
Approx. Weighted  N= 18 3259 3608 3645 3334 3238 3252 3078 3296 3300 2795 2556 2525 2630 2730 2581 2608 2407 2595 2541 2312 2153 2147 2162 2454 2456 2469
19-22 582 574 601 569 578 549 591 582 556 567 567 532 528 489 460 464 485 471 445 450 415 412 403 396 432 377
23-26 533 532 557 529 531 514 523 494 532 513 471 467 447 424 400 398 389 406 345 385 404 374
27-30 522 507 506 478 502 457 425 452 432 455 449 430 395 369 359 347 370 370
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:   s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change and prevalence estimates for the two 
most recent years is due to rounding.
aThese estimates were derived from responses to the questions listed above.  For the young adult sample, "any illicit drug" includes all of the drugs listed except cigarettes and alcohol. 
bIn 2001 the question text was changed from "other psychedelics" to "other hallucinogens," and "shrooms" was added to the list of examples. For tranquilizers, Xanax was added to the list of 
examples. These changes likely explain the discontinuity in the 2001 results. 
cIn 2004 the question text was changed from "barbiturates" to "sedatives/barbiturates" and the list of examples was changed from "downers, goofballs, reds, yellows, etc." to just "downers." These 
changes likely explain the discontinuity in the 2004 results.
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Q. How difficult do you 
think it would be for 
you to get each of the  
following types of 
drugs, if you wanted 
some?
Percentage saying "fairly easy" or "very easy" to get a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Marijuana 18 89.0 89.2 88.5 86.2 84.6 85.5 85.2 84.8 85.0 84.3 84.4 83.3 82.7 83.0 85.5 88.5 88.7 89.6 90.4 88.9 88.5 88.5 87.2 87.1 85.8 85.6 -0.2
19-22 95.6 91.1 92.4 89.7 88.3 89.5 87.2 85.9 87.1 87.1 86.2 86.0 87.8 85.6 87.2 87.9 89.3 90.6 89.9 87.4 89.6 91.7 88.1 87.7 87.3 88.0 +0.7
23-26 92.5 88.8 88.8 90.3 86.9 88.7 83.3 82.5 83.8 84.6 87.1 86.2 85.3 84.4 87.5 85.9 88.4 87.0 89.1 87.2 88.8 87.0 -1.8
27-30 89.3 86.0 83.1 83.8 80.7 82.8 80.3 83.3 82.6 84.5 82.1 83.0 81.5 84.8 83.6 81.8 86.0 84.6 -1.4
35 75.7 75.6 73.0 77.1 76.0 74.9 77.1 75.3 76.5 75.1 75.6 73.8 -1.8
40 73.4 71.7 73.1 70.4 72.1 72.3 68.9 73.6 +4.7 s
45 68.5 69.9 70.1 +0.2
Amyl & butyl nitrites 18 NA NA NA NA NA NA NA 23.9 25.9 26.8 24.4 22.7 25.9 25.9 26.7 26.0 23.9 23.8 25.1 21.4 23.3 22.5 22.3 19.7 20.0 19.7 -0.4
19-22 NA NA NA NA NA NA NA 22.8 26.0 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 NA NA NA 23.1 28.0 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 26.7 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
LSD 18 35.3 35.0 34.2 30.9 30.6 30.5 28.5 31.4 33.3 38.3 40.7 39.5 44.5 49.2 50.8 53.8 51.3 50.7 48.8 44.7 46.9 44.7 39.6 33.6 33.1 28.6 -4.5 ss
19-22 39.6 38.4 35.1 31.8 32.7 29.6 30.5 29.9 33.9 36.4 36.6 37.8 42.5 44.9 43.7 50.5 50.8 47.7 51.1 43.8 47.1 42.5 37.9 34.1 30.3 27.7 -2.6
23-26 32.7 29.1 30.0 27.5 32.7 32.6 30.2 32.8 33.5 33.4 40.1 41.0 43.6 39.2 40.4 41.2 40.4 38.3 37.2 34.1 38.5 26.5 -12.0 sss
27-30 29.4 29.9 32.3 27.0 30.9 30.5 27.2 35.6 33.6 35.2 32.9 35.7 35.6 38.3 32.3 33.5 30.0 29.3 -0.7
35 33.8 32.4 28.4 32.9 31.2 27.7 32.2 28.7 29.1 29.8 25.6 24.0 -1.7
40 31.1 31.0 28.5 25.7 27.4 25.0 24.4 24.3 -0.2
45 24.2 27.0 25.4 -1.6
Other psychedelics/ 18 35.0 32.7 30.6 26.6 26.6 26.1 24.9 25.0 26.2 28.2 28.3 28.0 29.9 33.5 33.8 35.8 33.9 33.9 35.1 29.5 34.5 48.5 47.7 47.2 49.4 45.0 -4.4 s
  hallucinogensb 19-22 42.1 37.7 33.5 31.0 28.9 28.7 26.3 27.5 28.7 28.1 28.9 26.6 28.3 29.5 28.6 31.5 31.5 33.4 34.1 31.1 33.4 45.9 48.8 45.1 46.9 48.5 +1.6
23-26 31.8 29.6 26.4 25.6 29.6 28.7 27.0 25.7 27.7 25.3 28.3 29.2 32.6 31.0 32.4 31.5 28.5 38.3 39.7 39.2 44.4 39.2 -5.2
27-30 28.6 29.6 30.8 24.9 24.8 25.4 24.7 29.3 25.9 28.0 25.2 30.3 25.0 38.6 33.3 35.6 31.2 30.8 -0.4
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
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Q. How difficult do you 
think it would be for 
you to get each of the  
following types of 
drugs, if you wanted 
some?
Percentage saying "fairly easy" or "very easy" to get a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
PCP 18 NA NA NA NA NA NA NA 22.8 24.9 28.9 27.7 27.6 31.7 31.7 31.4 31.0 30.5 30.0 30.7 26.7 28.8 27.2 25.8 21.9 24.2 23.2 -1.0  
19-22 NA NA NA NA NA NA NA 21.7 24.6 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
23-26 NA NA NA 21.2 27.6 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
27-30 24.3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA —
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
MDMA (ecstasy) 18 NA NA NA NA NA NA NA NA NA 21.7 22.0 22.1 24.2 28.1 31.2 34.2 36.9 38.8 38.2 40.1 51.4 61.5 59.1 57.5 47.9 40.3 -7.7 sss
19-22 NA NA NA NA NA NA NA NA NA NA 26.6 24.9 27.1 23.9 27.0 29.3 33.4 35.6 39.4 43.2 49.9 55.5 59.7 52.1 45.8 43.5 -2.4
23-26 NA NA NA NA NA NA 21.4 23.1 26.4 24.0 26.0 27.8 28.7 31.1 30.1 34.9 41.8 51.5 52.9 49.3 51.3 46.4 -4.8
27-30 NA NA 27.1 20.8 22.2 22.8 21.9 27.1 29.3 24.3 26.4 30.0 35.5 40.6 41.2 41.0 41.1 38.0 -3.1
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Cocaine 18 47.9 47.5 47.4 43.1 45.0 48.9 51.5 54.2 55.0 58.7 54.5 51.0 52.7 48.5 46.6 47.7 48.1 48.5 51.3 47.6 47.8 46.2 44.6 43.3 47.8 44.7 -3.1  
19-22 55.7 56.2 57.1 55.2 56.2 56.9 60.4 65.0 64.9 66.8 61.7 54.3 54.5 49.2 49.9 49.4 44.4 49.7 47.7 52.6 52.1 49.6 47.6 46.7 47.0 50.0 +3.0
23-26 63.7 67.2 65.8 69.0 71.7 70.0 65.6 58.0 61.1 53.8 54.4 54.7 50.2 46.9 51.8 45.7 45.0 44.6 47.8 40.8 50.7 48.4 -2.2
27-30 68.6 68.2 64.0 60.0 63.1 56.8 53.1 57.0 53.0 50.4 46.9 50.0 44.6 45.5 46.3 42.9 38.0 43.1 +5.2
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Crack 18 NA NA NA NA NA NA NA 41.1 42.1 47.0 42.4 39.9 43.5 43.6 40.5 41.9 40.7 40.6 43.8 41.1 42.6 40.2 38.5 35.3 39.2 39.3 +0.1  
19-22 NA NA NA NA NA NA NA 41.9 47.3 47.2 46.9 42.1 42.1 38.4 41.6 40.7 32.9 39.9 40.0 40.8 40.2 37.3 35.7 37.5 33.7 34.0 +0.3
23-26 NA NA NA 44.5 53.0 49.9 46.9 42.0 42.6 42.5 42.4 42.3 37.9 37.2 38.4 35.0 31.9 37.1 33.9 32.8 36.5 35.1 -1.4
27-30 46.5 46.8 46.8 43.1 45.2 45.8 41.1 44.7 39.9 36.5 33.3 38.8 35.9 36.9 33.4 33.7 28.0 34.4 +6.5  
35 49.6 48.2 43.1 44.3 45.0 41.6 45.0 41.2 38.9 40.5 36.1 34.2 -1.9
40 43.3 44.3 42.0 38.7 39.5 39.0 35.8 38.6 +2.8
45 37.0 40.0 40.6 +0.6
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Q. How difficult do you 
think it would be for 
you to get each of the  
following types of 
drugs, if you wanted 
some?
Percentage saying "fairly easy" or "very easy" to get a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Cocaine powder 18 NA NA NA NA NA NA NA 52.9 50.3 53.7 49.0 46.0 48.0 45.4 43.7 43.8 44.4 43.3 45.7 43.7 44.6 40.7 40.2 37.4 41.7 41.6 -0.1  
19-22 NA NA NA NA NA NA NA 58.7 60.2 61.7 56.5 52.5 48.9 45.7 47.8 45.5 41.3 46.0 47.1 45.2 45.2 43.3 43.9 45.5 43.2 44.3 +1.1
23-26 NA NA NA 64.9 69.1 60.1 58.6 53.2 56.4 50.5 49.7 49.6 45.9 43.6 44.4 44.3 41.8 44.4 40.7 43.4 48.5 45.1 -3.4
27-30 63.5 62.8 57.9 55.8 56.8 55.0 48.9 52.9 48.4 45.1 43.9 46.5 43.9 42.7 42.4 39.7 37.9 40.2 +2.2
35 53.9 52.1 46.7 48.3 47.0 43.4 47.9 43.1 41.7 42.0 39.6 35.8 -3.8
40 46.0 46.7 44.7 41.5 41.5 40.7 38.5 40.3 +1.8
45 39.0 40.2 40.6 +0.4
Heroin 18 21.2 19.2 20.8 19.3 19.9 21.0 22.0 23.7 28.0 31.4 31.9 30.6 34.9 33.7 34.1 35.1 32.2 33.8 35.6 32.1 33.5 32.3 29.0 27.9 29.6 27.3 -2.3
19-22 18.9 19.4 19.3 16.4 17.2 20.8 21.2 24.4 28.5 31.6 30.7 25.3 30.2 30.0 33.2 35.2 29.1 31.4 32.1 32.7 29.4 30.2 26.4 26.9 22.6 25.4 +2.9
23-26 18.6 18.1 21.0 22.3 28.4 31.2 28.1 25.6 25.7 25.7 29.2 29.3 32.3 30.5 35.1 31.9 25.7 26.6 27.2 25.5 30.9 22.5 -8.4 ss
27-30 23.6 27.4 29.5 22.1 25.6 28.5 24.4 30.7 29.5 30.0 28.3 33.0 29.3 29.9 27.0 27.5 22.0 27.8 +5.8
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Some other narcotic 18 29.4 29.6 30.4 30.0 32.1 33.1 32.2 33.0 35.8 38.3 38.1 34.6 37.1 37.5 38.0 39.8 40.0 38.9 42.8 40.8 43.9 40.5 44.0 39.3 40.2 39.2 -0.9  
19-22 32.7 32.4 30.8 31.0 28.7 34.3 32.6 33.8 37.9 37.9 35.6 35.4 35.2 33.5 35.1 38.7 37.3 38.3 38.9 39.5 41.1 44.1 40.4 40.6 39.4 41.4 +2.0
23-26 32.8 32.1 33.6 32.2 35.9 36.4 34.7 33.2 33.9 33.1 35.8 32.6 36.7 35.7 39.9 38.2 38.1 35.8 40.0 40.3 47.7 44.7 -2.9
27-30 31.6 36.2 36.1 29.0 31.8 33.0 34.8 36.9 37.2 35.2 32.2 36.9 32.4 39.4 38.5 38.9 35.8 37.7 +1.8
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Amphetamines 18 61.3 69.5 70.8 68.5 68.2 66.4 64.3 64.5 63.9 64.3 59.7 57.3 58.8 61.5 62.0 62.8 59.4 59.8 60.8 58.1 57.1 57.1 57.4 55.0 55.4 51.2 -4.2 s
19-22 71.7 72.6 73.5 69.7 69.1 69.1 63.1 61.8 61.3 62.2 57.7 58.3 56.3 56.0 56.6 60.3 56.9 55.5 56.3 57.6 60.2 56.5 53.7 55.1 53.9 56.9 +3.0
23-26 65.8 66.0 64.5 65.3 62.2 60.1 55.8 54.8 54.5 52.6 52.9 56.0 52.8 51.2 53.2 49.1 51.1 49.4 48.2 50.3 51.8 51.9 0.0
27-30 54.3 58.6 55.3 54.4 50.4 52.9 48.3 53.7 51.7 48.1 41.4 48.2 47.6 49.3 45.6 48.7 43.9 45.3 +1.4
35 45.6 43.5 39.1 40.9 39.4 38.5 42.2 39.6 39.2 39.2 35.4 35.4 0.0
40 41.0 41.9 39.4 37.5 39.4 38.7 37.9 41.1 +3.1
45 35.8 39.8 39.3 -0.5
TABLE 7-4 (cont.)
Trends in Reported Availability of Drugs
High School Seniors (Age 18) and Adults in Modal Age Groups of 19-22, 23-26, 27-30, 35, 40, and 45
(Table continued on next page)
224
Q. How difficult do you 
think it would be for 
you to get each of the  
following types of 
drugs, if you wanted 
some?
Percentage saying "fairly easy" or "very easy" to get a
Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
'04-'05 
change
Crystal meth. (ice) 18 NA NA NA NA NA NA NA NA NA NA 24.0 24.3 26.0 26.6 25.6 27.0 26.9 27.6 29.8 27.6 27.8 28.3 28.3 26.1 26.7 27.2 +0.4
19-22 NA NA NA NA NA NA NA NA NA NA 24.0 21.8 22.5 20.9 24.7 25.5 25.4 29.3 31.0 31.8 27.4 28.4 31.2 26.5 27.1 28.9 +1.8
23-26 NA NA NA NA NA NA 22.3 20.0 21.3 22.9 24.5 24.7 24.7 25.8 30.2 28.5 25.8 26.4 25.1 26.4 32.3 27.8 -4.5
27-30 NA NA 27.3 19.7 22.0 21.2 21.7 25.8 26.1 25.1 22.6 29.1 25.3 27.6 29.5 30.9 25.5 27.4 +1.9
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Sedatives/barbituratesc 18 49.1 54.9 55.2 52.5 51.9 51.3 48.3 48.2 47.8 48.4 45.9 42.4 44.0 44.5 43.3 42.3 41.4 40.0 40.7 37.9 37.4 35.7 36.6 35.3 46.3 44.4 -1.9
19-22 59.5 61.1 56.8 54.2 48.1 52.7 46.8 44.6 45.5 47.7 44.2 41.7 43.4 41.9 40.6 42.9 41.1 39.8 39.2 42.3 40.6 39.3 40.8 38.4 43.8 47.8 +4.0
23-26 52.7 47.7 46.4 45.9 47.4 44.8 41.6 39.6 42.0 38.8 40.3 42.1 40.6 39.1 42.6 39.7 37.6 36.1 36.4 37.8 49.4 48.4 -1.0
27-30 43.2 44.5 44.2 38.5 37.8 39.7 37.4 39.9 41.2 39.1 33.9 38.4 36.1 38.1 34.8 35.6 40.5 42.9 +2.4
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Tranquilizers 18 59.1 60.8 58.9 55.3 54.5 54.7 51.2 48.6 49.1 45.3 44.7 40.8 40.9 41.1 39.2 37.8 36.0 35.4 36.2 32.7 33.8 33.1 32.9 29.8 30.1 25.7 -4.4 ss
19-22 67.4 62.8 62.0 62.3 52.5 55.6 52.9 50.3 50.0 49.4 45.4 44.8 40.7 40.9 41.0 40.2 37.6 37.8 36.8 37.1 36.5 34.9 34.6 34.2 29.7 30.1 +0.4
23-26 60.2 54.3 54.1 56.3 52.8 51.4 47.8 45.1 48.1 43.2 45.9 44.3 42.3 36.4 39.4 38.3 37.6 38.7 33.7 32.5 36.6 32.9 -3.7
27-30 55.3 54.4 54.9 47.5 47.8 47.4 44.4 44.8 46.2 41.9 39.9 41.5 36.7 42.9 38.1 35.9 30.6 33.5 +2.9
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
Steroids 18 NA NA NA NA NA NA NA NA NA NA NA 46.7 46.8 44.8 42.9 45.5 40.3 41.7 44.5 44.6 44.8 44.4 45.5 40.7 42.6 39.7 -2.9  
19-22 NA NA NA NA NA NA NA NA NA NA 44.1 44.8 46.3 41.7 40.9 41.8 40.8 39.2 39.2 40.5 40.3 38.1 41.4 39.4 37.8 37.6 -0.2
23-26 NA NA NA NA NA NA 37.6 35.8 39.3 35.8 37.0 37.4 33.9 35.5 34.9 37.1 34.0 34.7 33.1 31.1 34.7 31.2 -3.5
27-30 NA NA 36.4 30.6 35.0 31.6 30.5 33.1 35.6 32.5 30.5 34.5 36.2 34.6 33.0 32.6 30.6 32.4 +1.9
35 NA NA NA NA NA NA NA NA NA NA NA NA —
40 NA NA NA NA NA NA NA NA —
45 NA NA NA —
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Age 
Group 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Approx. Weighted N= 18 3240 3578 3602 3385 3269 3274 3077 3271 3231 2806 2549 2476 2586 2670 2526 2552 2340 2517 2520 2215 2095 1850 2138 2391 2169 2161
19-22 582 601 582 588 559 571 592 581 568 572 571 534 512 480 459 470 467 463 433 425 400 398 375 386 441 392
23-26 540 541 548 539 526 514 532 511 523 500 463 449 418 419 395 415 388 401 362 356 411 359
27-30 519 513 510 487 475 473 437 446 468 459 425 424 365 357 349 368 393 359
35 1142 1141 1146 1150 1032 1022 981 977 890 934 963 1009
40 1029 1093 1096 1065 1037 898 967 928
45 911 1026 1005
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:   s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding.
'NA' indicates data not available.
aAnswer alternatives were: (1) Probably impossible, (2) Very difficult, (3) Fairly difficult, (4) Fairly easy, and (5) Very easy.
bIn 2001 the question text was changed from "other psychedelics" to "other hallucinogens," and "shrooms" was added to the list of examples. These changes likely explain the discontinuity in the 
2001 results.
cIn 2004 the question text was changed from "barbiturates" to "sedatives/barbiturates" and the list of examples was changed from "downers, goofballs, reds, yellows, etc." to just "downers." These 
changes likely explain the discontinuity in the 2004 results.
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PREVALENCE OF DRUG USE 




We believe that one of the more important functions of the study over the past quarter of a century 
has been to track various forms of substance use among the nation’s college students, in part because 
they often have been the harbingers of social and political changes that spread eventually to other 
segments of the population up and down the age spectrum. This was certainly the case for the 
epidemic of illicit drug use that emerged in the American population in the late 1960s, and that 
continues today. 
Monitoring the Future has been able to generate an excellent (and unparalleled) national sample of 
college students every year since 1980 by following representative samples of high school classes 
after they graduate. The graduating class of 1976 was the first such class followed after graduation, 
and by 1980 the survey included college students one to four years post–high school. The 2005 
survey is thus the 26th such survey covering this important segment of the general population.    
The absence of dropouts in the original high school senior samples has practically no effect on the 
representativeness of these college samples because very few dropouts go on to college. One notable 
limitation of the present design for the purpose of characterizing college students is that it limits the 
age range of the college sample. For trend estimation purposes, we decided to limit the age band to 
the most typical one for college attendance, that is, one to four years past high school, which 
corresponds to the modal ages of 19 to 22. According to the latest statistics available from the 
United States Census Bureau,49 this age band should encompass about 73% of all undergraduate 
college students enrolled full-time in 2004, down some from the 79% covered in 1989. Although 
expanding the age band to be covered by an additional two years would cover 83% of all enrolled 
college students, it would also reduce by two years the interval over which we could report trend 
data. Some special analyses conducted in 1985 indicated that the differences in prevalence-of-use 
estimates under the two definitions were extremely small. The annual prevalence of all drugs except 
cocaine shifted only about one or two tenths of a percent. Cocaine, which has the greatest amount of 
age-related change, would have had an annual prevalence rate only 0.8 percentage points higher if 
the six-year age span were included rather than the four-year age span. A replication of these 
analyses in 1997 yielded virtually the same results. Thus, for purposes of estimating all prevalence 
rates except lifetime prevalence, the four-year and six-year intervals are nearly interchangeable, 
suggesting that this limitation is negligible for our purposes. 
On the positive side, maintaining a consistent age band allows for trend estimation by controlling for 
changes in the age composition of college students over the years. Otherwise, college students 
                                                 
49U.S. Census Bureau, October 2004. Available at http://www.census.gov.  
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characterized in one year might represent a noncomparable segment of the larger population when 
compared to college students surveyed in another year. 
Definition of college students. College students are defined here as those follow-up respondents 
one to four years past high school who say they were registered as full-time students in a two- or 
four-year undergraduate college at the beginning of March in the year in question. Note that 
students at two-year colleges, such as community colleges, are included. The definition excludes 
those who are currently enrolled in college part-time and those who previously may have been 
college students or may have completed college. 
Prevalence-of-use rates for college students, as well as their same-age peers who are also high 
school graduates, are provided in Tables 8-1 to 8-5. Having statistics for both groups, a unique 
feature of the Monitoring the Future panels, makes it possible to see whether college students’ 
substance use rates are higher or lower than those of their age peers (one to four years past high 
school, i.e., of modal ages 19 to 22). The college-enrolled sample now constitutes well over half 
(61%) of the entire follow-up sample one to four years past high school. The differences reported 
here pertain to differences between those who are full-time college students versus those who are 
not, among high school graduates. If data from the missing high school dropout segment were 
available for inclusion as part of the noncollege segment, any difference between the two groups 
would likely be enlarged; therefore, any differences observed here are only an indication of the 
direction and relative size of differences between the college and the entire noncollege population, 
not an absolute estimate of them. 
 
PREVALENCE OF DRUG USE: COLLEGE STUDENTS VERSUS THOSE NOT 
ENROLLED IN COLLEGE  
 
In 2005, lifetime prevalence of use among college students is lower for all illicit drugs compared 
with use among their age peers, but the degree of difference varies considerably by drug, as Table 8-
1 shows. However, there is much less difference between the two groups on annual or 30-day 
prevalence-of-use rates. (See Tables 8-2 and 8-3.) Annual use rates for alcohol stand apart from the 
others as being higher among college students than among those not enrolled in college, while the 
prevalence rates of marijuana, inhalants, Ritalin, and GHB are about equivalent between the two 
groups. 
 
• In 2005, annual prevalence for the use of any illicit drug among college students stands at 
37%, compared to 40% among those high school graduates not in college—a rather modest 
difference. A slightly larger proportional difference exists for the annual prevalence of any 
illicit drug other than marijuana (19% versus 23%). 
 
• Annual marijuana use is very similar among college students and high school graduates of 
the same age that are not in college (33% versus 35%). However, the rate of current daily 
marijuana use is lower among college students (4.0% versus 7.8%). (See Table 8-4 for the 
prevalence of current daily use.) 
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• Annual prevalence for all the illicit drugs is lower among the college students; Vicodin, 
narcotics other than heroin, and OxyContin show the largest absolute difference in annual 
prevalence. For Vicodin it is 9.6% for college students versus 14.0% for those not in college; 
for narcotics other than heroin, 8.4% versus 12.7%; and for OxyContin, 2.1% versus 6.2%. 
 
• Smaller absolute differences occur for cocaine, with 5.7% of the college students versus 
9.0% of their noncollege age peers reporting use in the past year; methamphetamine, at 
1.7% versus 4.9%; tranquilizers, at 6.4% versus 9.3%; sedatives (barbiturates), at 3.9% 
versus 6.9%; hallucinogens, at 5.0% versus 7.3%; crack cocaine, at 0.8% versus 2.9%; 
MDMA (ecstasy), at 2.9% versus 4.9%; ice, at 1.4% versus 3.1%; and LSD, at 0.7% versus 
2.1%.   
 
• Annual use of heroin and amphetamines is also less prevalent (though not significantly) 
among college students than among their noncollege age peers, at 0.3% versus 1.1% for 
heroin and 6.7% versus 7.2% for amphetamines. 
 
• It should be noted that, while the absolute differences are not great between the two groups 
on many of the low prevalence drugs—including crack, OxyContin, methamphetamine, and 
ice—the ratio of the differences tends to be high (on the order of two or three to one in 
several cases). Further, these differences are diminished by the absence of the high school 
dropouts from the noncollege group. So, it is clear that use of a number of the illicit drugs 
other than marijuana tends to be concentrated among those not in college. 
 
• Ritalin, a drug in the amphetamine class and newly added to the MTF questionnaires in 
2002, previously had shown quite a different pattern, with use considerably higher among 
college students than among those not in college, quite possibly explained by college 
students using Ritalin to stay awake late at night to finish assignments or to study for tests. 
However, this pattern did not replicate in 2005, when the two groups showed virtually 
identical rates of annual prevalence for Ritalin use, at 4.2% for college students and 4.3% for 
the noncollege group. 
 
• In 2005, college students were modestly higher in their prevalence of lifetime or annual use 
of alcohol than the noncollege group, but were appreciably higher than their age peers in 
monthly use (68% versus 59%). 
 
• College students also had a significantly higher prevalence of occasions of heavy drinking 
(five or more drinks in a row in the past two weeks)—40% versus 35% among their age 
peers—but their rates of daily drinking were not significantly different from rates of their 
age peers (4.6% versus 5.1%). It is noteworthy that in high school, college-bound students, 
especially in earlier grades, were far less likely to drink alcohol at any level compared to 
their noncollege-bound peers; thus the relative and absolute increases in alcohol use in the 
first few years following high school are striking for college students. 
 
• In 2005 two thirds (67%) of college students reported using flavored alcoholic beverages in 
the prior year versus one half (51%) of the noncollege group. 
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• Among all substances studied, both licit and illicit, the largest absolute differences in 30-day 
and daily prevalence rates between the two groups occur for cigarette smoking. For 
example, the prevalence of daily smoking for college students is “only” 12% versus 28% for 
their age-mates not enrolled full-time in college. Smoking at the rate of a half-pack per day 
stands at 7% versus 18% for these two groups, respectively. Recall that the 12th-grade data 
show the college-bound to have much lower smoking rates in high school than the 
noncollege-bound; thus, in contrast to what was true for alcohol use, these substantial 
differences observed at college age actually preceded college attendance.50 The smoking 
differences would be even greater if dropouts were included in the noncollege group because 
they have an exceptionally high rate of smoking. 
 
 
GENDER DIFFERENCES IN PREVALENCE OF USE AMONG COLLEGE STUDENTS 
 
Tabular data are provided separately in Tables 8-1 to 8-5 for male and female college students and 
their same-age peers. 
• Most of the gender differences among college students replicate those discussed earlier for 
all young adults 1 to 12 years past high school, and they in turn replicate gender differences 
among secondary school students for the most part. That means that among college students, 
males have higher annual prevalence rates for most of the illicit drugs. The annual 
prevalence rates for use of any illicit drug are 41% versus 34%; for any illicit drug other 
than marijuana, 21% versus 17%; for marijuana, 38% versus 31%; for hallucinogens, 
7.3% versus 3.8%; and for LSD specifically, 0.9% versus 0.6%. 
 
• Daily marijuana use is higher among male college students (5.6%) than among female 
college students (3.2%). 
 
• Both male and female college students have higher rates of occasional heavy drinking than 
their counterparts not in college (34% for college females versus 29% for noncollege females 
and 50% versus 44% for males, respectively). 
 
• Flavored alcoholic beverages are favored by significantly more females regardless of 
whether they attend college or not (74% of females versus 56% of males for college students 
reporting use in the past year and 54% versus 46%, respectively, for the noncollege group). 
 
• There is currently no gender difference in the 30-day prevalence of smoking cigarettes 
among college students (24% for both genders); but among their noncollege age peers, 
smoking is still more prevalent among males (39%) than females (33%). The college 
segment has rates of daily smoking at 12% among males and 13% among females. Within 
the noncollege segment, 29% of males report daily smoking compared to 27% of females. 
Smoking a half-pack or more per day is modestly higher among noncollege males than 
                                                 
50See also Bachman, J. G., Wadsworth, K. N., O’Malley, P. M., Johnston, L. D., & Schulenberg, J. E. (1997). Smoking, drinking, and drug use in young 
adulthood: The impacts of new freedoms and new responsibilities. Mahwah, NJ: Lawrence Erlbaum Associates. 
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noncollege females (19% versus 17%); the rates for college males were a bit lower than for 
college females (6.0% versus 7.1%). As Figure 9-15b in the next chapter shows, there has 
generally not been a consistent gender difference among college students in their smoking 
rates for the past several years. 
 
• For a number of drugs in which college students have lower annual prevalence overall, those 
differences are caused largely or exclusively by the differences between college and 
noncollege males. (Put another way, the females from these two groups are not nearly as 
different in their use of these drugs as are the males. See Table 8-2.) These drugs include 
LSD, cocaine, OxyContin, ice, and ketamine. 
 
• On the other hand, it is the noncollege females who account for a disproportionately large 
part of the overall college versus noncollege differences in the use of MDMA (ecstasy), 
heroin, narcotics other than heroin, Vicodin, methamphetamine, and tranquilizers. 
 
In sum, the noncollege segment is generally more drug-experienced than the college student 
segment. This pattern is a continuation of the high school scenario in which those without college 
plans are more likely to use drugs. The only drugs for which college students are more likely to be 
users are alcohol (including binge drinking) and the very low prevalence club drugs Rohypnol, 
GHB, and ketamine. The gender differences observed among college students generally parallel 






College Others College Others College Others
Any Illicit Drug a 52.3 61.6 54.2 62.1 51.3 61.3
Any Illicit Drug a 
   Other Than Marijuana 26.5 35.2 29.0 36.5 25.1 34.1
Marijuana 49.1 57.5 52.3 58.6 47.3 56.6
Inhalants b,c 7.1 8.3 10.5 8.1 5.2 8.5
Hallucinogens c 11.0 16.3 15.2 19.8 8.7 13.7
     LSD 3.7 8.6 4.6 10.2 3.2 7.5
Cocaine 8.8 15.0 10.2 16.7 8.0 13.7
     Crackd 1.7 5.8 2.4 7.0 1.3 5.0
MDMA (Ecstasy)b 8.3 12.8 9.8 11.4 7.4 14.0
Heroin 0.5 2.3 0.9 2.5 0.3 2.2
Other Narcotics e 14.4 19.9 16.6 21.4 13.2 18.8
Amphetamines, Adjusted e,f 12.3 16.1 11.6 16.5 12.7 15.8
     Ice g 2.4 5.7 2.2 9.2 2.5 3.3
Sedatives (Barbiturates) e 8.5 11.9 9.3 13.3 8.0 10.8
Tranquilizerse 11.9 14.8 13.0 15.6 11.2 14.3
Alcohol 86.6 82.8 86.4 80.6 86.8 84.4
     Flavored Alcoholic Bvg. h 84.5 74.5 84.3 75.3 84.6 73.9
Cigarettes NA NA NA NA NA NA
Approximate Weighted N = 1360 850 500 360 860 490
Source :  The Monitoring the Future Study, the University of Michigan.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, 
sedatives (barbiturates), or tranquilizers not under a doctor's orders.
bThis drug was asked about in three of the six questionnaire forms.  Total N in 2005 for college students is approximately 680.
cUnadjusted for known underreporting of certain drugs.  See text for details.
dThis drug was asked about in five of the six questionnaire forms.  Total N in 2005 for college students is approximately 1130.
eOnly drug use that was not under a doctor's orders is included here.
fBased on the data from the revised question, which attempts to exclude inappropriate reporting of nonprescription 
amphetamines.
gThis drug was asked about in two of the six questionnaire forms.  Total N in 2005 for college students is approximately 450.
hThis drug was asked about in one of the six questionnaire forms.  Total N in 2005 for college students is approximately 230.
TABLE 8-1
Lifetime Prevalence of Use for Various Types of Drugs, 2005:
Full-Time College Students vs. Others





College Others College Others College Others
Any Illicit Drug a 36.6 39.6 40.7 40.8 34.2 38.7
Any Illicit Drug a 
   Other Than Marijuana 18.5 23.4 21.1 24.0 16.9 23.0
Marijuana 33.3 34.6 38.0 37.2 30.7 32.7
Inhalants b,c 1.8 1.8 2.8 1.6 1.3 2.0
Hallucinogens c 5.0 7.3 7.3 10.3 3.8 5.2
     LSD 0.7 2.1 0.9 2.8 0.6 1.6
Cocaine 5.7 9.0 6.2 10.1 5.4 8.3
     Crackd 0.8 2.9 1.2 3.2 0.5 2.6
MDMA (Ecstasy)b 2.9 4.9 3.1 3.2 2.8 6.3
Heroin 0.3 1.1 0.6 1.0 0.2 1.1
Other Narcotics e 8.4 12.7 9.6 12.4 7.7 12.9
     OxyContin f 2.1 6.2 1.1 8.5 2.8 4.7
     Vicodin f 9.6 14.0 13.5 16.9 7.4 12.0
Amphetamines, Adjusted e,g 6.7 7.2 7.4 7.0 6.3 7.4
     Ritalin f 4.2 4.3 3.9 5.4 4.4 3.6
     Methamphetamine f 1.7 4.9 3.5 4.8 0.6 4.9
     Ice f 1.4 3.1 1.5 5.3 1.3 1.5
Sedatives (Barbiturates) e 3.9 6.9 4.3 6.6 3.8 7.1
Tranquilizerse 6.4 9.3 7.3 9.2 5.8 9.5
Rohypnolf 0.1 0.6 0.0 1.5 0.2 0.0
GHBf 0.4 0.6 1.2 1.1 0.0 0.2
Ketaminef 0.5 1.5 0.6 3.2 0.5 0.4
Alcohol 83.0 76.9 82.4 77.4 83.4 76.6
     Flavored Alcoholic Bvg. h 67.0 50.6 55.5 46.3 74.0 54.0
Cigarettes 36.0 45.2 37.0 47.4 35.4 43.6
Approximate Weighted N = 1360 850 500 360 860 490
Source :  The Monitoring the Future Study, the University of Michigan.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, 
sedatives (barbiturates), or tranquilizers not under a doctor's orders. 
bThis drug was asked about in three of the six questionnaire forms.  Total N in 2005 for college students is approximately 680.
cUnadjusted for known underreporting of certain drugs.  See text for details.
dThis drug was asked about in five of the six questionnaire forms.  Total N in 2005 for college students is approximately 1130.
eOnly drug use that was not under a doctor's orders is included here.
fThis drug was asked about in two of the six questionnaire forms.  Total N in 2005 for college students is approximately 450.
gBased on the data from the revised question, which attempts to exclude inappropriate reporting of nonprescription 
amphetamines.
hThis drug was asked about in one of the six questionnaire forms.  Total N in 2005 for college students is approximately 230.
TABLE 8-2
Annual Prevalence of Use for Various Types of Drugs, 2005:
Full-Time College Students vs. Others





College Others College Others College Others
Any Illicit Drug a 19.5 23.9 22.9 27.0 17.5 21.7
Any Illicit Drug a 
   Other Than Marijuana 8.2 11.0 10.3 11.0 7.0 11.0
Marijuana 17.1 20.6 20.5 25.0 15.1 17.3
Inhalants b,c 0.3 0.1 0.5 0.0 0.3 0.2
Hallucinogens c 1.2 1.9 1.8 2.8 0.9 1.2
     LSD 0.1 0.5 0.2 0.9 0.1 0.2
Cocaine 1.8 2.3 2.2 3.2 1.5 1.7
     Crackd 0.1 0.8 0.1 1.4 0.1 0.4
MDMA (Ecstasy)b 0.8 0.6 1.3 0.5 0.5 0.7
Heroin 0.1 0.3 0.2 0.1 0.1 0.5
Other Narcotics e 3.1 5.6 3.8 4.2 2.7 6.7
Amphetamines, Adjusted e,f 2.9 3.0 4.0 2.9 2.3 3.1
     Ice g 0.2 0.9 0.6 1.5 0.0 0.5
Sedatives (Barbiturates) e 1.3 3.3 1.5 3.1 1.2 3.4
Tranquilizerse 2.2 3.3 2.5 2.4 2.1 4.0
Alcohol 67.9 58.7 70.5 64.2 66.4 54.5
     Flavored Alcoholic Bvg. h 30.9 26.6 22.0 24.5 36.3 28.3
Cigarettes 23.8 35.4 23.7 39.2 23.8 32.6
Approximate Weighted N = 1360 850 500 360 860 490
Source :  The Monitoring the Future Study, the University of Michigan.
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, 
sedatives (barbiturates), or tranquilizers not under a doctor's orders.
bThis drug was asked about in three of the six questionnaire forms.  Total N in 2005 for college students is approximately 680.
cUnadjusted for known underreporting of certain drugs.  See text for details.
dThis drug was asked about in five of the six questionnaire forms.  Total N in 2005 for college students is approximately 1130.
eOnly drug use that was not under a doctor's orders is included here.
fBased on the data from the revised question, which attempts to exclude inappropriate reporting of nonprescription 
amphetamines.
gThis drug was asked about in two of the six questionnaire forms.  Total N in 2005 for college students is approximately 450.
hThis drug was asked about in one of the six questionnaire forms.  Total N in 2005 for college students is approximately 230.
TABLE 8-3
Thirty-Day Prevalence of Use for Various Types of Drugs, 2005:
Full-Time College Students vs. Others





College Others College Others College Others
Marijuana 4.0 7.8 5.6 10.9 3.2 5.5
Cocaine 0.1 0.3 0.0 0.3 0.1 0.3
Amphetamines, Adjusted ba, 0.2 0.1 0.2 0.1 0.3 0.1
Alcohol
Daily 4.6 5.1 8.6 9.0 2.3 2.3
5+ Drinks in a Row in Past
  2 Weeks 40.1 35.1 50.1 43.6 34.4 28.8
Cigarettes
Daily 12.4 27.6 11.7 28.7 12.8 26.8
Half-Pack or More per Day 6.7 17.9 6.0 18.6 7.1 17.4
Approximate Weighted N = 1360 850 500 360 860 490
Source :  The Monitoring the Future Study, the University of Michigan.
aOnly drug use that was not under a doctor's orders is included here.
bBased on the data from the revised question, which attempts to exclude inappropriate reporting of nonprescription 
amphetamines.
TABLE 8-4
Thirty-Day Prevalence of Daily Use for Various Types of Drugs, 2005:
Full-Time College Students vs. Others





College Others College Others College Others
Lifetime
Any Illicit Drug 52.3 61.6 54.2 62.1 51.3 61.3
Any Illicit Drug
  Other Than Marijuana 26.5 35.2 29.0 36.5 25.1 34.1
Past 12 Months
Any Illicit Drug 36.6 39.6 40.7 40.8 34.2 38.7
Any Illicit Drug
  Other Than Marijuana 18.5 23.4 21.1 24.0 16.9 23.0
Past 30 Days
Any Illicit Drug 19.5 23.9 22.9 27.0 17.5 21.7
Any Illicit Drug
  Other Than Marijuana 8.2 11.0 10.3 11.0 7.0 11.0
Approximate Weighted N = 1360 850 500 360 860 490
Source :  The Monitoring the Future Study, the University of Michigan
aUse of "any illicit drug" includes any use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, 
sedatives (barbiturates), or tranquilizers not under a doctor's orders.
TABLE 8-5
Lifetime, Annual, and Thirty-Day Prevalence of an Illicit Drug Use Index,a 2005:
Full-Time College Students vs. Others
Among Respondents 1-4 Years Beyond High School
(Entries are percentages)
236





  Chapter 9 
 
TRENDS IN DRUG USE AMONG COLLEGE STUDENTS 
 
 
College students are often the harbingers of social change in society, and such was the case in the 
emergence of the illicit drug epidemic of the last 40 years. Illicit drug use increased dramatically 
among American college students in the mid-1960s, then spread quickly to their noncollege age 
peers and eventually down the age spectrum to high school students and even middle school 
students. College students were thus the leading edge of that critical social change in illicit drug use. 
As we shall show in this chapter, the diffusion process seems to have reversed during the more 
recent “relapse” of the epidemic in the 1990s, when use increased first among those in early 
adolescence and then radiated up the age spectrum as those cohorts grew older.  
The definition of college students is the same here as described in chapter 8: high school graduates 
one to four years past high school who are enrolled full-time in a two-year or four-year college at the 
beginning of March in the year in question. For comparison purposes, trend data are provided on the 
remaining follow-up respondents in this age band, who are also one to four years past high school. 
(See Figures 9-1 through 9-15c.) Because the rate of college enrollment declines steadily with the 
number of years beyond high school, this comparison group is slightly older on average than the 
college-enrolled group. It is also worth noting that the proportion of young adult high school 
graduates one to four years beyond high school who are enrolled full-time in college has increased 
considerably over the past 26 surveys. In 2005, about 62% of the weighted number of follow-up 
respondents one to four years past high school met our definition of college students, compared with 
only 38% in the 1980 survey. That 24-percentage-point increase represents a substantial rise over the 
past two and a half decades in the proportion of high school graduates attending college.   
The reader is reminded that the difference between the enrolled group and the other group provides 
an estimate of the degree to which college students are above or below average for other high school 
graduates in this age band. Were we able to include the high school dropout segment in the 
calculation for the noncollege group, many of the differences with the college-enrolled likely would 
be accentuated. 
For each year given, there are approximately 1,100–1,500 weighted respondents constituting the 
college student sample (see Table 9-5 for Ns per year) and roughly 800–1,700 respondents 
constituting the “other” group one to four years past high school. Comparisons of the trends for these 
two groups are provided in this chapter. Because it was not until 1980 that enough follow-up years 
had accrued to characterize young people one to four years past high school, the comparisons begin 
with that year. 
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TRENDS IN PREVALENCE 1980–2005: COLLEGE STUDENTS VERSUS THOSE 
NOT ENROLLED IN COLLEGE 
 
• The proportion of college students using any illicit drug in the 12 months prior to the survey 
(i.e., the annual prevalence rate) dropped fairly steadily between 1980 and 1991 (from 56% 
to 29%). (See Table 9-2.) In other words, illicit drug use by college students fell by nearly 
half over the 11-year period 1980–1991. After 1991, annual (and also 30-day) prevalence 
held fairly steady for a couple of years before beginning to rise, reaching 38% in 1998—still 
well below the peak of 56% in 1980. There has been little change since then (37% in 2005). 
The noncollege group moved similarly from 1980 to 1998. Twelfth graders also showed a 
similar trajectory in the decline phase through 1991, but their rise in use after 1992 was 
distinctly sharper, as Figure 9-1 illustrates. All three groups showed a leveling after 1998. 
However, in 2000, the noncollege group exhibited a four-percentage-point increase that was 
due largely to their sharper increases in marijuana, amphetamine, and tranquilizer use in that 
year, and their level remains above the college student sector. Also noteworthy is the fact 
that use among high school seniors has declined some since 1999 (by about four percentage 
points), whereas among college students or their counterparts not in college there has been 
little decline as of yet. As a result, all three groups have quite similar prevalence rates in 
2005, in contrast to the mid- to late-1990s, when 12th graders had considerably higher rates 
of use. We believe the divergence among the three groups and subsequent convergence 
reflect cohort effects. 
 
• Use of any illicit drugs other than marijuana declined fairly steadily and appreciably 
among college students between 1980 and 1994, with annual prevalence dropping by nearly 
two thirds from 32% to 12% (Table 9-2). This generally paralleled the trends for the 
noncollege group, as well as for 12th graders. All three groups showed some increase in use 
during the 1990s: the 12th graders after 1992, the noncollege group after 1993, and the 
college students after 1994. However, the rise in use of illicit drugs other than marijuana was 
not as sharp among college students as it was in either of the two other groups (Figure 9-2). 
Since 1999 the college students and noncollege segment have shown some further increase 
(particularly the noncollege group), whereas use among the 12th graders held steady and has 
even begun to decline. In fact, the college students continued to show an increase in their 
annual prevalence rate from 1998 through 2004, before leveling in 2005. College students 
and 12th graders in high school now have about the same prevalence rates, following more 
than a decade in which the 12th graders had higher rates. Again, this divergence and then 
convergence most likely reflect some cohort effects working their way up the age spectrum.   
 
In general, among those enrolled in college, the trends during the 1980s for most individual 
classes of illicit drugs tended to parallel those for the noncollege group and those observed 
among 12th graders. During the 1990s, however, there was more divergence in the trends, 
with the college students usually showing less increase than the 12th graders, and, for some 
drugs, less increase than their age-mates not in college. 
 
• The annual prevalence of marijuana use among college students decreased steadily from 
1981 through 1991, dropping by nearly half from 51% to 27% (Figure 9-3a). Their 
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noncollege peers showed a comparable decline over the same time interval. Use among 12th 
graders rose sharply after 1992, while use among college students and their age peers rose 
more gradually. From 1991 through 1998, annual prevalence rose by nearly 10 percentage 
points among college students, by 7 percentage points among their age peers not in college, 
but by 14 percentage points among 12th graders. As a result, the 12th graders exhibited the 
highest rate of marijuana use in the last half of the 1990s. The 12th graders were the first to 
show a leveling off in marijuana use (in 1998), followed by the college students in 1999 and 
the noncollege group in 2002. All three groups have very similar rates of use in 2005 after 
some gradual decline in use among college students and their noncollege counterparts, and a 
greater decline among 12th graders. 
 
• Daily marijuana use among college students (Figure 9-3b) fell appreciably between 1980 
and 1986, from 7.2% to 2.1%, as it did for those not in college and among the 12th graders. 
(The latter two groups were able to show sharper declines because they started higher than 
the college students in 1980.) After 1986, the decline decelerated, and by 1991 the rate stood 
at 1.8%. In sum, the proportion of American college students who actively smoked 
marijuana on a daily basis dropped by about three fourths between 1980 and 1991. Daily use 
then leveled until 1994 and began increasing thereafter, reaching 4.6% in 2000. Since then, 
daily use for college students has held fairly level (4.0% in 2005). The other two groups 
showed considerably larger increases after 1993 than did college students, with 12th graders’ 
daily use rates leveling after 2000. The noncollege segment showed further increase in 2001, 
reaching 9.4%, and then falling to 7.8% by 2005, still well above college students. Of the 
three groups, the college students have had the lowest rate of daily marijuana use throughout 
the life of the study. 
 
• A very appreciable decline occurred for amphetamine use between 1981 and 1991 (Figure 
9-11). Annual prevalence among college students dropped by more than eight tenths, from 
22% in 1981 to 4% in 1991. Proportionately, this was a larger drop than among 12th graders, 
but fairly parallel to the overall change among their age peers not in college. Amphetamine 
use among college students and their noncollege age peers leveled for a year before 
beginning to increase in both groups after 1992 and 1993, respectively, through 2001, with a 
leveling in 2002. During the 1990s and early 2000s, the prevalence rates for amphetamines 
in all three groups have remained well below the rates observed in the early 1980s. Since 
2002 there has been some nonparallel change among the three groups, with amphetamine use 
among college students (who have consistently had the lowest rate of use since the mid-
1980s) holding steady, while use among 12th graders and the noncollege group has declined. 
As a result, their prevalence rates are fairly close in 2005. 
 
• During the early 1980s, one of the largest proportional declines observed among college 
students was for LSD (see Figure 9-6). Annual prevalence fell from 6.3% in 1982 to 2.2% in 
1985. After 1985, their use began to increase, reaching 6.9% by 1995. Since 1995, use has 
fallen among college students, their age-mates, and 12th graders; in 2002 there was a 
particularly sharp decrease in all groups. All three groups now have annual prevalence rates 
between 0.7% and 2.1%. College students have continued to report lower levels of use than 
the other two groups since the mid-1990s. 
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• The use of ecstasy (MDMA) by American college students and their noncollege age peers 
began to rise after 1994 (Figure 9-8). After 1997 there was a sharp increase among college 
students. Their annual prevalence rose three- to fourfold in just three years, from 2.4% in 
1997 to 9.2% in 2001, before it began to decrease, reaching 2.9% in 2005. The trends among 
the noncollege segment have run fairly parallel to those for college students and 12th graders 
through 2005, although the period of sharp increase appeared to start later for them (after 
1999), eventually reaching a higher level of use. Since 2000, the noncollege segment has 
exhibited the highest rate of ecstasy use—reaching 14% in 2001, when use among the 
college students and 12th graders was at 9%. All three groups showed sharp declines in the 
following three years and a leveling of use by 2005.  
 
• When the college data were first available in 1980, sedative (barbiturate) use was already 
quite low among college students (at 2.9% annual prevalence) (see Figure 9-12), but it still 
fell by more than half to 1.3% by 1985. This proportional decline was, once again, sharper 
than among 12th graders and less sharp than among the young adults not in college, both of 
whom started at a higher level of use. Annual prevalence remained essentially unchanged 
between 1985 and 1993 among all three groups. The groups then showed a gradual increase 
in use between 1993 (or 1994 in the case of the college students) and 2001, with 12th graders 
showing a significant increase in 2002 and use in the other two groups leveling off. The 
college students showed a fairly steady increase over the ten-year period 1994–2004, with 
pauses in 1998 and 2002 and then a leveling in 2005; but the other two groups remained at 
higher levels than the college students throughout this period. 
 
• Figure 9-13 shows that the annual prevalence of tranquilizer use among college students 
dropped by half in the period 1980–1984, from 6.9% to 3.5%, and again fell by half between 
1984 and 1994, to 1.8%.51 After this long period of gradual decline, tranquilizer use then 
began to increase gradually, returning to 6.9% by 2003. Use by the noncollege segment and 
by 12th graders dropped more sharply, eliminating the differences among the three groups 
by 1992. Use rose after 1992 for all but the college students, again opening some differences, 
and then rose in all three groups after 1994; in 2002, tranquilizer use was at or near its recent 
high in all three groups. From 1999 through 2002 the increase in use was particularly sharp 
among the noncollege segment, making them the highest-using group. In 2003, however, 
they and the 12th graders showed their first declines in recent years, thus narrowing the 
differences among the three groups. No further decline was observed in any group through 
2005. Tranquilizer use is now at or very near the highest level reached since the early- to 
mid-1980s in all three groups. 
 
• The overall trends in the use of narcotics other than heroin52 have been quite parallel to 
those for sedatives (barbiturates) and tranquilizers. By 1994 the use of narcotics other than 
heroin (Figure 9-10a) by college students was about half what it was in 1980 (2.4% in 1994 
versus 5.1% in 1980) as a result of a gradual decline over the interval. This trend closely 
                                                 
51The use of sedatives (barbiturates) and tranquilizers very likely dropped during the latter half of the 1970s, as well, judging by the trends among 12th 
graders. 
52As discussed in the text in chapters 4 and 5, because the questions about narcotics other than heroin were changed in 2002, the prevalence figures are 
adjusted estimates. See the earlier discussion for details. 
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parallels use among their noncollege counterparts and the 12th graders. As with a number of 
other drugs, use among 12th graders began to rise after 1992, but use among college students 
did not begin to increase until after 1994, likely due to a cohort effect. In 2003, annual 
prevalence among college students reached an historic high point of 8.7% before leveling, 
while use among 12th graders finally leveled off after reaching an historic high in 2004 of 
9.5%. The noncollege group reached an all-time high of 13% in 2005, and—unlike the other 
two groups—does not yet show signs of leveling. 
 
• Although data were not collected until 2002, it is clear that OxyContin and Vicodin (Figures 
9-10b and 9-10c) help to explain the difference between the college and noncollege segments 
in their use of narcotics other than heroin. The noncollege group has had annual prevalence 
rates up to twice that for the college students in the use of both drugs (see Table 8-2). Annual 
prevalence of OxyContin use rose continuously among 12th graders (from 4.0% in 2002 to 
5.5% in 2005). Use in the noncollege segment also rose from 2002 to 2005, from 3.3% to 
6.2%. Among college students it rose from 1.5% in 2002 to 2.1% in 2005. Vicodin use 
showed a somewhat different pattern: annual prevalence among the college students is 
higher in 2005 (9.6%) than in 2002 (6.9%). The same is true for their noncollege 
counterparts (14.0%, up from 12.9%). The 12th graders’ 2005 rate (9.5%) was about the 
same as it was in 2002 (9.6%). 
    
• Like the 12th graders, college students showed a relatively stable pattern of cocaine use 
between 1980 and 1986, when their usage levels (and those of their age peers) were 
considerably higher than those observed among 12th graders. (See Figure 9-9.) This level 
period was followed by a dramatic drop of nearly nine tenths in annual prevalence among 
college students, from 17.1% in 1986 to 2.0% in 1994. Their noncollege counterparts also 
showed a large, but somewhat less dramatic decline, from 18.9% in 1986 to 5.1% in 1994. 
Because use among college students also dropped more sharply than among 12th graders, 
there was little or no difference between those two groups in annual prevalence rates for 
cocaine use between 1990 and 1995. After 1995, cocaine use rose the least among the 
college students, creating a reversal of the previous gap with the 12th graders having higher 
levels of use than the college students. Between 1994 and 1998 annual cocaine prevalence 
for college students increased significantly, from a 14-year low of 2.0% in 1994 to 4.5% by 
1998, roughly where it stayed through 2002. Their use then showed a gradual rise after 2002, 
with annual prevalence increasing from 4.8% to 6.6% in 2004; it then dropped off some to 
5.7% in 2005. Twelfth graders and noncollege students also exhibited an increase in annual 
prevalence of cocaine use after 1992 and 1993, respectively. Use has been level among 12th 
graders since 2000, but continued to increase among those not in college between 1999 and 
2001, considerably widening the gap between the noncollege segment and the other two 
groups.   
 
• College students have shown some shifts in alcohol use that are different from those 
observed both among their age peers not in college and among 12th graders. As can be seen 
in Figure 9-14d, both the noncollege segment and the 12th graders showed fairly substantial 
declines from 1981 through 1990 in the prevalence of having five or more drinks in a row at 
least once during the prior two weeks. (The 12th graders then showed further decline for 
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three more years.) In contrast, the college students showed no decline in binge drinking from 
1981 to 1986 and then only a modest decline of five percentage points from 1986 through 
1993. In the 11-year period between 1981 (when all three populations were very close in 
use) and 1992, this measure of heavy drinking dropped by 14 percentage points among 12th 
graders, by 11 percentage points among the noncollege 19- to 22-year-olds, but by only 2 
percentage points among full-time college students. After 1992, binge drinking began to rise 
among 12th graders while it was still declining some among college students—likely 
reflecting a cohort effect emerging during this period, similar to that observed for a number 
of illicit drugs—narrowing the gap somewhat. Binge drinking subsequently began to 
increase among the noncollege segment after 1995 and by less among college students after 
1996—increases that continued into 2001. Since 2001, college students have held steady in 
their rates of binge drinking while the noncollege segment has shown a small decline. 
Meanwhile, among 12th graders, binge drinking started a gradual decline after 1998 that 
continued through 2003, enlarging the difference between them and the other two groups 
among whom this behavior was still rising. Once again there is evidence of cohort effects at 
work here since the beginning of the 1990s, with the inflection points being later for the 
older strata. Despite the different patterns of trends, perhaps the most noteworthy facts are 
that college students have exhibited the highest level of, and greatest constancy of rate in, 
binge drinking throughout the entire 25-year interval that college students have been covered 
by the study. 
 
It is interesting to conjecture why college students did not show much decline in heavy 
drinking for a decade (1981–1991) while their noncollege peers and 12th graders did. One 
possibility is that campuses provided some insulation from the effects of changes in the 
drinking age laws that took place during that interval. Similarly, entrenched in many college 
campuses is a “culture of binge drinking” which has proven impervious to many societal 
trends (and intervention attempts) regarding excessive alcohol use.53 Also, individuals who 
are under the legal drinking age in college are mixed in with peers who are of legal age to 
purchase alcohol in a way that is no longer true in high schools and less true, perhaps, for 
many of those aged 19 to 22 who are not in college. Finally, much alcohol advertising and 
promotion was and is directed specifically at the college student population. 
 
College students generally have had slightly lower rates of daily drinking than their age 
group taken as a whole, though by the early 1990s such differences nearly disappeared 
(Figure 9-14c). Daily drinking among the young adults (one to four years past high school) 
not enrolled in college declined from 8.7% in 1981 to 6.5% in 1984, remained essentially 
unchanged through 1988, declined further (to 3.2%) by 1994, then increased to 5.8% by 
2004. College students’ daily drinking estimates—which appear a little less stable, perhaps 
due to smaller sample sizes in the 1980s—showed little or no decline between 1980 (6.5%) 
and 1984 (6.6%) but a considerable decline from 1984 through 1995 (to 3.0%), followed by 
a period of some increase, reaching 5.0% in 2002. After 2002 their daily drinking dropped, 
to 3.7% in 2004, but increased slightly to 4.6% in 2005. Twelfth graders showed a somewhat 
similar pattern of daily drinking with a long period of decline, followed by a somewhat 
                                                 
53Schulenberg, J. E., & Maggs, J. L. (2002). A developmental perspective on alcohol use and heavy drinking during adolescence and the transition to 
young adulthood. Journal of Studies on Alcohol, Supplement 14, 54–70. 
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earlier reversal, beginning in 1994. After 1998 their daily drinking rate actually declined a 
little, and then remained fairly level through 2005. Of the three groups, the 19- to 22-year-
olds not in college have had the highest rate of current daily drinking over most of the past 
25 years.  
 
• Cigarette smoking among American college students (Figure 9-15a) declined modestly in 
the first half of the 1980s. Thirty-day prevalence fell from 26% to 22% between 1980 and 
1985, remained fairly stable through 1990 (22%), then increased gradually but substantially, 
reaching 31% by 1999. It was not until 2000 that the first evidence of a decline in smoking 
among college students began to appear, two years after smoking had begun to decline 
among 12th graders. This lag no doubt reflects a cohort effect operating through generational 
replacement. The noncollege group showed the first evidence of a decline in their smoking 
rate in 2002—considerably later than the college students. College students as well as 12th 
graders showed a slight increase in 30-day smoking prevalence in 2004 (neither change was 
statistically significant)—but both groups resumed their decline in smoking in 2005. 
 
The daily smoking rate for college students (Figure 9-15b) fell from 18% in 1980 to 13% in 
1986, as the cohorts who had lower initiation rates by senior year replaced the earlier, 
heavier-smoking cohorts. It remained fairly level through 1990 (12%), but by 1999 had risen 
to 19%, the highest level of daily smoking we have recorded among American college 
students since we began tracking them in 1980. (The 1999 thirty-day prevalence rate was 
also the highest we have recorded.) After 1999, both statistics declined among college 
students, falling back to the 1990 level of 12% by 2005.  
 
While smoking rates have consistently been lower among college students than among those 
who were of the same age and were not in college, the trends for these two groups converged 
some after 1984, as smoking rates more or less stabilized among college students but 
continued to decline among young adults not in college (see Figure 9-15a). In fact, between 
1989 and 1991, use began to rise among college students while continuing to decline among 
their peers. Both groups showed fairly parallel increases in smoking between about 1991 and 
1999, after which use continued to increase among the noncollege segment but began to 
decline among college students. (Twelfth graders exhibited an increase from 1992 to 1997, 
and their use has declined significantly since.) The popularity of Camel cigarettes among the 
college-bound, which we have reported elsewhere, may help to explain some of the 
narrowing of the gap between college students and their age peers.54 The Joe Camel 
advertising and promotion campaign, commenced in the late 1980s and ended in the late 
1990s, may have succeeded in initiating more college students (particularly male college 
students) to smoking than had been the case previously or since. 
 
• For many drugs—amphetamines, sedatives (barbiturates), and tranquilizers—differences 
between college students and their noncollege age peers narrowed over the years. Much of 
                                                 
54Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (1999). Cigarette brand preferences among adolescents. (Monitoring the 
Future Occasional Paper No. 45) Ann Arbor, MI: Institute for Social Research. 
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this is due to general overall declines in usage rates during the 1980s, but some may also 
reflect the increasing proportion of the age group going to college. 
 
The overall drug use trends among college students are also parallel, for the most part, to the 
trends among 12th graders; still, declines in many drugs over the decade of 1980 to 1990 
were proportionately larger among college students, and for that matter, among all young 
adults of college age, than among 12th graders. Despite parallel trends in the early 1990s, the 
12th graders have shown a larger, and often earlier, increase in the use of a number of drugs 
in the years since; as indicated in Volume I, the 8th and 10th graders in secondary school 
showed increases a year earlier than the 12th graders. It is clear that this most recent upsurge, 
or what we have called a “relapse phase” in the illicit drug epidemic, did not originate on the 
nation’s campuses, as did the original epidemic. It originated among secondary school 
students—and the younger ones at that—and has been carried up the age spectrum through 
generational replacement, at least in part. Put in more general terms, there is clear evidence 
of some important cohort effects at work here. 
 
 
GENDER DIFFERENCES IN TRENDS AMONG COLLEGE STUDENTS 
 
One trend that is not obvious from the figures included here is the slow rise in the proportion of 
college students who are female. Females constituted 50% of our 1980 sample of college students 
compared to 63% of our 2005 sample. Given that substantial gender differences exist in the use of 
some drugs, we have been concerned all along that apparent long-term trends in the levels of drug 
use among college students might actually be attributable to changes in the gender composition of 
that population. For that reason, in particular, we have consistently presented separate trend lines for 
the male and female segments of the college student population. Differences in the trends observed 
for the two genders, illustrated in the lower panels of Figures 9-1 through 9-15c, are discussed next.  
In general, trends in the use of the various drugs and in the overall drug use indexes have been 
highly parallel for male and female college students, as an examination of the relevant figures will 
show. The most noteworthy exceptions are mentioned below. 
• Certain drug use measures showed a convergence of usage levels between the genders as 
they dropped to very low levels. Marijuana use was one example, with some convergence in 
the rates between 1980 and 1991 as overall use declined, and then some divergence between 
1991 and 1999 as usage rates rose. After 2001, however, the two genders diverged 
somewhat, with use among males increasing and use among females decreasing, though 
there was no further divergence in 2005 (see Figure 9-3a). Daily marijuana use presents a 
clearer example, with the decline among males between 1980 and 1986 narrowing the gap 
between the genders. Between 1986 and 1993 there was no further narrowing; but as use 
began to rise in the mid-1990s, a greater increase among males widened the gap again. Use 
among males held fairly steady in the late 1990s while use among females rose, once again 
narrowing the gender gap somewhat. In 2004 the rates for the two genders seemed to be 
moving in opposite directions—6.8% versus 3.1% for male and female college students, 
respectively, but no further divergence was seen in 2005. (See Figure 9-3b.) 
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• LSD use dropped more steeply among males from 1999 to 2005 than among females, 
bringing the genders close together at very low prevalence rates (Figure 9-6). Prior to that 
period of convergence, use had quite consistently been higher among males. 
 
• After 1986, cocaine use dropped more steeply for males than for females in general and 
among male college students in particular, considerably narrowing the sizable gap between 
the genders (see Figure 9-9). Since 1991 both genders have moved in parallel, with males 
reporting somewhat higher usage rates (6.2%, versus 5.4% for females in 2005).  
 
• Like a number of other drugs, methaqualone also showed a convergence in use through 
1989, with use among males declining more than among females (no figure given; questions 
about methaqualone use were dropped after 1989).   
 
• Amphetamine use (Figure 9-11) also showed some convergence in the early 1980s due to a 
greater decline among males. Since 1989 the trends have been quite parallel, with males 
generally having slightly higher annual prevalence. 
 
• The annual prevalence of alcohol use has been virtually identical for the two genders 
throughout the duration of the study (Figure 9-14a), and the 30-day prevalence rate has been 
quite close, with males slightly higher (Figure 9-14b); but college males have consistently 
had higher rates of daily drinking and binge drinking (Figures 9-14c and 9-14d). If anything, 
the gender difference in daily drinking has expanded since 2000, with males increasing and 
females showing some decrease. In 2005, the rates were 8.6% for college males versus 2.3% 
for college females. From 1988 through 1994, binge drinking among college females 
decreased some (from 37% to 31%); but binge drinking among college males declined more, 
from a high point in 1986 of 58% to a low of 47% in 1995 (see Figure 9-14d). Since 1998, 
there has been some closing of the gender gap in binge drinking, as the rate among college 
females has risen from 31% in 1998 to 34% in 2005, while it actually declined a bit from 
52% to 50% among college males. 
 
• Between 1980 and 1992, the 30-day prevalence of cigarette smoking was consistently higher 
among college females than males (Figure 9-15a). However, the gap in 30-day prevalence 
narrowed because use by female college students declined considerably between 1980 and 
1989, while use by male college students did not decline. After 1989, the gap remained quite 
small and the genders reversed position, with males catching up to, and passing, females in 
their rate of smoking by 1994 and then remaining higher through at least 2000. (A similar 
reversal had occurred among 12th graders a few years earlier, so this reversal probably 
reflected a cohort effect.) Both genders exhibited a considerable decrease in 30-day smoking 
between 1999 and 2003, leaving very little difference between them (22% for males, 23% for 
females), although the trend line for college males has been irregular during this interval. In 
2005, the two genders appear to have equivalent rates. 
 
While the rise in smoking among college students was longer-term and more gradual than in 
the other two groups, it nevertheless was substantial, rising by nearly half between 1989 
(21%) and 1999 (31%). The increase in smoking after 1988 was sharper among college 
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males than among college females, consistent with the notion that Camel cigarettes’ 
promotion and advertising—which ended in the late 1990s as a part of the tobacco 
settlement—may have played a role in the overall increase. Camels proved considerably 
more popular among males, especially among those college-bound and from more educated 
families.55 
                                                 
55Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (1999). Cigarette brand preferences among adolescents. (Monitoring 
the Future Occasional Paper No. 45) Ann Arbor, MI: Institute for Social Research. 
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Percentage who used in lifetime
'04-'05
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 change
  Approx. Wtd. N = 1040 1130 1150 1170 1110 1080 1190 1220 1310 1300 1400 1410 1490 1490 1410 1450 1450 1480 1440 1440 1350 1340 1260 1270 1400 1360
Any Illicit Drug a 69.4 66.8 64.6 66.9 62.7 65.2 61.8 60.0 58.4 55.6 54.0 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2 53.7 53.6 51.8 53.9 52.2 52.3 +0.1
Any Illicit Drug a
  Other Than Marijuana 42.2 41.3 39.6 41.7 38.6 40.0 37.5 35.7 33.4 30.5 28.4 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5 25.8 26.3 26.9 27.6 28.0 26.5 -1.5
Marijuana 65.0 63.3 60.5 63.1 59.0 60.6 57.9 55.8 54.3 51.3 49.1 46.3 44.1 42.0 42.2 41.7 45.1 46.1 49.9 50.8 51.2 51.0 49.5 50.7 49.1 49.1 0.0
Inhalantsb,c 10.2 8.8 10.6 11.0 10.4 10.6 11.0 13.2 12.6 15.0 13.9 14.4 14.2 14.8 12.0 13.8 11.4 12.4 12.8 12.4 12.9 9.6 7.7 9.7 8.5 7.1 -1.4
Hallucinogens c,d 15.0 12.0 15.0 12.2 12.9 11.4 11.2 10.9 10.2 10.7 11.2 11.3 12.0 11.8 10.0 13.0 12.6 13.8 15.2 14.8 14.4 14.8 13.6 14.5 12.0 11.0 -1.0
     LSD 10.3 8.5 11.5 8.8 9.4 7.4 7.7 8.0 7.5 7.8 9.1 9.6 10.6 10.6 9.2 11.5 10.8 11.7 13.1 12.7 11.8 12.2 8.6 8.7 5.6 3.7 -1.9 s
     MDMA (Ecstasy)e  NA  NA  NA  NA  NA  NA  NA  NA  NA 3.8 3.9 2.0 2.9 2.3 2.1 3.1 4.3 4.6 6.8 8.4 13.1 14.7 12.7 12.9 10.2 8.3 -2.0
Cocaine 22.0 21.5 22.4 23.1 21.7 22.9 23.3 20.6 15.8 14.6 11.4 9.4 7.9 6.3 5.0 5.5 5.0 5.6 8.1 8.4 9.1 8.6 8.2 9.2 9.5 8.8 -0.7
     Crackf  NA  NA  NA  NA  NA  NA  NA 3.3 3.4 2.4 1.4 1.5 1.7 1.3 1.0 1.8 1.2 1.4 2.2 2.4 2.5 2.0 1.9 3.1 2.0 1.7 -0.3
Heroin 0.9 0.6 0.5 0.3 0.5 0.4 0.4 0.6 0.3 0.7 0.3 0.5 0.5 0.6 0.1 0.6 0.7 0.9 1.7 0.9 1.7 1.2 1.0 1.0 0.9 0.5 -0.4
Other Narcoticsg,h 8.9 8.3 8.1 8.4 8.9 6.3 8.8 7.6 6.3 7.6 6.8 7.3 7.3 6.2 5.1 7.2 5.7 8.2 8.7 8.7 8.9 11.0 12.2 14.2 13.8 14.4 +0.6
Amphetamines g 29.5 29.4  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
Amphetamines, Adj.g,i  NA  NA 30.1 27.8 27.8 25.4 22.3 19.8 17.7 14.6 13.2 13.0 10.5 10.1 9.2 10.7 9.5 10.6 10.6 11.9 12.3 12.4 11.9 12.3 12.7 12.3 -0.4
     Crystal Meth. (Ice) j  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 1.0 1.3 0.6 1.6 1.3 1.0 0.8 1.6 2.2 2.8 1.3 2.3 2.0 2.9 2.2 2.4 +0.2
Sedatives (Barbiturates) g 8.1 7.8 8.2 6.6 6.4 4.9 5.4 3.5 3.6 3.2 3.8 3.5 3.8 3.5 3.2 4.0 4.6 5.2 5.7 6.7 6.9 6.0 5.9 5.7 7.2 8.5 +1.3
    Sedatives, Adj.g,k 13.7 14.2 14.1 12.2 10.8 9.3 8.0 6.1 4.7 4.1  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
     Methaqualone g 10.3 10.4 11.1 9.2 9.0 7.2 5.8 4.1 2.2 2.4  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
Tranquilizers d,g 15.2 11.4 11.7 10.8 10.8 9.8 10.7 8.7 8.0 8.0 7.1 6.8 6.9 6.3 4.4 5.4 5.4 6.9 7.7 8.2 8.8 9.7 10.7 11.0 10.6 11.9 +1.3
Alcoholl 94.3 95.2 95.2 95.0 94.2 95.3 94.9 94.1 94.9 93.7 93.1 93.6 91.8 89.3 88.2 88.5 88.4 87.3 88.5 88.0 86.6 86.1 86.0 86.2 84.6 86.6 +2.1
     Flvd. Alcoholic Bvg.m  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 79.0 84.5 +5.5
Cigarettes  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA —
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding. 'NA' indicates data not available. 
See footnotes on next page.
TABLE 9-1
Trends in Lifetime Prevalence of Various Types of Drugs
Among College Students 1-4 Years Beyond High School
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FOOTNOTES FOR TABLES 9-1 THROUGH 9-5
a "Any illicit drug" includes use of marijuana, hallucinogens, cocaine, heroin or other narcotics, amphetamines, sedatives (barbiturates), methaqualone (until 1990), or 
tranquilizers not under a doctor's orders.
bThis drug was asked about in four of the five questionnaire forms in 1980-1989, in five of the six forms in 1990-1998, and in three of the six forms in 1999-2005.  Total N in 2005 
is approximately 680.
cUnadjusted for known underreporting of certain drugs.  See text for details.
dIn 2001 the question text was changed on half the questionnaire forms. "Other psychedelics" was changed to "other hallucinogens," and "shrooms" was added to the list 
of examples.  For tranquilizers, "Miltown" was replaced with "Xanax" in the list of examples.  Beginning in 2002 the remaining forms were changed to the new wording. 
eThis drug was asked about in two of the five questionnaire forms in 1989, in two of the six questionnaire forms in 1990-2001, and in three of the six questionnaire forms in 
2002-2005.  Total N in 2005 is approximately 680.
fThis drug was asked about in two of the five questionnaire forms in 1987-1989, in all six questionnaire forms in 1990-2001, and in five of the six questionnaire forms in 2002-
2005. Total N in 2005 is approximately 1130.
gOnly drug use that was not under a doctor's orders is included here.
hIn 2002 the question text was changed on half of the questionnaire forms. The list of examples of narcotics other than heroin was updated: Talwin, laudanum, and 
paregoric--all of which had negligible rates of use by 2001--were replaced by Vicodin, OxyContin, and Percocet. The 2002 data presented here are based on the 
changed forms only; N is one-half of N indicated.  In 2003 the remaining forms were changed to the new wording. The data are based on all forms in 2003 and beyond.
iBased on the data from the revised question, which attempts to exclude inappropriate reporting of nonprescription amphetamines.
jThis drug was asked about in two of the six questionnaire forms.  Total N in 2005 is approximately 450.
k"Sedatives, adjusted" data are a combination of  barbiturate and methaqualone data.
lIn 1993 and 1994, the question text was changed slightly in three of the six questionnaire forms to indicate that a "drink" meant "more than just a few sips."  Because this 
revision resulted in rather little change in reported prevalence in the surveys of high school graduates, the data for all forms combined are used in order to provide the 
most reliable estimate of change.  After 1994 the new question text was used in all six of the questionnaire forms.
mThis drug was asked about in one of the six questionnaire forms. Total N in 2005 is approximately 230.
nRevised questions about amphetamine use were introduced in 1982 to exclude more completely inappropriate reporting of nonprescription amphetamines.  The data in
italics are therefore not strictly comparable to the other data. 
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Percentage who used in past year
'04-'05
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 change
  Approx. Wtd. N = 1040 1130 1150 1170 1110 1080 1190 1220 1310 1300 1400 1410 1490 1490 1410 1450 1450 1480 1440 1440 1350 1340 1260 1270 1400 1360
Any Illicit Drug a 56.2 55.0 49.5 49.8 45.1 46.3 45.0 40.1 37.4 36.7 33.3 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9 36.1 37.9 37.0 36.5 36.2 36.6 +0.4
Any Illicit Drug a
  Other Than Marijuana 32.3 31.7 29.9 29.9 27.2 26.7 25.0 21.3 19.2 16.4 15.2 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4 15.6 16.4 16.6 17.9 18.6 18.5 -0.1
Marijuana 51.2 51.3 44.7 45.2 40.7 41.7 40.9 37.0 34.6 33.6 29.4 26.5 27.7 27.9 29.3 31.2 33.1 31.6 35.9 35.2 34.0 35.6 34.7 33.7 33.3 33.3 0.0
Inhalantsb,c 3.0 2.5 2.5 2.8 2.4 3.1 3.9 3.7 4.1 3.7 3.9 3.5 3.1 3.8 3.0 3.9 3.6 4.1 3.0 3.2 2.9 2.8 2.0 1.8 2.7 1.8 -0.9
Hallucinogens c,d 8.5 7.0 8.7 6.5 6.2 5.0 6.0 5.9 5.3 5.1 5.4 6.3 6.8 6.0 6.2 8.2 6.9 7.7 7.2 7.8 6.7 7.5 6.3 7.4 5.9 5.0 -0.9
     LSD 6.0 4.6 6.3 4.3 3.7 2.2 3.9 4.0 3.6 3.4 4.3 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4 4.3 4.0 2.1 1.4 1.2 0.7 -0.5
     MDMA (Ecstasy)e  NA  NA  NA  NA  NA  NA  NA  NA  NA 2.3 2.3 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5 9.1 9.2 6.8 4.4 2.2 2.9 +0.8
Cocaine 16.8 16.0 17.2 17.3 16.3 17.3 17.1 13.7 10.0 8.2 5.6 3.6 3.0 2.7 2.0 3.6 2.9 3.4 4.6 4.6 4.8 4.7 4.8 5.4 6.6 5.7 -0.9
     Crackf  NA  NA  NA  NA  NA  NA 1.3 2.0 1.4 1.5 0.6 0.5 0.4 0.6 0.5 1.1 0.6 0.4 1.0 0.9 0.9 0.9 0.4 1.3 1.3 0.8 -0.5
Heroin 0.4 0.2 0.1 * 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.4 0.3 0.6 0.2 0.5 0.4 0.1 0.2 0.4 0.3 -0.1
Other Narcoticsg,h 5.1 4.3 3.8 3.8 3.8 2.4 4.0 3.1 3.1 3.2 2.9 2.7 2.7 2.5 2.4 3.8 3.1 4.2 4.2 4.3 4.5 5.7 7.4 8.7 8.2 8.4 +0.2
     OxyContinj  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 1.5 2.2 2.5 2.1 -0.4
     Vicodin j  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 6.9 7.5 7.4 9.6 +2.2
Amphetamines g 22.4 22.2  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA NA NA —
Amphetamines, Adj.g,i  NA  NA 21.1 17.3 15.7 11.9 10.3 7.2 6.2 4.6 4.5 3.9 3.6 4.2 4.2 5.4 4.2 5.7 5.1 5.8 6.6 7.2 7.0 7.1 7.0 6.7 -0.2
     Ritalin j  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 5.7 4.7 4.7 4.2 -0.5
     Methamphetamine j  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 3.3 1.6 2.4 1.2 2.6 2.9 1.7 -1.2
     Crystal Meth. (Ice) j  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 0.1 0.1 0.2 0.7 0.8 1.1 0.4 0.8 1.0 0.5 0.5 0.6 0.8 0.9 1.1 1.4 +0.3
 Sedatives (Barbiturates) g 2.9 2.8 3.2 2.2 1.9 1.3 2.0 1.2 1.1 1.0 1.4 1.2 1.4 1.5 1.2 2.0 2.3 3.0 2.5 3.2 3.7 3.8 3.7 4.1 4.2 3.9 -0.2
    Sedatives, Adj.g,k 8.3 8.0 8.0 4.5 3.5 2.5 2.6 1.7 1.5 1.0  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA NA NA —
     Methaqualone g 7.2 6.5 6.6 3.1 2.5 1.4 1.2 0.8 0.5 0.2  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA NA NA —
Tranquilizers d,g 6.9 4.8 4.7 4.6 3.5 3.6 4.4 3.8 3.1 2.6 3.0 2.4 2.9 2.4 1.8 2.9 2.8 3.8 3.9 3.8 4.2 5.1 6.7 6.9 6.7 6.4 -0.3
Rohypnolj  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 0.7 0.4 0.3 0.1 -0.2
GHBj  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 0.6 0.3 0.7 0.4 -0.3
Ketaminej  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 1.3 1.0 1.5 0.5 -1.0
Alcoholl 90.5 92.5 92.2 91.6 90.0 92.0 91.5 90.9 89.6 89.6 89.0 88.3 86.9 85.1 82.7 83.2 83.0 82.4 84.6 83.6 83.2 83.0 82.9 81.7 81.2 83.0 +1.8
     Flvd. Alcoholic Bvg.m  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 63.2 67.0 +3.8
Cigarettes 36.2 37.6 34.3 36.1 33.2 35.0 35.3 38.0 36.6 34.2 35.5 35.6 37.3 38.8 37.6 39.3 41.4 43.6 44.3 44.5 41.3 39.0 38.3 35.2 36.7 36.0 -0.7
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding. 'NA' indicates data not available.
See footnotes at end of Table 9-1.
TABLE 9-2
Trends in Annual Prevalence of Various Types of Drugs
Among College Students 1-4 Years Beyond High School
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Percentage who used in last 30 days
'04-'05
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 change
  Approx. Wtd. N = 1040 1130 1150 1170 1110 1080 1190 1220 1310 1300 1400 1410 1490 1490 1410 1450 1450 1480 1440 1440 1350 1340 1260 1270 1400 1360
Any Illicit Drug a 38.4 37.6 31.3 29.3 27.0 26.1 25.9 22.4 18.5 18.2 15.2 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6 21.5 21.9 21.5 21.4 21.2 19.5 -1.7
Any Illicit Drug a
  Other Than Marijuana 20.7 18.6 17.1 13.9 13.8 11.8 11.6 8.8 8.5 6.9 4.4 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4 6.9 7.5 7.8 8.2 9.1 8.2 -0.8
Marijuana 34.0 33.2 26.8 26.2 23.0 23.6 22.3 20.3 16.8 16.3 14.0 14.1 14.6 14.2 15.1 18.6 17.5 17.7 18.6 20.7 20.0 20.2 19.7 19.3 18.9 17.1 -1.8
Inhalantsb,c 1.5 0.9 0.8 0.7 0.7 1.0 1.1 0.9 1.3 0.8 1.0 0.9 1.1 1.3 0.6 1.6 0.8 0.7 0.6 1.5 0.9 0.4 0.7 0.4 0.4 0.3 -0.1
Hallucinogens c,d 2.7 2.3 2.6 1.8 1.8 1.3 2.2 2.0 1.7 2.3 1.4 1.2 2.3 2.5 2.1 3.3 1.9 2.1 2.1 2.0 1.4 1.8 1.2 1.8 1.3 1.2 -0.1
     LSD 1.4 1.4 1.7 0.9 0.8 0.7 1.4 1.4 1.1 1.4 1.1 0.8 1.8 1.6 1.8 2.5 0.9 1.1 1.5 1.2 0.9 1.0 0.2 0.2 0.2 0.1 0.0
     MDMA (Ecstasy)e  NA  NA  NA  NA  NA  NA  NA  NA  NA 0.3 0.6 0.2 0.4 0.3 0.2 0.7 0.7 0.8 0.8 2.1 2.5 1.5 0.7 1.0 0.7 0.8 +0.1
Cocaine 6.9 7.3 7.9 6.5 7.6 6.9 7.0 4.6 4.2 2.8 1.2 1.0 1.0 0.7 0.6 0.7 0.8 1.6 1.6 1.2 1.4 1.9 1.6 1.9 2.4 1.8 -0.6
     Crackf  NA  NA  NA  NA  NA  NA  NA 0.4 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.1 0.3 0.4 0.4 0.1 -0.3
Heroin 0.3 0.0 0.0 0.0 * * 0.0 0.1 0.1 0.1 0.0 0.1 0.0 * 0.0 0.1 * 0.2 0.1 0.1 0.2 0.1 0.0 * 0.1 0.1 0.0
Other Narcoticsg,h 1.8 1.1 0.9 1.1 1.4 0.7 0.6 0.8 0.8 0.7 0.5 0.6 1.0 0.7 0.4 1.2 0.7 1.3 1.1 1.0 1.7 1.7 3.2 2.3 3.0 3.1 +0.1
Amphetamines g 13.4 12.3  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA NA NA —
Amphetamines, Adj.g,i  NA  NA 9.9 7.0 5.5 4.2 3.7 2.3 1.8 1.3 1.4 1.0 1.1 1.5 1.5 2.2 0.9 2.1 1.7 2.3 2.9 3.3 3.0 3.1 3.2 2.9 -0.3
     Crystal Meth. (Ice) j  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 0.0 0.0 0.0 0.3 0.5 0.3 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.2 +0.1
 Sedatives (Barbiturates) g 0.9 0.8 1.0 0.5 0.7 0.4 0.6 0.5 0.5 0.2 0.2 0.3 0.7 0.4 0.4 0.5 0.8 1.2 1.1 1.1 1.1 1.5 1.7 1.7 1.5 1.3 -0.2
    Sedatives, Adj.g,k 3.8 3.4 2.5 1.1 1.0 0.7 0.6 0.6 0.6 0.2  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA NA NA —
     Methaqualone g 3.1 3.0 1.9 0.7 0.5 0.3 0.1 0.2 0.1 0.0  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA NA NA —
Tranquilizers d,g 2.0 1.4 1.4 1.2 1.1 1.4 1.9 1.0 1.1 0.8 0.5 0.6 0.6 0.4 0.4 0.5 0.7 1.2 1.3 1.1 2.0 1.5 3.0 2.8 2.7 2.2 -0.5
Alcoholl 81.8 81.9 82.8 80.3 79.1 80.3 79.7 78.4 77.0 76.2 74.5 74.7 71.4 70.1 67.8 67.5 67.0 65.8 68.1 69.6 67.4 67.0 68.9 66.2 67.7 67.9 +0.2
     Flvd. Alcoholic Bvg.m  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA  NA 34.0 30.9 -3.1
Cigarettes 25.8 25.9 24.4 24.7 21.5 22.4 22.4 24.0 22.6 21.1 21.5 23.2 23.5 24.5 23.5 26.8 27.9 28.3 30.0 30.6 28.2 25.7 26.7 22.5 24.3 23.8 -0.5
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the prevalence 
estimates for the two most recent years is due to rounding. '*' indicates a percentage of less than 0.05% but greater than true zero. 'NA' indicates data not available. 
See footnotes at end of Table 9-1.
TABLE 9-3
Trends in Thirty-Day Prevalence of Various Types of Drugs
Among College Students 1-4 Years Beyond High School
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Percentage who used daily in last 30 days
'04-'05
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 change
  Approx. Wtd. N = 1040 1130 1150 1170 1110 1080 1190 1220 1310 1300 1400 1410 1490 1490 1410 1450 1450 1480 1440 1440 1350 1340 1260 1270 1400 1360
Marijuana 7.2 5.6 4.2 3.8 3.6 3.1 2.1 2.3 1.8 2.6 1.7 1.8 1.6 1.9 1.8 3.7 2.8 3.7 4.0 4.0 4.6 4.5 4.1 4.7 4.5 4.0 -0.4
Cocaine 0.2 0.0 0.3 0.1 0.4 0.1 0.1 0.1 0.1  * 0.0  * 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 * 0.0 0.1 +0.1
Amphetamines g 0.5 0.4   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA   NA —
Amphetamines, Adj.g,i   NA   NA 0.3 0.2 0.2  * 0.1 0.1  *  * 0.0 0.1 0.0 0.1 0.1 0.1  * 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.2 0.2 +0.1
Alcoholl
      Daily 6.5 5.5 6.1 6.1 6.6 5.0 4.6 6.0 4.9 4.0 3.8 4.1 3.7 3.9 3.7 3.0 3.2 4.5 3.9 4.5 3.6 4.7 5.0 4.3 3.7 4.6 +0.9
     5+ Drinks in a Row
        in Last 2 Weeks 43.9 43.6 44.0 43.1 45.4 44.6 45.0 42.8 43.2 41.7 41.0 42.8 41.4 40.2 40.2 38.6 38.3 40.7 38.9 40.0 39.3 40.9 40.1 38.5 41.7 40.1 -1.6
Cigarettes
     Daily 18.3 17.1 16.2 15.3 14.7 14.2 12.7 13.9 12.4 12.2 12.1 13.8 14.1 15.2 13.2 15.8 15.9 15.2 18.0 19.3 17.8 15.0 15.9 13.8 13.8 12.4 -1.4
     Half-Pack or More
      per Day 12.7 11.9 10.5 9.6 10.2 9.4 8.3 8.2 7.3 6.7 8.2 8.0 8.9 8.9 8.0 10.2 8.5 9.1 11.3 11.0 10.1 7.8 7.9 7.6 6.8 6.7 -0.1
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change estimate and the 
prevalence estimates for the two most recent years is due to rounding. '*' indicates a percentage of less than 0.05% but greater than true zero.  'NA' indicates data not available. 
See footnotes at end of Table 9-1.
TABLE 9-4
Trends in Thirty-Day Prevalence of Daily Use of Various Types of Drugs
Among College Students 1-4 Years Beyond High School
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     Females 18.7 18.5 14.2 12.1 11.5 11.2 9.3 8.5 8.8 6.0 4.0 3.9 4.2 3.8 3.4 4.5 3.4 6.1 4.6 5.6 6.0 6.4 7.4 8.3 7.8 7.0 -0.7
'04-'05
1980 n 1981 n 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 change
Lifetime
Any Illicit Drug 69.4 66.8 64.6 66.9 62.7 65.2 61.8 60.0 58.4 55.6 54.0 50.4 48.8 45.9 45.5 45.5 47.4 49.0 52.9 53.2 53.7 53.6 51.8 53.9 52.2 52.3 +0.1
     Males 71.0 67.5 68.1 71.3 66.4 69.8 64.7 63.5 56.0 56.5 52.5 51.3 50.8 45.7 49.5 47.3 50.3 52.1 54.4 58.4 54.4 53.9 54.3 54.1 54.9 54.2 -0.8
     Females 67.5 66.3 61.5 63.0 59.2 61.6 59.4 57.4 60.2 54.9 55.1 49.7 47.1 46.0 42.6 44.3 45.6 46.7 52.0 49.6 53.2 53.5 50.2 53.7 50.6 51.3 +0.7
Any Illicit Drug
  Other Than Marijuana 42.2 41.3 39.6 41.7 38.6 40.0 37.5 35.7 33.4 30.5 28.4 25.8 26.1 24.3 22.0 24.5 22.7 24.4 24.8 25.5 25.8 26.3 26.9 27.6 28.0 26.5 -1.5
     Males 42.8 39.8 45.1 44.6 40.9 42.1 38.2 37.2 31.8 30.6 26.2 27.6 26.3 24.3 24.6 26.6 25.0 27.3 27.3 29.4 28.9 27.0 30.4 27.6 31.1 29.0 -2.1
     Females 41.6 42.6 34.7 39.2 36.4 38.3 37.0 34.6 34.6 30.4 30.1 24.3 26.1 24.3 20.1 22.9 21.2 22.2 23.3 22.8 23.5 25.9 24.6 27.5 26.2 25.1 -1.2
Past 12 Months
Any Illicit Drug 56.2 55.0 49.5 49.8 45.1 46.3 45.0 40.1 37.4 36.7 33.3 29.2 30.6 30.6 31.4 33.5 34.2 34.1 37.8 36.9 36.1 37.9 37.0 36.5 36.2 36.6 +0.4
     Males 58.9 56.2 54.6 53.4 48.4 50.9 49.8 43.3 37.0 38.2 34.2 30.2 32.8 32.6 33.9 36.1 36.6 38.3 40.1 42.5 38.0 38.8 39.5 39.2 40.9 40.7 -0.2
     Females 53.3 54.0 44.9 46.7 41.9 42.7 41.1 37.7 37.6 35.4 32.5 28.4 28.7 29.1 29.5 31.7 32.7 31.1 36.4 33.2 34.7 37.3 35.4 34.8 33.4 34.2 +0.8
Any Illicit Drug
  Other Than Marijuana 32.3 31.7 29.9 29.9 27.2 26.7 25.0 21.3 19.2 16.4 15.2 13.2 13.1 12.5 12.2 15.9 12.8 15.8 14.0 15.4 15.6 16.4 16.6 17.9 18.6 18.5 -0.1
     Males 33.7 32.8 33.4 33.5 29.2 29.7 28.6 23.5 19.4 18.7 15.7 14.4 13.8 15.0 14.9 19.5 15.1 18.1 17.0 19.0 18.6 17.2 19.2 19.3 22.1 21.1 -0.9
     Females 31.1 30.8 26.9 26.8 25.2 24.4 22.1 19.6 19.0 14.6 14.8 12.1 12.6 10.5 10.2 13.3 11.3 14.1 12.1 12.8 13.5 15.8 15.0 17.1 16.5 16.9 +0.4
Past 30 Days
Any Illicit Drug 38.4 37.6 31.3 29.3 27.0 26.1 25.9 22.4 18.5 18.2 15.2 15.2 16.1 15.1 16.0 19.1 17.6 19.2 19.7 21.6 21.5 21.9 21.5 21.4 21.2 19.5 -1.7
     Males 42.9 40.6 37.7 33.8 30.4 29.9 31.0 24.0 18.8 20.0 18.2 16.0 18.0 16.0 20.5 23.7 20.6 23.4 23.1 26.7 24.0 25.0 25.1 22.8 26.1 22.9 -3.1
     Females 34.0 34.8 25.6 25.5 23.7 23.2 21.7 21.1 18.3 16.7 12.7 14.6 14.5 14.5 12.7 15.7 15.8 16.2 17.6 18.1 19.6 19.8 19.3 20.5 18.4 17.5 -0.9
Any Illicit Drug
  Other Than Marijuana 20.7 18.6 17.1 13.9 13.8 11.8 11.6 8.8 8.5 6.9 4.4 4.3 4.6 5.4 4.6 6.3 4.5 6.8 6.1 6.4 6.9 7.5 7.8 8.2 9.1 8.2 -0.8
     Males 22.8 18.6 20.2 16.0 16.1 12.6 14.4 9.0 8.2 8.0 4.9 4.8 5.1 7.3 6.2 8.8 6.1 7.8 8.6 7.5 8.2 9.0 8.4 8.1 11.3 10.3 -1.0










1450 1450 1480 1440 1440 1350 1340 1260 1270 1400 1360
     Males 520 530 550 550 540 490 540 520 560 580 620 640 680 660 590 610 560 630 570 590 560 540 490 480 520 500
     Females 520 600 610 620 570 600 650 700 750 720 780 770 810 830 820 840 890 860 880 850 790 800 770 790 880 860
Source :  The Monitoring the Future Study, the University of Michigan.
Notes :  Level of significance of difference between the two most recent years:  s = .05, ss = .01, sss = .001.  Any apparent inconsistency between the change and prevalence estimates for the 
two most recent years is due to rounding.
See footnotes at end of Table 9-1.
TABLE 9-5
Trends in Lifetime, Annual, and Thirty-Day Prevalence of an Illicit Drug Use Indexa
Among College Students 1-4 Years Beyond High School, by Gender
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FIGURE 9-1
Any Illicit Drug:  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Any Illicit Drug:  Trends in Annual Prevalence 
Among Male vs. Female College Students






































Any Illicit Drug Other Than Marijuana:  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Any Illicit Drug Other Than Marijuana:  Trends in Annual Prevalence 
Among Male vs. Female College Students










































Marijuana:  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
Marijuana:  Trends in Annual Prevalence
Among Male vs. Female College Students





































Note :  "Others" refers to high school graduates 1-4 years beyond high school not currently enrolled full-time in college.
FIGURE 9-3b
Marijuana:  Trends in Thirty-Day Prevalence of Daily Use
Among College Students vs. Others
1-4 Years Beyond High School
Marijuana:  Trends in Thirty-Day Prevalence of Daily Use
































Inhalants:*  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Inhalants:*  Trends in Annual Prevalence 
Among Male vs. Female College Students
Note :  "Others" refers to high school graduates 1-4 years beyond high school not currently enrolled full-time in college.




































Hallucinogens:*  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Hallucinogens:*  Trends in Annual Prevalence 
Among Male vs. Female College Students
Note :  "Others" refers to high school graduates 1-4 years beyond high school not currently enrolled full-time in college.
































LSD:  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
LSD:  Trends in Annual Prevalence
Among Male vs. Female College Students
































Hallucinogens Other Than LSD:  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Hallucinogens Other Than LSD:  Trends in Annual Prevalence 
Among Male vs. Female College Students
































MDMA (Ecstasy):  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
MDMA (Ecstasy):  Trends in Annual Prevalence
Among Male vs. Female College Students
































Cocaine:  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
Cocaine:  Trends in Annual Prevalence
Among Male vs. Female College Students




































Narcotics Other Than Heroin:*  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Narcotics Other Than Heroin:*  Trends in Annual Prevalence 
Among Male vs. Female College Students
Note :  "Others" refers to high school graduates 1-4 years beyond high school not currently enrolled full-time in college.
*In 2002 the question text was changed on half of the questionnaire forms. The list of examples of narcotics other than 
heroin was updated: Talwin, laudanum, and paregoric—all of which had negligible rates of use by 2001—were 
replaced by Vicodin, OxyContin, and Percocet. The 2002 data presented here are based on the changed forms only.  
































Vicodin:  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School


















OxyContin:  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School




















Amphetamines:  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
Amphetamines:  Trends in Annual Prevalence
Among Male vs. Female College Students






































Sedatives (Barbiturates):  Trends in Annual Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
Sedatives (Barbiturates):  Trends in Annual Prevalence
Among Male vs. Female College Students




































Tranquilizers:  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Tranquilizers:  Trends in Annual Prevalence 
Among Male vs. Female College Students
































Alcohol:  Trends in Annual Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Alcohol:  Trends in Annual Prevalence
Among Male vs. Female College Students














































Alcohol:  Trends in Thirty-Day Prevalence 
Among College Students vs. Others
1-4 Years Beyond High School
Alcohol:  Trends in Thirty-Day Prevalence 
Among Male vs. Female College Students












































Alcohol:  Trends in Thirty-Day Prevalence of Daily Use 
Among College Students vs. Others
1-4 Years Beyond High School
Alcohol:  Trends in Thirty-Day Prevalence of Daily Use
Among Male vs. Female College Students
































Alcohol:  Trends in Two-Week Prevalence of Five or More Drinks in a Row 
Among College Students vs. Others
1-4 Years Beyond High School
Alcohol:  Trends in Two-Week Prevalence of Five or More Drinks in a Row 
Among Male vs. Female College Students






































Cigarettes:  Trends in Thirty-Day Prevalence
Among College Students vs. Others
1-4 Years Beyond High School
Cigarettes:  Trends in Thirty-Day Prevalence 
Among Male vs. Female College Students












































Cigarettes:  Trends in Thirty-Day Prevalence of Daily Use
Among College Students vs. Others
1-4 Years Beyond High School
Cigarettes:  Trends in Thirty-Day Prevalence of Daily Use 
Among Male vs. Female College Students










































Cigarettes: Trends in Thirty-Day Prevalence of Smoking a Half-Pack 
or More per Day Among College Students vs. Others
1-4 Years Beyond High School
Cigarettes: Trends in Thirty-Day Prevalence of Smoking a Half-Pack
or More per Day Among Male vs. Female College Students












































Chapter 10  
 
RISK AND PROTECTIVE BEHAVIORS  
RELATED TO HIV/AIDS 
 
 
During the three-decade span of the Monitoring the Future (MTF) study, the spread of the human 
immunodeficiency virus (HIV), which leads to the acquired immunodeficiency syndrome 
(AIDS), has become an extremely serious public health concern. Certain behaviors that put 
people at heightened risk of contracting and spreading HIV are connected to drug abuse—in 
particular drug use by injection, and specifically when it involves needle sharing. Another 
behavior related to heightened risk is having multiple sex partners, which itself is a behavior 
connected to drug us. Further, both drug abuse and having multiple sex partners tend to be 
particularly prevalent among young adults. A considerable literature has evolved based on 
studies of special populations at high risk, but relatively little information exists on these 
behaviors as they occur in the general population. Whatever changes occur in the proportions of 
American young adults choosing to engage in these risk behaviors and risk-reduction behaviors 
will have important consequences for the course of the nation’s AIDS epidemic.   
 
Accordingly, a set of questions was added to two of the six questionnaire forms used in the MTF 
follow-up surveys of 21- to 30-year-olds, beginning in 2004. One of the purposes of limiting the 
change to two forms was to determine whether the inclusion of these sensitive questions would 
have the effect of reducing response rates from panel respondents. Fortunately, no decrement in 
response rates associated with the inclusion of these questions was seen.   
 
The questions ask about both risk and protective behaviors. Among the variables included are 
the following risk factors: the lifetime and 12-month frequency of injecting drugs without a 
doctor’s order; the lifetime and 12-month prevalence of using a needle that respondents “knew 
(or suspected) had been used by someone else” before they used it; the number of sex partners 
the respondent has had during the 12 months prior to the survey; and whether those partners had 
been exclusively male, exclusively female, or both male and female. All of these behaviors are 
related to the risks both of contracting HIV and also of transmitting HIV to others.   
 
The protective behaviors for which measures were developed include lifetime and 12-month 
prevalence of being tested for HIV, actually getting the results of the most recent HIV test 
(because some people who take a test fail to get the results), and the frequency of condom use in 
the prior 12 months. We also ask about the lifetime and 12-month prevalence of donating blood 
or blood plasma. If individuals who engage in high risk behaviors refrain from donating blood, 





Of course, there are certain limitations to the present study for attempting to quantify these risk 
and protective behaviors in the general population. Perhaps the major limitation derives from the 
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sample under study, because MTF does not include the 15% or so of each class cohort that leaves 
school before graduating from high school. So, although our coverage includes the great majority 
of the population of interest (young adults who recently entered their twenties), an important and 
on average somewhat more deviant segment of the population is not covered (high school 
dropouts). In addition, panel attrition is a limitation, as discussed in chapter 3 under limitations 
of the study design. Techniques have been used here to compensate considerably for the effects 
of panel attrition, as will be described below.  
 
These limitations likely lower the estimates of risk behaviors and increase the estimates of 
protective behaviors from what their values would be if the entire population of 21- through 30-
year-olds could be surveyed, but it is difficult to quantify by how much. (We believe that we do a 
better job of characterizing the original target population, which is high school graduates.) 
However, because the school dropout rates have changed little over the life of the study, and the 
panel retention rates tend to change very slowly, we believe it likely that the trend estimates—
which ultimately will be among the most important results for policy purposes—will be little 
affected by these omissions from the sample, particularly given our procedures for compensating 
for panel loss.  
 
Because of the sensitivity of some of the behaviors covered in this section of the questionnaire, 
one might reasonably ask about the validity of the data reported. Recognizing this potential 
problem, we provided an introduction to the section explaining why these questions are 
important in helping us to increase our understanding of the HIV/AIDS epidemic, re-
emphasizing the protections of confidentiality by reminding respondents that their answers are 
never connected with their names, and inviting respondents to leave blank any questions that 
they “do not wish to answer.” The decrement in response rates between the preceding 
nonsensitive questions and those in this section was very small—on the order of about 1% for 
four questions, 2% for one, and 3% for one—suggesting that the great majority of respondents 
felt willing and able to answer these questions. The one question with a 3% decrement asked 
about the use of condoms; the slightly higher rate may possibly be due to high variability in use 
of condoms, making the question difficult to answer (females accounted for much of the increase 
in nonresponse). 
 
Because this is the first reporting on these behaviors, the emphasis here will be on establishing 
the prevalence, and when available, the frequency of these behaviors in the population in 2004 
and 2005 combined. Having two years of data is valuable because of the low rate of prevalence 
(and therefore, numbers of cases) for some of these behaviors, and because it raises the precision 
of the estimates in general. Because the intersection of some of these behaviors is also of 
particular importance, an initial attempt will be made to look at some of the bivariate 
associations among them, though the low numbers of cases sometimes severely limit the 
conclusions that can be reached at this time. Such work will be continued in other scientific 
publications, including future volumes in this monograph series, as additional data cumulate on 
this important topic. It is our intention to increase the number of questionnaire forms containing 
these questions, which will help to address the problem of low Ns on rare behaviors. 
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ADJUSTING FOR THE EFFECTS OF PANEL ATTRITION 
 
In chapter 3 we described the procedures used to adjust the substance use estimates to eliminate 
(insofar as possible) the effects of panel attrition—the loss of respondents in the follow-up data 
collections. In the case of substance use estimates, we had data on the prevalence and frequency 
of the same behaviors by all respondents in senior year in high school; this allowed us to 
implement a reweighting procedure for the follow-up respondents that generated a panel of 
reweighted cases that had the same frequency distribution on their 12th-grade answers to 
substance use questions as did the original panel. This procedure is one form of poststratification. 
 
However, we do not have 12th-grade measures of the variables of interest in the current chapter, 
which renders that particular form of poststratification unworkable. Instead, we have 
implemented a different type of poststratification reweighting procedure for the follow-up 
respondents in which we attempt to correct for their differential retention in the panels as a 
function of their demographic and other characteristics that were measured in 12th grade. For 
example, males have a somewhat lower retention rate than females, which means that their 
proportion in the attained follow-up sample is lower than it was in the original panel selected 
from 12th-grade participants in the in-school MTF survey. We are able to correct for that 
difference by up-weighting the data from males who did continue in the panel study, so that 
males will remain in the same proportion in the panel as they were when the panel was drawn 
initially. 
 
Using this strategy we corrected simultaneously for differential attrition using multiple variables 
identified as being related to attrition. To do so, we calculated the retention rate for the various 
cells defined by the intersection of these variables and then weighted the respondents in each cell 
by the reciprocal of the retention rate found for people who belong in that cell. That set of 
adjustments generates a newly weighted panel that has distributions on the variables used in this 
procedure (e.g., gender or grade point average in high school) that reproduce those of the original 
panel when it was first chosen in 12th grade. As a practical matter, the number of variables used 
in this procedure must be limited to some extent by the total sample size, lest certain cells 
become too small to be reliably reweighted. 
 
The variables that we used for defining the cells were as follows: gender (male/female), ethnicity 
(White/non-White), grade point average (GPA) in 12th grade (low/high/medium), and illicit drug 
use in 12th grade (none/marijuana only/any other illicit drug). The first two variables were 
prespecified, and the latter two were chosen out of a larger set entered into a regression analysis 
because they added the most additional explained variance in the retention rate. 
 
These four variables generated 36 nonoverlapping categories of individuals that could be 
reweighted to correct for differential rates of attrition among them. Retention rates in each of the 
36 cells were then calculated based on the number of people in each cell in the original panel and 
the number who subsequently provided data at the follow-up; the participating members of each 
cell were assigned a new weight that was the reciprocal of the retention rate—that is, one divided 
by the retention rate. This new weight was then multiplied by an individual weight in that cell to 
correct for any differential probability in being selected into the original panel. 
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With the resulting weight, we would have a total weighted N (sample size) equal to the original 
panel size, not the actual retained panel, which means that we would be overstating the accuracy 
with which we are making prevalence estimates, for example; so, in a final step, all individual 
weights were then multiplied by the overall sample retention rate to bring the weighted sum of 
cases down to the actual number of individually weighted cases still in the panel.  
 
We consider this correction procedure to be appropriate in this circumstance, but we caution the 
reader that it is not possible to correct entirely for the effects of panel attrition for two reasons. 
First, specific to our relatively small sample for these measures, we cannot adjust for all 
measured variables that might predict retention, because we are limited as to number of cells that 
can reasonably be generated to assign weights. Second, and more generally, even with a 
prediction model that accounted for nearly all of the variance in retention, there still likely would 
be some unmeasured characteristics that differentiate the people in each cell who do and do not 
remain in the study. For example, we believe that people who become heroin or crack addicts 
after high school would be less likely to return questionnaires, given the disrupted lives that 
many of them live. Fortunately, people in these circumstances represent a very small proportion 
of the general population. And, as we stated earlier, one of the most important uses of these data 
will be to track changes historically in the major risk and protective behaviors in the general 
population, a purpose for which these data will be well suited.  
 
 
PREVALENCE/FREQUENCY OF RISK BEHAVIORS: 21- TO 30-YEAR-OLDS 
 
In this section we present and discuss the prevalence and frequency of several risk behaviors 
measured among 21- to 30-year-olds in the 2004 and 2005 follow-up surveys combined. We 
begin by presenting data on the combined samples for all respondents (Total weighted N = 
3,644) and for males and females separately (weighted Ns = 1,727 and 1,917, respectively). 
Then, because different configurations of sexual contacts may carry differential risks of HIV 
transmission, particularly if condoms are not used, we examine these behaviors separately for 
different configurations. In theory we are able to distinguish six configurations: males with 
females, males with males, and males with partners of both genders, as well as females with 
males, females with females, and females with partners of both genders. However, the case 
counts turn out to be too small to make distinctions between the two categories that involve 
contact with the same gender, either for male respondents or female respondents. Therefore, 
these two groups have been combined for reporting purposes for both male and female 
respondents.   
 
Injection Drug Use 
While not itself a vector of HIV transmission, the amount of illicit injection drug use determines 
the pool of eligible persons from which the high risk behavior of needle sharing is drawn. The 
question to respondents reads, “On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, or steroids) in your lifetime? Do not 
include anything you took under a doctor’s orders.” A sequel question asks about the prior 12 
month interval. Trends in the prevalence of these behaviors would be indicative of changes in the 
pool of persons at risk for sharing of needles. 
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• Table 10-1 shows that 1.5% of this sample reports having ever used any drug by injection 
without medical supervision, and there is a fair-sized gender difference—2.1% of the 
males and 0.9% of the females indicate such behavior. The percentages using on 40 or 
more occasions is 0.4% overall—0.5% for males and 0.3% for females. So a relatively 
limited segment—about 1 in every 67 respondents—has ever illicitly used a drug by 
injection; and a smaller proportion—about 1 in every 250 respondents—reports an 
extended pattern of use. Of course, even though these appear to be very low prevalence 
rates, they can still result in significant absolute numbers of users in the population. 
According to the 2000 census, there are nearly 40 million Americans ages 21 to 30, so 
1% of them would represent almost 400,000 individuals. 
 
• The proportions who have injected drugs during the past 12 months without medical 
supervision is considerably smaller: 0.5% overall—1 in every 200 respondents—
including 0.8% of males and 0.3% of females. The proportions using 40 or more times in 
the past 12 months are 0.2% overall and 0.2% for both genders.   
 
Needle Sharing 
The risk of catching or transmitting a number of blood-borne diseases, including HIV in 
particular, emerges when injection drug use is combined with the sharing of needles with other 
users. Immediately following the questions about injecting illicit drugs, reported above, the 
following question was asked about needle sharing: “Have you ever taken such drugs using a 
needle that you knew (or suspected) had been used by someone else before you used it?”  
 
• The proportion who say they have ever shared needles in this way during their lifetime is 
0.3%, with no difference by gender. 
   
• The proportion who say that they have shared needles in the prior 12 months is 0.1%, 
again with no difference by gender.  
 
• Thus, needle sharing appears to be a very low prevalence behavior among high school 
graduates who are in the age range of 21 to 30, which puts severe limits on how much we 
can say about people in this category without having a considerably larger sample size. 
Again, it seems likely that this is an underestimate for the entire population in this age 
range due to the omission of high school dropouts, the likelihood that drug-addicted users 
would be more likely to leave the study than average, and the possibility that there may 
be some under-reporting of this behavior. Nevertheless, it appears that this is a low 
prevalence behavior for the entire age group. Conversely, if the rate had turned out to be 
much higher, it would have been cause for alarm. 
 
Contacts With Multiple Partners 
Having sexual relations with multiple partners is another class of behaviors that increases the risk 
of HIV transmission. The question used for obtaining information about this behavior was, 
“During the last 12 months, how many sex partners have you had? (This includes vaginal, oral, 
or anal sex.)” The results based on the answers to this question are presented in Table 10-2. 
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• About one seventh (15%) of the 21- to 30-year-old respondents reported not having any 
sex partners during the prior 12 months—more males (17% or about one in six) than 
females (12% or about one in eight). 
  
• The most common answer by far to this question was having just one partner during the 
year (61% overall) with a lower proportion of males (56%) than females (66%) giving 
this answer. 
 
• That leaves about one quarter (24%) of the sample of young adults ages 21 to 30 
reporting that they have had multiple (two or more) sex partners in the prior year—27% 
of the males and 22% of the females.  
 
• While having even one sex partner is not without risk, the risk rises rapidly with an 
increased number of partners. We found that about 10% reported that they had exactly 
two partners during the year (10.1% of the males and 10.2% of the females); 5.9% 
reported exactly three partners (6.1% of males and 5.6% of females); leaving about one in 
twelve (8.3%) reporting having four or more partners (10.6% of the males and 6.3% of 
the females).  
 
Contacts With Partners of the Same Gender 
Because males who have sexual contact with other males have been at particular risk of 
contracting and transmitting HIV, we also looked at subgroups by the different gender 
combinations. Only people reporting that they have had sexual contact with one or more partners 
in the prior year are asked the question: “During the last 12 months have your sex partner or 
partners been . . . .” The answer alternatives are: exclusively male, both male and female, and 
exclusively female.   
 
• Of the respondents having one or more sex partners in the prior 12 months, 95% of the 
males reported that their partners were exclusively female, and almost exactly the same 
proportion (96%) of the females indicated that their partners were exclusively male.   
 
• That leaves 5.0% of the males indicating some contact with other males during the last 12 
months—3.9% saying that their partners were males exclusively and 1.0% saying that 
they had both male and female partners.   
 
(Note that because of the low prevalence rates for these behaviors, the weighted numbers 
of cases are limited: a total of 71 respondents reported having any contact with other 
males—56 reported having contact exclusively with other males, and 15 reported having 
contact with both genders.) 
 
• Among the females, 4.2% reported having any female sex partners—2.3% indicating that 
their partners were exclusively female and 1.9% indicating that their partners were of 
both genders.   
 
282




(Again, note that the numbers of cases available for study are limited: 70 having any 
contact with other females—38 having contact with other females exclusively, and 32 
having contact with both female and male partners.) 
 
Number of Partners Among Those With Same-Gender Partners   
• We examined the number of partners reported as a function of the genders of those 
partners. Of the sexually active males who had contact exclusively with other males 
during the year (N = 56), 45% reported that they had only one partner. (This compares 
with a single partner rate of 69% among the males who reported that they had contact 
exclusively with females.) About a quarter (26%) of males with only male partners 
reported sexual contact with five or more partners, compared to 8% for males with 
exclusively female partners. Thus, although their proportion of the total population is 
small, and these particular findings are thus based on a small subsample, it still appears 
that significant numbers of young adult males are potentially placing themselves at 
considerable risk. 
 
• Among the sexually active females who had contact exclusively with other females 
during the year (N = 38), 70% reported having only one partner, indicating a high level of 
monogamy in this group. (This rate compares to 76% of females who had male partners 
exclusively being monogamous.) Again, these estimates are only suggestive given the 
very limited sample size involved. 
 
• Individuals who have sexual relations with both genders carry the risk of spreading the 
infection across genders, making their behavior of particular importance. Unfortunately, 
the numbers of cases are too small for us to be able to report with any accuracy on their 
behaviors. (Weighted Ns = 32 for females and 15 for males reporting relations with 
partners of both genders in the prior 12 months).  
 
Needle Sharing Among Those With Same-Gender Partners 
• While it is possible to look at the intersection of needle sharing with having same-gender 
partners for both males and females, we have chosen not to report these data in Table 10-
4 because of the low number of cases for those having same-gender contact combined 
with the very low rates of needle sharing. A very small number of cases can change the 
comparisons considerably and potentially generate a misconception. As cases cumulate in 
future years, we hope to be able to make estimates of these important intersections. What 
we can say now is that the rate of sharing needles is very low in all four of the partner 
groupings.   
 
Donating Blood 
While donating blood carries no risk of contracting an HIV infection, because only new and 
sterile needles are used to draw blood from donors, it does present the possibility of transmitting 
HIV if the donor is infected.56 The question of relevance here is to what extent do young adults 
                                                 
56This risk has been dramatically reduced in recent years by the routine screening of donated blood for HIV. Still, the Red Cross estimates that, if 
someone first became infected with HIV within what they call the “window period,” which they define as 12 to 16 days before donating blood, 
the infection might not be detected in the screening tests (http://www.wcredcross.org/bloodmobile/qa_aids.html—accessed 7/26/2006). 
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who are at higher-than-average risk of carrying HIV donate blood? We begin with the overall 
prevalence of blood donation.   
 
• The proportions of respondents saying that they have donated blood or blood plasma 
during their lifetime is 45% overall, with similar proportions for males and females. 
 
• Blood donation in the previous 12 months was reported by 11% overall—with similar 
proportions for males and females.  
 
• Equal proportions of males who reported any male sex partner(s) during the previous 12 
months (71 weighted cases) and males who reported only female sex partners said they 
had ever donated blood (about 46%). Slightly fewer of the men reporting any male sex 
partners said they donated blood in the prior 12 months (7%, versus 12% among males 
reporting only female partners), but the difference is not statistically significant. Whether 
or not the difference is real, it is clear that by no means all of this elevated risk group 
abstain from donating blood, as the Food and Drug Administration requires. 
 
• There was an inadequate sample size to examine the intersection between needle sharing 
and blood donation because the numbers of respondents indicating shared needle use, 




PREVALENCE OF PROTECTIVE BEHAVIORS 
 
People can take various precautions to diminish their likelihood of contracting HIV and/or of 
transmitting it to others. One, of course, is simply to avoid the high risk behaviors already 
discussed. Another is to use protection against viral transmission in the form of condom use 
during intercourse. A third approach—getting tested for HIV—increases the likelihood that an 
infected individual will receive appropriate treatment and also, if the diagnosis is positive, refrain 
from behaviors that put others at risk of contracting the virus from them. Answers to the 
questions about condom use and HIV testing are discussed next. 
 
Condom Use    
Respondents who indicated that they had one or more sexual partners during the prior 12 months 
were asked, “When you had sexual intercourse during the last 12 months, how often were 
condoms used? (This includes vaginal and anal sex, but not oral sex.)” The answer alternatives 
were never, seldom, sometimes, most times, and always. Both genders responded to this 
question. (Respondents who reported no sex partners in the prior 12 months are excluded from 
the data presented here.) 
 
• The majority (56%) of sexually active young adult respondents said that they “seldom” or 
“never” used condoms during the year—with 51% of the males and 60% of the females 
giving one of these answers. Indeed, a large proportion (42%) indicated that they did not 
use condoms at all during the prior 12 months—37% of the sexually active males and 
47% of the sexually active females. 
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• As might be expected, many of those not using condoms are respondents who had only 
one partner during the year (and indeed, perhaps many of these respondents were 
attempting to conceive a child). Among those reporting only one partner (the majority of 
all respondents), 52% said they did not use condoms at all. That statistic fell by more than 
half among those reporting two partners (to 23%), and fell by about half again among 
those reporting three or four partners (to 13%) and reached 12% among those reporting 
five or more partners during the year. 
 
• Only about one third (32%) of these sexually active young adults said that they used a 
condom “most times” or “always”—37% of males and 28% of females. This statistic 
rises considerably with the number of partners reported in the prior year, from 25% 
among those reporting only one partner, to 44% among those with two partners, to 53% 
for those with three or four partners, to 58% for those with five or more partners.  
 
• In sum, using condoms to prevent exposure to, and the transmission of, HIV (and many 
other sexually transmitted diseases) is considerably more prevalent among those who are 
at heightened risk both of exposure to, and of transmission of, HIV due to the number of 
sexual partners that they have. Many public health experts will be quick to point out, 
however, that 58% using “most times” or “always” is far short of 100% using “always.”   
 
• There have been considerable efforts made in past years to encourage the use of condoms 
by men who have relations with men, with the obvious intent being to stem the spread of 
AIDS in that population. While the numbers of such cases available here for analysis are 
quite limited (weighted N = 71), the results suggest that the use of condoms in this 
population is probably only slightly higher than in the population of men reporting 
relations exclusively with women in the prior year—35% reporting never (versus 37% in 
the latter group) and 43% reporting “most times” or “always” (versus 36% in the latter 
group). Of course, the rate of condom use among men having relations only with women 
is likely suppressed somewhat by the proportion seeking to conceive a child.  
 
Getting Tested for HIV 
Respondents were asked if they had ever been tested for HIV/AIDS; and they were instructed not 
to include any testing that they may have undergone when they were donating blood or blood 
plasma.   
 
• Less than half (44%) of all young adults in the age band 21 to 30 indicate that they have 
ever been tested for HIV outside of blood donation screening—38% of males and 50% of 
females.  
 
• About a fifth of the age group (20%) say they have been tested in the prior 12 months—
17% of males and 24% of females. Thus, females are somewhat more likely than males 
to engage in this protective behavior.  
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• Not all of those who took HIV tests, however, actually received their results. Asked if 
they received the results of their most recent HIV test, 7.8% of those who had ever been 
tested said that they had not—10.2% of the males tested and 6.1% of the females tested.   
 
• Because males having contact with male partners are at heightened risk for contracting 
and transmitting HIV, we looked to see if use of this protective behavior was more 
prevalent among them. While the number of cases is small (again, 71 weighted cases), 
the results are suggestive of increased vigilance in this population. Two thirds (67%) of 
those having exclusively male partners in the prior year indicated having been tested for 
HIV at some time, and more than four in every ten (43%) said that they had been tested 
in just the past year. These rates compare to 41% and 17%, respectively, among males 
who have had female partners exclusively during the past year. None of those reporting 
relations exclusively with other men in the past year said that they failed to get the results 
of their most recent test.   
 
• While the numbers of cases available for study are very small for males reporting 
partners of both genders in the past year (weighted N = 15) and for females reporting 
partners of both genders (weighted N = 16), both of these groups show considerably 
higher rates of getting tested for HIV than their counterparts who do not report having 
any same-gender partners. While only suggestive, given the limited sample sizes, these 
results are encouraging, because this group can cause cross-gender transmission of HIV, 
and because they tend to report having more partners than the other groups.   
 
This is the first time we have reported the prevalence of risk and protective factors associated 
with the spread of HIV. We believe there is real value in tracking these behaviors in the general 
population of young adults, and while the numbers are small in this first reporting, ongoing data 
collections will allow us to monitor these behaviors and provide more in-depth consideration of 
important subgroups and of correlates. Also, adding these questions to additional questionnaire 




Lifetime Frequency of Injecting
On how many occasions (if any) have you taken any 
drugs by injection with a needle (like heroin, cocaine, 
amphetamines, or steroids) in your lifetime? Do not 
include anything you took under a doctor's orders.
    0 Times 98.5 97.9 99.1
    1-2 0.5 0.6 0.3
    3-5 0.2 0.2 0.2
    6-9 0.1 0.1 *
    10-19 0.3 0.5 *
    20-39 0.1 0.2 0.0
    40+ Times 0.4 0.5 0.3
Weighted N 3643 1727 1916
Annual Frequency of Injecting
On how many occasions (if any) have you taken any 
drugs by injection with a needle (like heroin, cocaine, 
amphetamines, or steroids) during the last 12 months? Do 
not include anything you took under a doctor's orders.
    0 Times 99.5 99.2 99.7
    1-2 0.1 0.2 0.1
    3-5 * * *
    6-9 * * 0.0
    10-19 0.1 0.2 0.0
    20-39 * 0.1 0.0
    40+ Times 0.2 0.2 0.2
Weighted N 3644 1727 1917
Needle Sharing:  Lifetime and Last Year
Have you ever taken such drugs using a needle that you 
knew (or suspected) had been used by someone else 
before you used it?
    Yes, in the last 12 months 0.1 0.1 0.1
    Yes, but not in the last 12 months 0.3 0.3 0.3
    No, never 99.7 99.6 99.7
Weighted N 3610 1708 1902
Source :  The Monitoring the Future Study, the University of Michigan.
"*" indicates a prevalence rate of less than 0.05% but greater than true zero.
TABLE 10-1




Number of Partners in Last Year
During the LAST 12 MONTHS, how many sex partners have 
you had? (This includes vaginal, oral, or anal sex.)
    None 14.5 16.9 12.3
    One 61.2 56.3 65.6
    Two 10.1 10.1 10.2
    Three 5.9 6.1 5.6
    Four 3.2 3.5 2.9
    5-10 3.9 5.2 2.7
    11-20 0.9 1.5 0.4
    21-100 0.2 0.4 0.1
    More than 100 0.1 0.1 0.1
Weighted N 3628 1720 1908
Gender of Partners in Last Yeara
During the LAST 12 MONTHS, have your sex partner or 
partners been …
    Exclusively male? 53.4 3.9 95.8
    Both male and female? 1.5 1.0 1.9
    Exclusively female? 45.1 95.0 2.3
Weighted N 3103 1432 1672
Frequency of Condom Use in Last Yeara
When you had sexual intercourse during the LAST 12 
MONTHS, how often were condoms used? (This includes 
vaginal and anal sex, but not oral sex.)
    Never 42.1 37.0 46.5
    Seldom 13.7 13.7 13.7
    Sometimes 12.4 12.8 12.0
    Most times 15.5 17.8 13.5
    Always 16.4 18.8 14.3
Weighted N 3076 1423 1654
Source :  The Monitoring the Future Study, the University of Michigan.
aPercentagized on those reporting contact with one or more partners during the past year.  Those reporting no partners are omitted.
TABLE 10-2
Number of Partners, Gender of Partners,




Blood Donation:  Lifetime and Last Year
Have you ever donated blood or blood plasma?
    Yes, in the last 12 months 10.9 11.9 10.1
    Yes, but not in the last 12 months 33.8 33.6 33.9
    No, never 55.3 54.5 56.0
Weighted N 3669 1744 1926
Test for HIV:  Lifetime and Last Year
Have you ever been tested for HIV/AIDS? (Do not include 
tests that you may have had when donating blood or 
blood plasma.)
    Yes, in the last 12 months 20.4 16.7 23.7
    Yes, but not in the last 12 months 24.0 21.2 26.5
    No, never 55.7 62.2 49.8
Weighted N 3664 1738 1927
Received HIV Test Results
Did you receive the results of your most recent HIV/AIDS 
test? (We don't want to know your test results.)
    Yes 92.2 89.8 93.9
    No 7.8 10.2 6.1
Weighted N 1610 655 955
Source :  The Monitoring the Future Study, the University of Michigan.
TABLE 10-3
Blood Donation and Test for HIV; Lifetime and Last 12 Months:  
Total and by Gender
(Entries are percentages)
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MALE RESPONDENTS FEMALE RESPONDENTS
Gender of Partner(s) Gender of Partner(s)
Female M Only or Male F Only or
Only M and F Only F and M
Lifetime Frequency of Injecting
On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, 
or steroids) in your lifetime? Do not include anything you took 
under a doctor's orders.
    0 Times 97.6 † 99.1 †
    1-2 0.6 0.4
    3-5 0.2 0.1
    6-9 0.1 0.1
    10-19 0.6 0.1
    20-39 0.2 0.0
    40+ Times 0.6 0.2
Weighted N 1356 71 1598 69
Annual Frequency of Injecting
On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, 
or steroids) during the last 12 months? Do not include anything 
you took under a doctor's orders.
    0 Times 99.1 † 99.8 †
    1-2 0.2 0.1
    3-5 0.0 *
    6-9 * 0.0
    10-19 0.3 0.0
    20-39 0.1 0.0
    40+ Times 0.3 0.1
Weighted N 1357 71 1598 69
Needle Sharing:  Lifetime and Last Year
Have you ever taken such drugs using a needle that you knew 
(or suspected) had been used by someone else before you 
used it?
    Yes, in the last 12 months 0.2 † 0.1 †
    Yes, but not in the last 12 months 0.2 0.2
    No, never 99.7 99.7
Weighted N 1344 71 1586 70
Source :  The Monitoring the Future Study, the University of Michigan.
"*" indicates a prevalence rate of less than 0.05% but greater than true zero.
†Sample size is too limited to provide reliable estimates of the intersection of these two rare events.
TABLE 10-4
Injection Drug Use and Needle Sharing:  By Gender of Partners in Last 12 Months
(Entries are percentages)
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MALE RESPONDENTS FEMALE RESPONDENTS
Gender of Partner(s) Gender of Partner(s)
Female M Only or Male F Only or
Only M and F Only F and M
Number of Partners in Last Yeara
During the LAST 12 MONTHS, how many sex partners have 
you had? (This includes vaginal, oral, or anal sex.)
    None NA NA NA NA
    One 69.3 37.8 76.4 40.1
    Two 12.1 12.0 11.2 19.9
    Three 7.2 11.3 6.0 16.5
    Four 3.9 9.5 3.0 12.3
    5-10 6.0 12.1 2.9 7.8
    11-20 1.2 12.3 0.5 1.5
    21 or more partners 0.4 4.9 0.1 1.9
Weighted N 1355 71 1597 70
Frequency of Condom Use in Last Yeara
When you had sexual intercourse during the LAST 12 
MONTHS, how often were condoms used? (This includes 
vaginal and anal sex, but not oral sex.)
    Never 37.1 34.9 46.2 †
    Seldom 13.6 15.5 14.0
    Sometimes 13.1 6.6 12.2
    Most times 17.5 24.1 13.4
    Always 18.8 18.9 14.3
Weighted N 1350 71 1583 67
Source :  The Monitoring the Future Study, the University of Michigan.
"NA" indicates "not applicable."
†Note that the answers for the two subgroups comprising this category -- females who in the past year had relations only with other
females, and females who had relations with both genders -- are quite different for this question; and there are insufficient numbers of
cases to make reliable estimates for either of the subgroups.
aPercentagized on those reporting contact with one or more partners during the past year.  Those reporting no partners are omitted.
TABLE 10-5
Number of Partners and Condom Use:  By Gender of Partners in Last 12 Months
(Entries are percentages)
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MALE RESPONDENTS FEMALE RESPONDENTS
Gender of Partner(s) Gender of Partner(s)
Female M Only or Male F Only or
Only M and F  Only F and M
Blood Donation:  Lifetime and Last Year
Have you ever donated blood or blood plasma?
    Yes, in the last 12 months 11.9 6.9 10.2 5.2
    Yes, but not in the last 12 months 34.6 39.5 34.3 42.3
    No, never 53.4 53.6 55.5 52.5
Weighted N 1358 71 1597 70
Test for HIV:  Lifetime and Last Year
Have you ever been tested for HIV/AIDS? (Do not include 
tests that you may have had when donating blood or 
blood plasma.)
    Yes, in the last 12 months 17.4 39.0 26.3 †
    Yes, but not in the last 12 months 23.5 24.3 28.4
    No, never 59.2 36.7 45.3
Weighted N 1354 70 1601 70
Received HIV Test Results
Did you receive the results of your most recent HIV/AIDS 
test? (We don't want to know your test results.)
    Yes 90.8 89.7 94.3 †
    No 9.2 10.3 5.7
Weighted N 551 45 867 40
Source :  The Monitoring the Future Study, the University of Michigan.
†Note that the answers for the two subgroups comprising this category -- females who in the past year had relations only with other
females, and females who had relations with both genders -- are quite different for this question; and there are insufficient numbers of
cases to make reliable estimates for either of the subgroups.
TABLE 10-6
Blood Donation and Test for HIV; Lifetime and Last 12 Months:
 By Gender of Partners in Last 12 Months
(Entries are percentages)
292
Number of Partners in Past 12 Months
Three Five
None One Two Or Four Or More
Lifetime Frequency of Injecting
On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, 
or steroids) in your lifetime? Do not include anything you took 
under a doctor's orders.
    0 Times 99.0 98.9 98.1 98.2 94.1
    1-2 0.3 0.5 0.6 0.4 0.7
    3-5 0.3 0.1 0.2 0.3 0.3
    6-9 0.1 0.1 0.0 0.0 0.8
    10-19 0.0 0.2 0.3 0.1 2.0
    20-39 0.1 0.1 0.0 0.4 0.0
    40+ Times 0.3 0.2 0.7 0.6 2.1
Weighted N 525 2216 367 325 187
Annual Frequency of Injecting
On how many occasions (if any) have you taken any drugs by 
injection with a needle (like heroin, cocaine, amphetamines, 
or steroids) during the last 12 months? Do not include anything 
you took under a doctor's orders.
    0 Times 99.4 99.8 99.4 99.2 96.9
    1-2 0.1 * 0.1 0.4 0.9
    3-5 0.1 0.0 0.0 0.0 0.1
    6-9 0.0 * 0.0 0.0 0.0
    10-19 0.0 0.1 0.1 0.3 0.7
    20-39 0.1 0.1 0.0 0.0 0.0
    40+ Times 0.3 0.1 0.4 0.2 1.4
Weighted N 525 2217 367 325 187
Needle Sharing:  Lifetime and Last Year
Have you ever taken such drugs using a needle that you knew 
(or suspected) had been used by someone else before you 
used it?
    Yes, in the last 12 months 0.0 0.1 0.2 0.1 0.5
    Yes, but not in the last 12 months 0.3 0.1 0.8 0.6 0.0
    No, never 99.7 99.8 99.0 99.4 99.5
Weighted N 517 2199 362 324 188
Source :  The Monitoring the Future Study, the University of Michigan.
"*" indicates a prevalence rate of less than 0.05% but greater than true zero.
TABLE 10-7
Injection Drug Use and Needle Sharing:  
By Number of Partners in Last 12 Months
(Entries are percentages)
293
Number of Partners in Past 12 Months
Three Five
None One Two Or Four Or More
Gender of Partners in Last Yeara
During the LAST 12 MONTHS, have your sex partner or partners 
been …
    Males
    Exclusively female NA 42.4 44.8 45.7 55.1
    Exclusively male or both genders NA 1.2 2.4 4.5 11.2
    Females
    Exclusively male NA 55.1 49.1 43.6 29.5
    Exclusively female or both genders NA 1.3 3.8 6.2 4.2
Weighted N — 2213 365 328 187
Frequency of Condom Use in Last Yeara
When you had sexual intercourse during the LAST 12 MONTHS, 
how often were condoms used? (This includes vaginal and 
anal sex, but not oral sex.)
    Never NA 52.2 22.6 12.7 11.5
    Seldom NA 12.6 18.9 17.3 11.4
    Sometimes NA 10.6 14.7 17.4 19.1
    Most times NA 9.3 24.8 34.3 37.5
    Always NA 15.4 18.9 18.3 20.5
Weighted N — 2192 362 326 187
Source :  The Monitoring the Future Study, the University of Michigan.
"NA" indicates "not applicable."
aPercentagized on those reporting contact with one or more partners during the past year.  Those reporting no partners are omitted.
TABLE 10-8
Gender of Partners and Condom Use: 
 By Number of Partners in Last 12 Months
(Entries are percentages)
294
Number of Partners in Past 12 Months
Three Five
None One Two Or Four Or More
Blood Donation:  Lifetime and Last Year
Have you ever donated blood or blood plasma?
    Yes, in the last 12 months 12.5 10.8 11.6 10.6 10.0
    Yes, but not in the last 12 months 28.0 35.6 27.8 34.5 40.1
    No, never 59.5 53.6 60.6 54.9 49.9
Weighted N 523 2215 367 327 188
Test for HIV:  Lifetime and Last Year
Have you ever been tested for HIV/AIDS? (Do not include 
tests that you may have had when donating blood or 
blood plasma.)
    Yes, in the last 12 months 7.4 18.7 31.3 30.6 36.7
    Yes, but not in the last 12 months 9.9 28.2 22.6 22.6 21.0
    No, never 82.8 53.1 46.1 46.9 42.3
Weighted N 519 2214 365 328 188
Received HIV Test Results
Did you receive the results of your most recent HIV/AIDS 
test? (We don't want to know your test results.)
    Yes 82.8 93.0 92.0 89.8 96.2
    No 17.2 7.1 8.1 10.2 3.8
Weighted N 88 1030 195 173 108
Source :  The Monitoring the Future Study, the University of Michigan.
TABLE 10-9
Blood Donation and Test for HIV; Lifetime and Last 12 Months:  










AIDS (See HIV) 
alcohol 
daily use  
college enrollment, 22, 229, 242, 243, table 
8-4, figure 9-14c 
disapproval, 182, table 6-2 
friends’ attitudes, perceived, 192, table 7-1 
gender, 22, 83, 132, 245, table 4-1, table  
4-5, figure 9-14c 
harmfulness, perceived, 179, table 6-1 
population density (urbanicity), 86, 141, 
table 4-5 
prevalence, 30, 82, 83, table 4-1, table 4-5, 
figure 4-20b 
region, 136, table 4-5 
trends, 21, 22, 126, table 2-4, table 5-4, 
table 9-4, figure 5-18c, figure 9-14c 
disapproval, 181, 182, table 6-2 
drunk, getting, 28 
friends’ use, 196, table 7-2 
race/ethnicity, 27 
trends, tables 2-1–2-4 
exposure to use, table 7-3 (see also friends’ use) 
flavored alcoholic beverages  
college enrollment, 229, tables 8-1–8-3, 
tables 9-1–9-3 
gender, 230, tables 4-1–4-4 
prevalence, 229, tables 4-1–4-4   
trends, tables 2-1–2-3, tables 5-1–5-3, tables 
9-1–9-3 
friends’ use, 196, 198, table 7-2  
harmfulness, perceived, table 6-1 
heavy drinking 
college enrollment, 21, 22, 229, 231, table 
8-4, table 9-4, figure 9-14d 
disapproval, 182, table 6-2 
friends’ attitudes, perceived, 192, 193, 194, 
table 7-1 
gender, 22, 83, 132, 133, 230, 245, table 4-
1, table 4-5, figure 9-14d 
harmfulness, perceived, 179, table 6-1 
population density (urbanicity), 86, 141, 
table 4-5 
prevalence, 21, 30, 32, 78, 82, table 4-1, 
table 4-5, figure 4-20b 
race/ethnicity, 27, 28 
region, 85, 136, 137, table 4-5 
trends, 21, 125, 126, table 2-4, table 5-4, 
table 9-4, figure 5-18d, figure 9-14d 
prevalence, 21, 28, 30, 78, 82, tables 4-1– 
4-4, figure 4-20a 
college enrollment, 228, 229, 231, tables  
8-1–8-3 
gender, tables 4-1–4-4 
population density (urbanicity), 86, tables  
4-2–4-4 
race/ethnicity, 27 
region, 85, tables 4-2–4-4 
trends, 21, 125, 126, tables 2-1–2-3, tables 5-1–
5-3, figures 5-18a–5-18b 
college enrollment, 21, 241, 242, tables 9-
1–9-3, figures 9-14a–9-14b 
gender, 132, 245, figures 9-14a–9-14b 
population density (urbanicity), 141 
region, 136 
amphetamines 
availability, perceived, 200, 202, table 7-4 
daily use, table 5-4, table 8-4, table 9-4 
disapproval, 11, 180, 181, table 6-2 
exposure to use, table 7-3 (see also friends’ use) 
friends’ attitudes, perceived, 192, 193, table 7-1 
friends’ use, 195, 197, table 7-2 
harmfulness, perceived, 11, 176, 183, table 6-1 
prevalence, 17, 29, 30, 79, 80, tables 4-1–4-4, 
figure 4-4 
college enrollment, 20, 229, tables 8-1–8-4 
gender, 21, 84, tables 4-1–4-4 
population density (urbanicity), 86, tables 4-
2–4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 11, 17, 20, 120, 122, 123, 124, tables 2-
1–2-3, tables 5-1–5-3, figure 5-13 
college enrollment, 20, 239, 243, tables  
9-1–9-4, figure 9-11  
gender, 131, 245, figure 9-11 
population density (urbanicity), 140 
race/ethnicity, 28 
region, 133, 134 
androstenedione, 18, 19 
any illicit drug 
exposure to use, 194, 195, table 7-3 (see also 
friends’ use) 
friends’ use, 194, 195, 197, table 7-2 
prevalence, 6, 7, 32, 77, 78, 79, tables 4-1–4-4, 
figure 4-1 
college enrollment, 19, 228, tables 8-1–8-3, 
table 8-5  
gender, 83, 230, tables 4-1–4-4 
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any illicit drug, prevalence (continued) 
population density (urbanicity), 86, tables  
4-2–4-4 
region, 84, tables 4-2–4-4 
trends, 7, 120, 122, tables 2-1–2-3, tables 5-1– 
5-3, table 5-5, figure 2-1, figure 5-1 
college enrollment, 20, 238, tables 9-1–9-3, 
table 9-5, figure 9-1 
gender, 129, figure 9-1 
population density (urbanicity), 137 
race/ethnicity, 28 
region, 133, 134 
any illicit drug other than marijuana 
disapproval, 180 
exposure to use, 195, table 7-3 (see also friends’ 
use) 
friends’ attitudes, perceived, 192 
friends’ use, 195, 197, table 7-2 
prevalence, 6, 29, 32, 78, 79, tables 4-1–4-4, 
figure 4-2 
college enrollment, 20, 228, tables 8-1–8-3, 
table 8-5 
gender, 21, 230, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
region, 84, tables 4-2–4-4 
trends, 6, 7, 9, 20, 31, 120, 121, 122, tables 2-1–
2-3, tables 5-1–5-3, table 5-5, figure 5-
2 
college enrollment, 20, 238, tables 9-1–9-3, 
table 9-5, figure 9-2 
gender, 129, figure 9-2 
population density (urbanicity), 137 
region, 133, 134 
availability, perceived, table 7-4 
 
B 
barbiturates. See sedatives 




availability, perceived, 25 
daily use 
college enrollment, 24, 26, 243, table 8-4, 
figure 9-15b–9-15c 
disapproval, 179, table 6-2 
friends’ attitudes, perceived, 192, table 7-1 
gender, 26, 133, 230, table 4-1, table 4-5, 
figures 9-15b–9-15c 
harmfulness, perceived, 24, 179, table  
6-1 
population density (urbanicity), 86, table  
4-5 
prevalence, 30, 33, table 4-1, table 4-5 
region, table 4-5 
trends, 24, 25, 26, table 2-4, table 5-4, table 
9-4, figures 5-19b–5-19c 
disapproval, 24, 182 
friends attitudes, perceived, 192, 194 
friends’ use, 196, 198, 199, table 7-2 
harmfulness, perceived, 24, 28 
prevalence, 28, 30, 33, 82, tables 4-1–4-4, figure 
4-21 
college enrollment, 23, 25, 230, tables 8-1–
8-3 
gender, 84, 230, 231, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, 85, tables 4-2–4-4 
trends, 7, 8, 23, 24, 25, 26, 31, 126, 127, tables 
2-1–2-4, tables 5-1–5-3, figure 5-19a 
college enrollment, 25, 26, 243, tables  
9-1–9-3, figure 9-15a 
gender, 26, 133, 245, 246, figure 9-15a 
population density (urbanicity), 141 
race/ethnicity, 27 
region, 137 
club drugs. See GHB; ketamine; Rohypnol 
cocaine  
availability, perceived, 14, 200, 201, table 7-4 
daily use, table 5-4, table 8-4, table 9-4 
disapproval, 14, 180, 181, table 6-2 
exposure to use, table 7-3 (see also friends’ use) 
friends’ attitudes, perceived, 192, 193, table 7-1 
friends’ use, 195, 196, 197, table 7-2 
harmfulness, perceived, 14, 177, 183, table 6-1 
prevalence, 17, 29, 30, 32, 78, 79, 81, tables 4-
1–4-4, figure 4-7 
college enrollment, 20, 229, tables 8-1–8-4 
gender, 21, 83, 231, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 13, 14, 17, 20, 31, 122, tables 2-1–2-3, 
tables 5-1–5-3, figure 5-9 
college enrollment, 20, 241, tables 9-1–9-3, 
figure 9-9 
gender, 130, 245, figure 9-9 
population density (urbanicity), 139 
race/ethnicity, 28 
region, 133, 134 
See also cocaine powder; crack cocaine 
cocaine, other. See cocaine powder 
cocaine powder 
availability, perceived, 14, 200, table 7-4 
disapproval, 14 
friends’ use, 196, table 7-2 
harmfulness, perceived, 14, 176, table 6-1 




cocaine powder, prevalence (continued) 
gender, 83, table 4-1 
race/ethnicity, 27 
trends, 31, 120, tables 2-1–2-3, tables 5-1–5-3  
codeine, 16 
crack cocaine  
availability, perceived, 200, 201, table 7-4 
disapproval, 13 
friends’ use, 195, 196, 198, table 7-2 
harmfulness, perceived, 12, 13, 176, 177, 183, 
table 6-1 
prevalence, 13, 29, 30, 31, 32, 79, 81, tables 4-
1–4-4, figure 4-8 
college enrollment, 229, tables 8-1–8-3 
gender, 21, 83, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 12, 13, 31, 120, 122, tables 2-1–2-3, 
tables 5-1–5-3, figure 5-10 
college enrollment, tables 9-1–9-3 
gender, 130 
population density (urbanicity), 139, 140 
region, 133, 134 
See also cocaine 
creatine, 19 
crystal methamphetamine (ice) 
availability, perceived, 200, 202, table 7-4 
harmfulness, perceived, 177, 178, 183, table 6-1 
prevalence, 79, 80, tables 4-1–4-4, figure 4-6 
college enrollment, 229, tables 8-1–8-3 
gender, 83, 231 tables 4-1–4-4 
population density (urbanicity), 86, tables 4-
2–4-4 
race/ethnicity, 27 
region, 85, tables 4-2–4-4 
trends, 12, 122, 124, tables 2-1–2-3, tables 5-1–
5-3, figure 5-14 
college enrollment, tables 9-1–9-3 
gender, 131 




diet pills, 19 
disapproval of use, table 6-2 
 
E 
ecstasy. See MDMA 
exposure to drug use, table 7-3. See also friends’ use 
 
F 
flavored alcoholic beverages. See alcohol 
friends’ attitudes, perceived, table 7-1 




prevalence, 18, table 4-3 
college enrollment, 228, 231, table 8-2 
gender, 21, table 4-3, table 8-2 
population density (urbanicity), table 4-3 
region, table 4-3 
trends, 18, 33, table 2-2, table 5-2 






prevalence, 30, 79, tables 4-1–4-4, figure 4-10 
college enrollment, 229, tables 8-1–8-3 
gender, 230, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, 85, tables 4-2–4-4 
trends, 120, 122, tables 2-1–2-3, tables 5-1–5-3, 
figure 5-5 
college enrollment, tables 9-1–9-3, figure 9-
5 
gender, figure 9-5 
hallucinogens other than LSD 
availability, perceived, 200, 201, table 7-4 
exposure to use, table 7-3 (see also friends’ use) 
friends’ use, 195, table 7-2 
prevalence, 29, 30, figure 4-12 
gender, 83 
race/ethnicity, 27 
trends, 31, tables 2-1–2-3, figure 5-7 
college enrollment, figure 9-7 
gender, figure 9-7 
population density (urbanicity), 138 
harmfulness, perceived, table 6-1 
hashish. See marijuana 
heroin (including with and without a needle) 
availability, perceived, 200, 202, table 7-4 
disapproval, 180, 181, table 6-2 
exposure to use, table 7-3 (see also friends’ use) 
friends’ use, 196, table 7-2 
harmfulness, perceived, 15, 16, 176, 178, 179, 
183, table 6-1 
prevalence, 29, 30, 79, tables 4-1–4-4, figure 4-
19 
college enrollment, 19, 229, tables 8-1–8-3 
gender, 21, 231, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
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heroin (continued) 
trends, 15, 33, 124, tables 2-1–2-3, tables 5-1– 
5-3, figure 5-11 
college enrollment, tables 9-1–9-3 
gender, 130 
population density (urbanicity), 140 
region, 136 
HIV (AIDS) 
condom use, 284, 285, table 10-2, table 10-5, 
table 10-8 
 gender, table 10-2, table 10-5 
donating blood, 284, table 10-3, table 10-6, table 
10-9 
 gender, table 10-3, table 10-6 
gender of partners, table 10-2, table 10-4, table 
10-5, table 10-6, table 10-8 
gender, table 10-2, table 10-4, table 10-5, 
table 10-6 
getting tested, 285, 286, table 10-3, table 10-6, 
table 10-9 
 gender, table 10-3, table 10-6 
injection drug use, 280, 281, table 10-1, table 10-
4, table 10-7 
 gender, table 10-1, table 10-4 
multiple partners. See number of partners 
needle sharing, 281, 283, table 10-1, table 10-4, 
table 10-7 
 gender, table 10-1, table 10-4 
number of partners, 281, 282, 283, table 10-2, 
table 10-5, tables 10-7–10-9 
 gender, table 10-2, table 10-5 
partners of the same gender, 282, 283, table 10-2 
 gender, table 10-2 
 
I 
ice. See crystal methamphetamine 
inhalants  
friends’ use, 195, table 7-2 
harmfulness, perceived, 12 
prevalence, 17, 28, 79, tables 4-1–4-4, figure 4-
13 
college enrollment, 228, tables 8-1–8-3 
gender, 21, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 12, 17, 18, 31, 123, tables 2-1–2-3, tables 
5-1–5-3, figure 5-4 
college enrollment, tables 9-1–9-3, figure 9-
4 
gender, 131, 132, figure 9-4 
population density (urbanicity), 141 
region, 134, 135 
 
K 
ketamine (Special K)  
prevalence, 18, table 4-3  
college enrollment, 231, table 8-2 
gender, 231, table 4-3 
population density (urbanicity), table 4-3 
region, table 4-3 
trends, 18, 33, table 2-2, table 5-2 
college enrollment, table 9-2 
gender, 132 
region, 136 
kreteks, table 2-2 
 
L 
look-alike drugs, 19 
LSD 
availability, perceived, 9, 200, 201, table 7-4 
disapproval, 10, 180, 181, table 6-2 
exposure to use, table 7-3 (see also friends’ use) 
friends’ attitudes, perceived, 192, 193, table 7-1 
friends’ use, 195, table 7-2 
harmfulness, perceived, 10, 176, 183, table 6-1 
prevalence, 17, 29, 30, 79, tables 4-1–4-4, figure 
4-11 
college enrollment, 229, tables 8-1–8-3 
gender, 21, 83, 230, 231, tables 4-1–4-4,  
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 9, 10, 17, 18, 31, 33, 121, 122, tables  
2-1–2-3, tables 5-1–5-3, figure 5-6 
college enrollment, 239, tables 9-1–9-3, 
figure 9-6 
gender, 129, 245, figure 9-6 





availability, perceived, 199, 200, table 7-4 
daily use 
college enrollment, 19, 228, 239, table 8-4, 
figure 9-3b 
gender, 20, 83, 129, 230, 244, table 4-5, 
figure 9-3b 
population density (urbanicity), 138, table 
4-5 
prevalence, 8, 30, 32, 79, table 4-5 
region, table 4-5 
trends, 8, 20, 121, 128, table 2-4, table 5-4, 
table 9-4, figure 5-3c 
disapproval, 9, 180, table 6-2 






friends’ attitudes, perceived, 192, 193, table 7-1 
friends’ use, 195, 197, table 7-2 
harmfulness, perceived, 8, 9, 176, 183, table 6-1 
prevalence, 8, 17, 28, 29, 77, 78, 79, tables 4-1–
4-4, figure 4-3 
college enrollment, 19, 228, tables 8-1–8-4 
gender, 21, 230, tables 4-1–4-4  
population density (urbanicity), 86, tables  
4-2–4-4 
race/ethnicity, 28 
region, 84, tables 4-2–4-4 
trends, 6, 7, 8, 17, 18, 31, 120, 121, 122, tables  
2-1–2-3, tables 5-1–5-3, figure 5-3a–5-
3b 
college enrollment, 20, 238, 239, tables 9-
1–9-3, figure 9-3a 
gender, 129, 244, figure 9-3a 
population density (urbanicity), 137, 138 
region, 133, 134 
MDMA (ecstasy) 
availability, perceived, 11, 199, 202, table 7-4 
disapproval, table 6-2 
friends’ use, 195, 198, table 7-2 
harmfulness, perceived, 11, 123, 139, 176, 178, 
183, table 6-1 
prevalence, 10, 29, 79, 81, tables 4-1–4-4, figure 
4-17 
college enrollment, 229, tables 8-1–8-3 
gender, 21, 84, 231, tables 4-1–4-4 
population density (urbanicity), 86, tables  
4-2–4-4 
race/ethnicity, 27 
region, 85, tables 4-2–4-4 
trends, 10, 11, 18, 33, 123, tables 2-1–2-3, tables 
5-1–5-3, figure 5-8 
college enrollment, 240, tables 9-1–9-3, 
figure 9-8 
gender, 129, figure 9-8 
population density (urbanicity), 138, 139 
region, 134 
methamphetamine 
prevalence, 29, 80, tables 4-1–4-4, figure 4-5 
college enrollment, 229, table 8-2 
gender, 231, tables 4-2–4-4, table 8-2 
population density (urbanicity), 86, tables  
4-2–4-4 
race/ethnicity, 27 
region, 85, tables 4-2–4-4 
trends, 12, 124, tables 2-1–2-3, table 5-2 
college enrollment, table 9-2 
region, 135 
methaqualone  
trends, 17, 122, tables 2-1–2-3, tables 5-1–5-3 
 college enrollment, tables 9-1–9-3 
 gender, 245 
 population density (urbanicity), 140 
 
N 
narcotics other than heroin 
availability, perceived, 200, 202, table 7-4 
exposure to use, table 7-3 (see also friends’ use) 
friends’ use, 195, 196, 198, table 7-2 
prevalence, 30, 79, 80, tables 4-1–4-4, figure 4-
15 
college enrollment, 20, 229, tables 8-1–8-3 
gender, 84, 231, tables 4-1–4-4, tables 8-1–
8-3 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 16, 17, 18, 20, 120, 122, 124, tables 2-1–
2-3, tables 5-1–5-3, figure 5-12 
college enrollment, 20, 240, 241, tables 9-
1–9-3, figure 9-10a 
gender, 131, figure 9-10a 
population density (urbanicity), 140 
region, 136 
nitrites  
availability, perceived, table 7-4 
friends’ use, table 7-2 
trends, 12, tables 2-1–2-3, tables 5-1–5-3  




prevalence, 18, table 4-3 
college enrollment, 229, table 8-2 
gender, 84, 231, table 4-3, table 8-2 
population density (urbanicity), table 4-3 
region, 85, table 4-3 
trends, 16, 18, 124, 125, table 2-2, table 5-2 
college enrollment, 241, table 9-2, figure  
9-10c 
gender, 131 




availability, perceived, table 7-4 
friends’ use, table 7-2 
gender, 83 
harmfulness, perceived, table 6-1 
prevalence, tables 4-1–4-4 
 gender, table 4-1 
trends, 14, tables 2-1–2-3, tables 5-1–5-3 
perceived harmfulness. See harmfulness, perceived 
perceived risk. See harmfulness, perceived 
Percocet, 16 
powder cocaine. See cocaine powder 
psychedelics. See hallucinogens 
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Q 
quaaludes, table 7-2 
 
R 
risk, perceived. See harmfulness, perceived 
Ritalin 
prevalence, 80, table 4-3 
college enrollment, 228, 229, table 8-2 
gender, 21, table 4-3 
population density (urbanicity), table 4-3 
region, table 4-3 
trends, 12, table 2-2, table 5-2, table 9-2 
Rohypnol 
prevalence, 18, 29, table 4-3 
college enrollment, 231, table 8-2 
gender, 21, table 4-3 
population density, table 4-3 
region, table 4-3 
trends, 18, 33, tables 2-1–2-3, table 5-2 






availability, perceived, 200, 202, 203, table 7-4 
disapproval, 180, 181, table 6-2 
exposure to use, table 7-3 (see also friends’ use) 
friends’ use, 195, 197, table 7-2 
harmfulness, perceived, 176, 183, table 6-1 
prevalence, 30, 79, 80, tables 4-1–4-4, figure  
4-14 
college enrollment, 20, 229, tables 8-1–8-3 
gender, tables 4-1–4-4, tables 8-1–8-3 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 17, 18, 20, 120, 125, tables 2-1–2-3, 
tables 5-1–5-3, figure 5-15 
college enrollment, 20, 240, 243, tables 9-
1–9-3, figure 9-12 
gender, 130, figure 9-12 
population density (urbanicity), 140 
race/ethnicity, 28 
region, 135 
smokeless tobacco  




trends, table 2-1, tables 2-3–2-4 
stay-awake pills, 19 
steroids 
availability, perceived, 200, 203, table 7-4 
friends’ use, 195, table 7-2 
prevalence, 29, 82, 83, tables 4-1–4-4, figure 4-
18 
gender, 84, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
region, tables 4-2–4-4  
trends, 19, 125, tables 2-1–2-3, tables 5-1– 
5-3, figure 5-17 
stimulants, nonprescription, 19 
 
T 
tobacco. See cigarettes; smokeless tobacco 
tranquilizers  
availability, perceived, 200, 203, table 7-4 
exposure to use, table 7-3 (see also friends’ use) 
friends’ use, 195, 197, table 7-2 
prevalence, 29, 30, 79, 81, tables 4-1–4-4, figure  
4-16 
college enrollment, 20, 229, tables 8-1–8-3 
gender, 21, 231, tables 4-1–4-4 
population density (urbanicity), tables 4-2–
4-4 
race/ethnicity, 27 
region, tables 4-2–4-4 
trends, 16, 17, 18, 20, 120, 122, 125, tables 2-1–
2-3, tables 5-1–5-3, figure 5-16 
college enrollment, 240, 243, tables  
9-1–9-3, figure 9-13 
gender, 131, figure 9-13 
population density (urbanicity), 140 
race/ethnicity, 28 





prevalence, 18, table 4-3 
college enrollment, 229, table 8-2 
gender, 84, 231, table 4-3 
population density (urbanicity), table 4-3 
region, 85, table 4-3 
trends, 16, 124, table 2-2, table 5-2 
college enrollment, 241, table 9-2, figure  
9-10b 
gender, 131  
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